10-K 1 a201310-k.htm 10-K 2013 10-K
 
 
 
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
(Mark One)
x
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the fiscal year ended December 31, 2013
or
¨
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the transition period from                    to                     
Commission File Number: 000-54371
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(Exact name of registrant as specified in its charter)
Maryland
 
26-4008719
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)
18191 Von Karman Avenue, Suite 300,
Irvine, California
 
92612
(Address of principal executive offices)
 
(Zip Code)
Registrant’s telephone number, including area code: (949) 270-9200
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
 
Name of each exchange on which registered
None
 
None
Securities registered pursuant to Section 12(g) of the Act:
Common Stock, $0.01 par value per share
(Title of class)
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    ¨  Yes    x  No
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.    ¨  Yes    x  No
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Sections 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    x  Yes    ¨  No
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    x  Yes    ¨  No
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.    x
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer
¨
Accelerated filer
¨
Non-accelerated filer
x (Do not check if a smaller reporting company)
Smaller reporting company
¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    ¨  Yes    x  No
There is no established market for the registrant’s common stock. As of June 30, 2013, the last business day of the registrant's most recently completed second fiscal quarter, the registrant was conducting an ongoing public offering of its shares of common stock pursuant to a Registration Statement on Form S-11, which shares were sold at $10.22 per share, with discounts available for certain categories of purchasers. There were approximately 182,693,667 shares of common stock held by non-affiliates as of June 30, 2013 for an aggregate market value of $1,867,129,000, assuming a market value as of that date of $10.22 per share.
As of March 7, 2014, there were 292,698,141 shares of common stock of Griffin-American Healthcare REIT II, Inc. outstanding.
______________________________________ 

DOCUMENTS INCORPORATED BY REFERENCE
None
 
 
 
 
 


GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
(A Maryland Corporation)
TABLE OF CONTENTS
 
 
Page


2

PART I
Item 1. Business.
The use of the words “we,” “us” or “our” refers to Griffin-American Healthcare REIT II, Inc. and its subsidiaries, including Griffin-American Healthcare REIT II Holdings, LP, except where the context otherwise requires.
Our Company
Griffin-American Healthcare REIT II, Inc., a Maryland corporation, was incorporated as Grubb & Ellis Healthcare REIT II, Inc. on January 7, 2009 and therefore we consider that our date of inception. We were initially capitalized on February 4, 2009. Our board of directors adopted an amendment to our charter, which was filed with the Maryland State Department of Assessments and Taxation on January 3, 2012, to change our name from Grubb & Ellis Healthcare REIT II, Inc. to Griffin-American Healthcare REIT II, Inc. We invest in a diversified portfolio of real estate properties, focusing primarily on medical office buildings and healthcare-related facilities. We may also originate and acquire secured loans and real estate-related investments. We also operate healthcare-related facilities utilizing the structure permitted by the REIT Investment Diversification and Empowerment Act of 2007, which is commonly referred to as a "RIDEA" structure (the provisions of the Internal Revenue Code of 1986, as amended, or the Code, authorizing the RIDEA structure were enacted as part of the Housing and Economic Recovery Act of 2008). We generally seek investments that produce current income. We qualified to be taxed as a real estate investment trust, or REIT, under the Code for federal income tax purposes beginning with our taxable year ended December 31, 2010 and we intend to continue to be taxed as a REIT.
On August 24, 2009, we commenced a best efforts initial public offering, or our initial offering, of up to $3,285,000,000 of shares of our common stock. Until November 6, 2012, we offered to the public up to $3,000,000,000 of shares of our common stock for $10.00 per share in our primary offering and $285,000,000 of shares of our common stock pursuant to our distribution reinvestment plan, or the DRIP, for $9.50 per share. On November 7, 2012, we began selling shares of our common stock in our initial offering at $10.22 per share in our primary offering and issuing shares pursuant to the DRIP for $9.71 per share.
On February 14, 2013, we terminated our initial offering. As of February 14, 2013, we had received and accepted subscriptions in our initial offering for 123,179,064 shares of our common stock, or $1,233,333,000, and a total of $40,167,000 in distributions were reinvested and 4,205,920 shares of our common stock were issued pursuant to the DRIP.
On February 14, 2013, we commenced a best efforts follow-on public offering, or our follow-on offering, of up to $1,650,000,000 of shares of our common stock, in which we initially offered to the public up to $1,500,000,000 of shares of our common stock for $10.22 per share in our primary offering and $150,000,000 of shares of our common stock for $9.71 per share pursuant to the DRIP. We reserved the right to reallocate the shares of common stock we offered in our follow-on offering between the primary offering and the DRIP. As such, during our follow-on offering, we reallocated an aggregate of $107,200,000 of shares from the DRIP to the primary offering. Accordingly, we offered to the public up to $1,607,200,000 of shares of our common stock in our primary offering and up to $42,800,000 of shares of our common stock pursuant to the DRIP.
On October 30, 2013, we terminated our follow-on offering. As of December 31, 2013, we had received and accepted subscriptions in our follow-on offering for 157,622,743 shares of our common stock, or $1,604,996,000, and a total of $42,713,000 in distributions were reinvested and 4,398,862 shares of our common stock were issued pursuant to the DRIP.
On September 9, 2013, we filed a Registration Statement on Form S-3 under the Securities Act of 1933, as amended, or the Securities Act, to register a maximum of $100,000,000 of additional shares of our common stock pursuant to our distribution reinvestment plan, or the Secondary DRIP. The Registration Statement on Form S-3 was automatically effective with the Securities and Exchange Commission, or the SEC, upon its filing; however, we did not commence offering shares pursuant to the Secondary DRIP until October 30, 2013 following the termination of our follow-on offering. As of December 31, 2013, a total of $18,448,000 in distributions were reinvested and 1,899,892 shares of our common stock were issued pursuant to the Secondary DRIP.
We conduct substantially all of our operations through Griffin-American Healthcare REIT II Holdings, LP, or our operating partnership. On January 3, 2012, our operating partnership filed an Amendment to the Certificate of Limited Partnership with the Delaware Department of State to change its name from Grubb & Ellis Healthcare REIT II Holdings, LP to Griffin-American Healthcare REIT II Holdings, LP. Until January 6, 2012, we were externally advised by Grubb & Ellis Healthcare REIT II Advisor, LLC, or our former advisor, pursuant to an advisory agreement, as amended and restated, or the G&E Advisory Agreement, between us and our former advisor. From August 24, 2009 through January 6, 2012, our former advisor supervised and managed our day-to-day operations and selected the properties and real estate-related investments we

3

acquired, subject to the oversight and approval of our board of directors. Our former advisor also provided marketing, sales and client services on our behalf and engaged affiliated entities to provide various services to us. Our former advisor was managed by and was a wholly owned subsidiary of Grubb & Ellis Equity Advisors, LLC, or GEEA, which was a wholly owned subsidiary of Grubb & Ellis Company, or Grubb & Ellis, or our former sponsor.
On November 7, 2011, our independent directors determined that it was in the best interests of our company and its stockholders to transition advisory and dealer manager services rendered to us by affiliates of Grubb & Ellis and to engage American Healthcare Investors LLC, or American Healthcare Investors, and Griffin Capital Corporation, or Griffin Capital, as replacement co-sponsors, or our co-sponsors. As a result, on November 7, 2011, we notified our former advisor that we terminated the G&E Advisory Agreement. Pursuant to the G&E Advisory Agreement, either party could terminate the G&E Advisory Agreement without cause or penalty; however, certain rights and obligations of the parties would survive during a 60-day transition period and beyond.
In addition, on November 7, 2011, we notified Grubb & Ellis Capital Corporation, our former dealer manager, that we terminated the Amended and Restated Dealer Manager Agreement dated June 1, 2011 between us and Grubb & Ellis Capital Corporation, or the G&E Dealer Manager Agreement, in accordance with the terms thereof. Until January 6, 2012, Grubb & Ellis Capital Corporation remained a non-exclusive agent of our company and distributor of shares of our common stock.
As a result of the co-sponsorship arrangement, an affiliate of Griffin Capital, Griffin-American Healthcare REIT Advisor, LLC, or Griffin-American Advisor, or our advisor, began serving as our advisor on January 7, 2012 pursuant to an advisory agreement, or the Advisory Agreement, that took effect upon the expiration of the 60-day transition period provided for in the G&E Advisory Agreement. The Advisory Agreement had an initial one-year term, but was subject to successive one year renewals upon mutual consent of the parties. On January 6, 2014, the Advisory Agreement was renewed pursuant to the mutual consent of the parties for a term of six months and expires on July 6, 2014. Our advisor delegates advisory duties to Griffin-American Healthcare REIT Sub-Advisor, LLC, or Griffin-American Sub-Advisor, or our sub-advisor. Griffin-American Sub-Advisor is jointly owned by our co-sponsors. Our advisor, through our sub-advisor, uses its best efforts, subject to the oversight, review and approval of our board of directors, to, among other things, research, identify, review and make investments in and dispositions of properties, real estate-related investments and securities on our behalf consistent with our investment policies and objectives. Our advisor performs its duties and responsibilities under the Advisory Agreement as our fiduciary. Our sub-advisor performs its duties and responsibilities pursuant to a sub-advisory agreement with our advisor and also acts as our fiduciary. Collectively, we refer to our advisor and our sub-advisor as our advisor entities. Griffin Capital Securities, Inc., or Griffin Securities, or our dealer manager, an affiliate of Griffin Capital, serves as our dealer manager pursuant to a dealer manager agreement, or the Dealer Manager Agreement, that also became effective on January 7, 2012. We are not affiliated with Griffin Capital, Griffin-American Advisor or Griffin Securities; however, we are affiliated with Griffin-American Sub-Advisor and American Healthcare Investors.
American Healthcare Investors and Griffin Capital paid the majority of the expenses we incurred in connection with the transition to our co-sponsors.
Key Developments during 2013 and 2014
•
On February 14, 2013, we terminated our initial offering and commenced our follow-on offering of up to $1,650,000,000 of shares of common stock. On October 30, 2013, we terminated our follow-on offering. As of December 31, 2013, we had issued $2,838,330,000 of shares of our common stock in connection with our initial offering and follow-on offering, or our offerings.
•
On May 24, 2013, we entered into a Second Amendment to the Credit Agreement, or the Amendment, which increased the aggregate maximum principal amount of our unsecured line of credit from $200,000,000 to $450,000,000, with Bank of America, N.A., KeyBank National Association, RBS Citizens, N.A., and Comerica Bank, as existing lenders, and Barclays Bank PLC, Fifth Third Bank, Wells Fargo Bank, N.A., Credit Agricole Corporate and Investment Bank, and Sumitomo Mitsui Banking Corporation, as new lenders. The Amendment also revised the amount that may be obtained by our operating partnership in the form of swingline loans from up to 15.0% of the maximum principal amount to up to $50,000,000. The maximum principal amount of our unsecured line of credit may be increased by up to $200,000,000, for a total principal amount of $650,000,000, subject to certain terms and conditions. See Note 9, Line of Credit — Unsecured Revolving Line of Credit, to the Consolidated Financial Statements that are a part of this Annual Report on Form 10-K, for further details.
•
On September 11, 2013, we expanded our real estate portfolio internationally through the acquisition of a portfolio of senior housing facilities located in the United Kingdom for £298,500,000, or approximately $472,167,000, based on the currency exchange rate on the acquisition date.
•
On December 20, 2013, we purchased Midwest CCRC Portfolio, our first acquisition of senior housing facilities operated utilizing a RIDEA structure, located in Ohio, Colorado and Illinois for a contract price of $310,000,000.

4

•
As of March 13, 2014, we had completed 72 acquisitions, comprised of 285 buildings and 11,046,000 square feet of gross leasable area, or GLA, for an aggregate purchase price of $2,870,861,000, thereby increasing our property portfolio by 117%, based on aggregate purchase price, since January 1, 2013.
Our Structure
The following is a summary of our organizational structure as of March 13, 2014:
 
Our principal executive offices are located at 18191 Von Karman Avenue, Suite 300, Irvine, California 92612, and the telephone number is (949) 270-9200. We maintain a web site at http://www.healthcarereit2.com, at which there is additional information about us and our affiliates. The contents of that site are not incorporated by reference in, or otherwise a part of, this filing. We make our periodic and current reports, as well as our Registration Statement on Form S-3 (File No. 333-191060), and all amendments to those reports and to our registration statement and supplements to our prospectus, available at http://www.healthcarereit2.com as soon as reasonably practicable after such materials are electronically filed with the United States Securities and Exchange Commission, or the SEC. They also are available for printing by any stockholder upon request. In addition, copies of our filings with the SEC may be obtained from the SEC’s website, http://www.sec.gov. Access to these filings is free of charge.

5

Investment Objectives
Our investment objectives are:
•
to preserve, protect and return our stockholders’ capital contributions;
•
to pay regular cash distributions; and
•
to realize growth in the value of our investments upon our ultimate sale of such investments.
We may not attain these objectives. Our board of directors may change our investment objectives if it determines it is advisable and in the best interest of our stockholders.
During the term of the Advisory Agreement, decisions relating to the purchase or sale of investments will be made by our advisor entities, subject to approval by our investment committee and oversight and approval by our board of directors.
Investment Strategy
We have and we intend to continue to invest in a diversified portfolio of real estate properties, focusing primarily on medical office buildings and healthcare-related facilities. We also may originate or acquire real estate-related investments such as mortgage, mezzanine, bridge and other loans, common and preferred stock of, or other interests in, public or private unaffiliated real estate companies, commercial mortgage-backed securities, and certain other securities, including collateralized debt obligations and foreign securities. We generally seek investments that produce current income. In order to maintain our exemption from regulation as an investment company under the Investment Company Act of 1940, as amended, or the Investment Company Act, we may be required to limit our investments in certain types of real estate-related investments.
We seek to maximize long-term stockholder value by generating sustainable growth in cash flows and portfolio value. In order to achieve these objectives, we may invest using a number of investment structures which may include direct acquisitions, joint ventures, leveraged investments, issuing securities for property and direct and indirect investments in real estate. In order to maintain our exemption from regulation as an investment company under the Investment Company Act, we may be required to limit our investments in certain types of real estate-related investments.
In addition, when and as determined appropriate by our advisor entities, our portfolio may also include properties in various stages of development other than those producing current income. These stages include, without limitation, unimproved land both with and without entitlements and permits, property to be redeveloped and repositioned, newly constructed properties and properties in lease-up or other stabilization scenarios, all of which have limited or no relevant operating histories and no current income. Our advisor entities will make this determination based upon a variety of factors, including the available risk adjusted returns for such properties when compared with other available properties, the appropriate diversification of the portfolio, and our objectives of realizing both current income and capital appreciation upon the ultimate sale of properties.
For each of our investments, regardless of property type, we seek to invest in properties with the following attributes:
 
•
Quality. We seek to acquire properties that are suitable for their intended use with a quality of construction that is capable of sustaining the property’s investment potential for the long-term, assuming funding of budgeted maintenance, repairs and capital improvements.
•
Location. We seek to acquire properties that are located in established or otherwise appropriate markets for comparable properties, with access and visibility suitable to meet the needs of its occupants.
•
Market; Supply and Demand. We focus on local or regional markets that have potential for stable and growing property level cash flows over the long-term. These determinations will be based in part on an evaluation of local and regional economic, demographic and regulatory factors affecting the property. For instance, we favor markets that indicate a growing population and employment base or markets that exhibit potential limitations on additions to supply, such as barriers to new construction. Barriers to new construction include lack of available land and stringent zoning restrictions. In addition, we generally will seek to limit our investments in areas that have limited potential for growth.
•
Predictable Capital Needs. We seek to acquire properties where the future expected capital needs can be reasonably projected in a manner that would enable us to meet our objectives of growth in cash flows and preservation of capital and stability.
•
Cash Flows. We seek to acquire properties where the current and projected cash flows, including the potential for appreciation in value, would enable us to meet our overall investment objectives. We evaluate cash flows as well as expected growth and the potential for appreciation.

6

We will not invest more than 10.0% of the proceeds available for investment from our offerings in unimproved or non-income producing properties or in other investments relating to unimproved or non-income producing property. A property will be considered unimproved or non-income producing property for purposes of this limitation if it: (1) is not acquired for the purpose of producing rental or other operating income; or (2) has no development or construction in process at the date of acquisition or planned in good faith to commence within one year of the date of acquisition.
We will not invest more than 10.0% of the proceeds available for investment from our offerings in commercial mortgage-backed securities. In addition, we will not invest more than 10.0% of the proceeds available for investment from our offerings in equity securities of public or private real estate companies.
We are not limited as to the geographic area where we may acquire properties. We are not specifically limited in the number or size of properties we may acquire or on the percentage of our assets that we may invest in a single property or investment. The number and mix of properties and real estate-related investments we will acquire will depend upon real estate and market conditions and other circumstances existing at the time we are acquiring our properties and making our investments, and the amount of debt financing available.
Real Estate Investments
We have and we intend to continue to invest in a diversified portfolio of real estate investments, focusing primarily on medical office buildings and healthcare-related facilities. We generally seek investments that produce current income. Our investments in healthcare-related facilities may include:
 
•
senior housing facilities;
•
skilled nursing facilities;
•
hospitals;
•
long-term acute care facilities;
•
surgery centers;
•
memory care facilities;
•
specialty medical and diagnostic service facilities;
•
laboratories and research facilities;
•
pharmaceutical and medical supply manufacturing facilities;
•
offices leased to tenants in healthcare-related industries; and
•
healthcare-related facilities owned and operated utilizing a RIDEA structure.
We generally seek to acquire real estate of the types described above that will best enable us to meet our investment objectives, taking into account the diversification of our portfolio at the time, relevant real estate and financial factors, the location, the income-producing capacity, and the prospects for long-range appreciation of a particular property and other considerations. As a result, we may acquire properties other than the types described above. In addition, we may acquire properties that vary from the parameters described above for a particular property type.
The consideration for each real estate investment must be authorized by a majority of our independent directors or a duly authorized committee of our board of directors, ordinarily based on the fair market value of the investment. If the majority of our independent directors or a duly authorized committee of our board of directors so determines, or if the investment is to be acquired from an affiliate, the fair market value determination must be supported by an appraisal obtained from a qualified, independent appraiser selected by a majority of our independent directors.
Our real estate investments generally take the form of holding fee title or long-term leasehold interests. Our investments may be made either directly through our operating partnership or indirectly through investments in joint ventures, limited liability companies, general partnerships or other co-ownership arrangements with the developers of the properties, affiliates of our advisor entities or other persons.
In addition, we may purchase real estate investments and lease them back to the sellers of such properties. Our advisor entities will use their best efforts to structure any such sale-leaseback transaction such that the lease will be characterized as a “true lease” and so that we will be treated as the owner of the property for federal income tax purposes. However, we cannot assure our stockholders that the Internal Revenue Service, or the IRS, will not challenge such characterization. In the event that any such sale-leaseback transaction is re-characterized as a financing transaction for federal income tax purposes, deductions for depreciation and cost recovery relating to such real estate investment would be disallowed or significantly reduced.

7

Our obligation to close a transaction involving the purchase of real estate is generally conditioned upon the delivery and verification of certain documents from the seller or developer, including, where appropriate:
 
•
plans and specifications;
•
environmental reports (generally a minimum of a Phase I investigation);
•
building condition reports;
•
surveys;
•
evidence of marketable title subject to such liens and encumbrances as are acceptable to our advisor entities;
•
audited financial statements covering recent operations of real properties having operating histories or audited financial statements or summarized financial information of the lessee or guarantor, unless such statements are not required to be filed with the SEC and delivered to stockholders;
•
title insurance policies;
•
liability insurance policies; and
•
tenant leases and operating agreements.
In determining whether to purchase a particular real estate investment, we may, in circumstances in which our advisor entities deem it appropriate, obtain an option on such property, including land suitable for development. The amount paid for an option is normally surrendered if the real estate is not purchased, and is normally credited against the purchase price if the real estate is purchased. We also may enter into arrangements with the seller or developer of a real estate investment whereby the seller or developer agrees that if, during a stated period, the real estate investment does not generate specified cash flows, the seller or developer will pay us cash in an amount necessary to reach the specified cash flows level, subject in some cases to negotiated dollar limitations.
We will not purchase or lease real estate in which one of our co-sponsors, our advisor entities, our directors or any of their affiliates have an interest without a determination by a majority of our disinterested directors and a majority of our disinterested independent directors that such transaction is fair and reasonable to us and at a price to us no greater than the cost of the real estate investment to the affiliated seller or lessor, unless there is substantial justification for the excess amount and the excess amount is reasonable. In no event will we acquire any such real estate investment at an amount in excess of its current appraised value as determined by an independent expert selected by our disinterested independent directors.
We intend to obtain adequate insurance coverage for all real estate investments in which we invest. However, there are types of losses, generally catastrophic in nature, for which we do not intend to obtain insurance unless we are required to do so by mortgage lenders. See Item 1A. Risk Factors, Risks Related to Investments in Real Estate — Uninsured losses relating to real estate and lender requirements to obtain insurance may reduce our stockholders’ returns.
We have and we intend to continue to acquire leased properties with long-term leases in-place and we generally do not intend to operate any healthcare-related facilities directly. As a REIT, we are prohibited from operating healthcare-related facilities directly; however, from time to time we may lease a healthcare-related facility that we acquire to a wholly-owned taxable REIT subsidiary, or TRS. In such an event, our TRS will engage a third party in the business of operating healthcare-related facilities to manage the property utilizing a RIDEA structure.
Joint Ventures
We may enter into joint ventures, general partnerships and other arrangements with one or more institutions or individuals, including real estate developers, operators, owners, investors and others, some of whom may be affiliates of our advisor entities, for the purpose of acquiring real estate. Such joint ventures may be leveraged with debt financing or unleveraged. We may enter into joint ventures to further diversify our investments or to access investments which meet our investment criteria that would otherwise be unavailable to us. In determining whether to invest in a particular joint venture, our advisor entities will evaluate the real estate that such joint venture owns or is being formed to own under the same criteria used in the selection of our other properties. However, we will not participate in tenant in common syndications or transactions.
Joint ventures with unaffiliated third parties may be structured such that the investment made by us and the co-venturer are on substantially different terms and conditions. For example, while we and a co-venturer may invest an equal amount of capital in an investment, the investment may be structured such that we have a right to priority distributions of cash flows up to a certain targeted return while the co-venturer may receive a disproportionately greater share of cash flows than we are to receive once such targeted return has been achieved. This type of investment structure may result in the co-venturer receiving more of the cash flows, including appreciation, of an investment than we would receive.

8

We may only enter into joint ventures with other Griffin Capital programs, other American Healthcare Investors’ programs, affiliates of our advisor entities or any of our directors for the acquisition of properties if:
 
•
a majority of our directors, including a majority of our independent directors, not otherwise interested in such transaction, approves the transaction as being fair and reasonable to us; and
•
the investment by us and such affiliates are on substantially the same terms and conditions.
We may invest in general partnerships or joint ventures with other Griffin Capital programs, other American Healthcare Investors programs or affiliates of our advisor entities to enable us to increase our equity participation in such ventures, so that ultimately we own a larger equity percentage of the property. Our entering into joint ventures with our advisor entities or any of their affiliates will result in certain conflicts of interest. See Item 1A. Risk Factors, Risks Related to Conflicts of Interest — If we enter into joint ventures with affiliates, we may face conflicts of interest or disagreements with our joint venture partners that may not be resolved as quickly or on terms as advantageous to us as would be the case if the joint venture had been negotiated at arm’s length with an independent joint venture partner.
Real Estate-Related Investments
In addition to our acquisition of medical office buildings and healthcare-related facilities, we also may invest in real estate-related investments, including loans (mortgage, mezzanine, bridge and other loans) and securities investments (common and preferred stock of or other interests in public or private unaffiliated real estate companies, commercial mortgage-backed securities, and certain other securities, including collateralized debt obligations and foreign securities). Our charter provides that we may not invest in real estate-related investments unless a majority of our directors, including a majority of our independent directors, not otherwise interested in the transaction approve such investment as being fair, competitive and commercially reasonable.
Investing In and Originating Loans
Our criteria for making or investing in loans will be substantially the same as those involved in our investment in properties. We do not intend to make loans to other persons, to underwrite securities of other issuers or to engage in the purchase and sale of any types of investments other than those relating to real estate. We will not make or invest in mortgage loans on any one property if the aggregate amount of all mortgage loans outstanding on the property, including our loan, would exceed an amount equal to 85.0% of the appraised value of the property, as determined by an independent third party appraiser, unless we find substantial justification due to other underwriting criteria; however, our policy generally will be that the aggregate amount of all mortgage loans outstanding on the property, including our loan, would not exceed 75.0% of the appraised value of the property. We may find such justification in connection with the purchase of loans in cases in which we believe there is a high probability of our foreclosure upon the property in order to acquire the underlying assets and in which the cost of the loan investment does not exceed the fair market value of the underlying property. We will not invest in or make loans unless an appraisal has been obtained concerning the underlying property, except for those loans insured or guaranteed by a government or government agency. In cases in which a majority of our independent directors so determine and in the event the transaction is with our advisor, any of our directors or their respective affiliates, the appraisal will be obtained from a certified independent appraiser to support its determination of fair market value.
We may invest in first, second and third mortgage loans, mezzanine loans, bridge loans, wraparound mortgage loans, construction mortgage loans on real property, and loans on leasehold interest mortgages. However, we will not make or invest in any loans that are subordinate to any mortgage or equity interest of our advisor, any of our directors, one of our co-sponsors, or any of our affiliates. We also may invest in participations in mortgage loans. A mezzanine loan is a loan made in respect of certain real property but is secured by a lien on the ownership interests of the entity that, directly or indirectly, owns the real property. A bridge loan is short term financing, for an individual or business, until permanent or the next stage of financing can be obtained. Second mortgage and wraparound loans are secured by second or wraparound deeds of trust on real property that is already subject to prior mortgage indebtedness. A wraparound loan is one or more junior mortgage loans having a principal amount equal to the outstanding balance under the existing mortgage loan, plus the amount actually to be advanced under the wraparound mortgage loan. Under a wraparound loan, we would generally make principal and interest payments on behalf of the borrower to the holders of the prior mortgage loans. Third mortgage loans are secured by third deeds of trust on real property that is already subject to prior first and second mortgage indebtedness. Construction loans are loans made for either original development or renovation of property. Construction loans in which we would generally consider an investment would be secured by first deeds of trust on real property for terms of six months to two years. Loans on leasehold interests are secured by an assignment of the borrower’s leasehold interest in the particular real property. These loans are generally for terms of six months to 15 years. The leasehold interest loans are either amortized over a period that is shorter than the lease term or have a maturity date prior to the date the lease terminates. These loans would generally permit us to cure any default under the lease.

9

Mortgage participation investments are investments in partial interests of mortgages of the type described above that are made and administered by third-party mortgage lenders.
We may originate loans from mortgage brokers or personal solicitations of suitable borrowers, or may purchase existing loans that were originated by other lenders. We may purchase existing loans from affiliates, and we may make or invest in loans in which the borrower is an affiliate. Our advisor entities will evaluate all potential loan investments to determine if the security for the loan and the loan-to-value ratio meets our investment criteria and objectives. Most loans that we will consider for investment would provide for monthly payments of interest and some may also provide for principal amortization, although many loans of the nature that we will consider provide for payments of interest only and a payment of principal in full at the end of the loan term. We will not originate loans with negative amortization provisions.
We are not limited as to the amount that may be invested in construction loans, mezzanine loans, bridge loans, loans secured by leasehold interests and second, third and wraparound mortgage loans. However, we recognize that these types of loans are riskier than first deeds of trust or first priority mortgages on income-producing, fee-simple properties, and we expect to minimize the amount of these types of loans in our portfolio, to the extent that we make or invest in loans at all. Our advisor entities will evaluate the fact that these types of loans are riskier in determining the rate of interest on the loans. We do not have any policy that limits the amount that we may invest in any single loan or the amount we may invest in loans to any one borrower. We are not limited as to the amount that we may use to invest in or originate loans.
Securities Investments
We may invest in the following types of securities: (1) equity securities such as common stocks, preferred stocks and convertible preferred securities of public or private unaffiliated real estate companies (including other REITs, real estate operating companies and other real estate companies); (2) debt securities such as commercial mortgage-backed securities and debt securities issued by other unaffiliated real estate companies; and (3) certain other types of securities that may help us reach our diversification and other investment objectives. These other securities may include, but are not limited to, various types of collateralized debt obligations and certain non-U.S. dollar denominated securities.
We have substantial discretion with respect to the selection of specific securities investments. Consistent with such requirements, in determining the types of securities investments to make, our advisor entities will adhere to a board approved asset allocation framework consisting primarily of components such as: (1) target mix of securities across a range of risk/reward characteristics; (2) exposure limits to individual securities; and (3) exposure limits to securities subclasses (such as common equities, debt securities and foreign securities). Within this framework, our advisor entities will evaluate specific criteria for each prospective securities investment including:
 
•
positioning the overall portfolio to achieve an optimal mix of real estate and real estate-related investments;
•
diversification benefits relative to the rest of the securities assets within our portfolio;
•
fundamental securities analysis;
•
quality and sustainability of underlying property cash flows;
•
broad assessment of macroeconomic data and regional property level supply and demand dynamics;
•
potential for delivering high current income and attractive risk-adjusted total returns; and
•
additional factors considered important to meeting our investment objectives.
We may invest in investment grade and non-investment grade commercial mortgage-backed securities classes. However, we will not invest more than 10.0% of the proceeds available for investment from our offerings in commercial mortgage-backed securities. Commercial mortgage-backed securities are subject to all of the risks of the underlying mortgage loans. Similarly, we will not invest more than 10.0% of the proceeds available for investment from our offerings in equity securities of public or private real estate companies. The specific number and mix of securities in which we invest will depend upon real estate market conditions, other circumstances existing at the time we are investing in our securities and the amount of any future indebtedness that we may incur and any possible future equity offerings. We will not invest in securities of other issuers for the purpose of exercising control and the first or second mortgages in which we intend to invest will likely not be insured by the Federal Housing Administration or guaranteed by the Veterans Administration or otherwise guaranteed or insured. Real estate-related equity securities are generally unsecured and also may be subordinated to other obligations of the issuer. Our investments in real estate-related equity securities will involve special risks relating to the particular issuer of the equity securities, including the financial condition and business outlook of the issuer.

10

Development Strategy
We may engage our advisor entities or their affiliates to provide development-related services for all or some of the properties that we acquire for development or refurbishment. In those cases, we will pay our advisor entities or their affiliates a development fee that is usual and customary for comparable services rendered for similar projects in the geographic market where the services are provided if a majority of our independent directors determines that such development fees are fair and reasonable and on terms and conditions not less favorable than those available from unaffiliated third parties. However, we will not pay a development fee to our advisor entities or their affiliates if our advisor entities or their affiliates elect to receive an acquisition fee based on the cost of such development. In the event that our advisor entities or their affiliates assist with planning and coordinating the construction of any tenant improvements or capital improvements, the respective party may be paid a construction management fee of up to 5.0% of the cost of such improvements.
Disposition Strategy
We intend to hold each property or real estate-related investment we acquire for an extended period. However, circumstances might arise which could result in a shortened holding period for certain investments. In general, the holding period for real estate-related investments other than real property is expected to be shorter than the holding period for real property assets. A property or real estate-related investment may be sold before the end of the expected holding period if:
 
•
diversification benefits exist associated with disposing of the investment and rebalancing our investment portfolio;
•
an opportunity arises to pursue a more attractive investment;
•
in the judgment of our advisor entities, the value of the investment might decline;
•
with respect to properties, a major tenant involuntarily liquidates or is in default under its lease;
•
the investment was acquired as part of a portfolio acquisition and does not meet our general acquisition criteria;
•
an opportunity exists to enhance overall investment returns by raising capital through sale of the investment; or
•
in the judgment of our advisor entities, the sale of the investment is in the best interest of our stockholders.
The determination of whether a particular property or real estate-related investment should be sold or otherwise disposed of will be made after consideration of relevant factors, including prevailing economic conditions, with a view toward maximizing our investment objectives. We cannot assure our stockholders that this objective will be realized. The selling price of a property which is net leased will be determined in large part by the amount of rent payable under the lease(s) for such property. If a tenant has a repurchase option at a formula price, we may be limited in realizing any appreciation. In connection with our sales of properties, we may lend the purchaser all or a portion of the purchase price. In these instances, our taxable income may exceed the cash received in the sale. The terms of payment will be affected by custom practices in the area in which the investment being sold is located and the then prevailing economic conditions.
Borrowing Policies
We have and we intend to continue to use secured and unsecured debt as a means of providing additional funds for the acquisition of properties and other real estate-related assets. Our ability to enhance our investment returns and to increase our diversification by acquiring assets using additional funds provided through borrowing could be adversely affected if banks and other lending institutions reduce the amount of funds available for the types of loans we seek. When interest rates are high or financing is otherwise unavailable on a timely basis, we may purchase certain assets for cash with the intention of obtaining debt financing at a later time. We may also utilize derivative financial instruments such as fixed interest rate swaps and caps to add stability to interest expense and to manage our exposure to interest rate movements.
We anticipate that our aggregate borrowings, both secured and unsecured, will not exceed 45.0% of the combined fair market value of all of our real estate and real estate-related investments, as determined at the end of each calendar year beginning with our first full year of operations. For these purposes, the fair market value of each asset will be equal to the purchase price paid for the asset or, if the asset was appraised subsequent to the date of purchase, then the fair market value will be equal to the value reported in the most recent independent appraisal of the asset. Our policies do not limit the amount we may borrow with respect to any individual investment. As of December 31, 2013, our aggregate borrowings were 13.2% of the combined fair market value of all of our real estate and real estate-related investments.
Our board of directors reviews our aggregate borrowings at least quarterly to ensure that such borrowings are reasonable in relation to our net assets. Our borrowing policies provide that the maximum amount of such borrowings in relation to our net assets will not exceed 300% of our net assets, unless any excess in such borrowing is approved by a majority of our directors and is disclosed in our next quarterly report along with the justification for such excess. For purposes of this determination, net assets are our total assets, other than intangibles, valued at cost before deducting depreciation, amortization, bad debt and other

11

similar non-cash reserves, less total liabilities. We compute our leverage at least quarterly on a consistently applied basis. Generally, the preceding calculation is expected to approximate 75.0% of the sum of the aggregate cost of our real estate and real estate-related assets before depreciation, amortization, bad debt and other similar non-cash reserves. As of March 13, 2014 and December 31, 2013, our leverage did not exceed 300% of the value of our net assets.
By operating on a leveraged basis, we will have more funds available for our investments. This generally allows us to make more investments than would otherwise be possible, potentially resulting in enhanced investment returns and a more diversified portfolio. However, our use of leverage increases the risk of default on loan payments and the resulting foreclosure of a particular asset. In addition, lenders may have recourse to assets other than those specifically securing the repayment of the indebtedness.
We will use our best efforts to obtain financing on the most favorable terms available to us and we will refinance assets during the term of a loan only in limited circumstances, such as when a decline in interest rates makes it beneficial to prepay an existing loan, when an existing loan matures or if an attractive investment becomes available and the proceeds from the refinancing can be used to purchase such investment. The benefits of the refinancing may include an increased cash flow resulting from reduced debt service requirements, an increase in distributions from proceeds of the refinancing and an increase in diversification of assets owned if all or a portion of the refinancing proceeds are reinvested.
Our charter restricts us from borrowing money from any of our directors or from our advisor entities or their affiliates unless such loan is approved by a majority of our directors, including a majority of the independent directors, not otherwise interested in the transaction, as fair, competitive and commercially reasonable and no less favorable to us than comparable loans between unaffiliated parties.
Board Review of Our Investment Policies
Our board of directors has established written policies on investments and borrowing. Our board of directors is responsible for monitoring the administrative procedures, investment operations and performance of our company and our advisor entities to ensure such policies are carried out. Our charter requires that our independent directors review our investment policies at least annually to determine that our policies are in the best interest of our stockholders. Each determination and the basis thereof is required to be set forth in the minutes of our applicable meetings of our directors. Implementation of our investment policies also may vary as new investment techniques are developed. Our investment policies may not be altered by our board of directors without the approval of our stockholders.
As required by our charter, our independent directors have reviewed our policies outlined above and determined that they are in the best interests of our stockholders because: (1) they increase the likelihood that we will be able to acquire a diversified portfolio of income-producing properties, thereby reducing risk in our portfolio; (2) there are sufficient property acquisition opportunities with the attributes that we seek; (3) our executive officers, directors and affiliates of our advisor entities have expertise with the type of real estate investments we seek; and (4) our borrowings will enable us to purchase assets and earn real estate revenue more quickly, thereby increasing our likelihood of generating income for our stockholders and preserving stockholder capital.
Tax Status
We qualified and elected to be taxed as a REIT under the Code beginning with our taxable year ended December 31, 2010. To maintain our qualification as a REIT, we must meet certain organizational and operational requirements, including a requirement to currently distribute at least 90.0% of our annual taxable income, excluding net capital gains, to our stockholders. As a REIT, we generally will not be subject to federal income tax on taxable income that we distribute to our stockholders.
If we fail to maintain our qualification as a REIT in any taxable year, we will then be subject to federal income taxes on our taxable income at regular corporate rates and will not be permitted to qualify for treatment as a REIT for federal income tax purposes for four years following the year during which qualification is lost unless the IRS grants us relief under certain statutory provisions. Such an event could materially adversely affect our net income and net cash available for distribution to our stockholders.

12

Distribution Policy
In order to maintain our qualification as a REIT for federal income tax purposes, among other things, we are required to distribute 90.0% of our annual taxable income, excluding net capital gains, to our stockholders. We cannot predict if we will generate sufficient cash flow to pay cash distributions to our stockholders on an ongoing basis or at all. The amount of any cash distributions will be determined by our board of directors and will depend on the amount of distributable funds, current and projected cash requirements, tax considerations, any limitations imposed by the terms of indebtedness we may incur and other factors. If our investments produce sufficient cash flow, we expect to continue to pay distributions to our stockholders on a monthly basis. Because our cash available for distribution in any year may be less than 90.0% of our annual taxable income, excluding net capital gains, for the year, we may be required to borrow money, use proceeds from the issuance of securities (in subsequent offerings, if any) or sell assets to pay out enough of our taxable income to satisfy the distribution requirement. These methods of obtaining funds could affect future distributions by increasing operating costs. We did not establish any limit on the amount of proceeds from our offerings, and we have not established any limit on the amount of proceeds from any future offerings, that may be used to fund distributions, except that, in accordance with our organizational documents and Maryland law, we may not make distributions that would: (1) cause us to be unable to pay our debts as they become due in the usual course of business; (2) cause our total assets to be less than the sum of our total liabilities plus senior liquidation preferences; or (3) jeopardize our ability to maintain our qualification as a REIT.
To the extent that distributions to our stockholders are paid out of our current or accumulated earnings and profits, such distributions are taxable as ordinary income. To the extent that our distributions exceed our current and accumulated earnings and profits, such amounts constitute a return of capital to our stockholders for federal income tax purposes, to the extent of their basis in their stock, and thereafter will constitute capital gain. All or a portion of a distribution to stockholders may be paid from net offering proceeds and thus, constitute a return of capital to our stockholders.
Monthly distributions are calculated with daily record dates so distribution benefits begin to accrue immediately upon becoming a stockholder. However, our board of directors could, at any time, elect to pay distributions quarterly to reduce administrative costs. Subject to applicable REIT rules, generally we intend to reinvest proceeds from the sale, financing, refinancing or other disposition of our properties through the purchase of additional properties, although we cannot assure our stockholders that we will be able to do so.
The amount of distributions we pay to our stockholders is determined by our board of directors and is dependent on a number of factors, including funds available for the payment of distributions, our financial condition, capital expenditure requirements, annual distribution requirements needed to maintain our status as a REIT under the Code and restrictions imposed by our organizational documents and Maryland Law.
See Part II, Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities — Distributions, for a further discussion on distributions approved by our board of directors.
Competition
We compete with many other entities engaged in real estate investment activities for acquisitions of medical office buildings and healthcare-related facilities, including international, national, regional and local operators, acquirers and developers of healthcare real estate properties. The competition for healthcare real estate properties may significantly increase the price we must pay for medical office buildings and healthcare-related facilities or other assets we seek to acquire, and our competitors may succeed in acquiring those properties or assets themselves. In addition, our potential acquisition targets may find our competitors to be more attractive because they may have greater resources, may be willing to pay more for the properties or may have a more compatible operating philosophy. In particular, larger healthcare REITs may enjoy significant competitive advantages that result from, among other things, a lower cost of capital and enhanced operating efficiencies. In addition, the number of entities and the amount of funds competing for suitable investment properties may increase. This competition will result in increased demand for these assets, and therefore, increased prices paid for them. Due to an increased interest in single-property acquisitions among tax-motivated individual purchasers, we may pay higher prices if we purchase single properties in comparison with portfolio acquisitions. If we pay higher prices for medical office buildings or healthcare-related facilities, our business, financial condition, results of operations and our ability to pay distributions to our stockholders may be materially and adversely affected and our stockholders may experience a lower return on their investment.
Government Regulations
Many laws and governmental regulations are applicable to our properties and changes in these laws and regulations, or their interpretation by agencies and the courts, occur frequently.
Costs of Compliance with the Americans with Disabilities Act. Under the Americans with Disabilities Act of 1990, as amended, or the ADA, all public accommodations must meet federal requirements for access and use by disabled persons.

13

Although we believe that we are in substantial compliance with present requirements of the ADA, none of our properties have been audited, nor have investigations of our properties been conducted to determine compliance. Additional federal, state and local laws also may require modifications to our properties or restrict our ability to renovate our properties. We cannot predict the cost of compliance with the ADA or other legislation. We may incur substantial costs to comply with the ADA or any other legislation.
Costs of Government Environmental Regulation and Private Litigation. Environmental laws and regulations hold us liable for the costs of removal or remediation of certain hazardous or toxic substances which may be on our properties. These laws could impose liability without regard to whether we are responsible for the presence or release of the hazardous materials. Government investigations and remediation actions may have substantial costs and the presence of hazardous substances on a property could result in personal injury or similar claims by private plaintiffs. Various laws also impose liability on a person who arranges for the disposal or treatment of hazardous or toxic substances and such person often must incur the cost of removal or remediation of hazardous substances at the disposal or treatment facility. These laws often impose liability whether or not the person arranging for the disposal ever owned or operated the disposal facility. As the owner of our properties, we may be deemed to have arranged for the disposal or treatment of hazardous or toxic substances.
Other International, Federal, State and Local Regulations. Our properties are subject to various international, federal, state and local regulatory requirements, such as state and local fire and life safety requirements. If we fail to comply with these various requirements, we may incur governmental fines or private damage awards. While we believe that our properties are and will be in material compliance with all of these regulatory requirements, we do not know whether existing requirements will change or whether future requirements will require us to make significant unanticipated expenditures that will adversely affect our ability to make distributions to our stockholders. We believe, based in part on engineering reports which are generally obtained at the time we acquire the properties, that all of our properties comply in all material respects with current regulations. However, if we were required to make significant expenditures under applicable regulations, our financial condition, results of operations, cash flows and ability to satisfy our debt service obligations and to pay distributions could be adversely affected.
Significant Tenants and Operators
As of December 31, 2013, one of our tenants at our consolidated properties accounted for 10.0% or more of our aggregate annualized base rent, as set forth below.
Tenant
 
2013 Annualized
Base Rent(1)
 
Percentage of
Annualized
Base Rent
 
Property
 
Reportable Segment
 
GLA
(Sq Ft)
 
Lease Expiration
Date(2)
Myriad Healthcare Limited(3)
 
£
21,610,000

 
14.8
%
 
UK Senior Housing Portfolio
 
Senior Housing
 
962,000

 
09/10/48
__________
(1)
Annualized base rent is based on contractual base rent from leases in effect as of December 31, 2013 and was approximately $35,780,000 based on the currency exchange rate as of December 31, 2013. The loss of this tenant or its inability to pay rent could have a material adverse effect on our business and results of operations.
(2)
UK Senior Housing Portfolio is leased to one tenant under a 35-year absolute net lease with lease termination options on October 1, 2028 and October 1, 2038.
(3)
As of December 31, 2013, we had advanced £10,022,000, or approximately $16,593,000 based on the currency exchange rate as of December 31, 2013, under real estate notes receivable, to affiliates of Myriad Healthcare Limited. See Note 4, Real Estate Notes Receivable, Net, to the Consolidated Financial Statements that are a part of this Annual Report on Form 10-K, for a further discussion.
In addition, using annualized net operating income as a proxy for annualized based rent, Midwest CCRC Portfolio accounted for 10.3% of our annualized base rent as of December 31, 2013. Midwest CCRC Portfolio is managed by Senior Lifestyle Corporation utilizing a RIDEA structure. As a manager, Senior Lifestyle Corporation does not lease our properties, and, therefore, we are not directly exposed to its credit risk in the same manner or to the same extent as our triple-net lease tenants. However, the loss of this manager or its inability to efficiently and effectively manage our properties or to provide timely and accurate accounting information with respect thereto could have a material adverse effect on our business and results of operations.
Geographic Concentration
Based on leases in effect as of December 31, 2013, no one state in the United States accounted for 10.0% or more of our annualized base rent. However, we own UK Senior Housing Portfolio located in the United Kingdom, which accounted for 14.8% of our annualized base rent as of December 31, 2013. Accordingly, there is a geographic concentration of risk subject to fluctuations in the United Kingdom's economy. For a further discussion, see Item 2. Properties – Geographic Diversification/Concentration Table.

14

Employees
We have no employees and our executive officers are all employees of affiliates of our advisor entities. Our day-to-day management is performed by our advisor entities and their affiliates. We cannot determine at this time if or when we might hire any employees during the next twelve months. We do not directly compensate our executive officers for services rendered to us. However, our executive officers, consultants and the executive officers and key employees of our advisor entities are eligible for awards pursuant to the 2009 Incentive Plan, or our incentive plan. As of December 31, 2013, no awards had been granted to our executive officers, consultants or the executive officers or key employees of our advisor entities under this plan.
Financial Information About Industry Segments
Financial Accounting Standards Board, or FASB, Accounting Standards Codification, or ASC, Topic 280, Segment Reporting, establishes standards for reporting financial and descriptive information about a public entity’s reportable segments. As of December 31, 2013, we operate through five reportable business segments—medical office buildings, hospitals, skilled nursing facilities, senior housing and senior housing–RIDEA. Prior to December 2013, we operated through four reportable segments; however, with the acquisition of our first senior housing facilities owned and operated utilizing a RIDEA structure in December 2013, we felt it useful to segregate our operations into five reporting segments to assess the performance of our business in the same way that management intends to review our performance and make operating decisions. Prior to June 2013, our senior housing segment was referred to as our assisted living facilities segment. Prior to August 2012, we operated through three reportable business segments; however, with the addition of our first senior housing facilities in August 2012, we felt it was useful to segregate our operations into four reporting segments to assess the performance of our business in the same way that management intended to review our performance and make operating decisions.
Medical Office Buildings. As of December 31, 2013, we owned 139 medical office buildings, or MOBs. These facilities typically contain physicians' offices and examination rooms, and may also include pharmacies, hospital ancillary service space and outpatient services such as diagnostic centers, rehabilitation clinics and day-surgery operating rooms. While these facilities are similar to commercial office buildings, they require additional parking spaces as well as plumbing, electrical and mechanical systems to accommodate multiple exam rooms that may require sinks in every room, and special equipment such as x-ray machines. In addition, MOBs are often built to accommodate higher structural loads for certain equipment and may contain "vaults" or other specialized construction. Our MOBs are typically multi-tenant properties leased to healthcare providers (hospitals and physician practices). Based on square footage, approximately 59.8% of our MOBs are located on hospital campuses and 30.0% are affiliated with hospital systems. Our medical office buildings segment accounted for approximately 52.2%, 49.6% and 70.5% of total revenues for the years ended December 31, 2013, 2012 and 2011, respectively.
Hospitals. As of December 31, 2013, we owned 14 hospital buildings. Services provided by our operators and tenants in our hospitals are paid for by private sources, third-party payors (e.g., insurance and Health Maintenance Organizations, or HMOs), or through the Medicare and Medicaid programs. Our hospital property types include acute care, long-term acute care, specialty and rehabilitation hospitals, and are generally leased to single tenants or operators under triple-net lease structures. Our hospitals segment accounted for approximately 11.5%, 12.2% and 25.1% of total revenues for the years ended December 31, 2013, 2012 and 2011, respectively.
Skilled Nursing Facilities. As of December 31, 2013, we owned 41 skilled nursing facilities, or SNFs, buildings. SNFs offer restorative, rehabilitative and custodial nursing care for people not requiring the more extensive and sophisticated treatment available at hospitals. Ancillary revenues and revenues from sub-acute care services are derived from providing services to residents beyond room and board and include occupational, physical, speech, respiratory and intravenous therapy, wound care, oncology treatment, brain injury care and orthopedic therapy as well as sales of pharmaceutical products and other services. Certain SNFs provide some of the foregoing services on an out-patient basis. Skilled nursing services provided by our tenants in these SNFs are primarily paid for either by private sources or through the Medicare and Medicaid programs. All of our SNFs are leased to single tenants under triple-net lease structures. Our skilled nursing facilities segment accounted for approximately 24.2%, 37.2% and 4.4% of total revenues for the years ended December 31, 2013, 2012 and 2011, respectively.
Senior Housing. As of December 31, 2013, we owned 59 senior housing facilities buildings. Senior housing facilities cater to different segments of the elderly population based upon their personal needs. Services provided by our tenants in these facilities are primarily paid for by the residents directly or through private insurance and are less reliant on government reimbursement programs such as Medicaid and Medicare. All of our senior housing facilities are leased to single tenants under triple-net lease structures. Our senior housing segment accounted for approximately 11.0%, 1.0% and 0% of total revenues for the years ended December 31, 2013, 2012 and 2011, respectively. For the year ended December 31, 2013, Myriad Healthcare Limited, as our tenant in the United Kingdom, accounted for 57.7% of our senior housing segment revenues.
Senior Housing–RIDEA. As of December 31, 2013, we owned and operated 26 senior housing facilities buildings utilizing a RIDEA structure. Such facilities are of a similar property type as our senior housing segment discussed above,

15

however we enter into agreements with healthcare operators to manage the facilities on our behalf utilizing a RIDEA structure. Substantially all of our leases with residents in the senior housing facilities are for a term of one year or less. For the year ended December 31, 2013, our senior housing–RIDEA segment accounted for approximately 1.1% of total revenues. We did not own and operate any senior housing facilities utilizing a RIDEA structure for the years ended December 31, 2012 and 2011.
For a further discussion of our segment reporting for the years ended December 31, 2013, 2012 and 2011, including revenue attributable to the country in which the property is physically located, see Note 18, Segment Reporting, to the Consolidated Financial Statements that are a part of this Annual Report on Form 10-K.
Item 1A. Risk Factors.
Investment Risks
There is no public market for the shares of our common stock. Therefore, it will be difficult for our stockholders to sell their shares of our common stock and, if our stockholders are able to sell their shares of our common stock, they will likely sell them at a substantial discount.
There currently is no public market for shares of our common stock. We do not expect a public market for our stock to develop prior to the listing of the shares of our common stock on a national securities exchange, which may not occur at all. Additionally, our charter contains restrictions on the ownership and transfer of shares of our stock, and these restrictions may inhibit our stockholders’ ability to sell their shares of our common stock. Our charter provides that no person may own more than 9.9% in value of our issued and outstanding shares of capital stock or more than 9.9% in value or in number of shares, whichever is more restrictive, of the issued and outstanding shares of our common stock. Any purported transfer of the shares of our common stock that would result in a violation of either of these limits will result in such shares being transferred to a trust for the benefit of a charitable beneficiary or such transfer being declared null and void. We have adopted a share repurchase plan, but it is limited in terms of the amount of shares of our common stock which may be repurchased annually and subject to our board of directors’ discretion. Our board of directors may also amend, suspend or terminate our share repurchase plan upon 30 days written notice. Therefore, it will be difficult for our stockholders to sell their shares of our common stock promptly or at all. If our stockholders are able to sell their shares of our common stock, they may only be able to sell them at a substantial discount from the price they paid. This may be the result, in part, of the fact that, at the time we make our investments, the amount of funds available for investment may have been reduced by up to 11.0% of the gross offering proceeds, which was used to pay selling commissions, a dealer manager fee and other organizational and offering expenses. We also were required to use the gross proceeds from our offerings to pay acquisition fees and acquisition expenses. Unless our aggregate investments increase in value to compensate for these fees and expenses, which may not occur, it is unlikely that our stockholders will be able to sell their shares of our common stock, whether pursuant to our share repurchase plan or otherwise, without incurring a substantial loss. We cannot assure our stockholders that their shares of our common stock will ever appreciate in value to equal the price they paid for their shares of our common stock. Therefore, our stockholders should consider the purchase of shares of our common stock as illiquid and a long-term investment, and they must be prepared to hold their shares of our common stock for an indefinite length of time.
We have a limited operating history; therefore, our stockholders may not be able to adequately evaluate our ability to achieve our investment objectives, and the prior performance of other programs sponsored by Griffin Capital may not be an accurate predictor of our future results.
We were formed in January 2009, did not engage in any material business operations prior to our initial offering and acquired our first property in March 2010. As a result, an investment in shares of our common stock may entail more risks than the shares of common stock of a REIT with a more substantial operating history. In addition, this is the first real estate program sponsored by American Healthcare Investors, and you should not rely on the past performance of other Griffin Capital-sponsored programs to predict our future results. Our stockholders should consider our prospects in light of the risks, uncertainties and difficulties frequently encountered by companies like ours that do not have a substantial operating history, many of which may be beyond our control. Therefore, to be successful in this market, we must, among other things:
 
•
identify and acquire investments that further our investment strategy;
•
respond to competition both for investment opportunities and potential investors in us; and
•
build and expand our operations structure to support our business.
We cannot guarantee that we will succeed in achieving these goals, and our failure to do so could cause our stockholders to lose all or a portion of their investment.

16

We have experienced losses in the past, and we may experience additional losses in the future.
Historically, we have experienced net losses and we may not be profitable or realize growth in the value of our investments. Many of our losses can be attributed to start-up costs and general and administrative expenses, as well as acquisition expenses incurred in connection with purchasing properties or making other investments. For a further discussion of our operational history and the factors for our losses, see Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations and our consolidated financial statements and the notes thereto.
If we are unable to find suitable investments, we may not have sufficient cash flows available for distributions to our stockholders.
Our ability to achieve our investment objectives and to pay distributions to our stockholders is dependent upon the performance of our advisor entities in selecting investments for us to acquire, selecting tenants for our properties and securing financing arrangements. Except for stockholders who purchased shares of our common stock in our offerings after such time as we supplemented our prospectus to describe one or more identified investments, our stockholders generally have no opportunity to evaluate the terms of transactions or other economic or financial data concerning our investments. Our stockholders must rely entirely on the management ability of our advisor entities and the oversight of our board of directors. Our advisor entities may not be successful in identifying suitable investments on financially attractive terms and, even if they identify suitable investments, our investment objectives may not be achieved. In such an event, our ability to pay distributions to our stockholders would be adversely affected.
We face competition for the acquisition of medical office buildings and other healthcare-related facilities, which may impede our ability to make acquisitions or may increase the cost of these acquisitions and may reduce our profitability and could cause our stockholders to experience a lower return on their investment.
We compete with many other entities engaged in real estate investment activities for acquisitions of medical office buildings and healthcare-related facilities, including international, national, regional and local operators, acquirers and developers of healthcare real estate properties. The competition for healthcare real estate properties may significantly increase the price we must pay for medical office buildings and healthcare-related facilities or other assets we seek to acquire, and our competitors may succeed in acquiring those properties or assets themselves. In addition, our potential acquisition targets may find our competitors to be more attractive because they may have greater resources, may be willing to pay more for the properties or may have a more compatible operating philosophy. In particular, larger healthcare real estate REITs may enjoy significant competitive advantages that result from, among other things, a lower cost of capital and enhanced operating efficiencies. In addition, the number of entities and the amount of funds competing for suitable investment properties may increase. This competition will result in increased demand for these assets, and therefore, increased prices paid for them. Due to an increased interest in single-property acquisitions among tax-motivated individual purchasers, we may pay higher prices if we purchase single properties in comparison with portfolio acquisitions. If we pay higher prices for medical office buildings or healthcare-related facilities, our business, financial condition and results of operations and our ability to pay distributions to our stockholders may be materially and adversely affected and our stockholders may experience a lower return on their investment.
Our stockholders may be unable to sell their shares of our common stock because their ability to have their shares of our common stock repurchased pursuant to our share repurchase plan is subject to significant restrictions and limitations.
Our share repurchase plan includes significant restrictions and limitations. Except in cases of death or qualifying disability, our stockholders must hold their shares of our common stock for at least one year. Requesting stockholders must present at least 25.0% of their shares of our common stock for repurchase and until they have held their shares of our common stock for at least four years, repurchases will be made for less than our stockholders paid for their shares of our common stock. Shares of our common stock may be repurchased quarterly, at our discretion, on a pro rata basis, and are limited during any calendar year to 5.0% of the weighted average number of shares of our common stock outstanding during the prior calendar year; provided however, that shares of our common stock subject to a repurchase requested upon the death of a stockholder will not be subject to this cap. Funds for the repurchase of shares of our common stock will come exclusively from the cumulative proceeds we receive from the sale of shares of our common stock pursuant to the DRIP. In addition, our board of directors may reject share repurchase requests in its sole discretion and reserves the right to amend, suspend or terminate our share repurchase plan at any time upon 30 days written notice. Therefore, our stockholders should not assume that they will be able to sell any of their shares of our common stock back to us pursuant to our share repurchase plan and they also should understand that the repurchase price will not necessarily correlate to the value of our real estate holdings or other assets. If our board of directors terminates our share repurchase plan, our stockholders may not be able to sell their shares of our common stock even if our stockholders deem it necessary or desirable to do so.

17

Our success is increasingly dependent on the performance of our Chairman of the Board of Directors and Chief Executive Officer, and our President and Chief Operating Officer.
Since our transition to American Healthcare Investors and Griffin Capital as our co-sponsors, Griffin-American Sub-Advisor has been responsible for managing our day-to-day operations. Through Griffin-American Sub-Advisor’s affiliation with American Healthcare Investors, we are increasingly dependent upon the services of Messrs. Hanson and Prosky to manage our operations. We have limited prior experience working with Griffin Capital or its affiliates, most of whom are unfamiliar with our company and our operations. Accordingly, our ability to achieve our investment objectives and to pay distributions depends upon the ability of Mr. Hanson and Mr. Prosky to manage the identification and acquisition of investments, the determination of any financing arrangements and the management of our investments. We currently do not have an employment agreement with either Mr. Hanson or Mr. Prosky. If we were to lose the benefit of either of Mr. Hanson’s or Mr. Prosky’s experience, efforts and abilities, we may not be able to achieve our investment objectives and our operating results could suffer.
Griffin-American Advisor and certain of its key personnel face competing demands relating to their time, and this may cause our operating results to suffer.
Griffin-American Advisor and certain of its key personnel, and their respective affiliates, serve as key personnel, advisors, managers and sponsors of 14 other Griffin Capital-sponsored real estate programs, including Griffin Capital Essential Asset REIT, Inc., a publicly registered, non-traded real estate investment trust, and may have other business interests as well. Because these persons have competing demands on their time and resources, they may have conflicts of interest in allocating their time between our business and these other activities. During times of intense activity in other programs and ventures, they may devote less time and fewer resources to our business than is necessary or appropriate. If this occurs, the returns on an investment may suffer.
In addition, executive officers of Griffin Capital also are officers of Griffin Securities and other affiliated entities. As a result, these individuals owe fiduciary duties to these other entities and their owners, which fiduciary duties may conflict with the duties that they owe to our stockholders and us. Their loyalties to these other entities could result in actions or inactions that are detrimental to our business, which could harm the implementation of our investment objectives. Conflicts with our business and interests are most likely to arise from involvement in activities related to allocation of management time and services between us and the other entities.
Our advisor entities may be entitled to receive significant compensation in the event of our liquidation or in connection with a termination of the Advisory Agreement.
We are externally advised by our advisor entities pursuant to an Advisory Agreement between us and our advisor, and a sub-advisory agreement between our advisor and our sub-advisor, each of which had a one-year term, but was subject to successive one-year renewals upon mutual consent of the parties. The Advisory Agreement and the sub-advisory agreement were renewed on January 6, 2014 pursuant to the mutual consent of the parties for a term of six months and expire on July 6, 2014. In the event of a partial or full liquidation of our assets, our advisor entities will be entitled to receive an incentive distribution equal to 15.0% of the net proceeds of the liquidation, after we have received and paid to our stockholders the sum of the gross proceeds from the sale of shares of our common stock and any shortfall in an annual 8.0% cumulative, non-compounded return to stockholders in the aggregate, subject to certain reductions relating to properties acquired prior to Griffin-American Advisor's appointment as our advisor as set forth in the partnership agreement for our operating partnership, or the operating partnership agreement. In the event of a termination of the Advisory Agreement in connection with the listing of our common stock on a national securities exchange, the operating partnership agreement provides that our advisor entities will receive an incentive distribution equal to 15.0% of the amount, if any, by which (1) the market value of our outstanding common stock plus distributions paid by us prior to the listing of the shares of our common stock on a national securities exchange, exceeds (2) the sum of the gross proceeds from the sale of shares of our common stock plus an annual 8.0% cumulative, non-compounded return on the gross proceeds from the sale of shares of our common stock, subject to certain reductions relating to properties acquired prior to Griffin-American Advisor's appointment as our advisor as set forth in the operating partnership agreement. Upon our advisor’s receipt of the incentive distribution upon listing, our advisor’s limited partnership units will be redeemed and our advisor entities will not be entitled to receive any further incentive distributions upon sales of our properties. Further, in connection with the termination of the Advisory Agreement, other than due to a listing of the shares of our common stock on a national securities exchange, our advisor entities shall be entitled to receive a distribution equal to the amount that would be payable as an incentive distribution upon sales of properties, which equals 15.0% of the net proceeds if we liquidated all of our assets at fair market value, after we have received and paid to our stockholders the sum of the gross proceeds from the sale of shares of our common stock and any shortfall in the annual 8.0% cumulative, non-compounded return to our stockholders in the aggregate, subject to certain reductions relating to properties acquired prior to Griffin-American Advisor's appointment as our advisor as set forth in the operating partnership agreement. Upon our advisor’s receipt of this distribution, our advisor’s limited partnership units will be redeemed and our advisor entities

18

will not be entitled to receive any further incentive distributions upon sales of our properties. Any amounts to be paid to our advisor entities in connection with the termination of the Advisory Agreement cannot be determined at the present time, but such amounts, if paid, will reduce the cash available for distribution to our stockholders.
We may not effect a liquidity event within our targeted time frame of five years after the completion of our offering stage, or at all. If we do not effect a liquidity event, our stockholders may have to hold their investment in shares of our common stock for an indefinite period of time.
On a limited basis, our stockholders may be able to sell shares of our common stock through our share repurchase plan. However, in the future we may also consider various forms of liquidity events, including but not limited to: (1) the listing of the shares of our common stock on a national securities exchange; (2) our sale or merger in a transaction that provides our stockholders with a combination of cash and/or securities of a publicly traded company; and (3) the sale of all or substantially all of our real estate and real estate-related investments for cash or other consideration. We presently intend to effect a liquidity event within five years after the completion of our offering stage, which we deem to be October 30, 2013. However, we are not obligated, through our charter or otherwise, to effectuate a liquidity event and may not effect a liquidity event within such time or at all. If we do not effect a liquidity event, it will be very difficult for our stockholders to have liquidity for their investment in the shares of our common stock other than limited liquidity through our share repurchase plan.
Because a portion of the offering price from the sale of shares of our common stock in our offerings was used to pay expenses and fees, the full offering price paid by our stockholders was not invested in real estate investments. As a result, our stockholders will only receive a full return of their invested capital if we either (1) sell our assets or our company for a sufficient amount in excess of the original purchase price of our assets, or (2) list the shares of our common stock on a national securities exchange and the market value of our company after we list is substantially in excess of the original purchase price of our assets.
Our board of directors may change our investment objectives without seeking our stockholders’ approval.
Our board of directors may change our investment objectives without seeking our stockholders’ approval if our directors, in accordance with their fiduciary duties to our stockholders, determine that a change is in our stockholders’ best interest. A change in our investment objectives could reduce our payment of cash distributions to our stockholders or cause a decline in the value of our investments.
Risks Related to Our Business
We have not had sufficient cash available from operations to pay distributions, and, therefore, we have paid distributions from the net proceeds of our offerings, from borrowings in anticipation of future cash flows or from other sources. Any such distributions may reduce the amount of capital we ultimately invest in assets and negatively impact the value of our stockholders’ investment.
Distributions payable to our stockholders may include a return of capital, rather than a return on capital. We did not establish any limit on the amount of proceeds from our offerings, and we have not established any limit on the amount of proceeds from any future offerings, that may be used to fund distributions, except that, in accordance with our organizational documents and Maryland law, we may not make distributions that would: (i) cause us to be unable to pay our debts as they become due in the usual course of business; (ii) cause our total assets to be less than the sum of our total liabilities plus senior liquidation preferences; or (iii) jeopardize our ability to maintain our qualification as a REIT. The actual amount and timing of distributions are determined by our board of directors in its sole discretion and typically will depend on the amount of funds available for distribution, which will depend on items such as our financial condition, current and projected capital expenditure requirements, tax considerations and annual distribution requirements needed to maintain our qualification as a REIT. As a result, our distribution rate and payment frequency vary from time to time.
We have used the net proceeds from our offerings, borrowed funds, or other sources, and in the future may use borrowed funds, or other sources, to pay cash distributions to our stockholders, which may reduce the amount of proceeds available for investment and operations or cause us to incur additional interest expense as a result of borrowed funds. As a result, the amount of net proceeds available for investment and operations would be reduced, or we may incur additional interest expense as a result of borrowed funds. Further, if the aggregate amount of cash distributed in any given year exceeds the amount of our current and accumulated earnings and profits, the excess amount will be deemed a return of capital.
Our board of directors authorized a daily distribution to our stockholders of record as of the close of business on each day of the period commencing on January 1, 2010 and ending on June 30, 2010, as a result of our former sponsor, Grubb & Ellis, advising us that it intended to fund these distributions until we acquired our first property. We acquired our first property, Lacombe Medical Office Building, on March 5, 2010. Our former sponsor did not receive any additional shares of our common stock or other consideration for funding these distributions, and we will not repay the funds provided by our former sponsor for

19

these distributions. Subsequently, our board of directors authorized, on a quarterly basis, a daily distribution to our stockholders of record as of the close of business on each day of the quarterly periods commencing on July 1, 2010 and ending March 31, 2014.
For distributions declared for each record date in the January 2010 through December 2011 periods, the distributions were calculated based on 365 days in the calendar year and were equal to $0.001780822 per day per share of common stock, which is equal to an annualized distribution rate of 6.5%, assuming a purchase price of $10.00 per share. For distributions declared for each record date in the January 2012 through October 2012 periods, the distributions were calculated based on 365 days in the calendar year and were equal to $0.001808219 per day per share of common stock, which is equal to an annualized distribution rate of 6.6%, assuming a purchase price of $10.00 per share. For distributions declared for each record date in the November 2012 through March 2014 periods, the distributions are calculated based on 365 days in the calendar year and are equal to $0.001863014 per day per share of common stock, which is equal to an annualized distribution rate of 6.65%, assuming a purchase price of $10.22 per share. These distributions are aggregated and paid in cash or shares of our common stock pursuant to the DRIP monthly in arrears. The distributions declared for each record date are paid only from legally available funds. We can provide no assurance that we will be able to continue this distribution rate or pay any subsequent distributions.
The distributions paid for the years ended December 31, 2013 and 2012, along with the amount of distributions reinvested pursuant to the DRIP and the sources of our distributions as compared to cash flows from operations, are as follows:
 
Years Ended December 31,
 
2013
 
2012
Distributions paid in cash
$
57,642,000

 
 
 
$
22,972,000

 
 
Distributions reinvested
67,905,000

 
 
 
22,622,000

 
 
 
$
125,547,000

 
 
 
$
45,594,000

 
 
Sources of distributions:
 
 
 
 
 
 
 
Cash flows from operations
$
42,748,000

 
34.0
%
 
$
23,462,000

 
51.5
%
Offering proceeds
82,799,000

 
66.0

 
22,132,000

 
48.5

 
$
125,547,000

 
100
%
 
$
45,594,000

 
100
%
Under accounting principles generally accepted in the United States of America, or GAAP, acquisition related expenses are expensed, and therefore, subtracted from cash flows from operations. However, these expenses are paid from offering proceeds.
For a further discussion of distributions, see Part II, Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities — Distributions and Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations — Liquidity and Capital Resources — Distributions.
As of December 31, 2013, we had an amount payable of $2,285,000 to our sub-advisor or its affiliates primarily comprised of asset and property management fees and lease commissions, which will be paid from cash flows from operations in the future as they become due and payable by us in the ordinary course of business consistent with our past practice.
As of December 31, 2013, no amounts due to our advisor entities or its affiliates had been deferred, waived or forgiven. Our advisor entities and their affiliates have no obligations to defer, waive or forgive amounts due to them. In the future, if our advisor entities or their affiliates do not defer, waive or forgive amounts due to them, this would negatively affect our cash flows from operations, which could result in us paying distributions, or a portion thereof, using borrowed funds. As a result, the amount of proceeds available for investment and operations would be reduced, or we may incur additional interest expense as a result of borrowed funds.
The distributions paid for the years ended December 31, 2013 and 2012, along with the amount of distributions reinvested pursuant to the DRIP and the sources of our distributions as compared to funds from operations, or FFO, are as follows: 

20

 
Years Ended December 31,
 
2013
 
2012
Distributions paid in cash
$
57,642,000

 
 
 
$
22,972,000

 
 
Distributions reinvested
67,905,000

 
 
 
22,622,000

 
 
 
$
125,547,000

 
 
 
$
45,594,000

 
 
Sources of distributions:
 
 
 
 
 
 
 
FFO
$
85,154,000

 
67.8
%
 
$
—

 
—
%
Offering proceeds
40,393,000

 
32.2

 
45,594,000

 
100

 
$
125,547,000

 
100
%
 
$
45,594,000

 
100
%
The payment of distributions from sources other than FFO may reduce the amount of proceeds available for investment and operations or cause us to incur additional interest expense as a result of borrowed funds. For a further discussion of FFO, which includes a reconciliation of our GAAP net income (loss) to FFO, see Part II, Item 6. Selected Financial Data.
The availability and timing of cash distributions to our stockholders is uncertain. If we fail to pay distributions, our stockholders’ investment in shares of our common stock could suffer.
We expect to continue to pay monthly distributions to our stockholders. However, we bear all expenses incurred in our operations, which are deducted from cash flows generated by operations prior to computing the amount of cash distributions to our stockholders. In addition, our board of directors, in its discretion, may retain any portion of such funds for working capital. We cannot assure our stockholders that sufficient cash will be available to pay distributions to them monthly, or at all. Should we fail for any reason to distribute at least 90.0% of our annual taxable income, excluding net capital gains, we would not qualify for the favorable tax treatment accorded to REITs.
Because not all REITs calculate modified funds from operations, or MFFO, the same way, our use of MFFO may not provide meaningful comparisons with other REITs.
We use MFFO and the adjustments used to calculate it in order to evaluate our performance against other publicly registered, non-listed REITs which intend to have limited lives with short and defined acquisition periods and targeted exit strategies shortly thereafter. However, not all REITs calculate MFFO the same way. If REITs use different methods of calculating MFFO, it may not be possible for investors to meaningfully compare the performance of certain REITs.
We are uncertain of all of our sources of debt or equity for funding our capital needs. If we cannot obtain funding on acceptable terms, our ability to acquire and make necessary capital improvements to properties may be impaired or delayed.
We have used the gross proceeds of our offerings to buy a diversified portfolio of real estate and real estate-related investments and to pay various fees and expenses. In addition, to maintain our qualification as a REIT, we generally must distribute to our stockholders at least 90.0% of our annual taxable income, excluding net capital gains, each year, excluding capital gains. Because of this distribution requirement, it is not likely that we will be able to fund a significant portion of our capital needs from retained earnings. We have not identified all of our sources of debt or equity for funding, and such sources of funding may not be available to us on favorable terms or at all. If we do not have access to sufficient funding in the future, we may not be able to acquire and make necessary capital improvements to properties, pay other expenses or expand our business.
We intend to incur mortgage indebtedness and other borrowings, which may increase our business risks, could hinder our ability to pay distributions and could decrease the value of our stockholders’ investment.
We have financed and will continue to finance a portion of the purchase price of our investments in real estate and real estate-related investments by borrowing funds. We anticipate that aggregate borrowings, both secured and unsecured, will not exceed 45.0% of the combined market value of our real estate and real estate-related investments, as determined at the end of each calendar year beginning with our first full year of operations. Under our charter, we have a limitation on borrowing that precludes us from borrowing in excess of 300% of our net assets without the approval of a majority of our independent directors. Net assets for purposes of this calculation are defined to be our total assets (other than intangibles), valued at cost prior to deducting depreciation, amortization, bad debt and other non-cash reserves, less total liabilities. Generally speaking, the preceding calculation is expected to approximate 75.0% of the aggregate cost of our real estate and real estate-related investments before depreciation, amortization, bad debt and other similar non-cash reserves. In addition, we may incur mortgage debt and pledge some or all of our real properties as security for that debt to obtain funds to acquire additional real properties or for working capital. We may also borrow funds to satisfy the REIT tax qualification requirement that we distribute at least 90.0% of our annual taxable income, excluding net capital gains, to our stockholders. Furthermore, we may borrow if

21

we otherwise deem it necessary or advisable to ensure that we maintain our qualification as a REIT for federal income tax purposes.
High debt levels may cause us to incur higher interest charges, which would result in higher debt service payments and could be accompanied by restrictive covenants. If there is a shortfall between the cash flows from a property and the cash flows needed to service mortgage debt on that property, then the amount available for distributions to our stockholders may be reduced. In addition, incurring mortgage debt increases the risk of loss since defaults on indebtedness secured by a property may result in lenders initiating foreclosure actions. In that case, we could lose the property securing the loan that is in default, thus reducing the value of our stockholders’ investment. For tax purposes, a foreclosure on any of our properties will be treated as a sale of the property for a purchase price equal to the outstanding balance of the debt secured by the mortgage. If the outstanding balance of the debt secured by the mortgage exceeds our tax basis in the property, we will recognize taxable income on foreclosure, but we would not receive any cash proceeds. We may give full or partial guarantees to lenders of mortgage debt to the entities that own our properties. When we give a guaranty on behalf of an entity that owns one of our properties, we will be responsible to the lender for satisfaction of the debt if it is not paid by such entity. If any mortgage contains cross collateralization or cross default provisions, a default on a single property could affect multiple properties. If any of our properties are foreclosed upon due to a default, our ability to pay cash distributions to our stockholders will be adversely affected.
Higher mortgage rates may make it more difficult for us to finance or refinance properties, which could reduce the number of properties we can acquire and the amount of cash available for distribution to our stockholders.
If mortgage debt is unavailable on reasonable terms as a result of increased interest rates or other factors, we may not be able to finance the purchase of properties. In addition, if we place mortgage debt on properties, we run the risk of being unable to refinance such debt when the loans come due, or of being unable to refinance on favorable terms. If interest rates are higher when we refinance debt, our income could be reduced. We may be unable to refinance debt at appropriate times, which may require us to sell properties on terms that are not advantageous to us, or could result in the foreclosure of such properties. If any of these events occur, our cash flows would be reduced. This, in turn, would reduce cash available for distribution to our stockholders and may hinder our ability to raise more capital by issuing securities or by borrowing more money.
Financial market disruptions may adversely affect our operating results and financial condition.
The global financial markets have undergone pervasive and fundamental disruptions over the past number of years. Such volatility may have an adverse impact on the availability of credit to businesses generally and could lead to weakening of the U.S. and global economies. To the extent that turmoil in the financial markets exists, it has the potential to materially affect the value of our properties and other investments, the availability or the terms of financing that we may anticipate utilizing, our ability to make principal and interest payments on, or refinance, any outstanding debt when due and/or the ability of our tenants to enter into new leasing transactions or satisfy rental payments under existing leases. Financial market disruptions could also affect our operating results and financial condition as follows:
 
•
Debt and Equity Markets — Our results of operations are sensitive to the volatility of the credit markets. The real estate debt markets have experienced volatility as a result of certain factors in recent years, including the tightening of underwriting standards by lenders and credit rating agencies. Credit spreads for major sources of capital have widened significantly as investors have demanded a higher risk premium, which may result in lenders increasing the cost for debt financing. Should the overall cost of borrowings increase, either by increases in the index rates or by increases in lender spreads, we will need to factor such increases into the economics of our acquisitions, developments and property contributions. This may result in our property operations generating lower overall economic returns and a reduced level of cash flows, which could potentially impact our ability to pay distributions to our stockholders. In addition, any dislocation in the debt markets may reduce the amount of capital that is available to finance real estate, which, in turn: (1) limits the ability of real estate investors to benefit from reduced real estate values or to realize enhanced returns on real estate investments; (2) has slowed real estate transaction activity; and (3) may result in an inability to refinance debt as it becomes due, all of which may reasonably be expected to have a material impact, favorable or unfavorable, on revenues, income and/or cash flows from the acquisition and operations of real estate and mortgage loans. In addition, the state of the debt markets could have an impact on the overall amount of capital being invested in real estate, which may result in price or value decreases of real estate assets and impact our ability to raise equity capital.
•
Valuations — Any persistent market volatility will likely make the valuation of our properties more difficult. There may be significant uncertainty in the valuation, or in the stability of the value, of our properties that could result in a substantial decrease in the value of our properties. As a result, we may not be able to recover the carrying amount of our properties, which may require us to recognize an impairment charge in earnings.

22

•
Government Intervention — The pervasive and fundamental disruptions that the global financial markets have been undergoing have led to extensive and unprecedented governmental intervention, and there is a possibility that regulation of the financial markets will be significantly increased in the future. Such increased regulation could have a material impact on our operating results and financial condition.
Our results of operations, our ability to pay distributions to our stockholders and our ability to dispose of our investments are subject to international, national and local economic factors we cannot control or predict.
Our results of operations are subject to the risks of an international or national economic slowdown or downturn and other changes in international, national and local economic conditions. The following factors may affect income from our properties, our ability to acquire and dispose of properties, and yields from our properties:
 
•
poor economic times may result in defaults by tenants of our properties due to bankruptcy, lack of liquidity, or operational failures. We may also be required to provide rent concessions or reduced rental rates to maintain or increase occupancy levels;
•
reduced values of our properties may limit our ability to dispose of assets at attractive prices or to obtain debt financing secured by our properties and may reduce the availability of unsecured loans;
•
the value and liquidity of our short-term investments and cash deposits could be reduced as a result of a deterioration of the financial condition of the institutions that hold our cash deposits or the institutions or assets in which we have made short-term investments, the dislocation of the markets for our short-term investments, increased volatility in market rates for such investment or other factors;
•
our lenders under our line of credit could refuse to fund their financing commitments to us or could fail and we may not be able to replace the financing commitment of such lender on favorable terms, or at all;
•
one or more counterparties to our interest rate swaps could default on their obligations to us or could fail, increasing the risk that we may not realize the benefits of these instruments;
•
increases in supply of competing properties or decreases in demand for our properties may impact our ability to maintain or increase occupancy levels and rents;
•
constricted access to credit may result in tenant defaults or non-renewals under leases;
•
job transfers and layoffs may cause vacancies to increase and a lack of future population and job growth may make it difficult to maintain or increase occupancy levels; and
•
increased insurance premiums, real estate taxes or utilities or other expenses may reduce funds available for distribution or, to the extent such increases are passed through to tenants, may lead to tenant defaults. Also, any such increased expenses may make it difficult to increase rents to tenants on turnover, which may limit our ability to increase our returns.
The length and severity of any economic slowdown or downturn cannot be predicted. Our results of operations, our ability to pay distributions to our stockholders and our ability to dispose of our investments may be negatively impacted to the extent an economic slowdown or downturn is prolonged or becomes more severe.
Increasing vacancy rates for commercial real estate resulting from ongoing disruptions in the financial markets and deteriorating economic conditions could reduce revenue and the resale value of our properties.
We depend upon tenants for a majority of our revenue from real property investments. Ongoing disruptions in the financial markets and deteriorating economic conditions have resulted in a trend towards increasing vacancy rates for virtually all classes of commercial real estate, including medical office buildings and healthcare-related facilities, due to generally lower demand for rentable space, as well as potential oversupply of rentable space. Increased unemployment rates have led to reduced demand for medical services, causing physician groups and hospitals to delay expansion plans, leaving a growing number of vacancies in new buildings. Reduced demand for medical office buildings and healthcare-related facilities could require us to increase concessions, tenant improvement expenditures or reduce rental rates to maintain occupancies beyond those anticipated at the time we acquire the property. In addition, the market value of a particular property could be diminished by prolonged vacancies. The continuation of disruptions in the financial markets and deteriorating economic conditions could impact certain properties we acquire and such properties could experience higher levels of vacancy than anticipated at the time we acquire them. The value of our real estate investments could decrease below the amounts we paid for the investments. Revenues from properties could decrease due to lower occupancy rates, reduced rental rates and potential increases in uncollectible rent. We will incur expenses, such as for maintenance costs, insurance costs and property taxes, even though a property is vacant. The longer the period of significant vacancies for a property, the greater the potential negative impact on our revenues and results of operations.

23

We are dependent on tenants for our revenue and lease terminations could reduce our distributions to our stockholders.
The successful performance of our real estate investments is materially dependent on the financial stability of our tenants. Lease payment defaults by tenants would cause us to lose the revenue associated with such leases and could cause us to reduce the amount of distributions to our stockholders. If the property is subject to a mortgage, a default by a significant tenant on its lease payments to us may result in a foreclosure on the property if we are unable to find an alternative source of revenue to meet mortgage payments. In the event of a tenant default, we may experience delays in enforcing our rights as landlord and may incur substantial costs in protecting our investment and re-leasing our property. Further, we cannot assure our stockholders that we will be able to re-lease the property for the rent previously received, if at all, or that lease terminations will not cause us to sell the property at a loss.
A significant portion of our annual base rent may be concentrated in a small number of tenants. Therefore, non-renewals, terminations or lease defaults by any of these significant tenants could reduce our net income and limit our ability to make distributions to our stockholders.
As of March 13, 2014, rental payments by one of our tenants, Myriad Healthcare Limited, accounted for approximately 14.6% of our annual base rent. The success of our investments materially depends upon the financial stability of the tenants leasing the properties we own. Therefore, a non-renewal after the expiration of a lease term, termination, default or other failure to meet rental obligations by a significant tenant, such as Myriad Healthcare Limited, would significantly lower our net income. These events could cause us to reduce the amount of distributions to our stockholders.
If a tenant declares bankruptcy, we may be unable to collect balances due under relevant leases.
Any of our current or future tenants, or any guarantor of one of our current or future tenant’s lease obligations, could be subject to a bankruptcy proceeding, including a bankruptcy proceeding, pursuant to Title 11 of the bankruptcy laws of the U.S. Such bankruptcy filings could bar us from attempting to collect pre-bankruptcy debts from the bankrupt tenant or its properties unless we receive an enabling order from the bankruptcy court. Post-bankruptcy debts would be paid currently. If we assume a lease, all pre-bankruptcy balances owing under it must be paid in full. If a lease is rejected by a tenant in bankruptcy, we would have a general unsecured claim for damages. If a lease is rejected, it is unlikely we would receive any payments from the tenant because our claim would be capped at the rent reserved under the lease, without acceleration, for the greater of one year or 15.0% of the remaining term of the lease, but not greater than three years, plus rent already due but unpaid. This claim could be paid only in the event funds were available, and then only in the same percentage as that realized on other unsecured claims.
The bankruptcy of a tenant or lease guarantor could delay our efforts to collect past due balances under the relevant lease, and could ultimately preclude full collection of these sums. Such an event also could cause a decrease or cessation of current rental payments, reducing our cash flows and the amount available for distributions to our stockholders. In the event a tenant or lease guarantor declares bankruptcy, the tenant or its trustee may not assume our lease or its guaranty. If a given lease or guaranty is not assumed, our cash flows and the amounts available for distributions to our stockholders may be adversely affected.
Long-term leases may not result in fair market lease rates over time; therefore, our income and our distributions could be lower than if we did not enter into long-term leases.
We may enter into long-term leases with tenants of certain of our properties. Our long-term leases would likely provide for rent to increase over time. However, if we do not accurately judge the potential for increases in market rental rates, we may set the terms of these long-term leases at levels such that even after contractual rental increases, the rent under our long-term leases is less than the then current market rental rates. Further, we may have no ability to terminate those leases or to adjust the rent to the then prevailing market rates. As a result, our income and distributions could be lower than if we did not enter into long-term leases.

24

We may incur additional costs in acquiring or re-leasing properties, which could adversely affect the cash available for distribution to our stockholders.
We have and may continue to invest in properties designed or built primarily for a particular tenant of a specific type of use known as a single-user facility. If the tenant fails to renew its lease or defaults on its lease obligations, we may not be able to readily market a single-user facility to a new tenant without making substantial capital improvements or incurring other significant re-leasing costs. We also may incur significant litigation costs in enforcing our rights as a landlord against the defaulting tenant. These consequences could adversely affect our revenues and reduce the cash available for distribution to our stockholders.
We may be unable to secure funds for future tenant or other capital improvements, which could limit our ability to attract, or replace or retain tenants and decrease our stockholders’ return on their investment.
When tenants do not renew their leases or otherwise vacate their space, it is common that, in order to attract replacement tenants, we will be required to expend substantial funds for tenant improvements and leasing commissions related to the vacated space. Such tenant improvements may require us to incur substantial capital expenditures. If we have not established capital reserves for such tenant or other capital improvements, we will have to obtain financing from other sources and we have not identified any sources for such financing. We may also have future financing needs for other capital improvements to refurbish or renovate our properties. If we need to secure financing sources for tenant improvements or other capital improvements in the future, but are unable to secure such financing or are unable to secure financing on terms we feel are acceptable, we may be unable to make tenant and other capital improvements or we may be required to defer such improvements. If this happens, it may cause one or more of our properties to suffer from a greater risk of obsolescence or a decline in value, or a greater risk of decreased cash flows as a result of fewer potential tenants being attracted to the property or existing tenants not renewing their leases. If we do not have access to sufficient funding in the future, we may not be able to make necessary capital improvements to our properties, pay other expenses or pay distributions to stockholders.
Our success is dependent on the performance of our advisor entities and certain key personnel.
Our ability to achieve our investment objectives and to conduct our operations is dependent upon the performance of our advisor entities in identifying and acquiring investments, the determination of any financing arrangements, the asset management of our investments and the management of our day-to-day activities. Our advisor entities have broad discretion over our investment decisions and our stockholders will have no opportunity to evaluate the terms of transactions or other economic or financial data concerning our investments that are not described in our public filings with the SEC. We rely on the management ability of our advisor entities, subject to the oversight and approval of our board of directors. Accordingly, investors should not purchase shares of our common stock unless they are willing to entrust all aspects of our day-to-day management to our advisor entities. If our advisor entities suffer or are distracted by adverse financial or operational problems in connection with their own operations or the operations of American Healthcare Investors or Griffin Capital unrelated to us, our advisor entities may be unable to allocate time and/or resources to our operations. If our advisor entities are unable to allocate sufficient resources to oversee and perform our operations for any reason, we may be unable to achieve our investment objectives or to pay distributions to our stockholders. In addition, our success depends to a significant degree upon the continued contributions of our advisor entities’ principals and officers who manage our sub-advisor, in particular Mr. Hanson and Mr. Prosky, each of whom would be difficult to replace. In the event that Mr. Hanson or Mr. Prosky are no longer affiliated with American Healthcare Investors, for any reason, it could have a material adverse effect on our success and American Healthcare Investors may not be able to attract and hire as capable individuals to replace Mr. Hanson and/or Mr. Prosky. We do not have key man life insurance on any of our co-sponsors’ key personnel. If our advisor entities or American Healthcare Investors were to lose the benefit of the experience, efforts and abilities of one or more of these individuals, our operating results could suffer.
Our advisor may terminate the Advisory Agreement, which could require us to pay substantial fees and may require us to find a new advisor.
Either we or our advisor, with the consent of the sub-advisor, can terminate the Advisory Agreement subject to a 60-day transition period with respect to certain provisions of the Advisory Agreement. However, if the Advisory Agreement is terminated in connection with the listing of shares of our common stock on a national securities exchange, the operating partnership agreement provides that our advisor will receive an incentive distribution equal to 15.0% of the amount, if any, by which (1) the market value of the outstanding shares of our common stock plus distributions paid by us prior to listing, exceeds (2) the sum of the gross proceeds from the sale of shares of our common stock plus an annual 8.0% cumulative, non-compounded return on the gross proceeds from the sale of shares of our common stock, subject to certain reductions relating to properties acquired prior to Griffin-American Advisor's appointment as our advisor as set forth in the operating partnership agreement. Upon our advisor’s receipt of the incentive distribution upon listing, our advisor’s limited partnership units will be redeemed and our advisor will not be entitled to receive any further incentive distributions upon sales of our properties. Further,

25

in connection with the termination of the Advisory Agreement, other than due to a listing of the shares of our common stock on a national securities exchange, our advisor entities shall be entitled to receive a distribution equal to the amount that would be payable to our advisor entities pursuant to the incentive distribution upon sales if we liquidated all of our assets for their fair market value, subject to certain reductions relating to properties acquired prior to Griffin-American Advisor's appointment as our advisor as set forth in the operating partnership agreement. Upon our advisor’s receipt of this distribution, our advisor’s limited partnership units will be redeemed and our advisor will not be entitled to receive any further incentive distributions upon sales of our properties. Any amounts to be paid to our advisor entities upon termination of the Advisory Agreement cannot be determined at the present time.
If our advisor entities were to terminate the Advisory Agreement, we would need to find another advisor to provide us with day-to-day management services or have employees to provide these services directly to us. There can be no assurances that we would be able to find new advisors or employees or enter into agreements for such services on acceptable terms.
If we internalize our management functions, we could incur significant costs associated with being self-managed.
Our strategy may involve internalizing our management functions. If we internalize our management functions, we would no longer bear the costs of the various fees and expenses we expect to pay to our advisor entities under the Advisory Agreement; however our direct expenses would include general and administrative costs, including legal, accounting, and other expenses related to corporate governance, SEC reporting and compliance. We would also incur the compensation and benefits costs of our officers and other employees and consultants that are now paid by our advisor entities or their affiliates. In addition, we may issue equity awards to officers, employees and consultants, which awards would decrease net income and FFO, and may further dilute our stockholders’ investment. We cannot reasonably estimate the amount of fees to our advisor entities that we would save and the costs we would incur if we became self-managed. If the expenses we assume as a result of an internalization are higher than the expenses we no longer pay to our advisor entities, our net income per share and FFO per share may be lower as a result of the internalization than they otherwise would have been, potentially decreasing the amount of funds available to distribute to our stockholders.
As currently organized, we do not directly have any employees. If we elect to internalize our operations, we would employ personnel and would be subject to potential liabilities commonly faced by employers, such as worker’s disability and compensation claims, potential labor disputes and other employee-related liabilities and grievances. Upon any internalization of our advisor entities, certain key personnel of our advisor or American Healthcare Investors may not be employed by us, but instead may remain employees of our co-sponsors or their affiliates.
If we internalize our management functions, we could have difficulty integrating these functions as a stand-alone entity. Currently, our advisor entities and their affiliates perform asset management and general and administrative functions, including accounting and financial reporting, for multiple entities. They have a great deal of know-how and can experience economies of scale. We may fail to properly identify the appropriate mix of personnel and capital needs to operate as a stand-alone entity. An inability to manage an internalization transaction effectively could, therefore, result in our incurring additional costs and/or experiencing deficiencies in our disclosure controls and procedures or our internal control over financial reporting. Such deficiencies could cause us to incur additional costs, and our management’s attention could be diverted from most effectively managing our properties.
Our success is dependent on the performance of our co-sponsors.
Our ability to achieve our investment objectives and to conduct our operations is dependent upon the performance of our sub-advisor which has assumed responsibility for the day to day management of our company from our advisor. The sub-advisor is a joint venture between our two co-sponsors. Our sub-advisor’s and co-sponsors’ ability to manage our operations successfully will be impacted by trends in the general economy, as well as the commercial real estate and credit markets. The current macroeconomic environment may negatively impact the value of commercial real estate assets and contribute to a general slow-down in our industry, which could put downward pressure on our co-sponsors’ revenues and operating results. To the extent that any decline in our co-sponsors’ revenues and operating results impacts the performance of our advisor entities, our results of operations and financial condition could also suffer.
Our advisor, sub-advisor and their affiliates have no obligation to defer or forgive fees or loans or advance any funds to us, which could reduce our ability to acquire investments or pay distributions.
Our advisor entities and their affiliates, including our co-sponsors, have no obligation to defer or forgive fees owed by us to our advisor entities or their affiliates or to advance any funds to us. As a result, we may have less cash available to acquire investments or pay distributions.

26

We have and may continue to structure acquisitions of property in exchange for limited partnership units in our operating partnership on terms that could limit our liquidity or our flexibility.
We have and may continue to acquire properties by issuing limited partnership units in our operating partnership in exchange for a property owner contributing property to the partnership. If we enter into such transactions, in order to induce the contributors of such properties to accept units in our operating partnership, rather than cash, in exchange for their properties, it may be necessary for us to provide them additional incentives. For instance, the operating partnership agreement provides that any holder of units may exchange limited partnership units on a one-for-one basis for shares of our common stock, or, at our option, cash equal to the value of an equivalent number of shares of our common stock. We may, however, enter into additional contractual arrangements with contributors of property under which we would agree to redeem a contributor’s units for shares of our common stock or cash, at the option of the contributor, at set times. If the contributor required us to redeem units for cash pursuant to such a provision, it would limit our liquidity and thus our ability to use cash to make other investments, satisfy other obligations or pay distributions to our stockholders. Moreover, if we were required to redeem units for cash at a time when we did not have sufficient cash to fund the redemption, we might be required to sell one or more properties to raise funds to satisfy this obligation. Furthermore, we might agree that if distributions the contributor received as a limited partner in our operating partnership did not provide the contributor with a defined return, then upon redemption of the contributor’s units we would pay the contributor an additional amount necessary to achieve that return. Such a provision could further negatively impact our liquidity and flexibility. Finally, in order to allow a contributor of a property to defer taxable gain on the contribution of property to our operating partnership, we might agree not to sell a contributed property for a defined period of time or until the contributor exchanged the contributor’s units for cash or shares of our common stock. Such an agreement would prevent us from selling those properties, even if market conditions made such a sale favorable to us.
The failure of any bank in which we deposit our funds could reduce the amount of cash we have available to pay distributions and acquire investments.
We have cash and cash equivalents and restricted cash deposited in certain financial institutions in excess of federally-insured levels. If any banking institution in which we have deposited funds ultimately fails, we may lose the amount of our deposits over any federally-insured amount. The loss of our deposits could reduce the amount of cash we have available to distribute or invest and could result in a decline in the value of our stockholders’ investment.

Our use of derivative financial instruments to hedge against foreign currency exchange rate fluctuations could expose us to risks that may adversely affect our results of operations, financial condition and ability to pay distributions to our stockholders.
We have used derivative financial instruments to hedge against foreign currency exchange rate fluctuations, and are exposed to credit risk and legal enforceability risks. In this context, credit risk is the failure of the counterparty to perform under the terms of the derivative contract. If the fair value of a derivative contract is positive, the counterparty owes us, which creates credit risk for us. Legal enforceability risks encompass general contractual risks, including the risk that the counterparty will breach the terms of, or fail to perform its obligations under, the derivative contract. If we are unable to manage these risks effectively, our results of operations, financial condition and ability to pay distributions to our stockholders will be adversely affected.
Our properties operated utilizing a RIDEA structure will account for a significant portion of our revenues and operating income; although the managers of the properties operated utilizing a RIDEA structure, which we refer to as our RIDEA managers, are not tenants of our properties, adverse developments in their businesses and affairs or financial condition could have a material adverse effect on us.
Our properties operated utilizing a RIDEA structure represent a substantial portion of our portfolio, based on their gross book value, and will account for a significant portion of our revenues and net operating income. Although we have various rights as the property owner under our management agreements, we rely on our RIDEA managers’ personnel, expertise, technical resources and information systems, proprietary information, good faith and judgment to manage our senior housing facilities efficiently and effectively. We also rely on our RIDEA managers to set resident fees, to provide accurate property-level financial results for our properties in a timely manner and to otherwise operate our properties in accordance with the terms of our management agreements and in compliance with all applicable laws and regulations. For example, we depend on our RIDEA managers' ability to attract and retain skilled management personnel who are responsible for the day-to-day operations of our senior housing facilities. A shortage of nurses or other trained personnel or general inflationary pressures may force our RIDEA managers to enhance their pay and benefits package to compete effectively for such personnel, and our RIDEA managers may not be able to offset such added costs by increasing the rates charged to residents. Any increase in labor costs and other property operating expenses, any failure by our RIDEA managers to attract and retain qualified personnel, or significant changes in our RIDEA managers’ senior management could adversely affect the income we receive from our senior housing facilities and have a material adverse effect on us.

27

Because our RIDEA managers manage, but do not lease, our properties, we are not directly exposed to their credit risk in the same manner or to the same extent as a triple-net lease tenant. However, any adverse developments in our RIDEA managers’ business and affairs or financial condition could impair their ability to manage our properties efficiently and effectively and could have a material adverse effect on us. If our RIDEA managers experience any significant financial, legal, accounting or regulatory difficulties due to a weak economy or otherwise, such difficulties could result in, among other adverse events, acceleration of their indebtedness, impairment of their continued access to capital, the enforcement of default remedies by their counterparties, or the commencement of insolvency proceedings by or against them under the U.S. Bankruptcy Code, any one or a combination of which indirectly could have a material adverse effect on us.
We have rights to terminate our management agreements on our properties operated utilizing a RIDEA structure in whole or with respect to specific properties under certain circumstances, and we may be unable to replace our RIDEA managers if our management agreements are terminated or not renewed.
Generally, we expect to enter into long-term management agreements with our RIDEA managers pursuant to which our RIDEA managers provide comprehensive property management and accounting services with respect to our senior housing facilities operated utilizing a RIDEA structure. Our ability to terminate these long-term management agreements will be limited to specific circumstances set forth in the agreements and may relate to all properties or a specific property or group of properties.
We continually monitor our contractual rights with our RIDEA managers under their respective management agreements and assess our rights and remedies. When determining whether to pursue any existing or future rights or remedies under the management agreements, including termination rights, we consider numerous factors, including legal, contractual, regulatory, business and other relevant considerations. In the event that we exercise our rights to terminate our management agreements for any reason or such agreements are not renewed upon expiration of their terms, we would attempt to find another RIDEA manager for the properties covered by those agreements. Although we believe that many qualified national and regional senior care providers would be interested in managing our senior housing facilities, we cannot provide any assurance that we would be able to locate another suitable RIDEA manager or, if we are successful in locating such a RIDEA manager, that it would manage the properties effectively. Moreover, any such replacement RIDEA manager would require approval by the applicable regulatory authorities and we cannot provide any assurance that such approvals would be granted on a timely basis or at all. Any inability to replace, or a lengthy delay in replacing, our RIDEA managers following termination or non-renewal of our management agreements could have a material adverse effect on us.
Risks Related to Conflicts of Interest
We are subject to conflicts of interest arising out of relationships among us, our officers, our advisor entities and their affiliates, including the material conflicts discussed below.
We may compete with other programs sponsored by our co-sponsors for investment opportunities. As a result, our advisor entities may not cause us to invest in favorable investment opportunities, which may reduce our returns on our investments.
Griffin Capital and American Healthcare Investors are currently the co-sponsors for other publicly held, non-traded REITs and are not precluded from sponsoring other real estate programs in the future. Additionally, the right of first refusal granted to us by our advisor on all medical and healthcare real estate assets that fit within our investment objectives will expire no later than April 28, 2014. As a result, we may be buying properties at the same time as one or more other Griffin Capital or American Healthcare Investors programs that are managed or advised by affiliates of our advisor entities. Officers and employees of our advisor entities may face conflicts of interest in allocating investment opportunities between us and these other programs. For instance, our advisor entities may select properties for us that provide lower returns to us than properties that their affiliates select to be purchased by another Griffin Capital or American Healthcare Investors program. We cannot be sure that officers and employees acting for or on behalf of our advisor entities and on behalf of managers of other Griffin Capital or American Healthcare Investors programs will act in our best interest when deciding whether to allocate any particular investment to us. We are subject to the risk that as a result of the conflicts of interest between us, our advisor, our sub-advisor and other entities or programs managed by their affiliates, our advisor entities may not cause us to invest in favorable investment opportunities that our advisor entities locate when it would be in our best interest to make such investments. As a result, we may invest in less favorable investments, which may reduce our returns on our investments and ability to pay distributions.
The conflicts of interest faced by our officers may cause us not to be managed solely in our stockholders’ best interests, which may adversely affect our results of operations and the value of our stockholders’ investment.
All of our officers also are principals, officers or employees of American Healthcare Investors or other affiliated entities that will receive fees in connection with our offerings and our operations. These relationships are described in Part III, Item 10, Directors, Executive Officers and Corporate Governance of this Annual Report on Form 10-K. These persons are not precluded

28

from working with, or investing in, any current or future program sponsored by American Healthcare Investors. Their loyalties to these other entities could result in actions or inactions that are detrimental to our business, which could harm the implementation of our investment strategy and our investment opportunities. Furthermore, they may have conflicts of interest in allocating their time and resources between our business and these other activities. During times of intense activity in other programs, the time they devote to our business may decline and be less than we require. If our officers, for any reason, are not able to provide sufficient resources to manage our business, our business will suffer and this may adversely affect our results of operations and the value of our stockholders’ investment.
American Healthcare Investors and our advisor entities’ officers face conflicts of interest relating to the allocation of their time and other resources among the various entities that they serve or have interests in, and such conflicts may not be resolved in our favor.
Certain of the officers of American Healthcare Investors and our advisor entities face competing demands relating to their time and resources because they are also or may become affiliated with entities with investment programs similar to ours, and they may have other business interests as well, including business interests that currently exist and business interests they develop in the future. Because these persons have competing interests for their time and resources, they may have conflicts of interest in allocating their time between our business and these other activities. Further, during times of intense activity in other programs, those executives may devote less time and fewer resources to our business than are necessary or appropriate to manage our business. Poor or inadequate management of our business would adversely affect our results of operations and the ownership value of shares of our common stock.
Our advisor entities face conflicts of interest relating to their compensation structure, which could result in actions that are not necessarily in our stockholders’ long-term best interests.
Under the Advisory Agreement and sub-advisory agreement, and pursuant to the subordinated participation interest our advisor holds in our operating partnership, our advisor entities are entitled to fees and distributions that are structured in a manner intended to provide incentives to our advisor entities to perform in both our and our stockholders’ long-term best interests. The fees to which our advisor entities or their affiliates are entitled include acquisition fees, asset management fees, property management fees, disposition fees and other fees as provided for under the Advisory Agreement and agreement of limited partnership with our operating partnership. The distributions our advisor entities may become entitled to receive would be payable upon distribution of net sales proceeds to our stockholders, the listing of the shares of our common stock on a national securities exchange, certain merger transactions or the termination of the Advisory Agreement. See Note 12, Related Party Transactions, to the Consolidated Financial Statements that are a part of this Annual Report on Form 10-K for a description of the fees and distributions payable to our advisor entities and their affiliates. However, because our advisor entities are entitled to receive substantial minimum compensation regardless of our performance, our advisor entities’ interests may not be wholly aligned with our stockholders. In that regard, our advisor entities or their affiliates receive an asset management fee with respect to the ongoing operation and management of properties based on the amount of our initial investment and not the performance of those investments, which could result in our advisor entities not having adequate incentive to manage our portfolio to provide profitable operations during the period we hold our investments. On the other hand, our advisor entities could be motivated to recommend riskier or more speculative investments in order to increase the fees payable to our advisor entities or for us to generate the specified levels of performance or net sales proceeds that would entitle our advisor entities to fees or distributions.
Our advisor may receive economic benefits from its status as a limited partner without bearing any of the investment risk.
Our advisor is a limited partner in our operating partnership. Our advisor is entitled to receive an incentive distribution equal to 15.0% of net sales proceeds of properties after we have received and paid to our stockholders a return of their invested capital and an annual 8.0% cumulative, non-compounded return on the gross proceeds of the sale of shares of our common stock, subject to certain reductions relating to properties acquired prior to Griffin-American Advisor's appointment as our advisor as set forth in the operating partnership agreement. We bear all of the risk associated with the properties but, as a result of the incentive distributions to our advisor, we are not entitled to all of our operating partnership’s proceeds from property dispositions.
The distribution payable to our advisor entities may influence our decisions about listing the shares of our common stock on a national securities exchange, merging our company with another company and acquisition or disposition of our investments.
Our advisor entities’ entitlement to fees upon the sale of our assets and to participate in net sales proceeds could result in our advisor recommending sales of our investments at the earliest possible time at which sales of investments would produce the level of return which would entitle our advisor entities to compensation relating to such sales, even if continued ownership of those investments might be in our stockholders’ long-term best interest. The subordinated participation interest may require

29

our operating partnership to make a distribution to our advisor entities upon the listing of the shares of our common stock on a national securities exchange or the merger of our company with another company in which our stockholders receive shares that are traded on a national securities exchange, if our advisor entities meet the performance thresholds included in the operating partnership agreement even if our advisor or sub-advisor are no longer serving as our advisor or sub-advisor. To avoid making this distribution, our independent directors may decide against listing the shares of our common stock or merging with another company even if, but for the requirement to make this distribution, such listing or merger would be in our stockholders’ best interest. In addition, the requirement to pay these fees could cause our independent directors to make different investment or disposition decisions than they would otherwise make, in order to satisfy our obligation to our advisor entities.
We may acquire assets from, or dispose of assets to, affiliates of our advisor entities, which could result in us entering into transactions on less favorable terms than we would receive from a third party or that negatively affect the public’s perception of us.
We may acquire assets from affiliates of our advisor entities. Further, we may also dispose of assets to affiliates of our advisor entities. Affiliates of our advisor entities may make substantial profits in connection with such transactions and may owe fiduciary and/or other duties to the selling or purchasing entity in these transactions, and conflicts of interest between us and the selling or purchasing entities could exist in such transactions. Because our independent directors would rely on our advisor entities in identifying and evaluating any such transaction, these conflicts could result in transactions based on terms that are less favorable to us than we would receive from a third party. Also, the existence of conflicts, regardless of how they are resolved, might negatively affect the public’s perception of us.
If we enter into joint ventures with affiliates, we may face conflicts of interest or disagreements with our joint venture partners that may not be resolved as quickly or on terms as advantageous to us as would be the case if the joint venture had been negotiated at arm’s length with an independent joint venture partner.
In the event that we enter into a joint venture with any other program sponsored or advised by one of our co-sponsors or one of their affiliates, we may face certain additional risks and potential conflicts of interest. For example, securities issued by other current and future programs sponsored by Griffin Capital and American Healthcare Investors may never have an active trading market. Therefore, if we were to become listed on a national securities exchange, we may no longer have similar goals and objectives with respect to the resale of properties in the future. Joint ventures between us and other current and future programs sponsored by Griffin Capital and American Healthcare Investors will not have the benefit of arm’s-length negotiation of the type normally conducted between unrelated co-venturers. Under these joint venture agreements, none of the co-venturers may have the power to control the venture, and an impasse could occur regarding matters pertaining to the joint venture, including determining when and whether to buy or sell a particular property and the timing of a liquidation, which might have a negative impact on the joint venture and decrease returns to our stockholders.
Risks Related to Our Organizational Structure
Several potential events could cause our stockholders’ investment in us to be diluted, which may reduce the overall value of their investment.
Our stockholders’ investment in us could be diluted by a number of factors, including:
 
•
future offerings of our securities, including issuances pursuant to the DRIP and up to 200,000,000 shares of any preferred stock that our board of directors may authorize;
•
private issuances of our securities to other investors, including institutional investors;
•
issuances of our securities pursuant to our incentive plan; or
•
redemptions of units of limited partnership interest in our operating partnership in exchange for shares of our common stock.
To the extent we issue additional equity interests after our stockholders purchase shares of our common stock in our offerings, their percentage ownership interest in us will be diluted. In addition, depending upon the terms and pricing of any additional offerings and the value of our real estate and real estate-related investments, our stockholders may also experience dilution in the book value and fair market value of their shares of our common stock.
Our ability to issue preferred stock may include a preference in distributions superior to our common stock and also may deter or prevent a sale of shares of our common stock in which our stockholders could profit.
Our charter authorizes our board of directors to issue up to 200,000,000 shares of preferred stock. Our board of directors has the discretion to establish the preferences and rights, including a preference in distributions superior to our common stockholders, of any issued preferred stock. If we authorize and issue preferred stock with a distribution preference over our

30

common stock, payment of any distribution preferences of outstanding preferred stock would reduce the amount of funds available for the payment of distributions on our common stock. Further, holders of preferred stock are normally entitled to receive a preference payment in the event we liquidate, dissolve or wind up before any payment is made to our common stockholders, likely reducing the amount our common stockholders would otherwise receive upon such an occurrence. In addition, under certain circumstances, the issuance of preferred stock or a separate class or series of common stock may render more difficult or tend to discourage:
 
•
a merger, tender offer or proxy contest;
•
assumption of control by a holder of a large block of our securities; or
•
removal of incumbent management.
The limit on the percentage of shares of our common stock that any person may own may discourage a takeover or business combination that may have benefited our stockholders.
Our charter restricts the direct or indirect ownership by one person or entity to no more than 9.9% of the value of our then outstanding capital stock (which includes common stock and any preferred stock we may issue) and no more than 9.9% of the value or number of shares, whichever is more restrictive, of our then outstanding common stock. This restriction may discourage a change of control of us and may deter individuals or entities from making tender offers for shares of our stock on terms that might be financially attractive to our stockholders or which may cause a change in our management. This ownership restriction may also prohibit business combinations that would have otherwise been approved by our board of directors and our stockholders. In addition to deterring potential transactions that may be favorable to our stockholders, these provisions may also decrease their ability to sell their shares of our common stock.
Our stockholders’ ability to control our operations is severely limited.
Our board of directors determines our major strategies, including our strategies regarding investments, financing, growth, debt capitalization, REIT qualification and distributions. Our board of directors may amend or revise these and other strategies without a vote of the stockholders. Our charter sets forth the stockholder voting rights required to be set forth therein under the Statement of Policy Regarding Real Estate Investment Trusts adopted by the North American Securities Administrators Association, or the NASAA Guidelines. Under our charter and Maryland law, our stockholders have a right to vote only on the following matters:
 
•
the election or removal of directors;
•
any amendment of our charter, except that our board of directors may amend our charter without stockholder approval to change our name or the name of other designation or the par value of any class or series of our stock and the aggregate par value of our stock, increase or decrease the aggregate number of our shares of stock, increase or decrease the number of our shares of any class or series that we have the authority to issue, effect certain reverse stock splits, or qualify as a REIT under the Code;
•
our dissolution; and
•
certain mergers, consolidations and sales or other dispositions of all or substantially all of our assets.
All other matters are subject to the discretion of our board of directors.
Limitations on share ownership and transfer may deter a sale of our common stock in which our stockholders could profit.
The limits on ownership and transfer of our equity securities in our charter may have the effect of delaying, deferring or preventing a transaction or a change in control that might involve a premium price for our stockholders’ common stock. The ownership limits and restrictions on transferability will continue to apply until our board of directors determines that it is no longer in our best interest to continue to qualify as a REIT.
Maryland takeover statutes may deter others from seeking to acquire us and prevent our stockholders from making a profit in such transaction.
The Maryland General Corporation Law, or the MGCL, contains many provisions, such as the business combination statute and the control share acquisition statute, that are designed to prevent, or have the effect of preventing, someone from acquiring control of us. Our bylaws exempt us from the control share acquisition statute (which eliminates voting rights for certain levels of shares that could exercise control over us) and our board of directors has adopted a resolution opting out of the business combination statute (which, among other things, prohibits a merger or consolidation with a 10.0% stockholder for a period of time) with respect to our affiliates. However, if the bylaw provisions exempting us from the control share acquisition statute or our board resolution opting out of the business combination statute were repealed, these provisions of Maryland law

31

could delay or prevent offers to acquire us and increase the difficulty of consummating any such offers, even if such a transaction would be in our stockholders’ best interest.
The MGCL and our organizational documents limit our stockholders’ right to bring claims against our officers and directors.
The MGCL provides that a director will not have any liability as a director so long as he or she performs his or her duties in good faith, in a manner he or she reasonably believes to be in our best interests, and with the care that an ordinarily prudent person in a like position would use under similar circumstances. In addition, our charter provides that, subject to the applicable limitations set forth therein or under the MGCL, no director or officer will be liable to us or our stockholders for monetary damages. Our charter also provides that we will generally indemnify our directors, our officers, our advisor and its affiliates for losses they may incur by reason of their service in those capacities unless: (1) their act or omission was material to the matter giving rise to the proceeding and was committed in bad faith or was the result of active and deliberate dishonesty; (2) they actually received an improper personal benefit in money, property or services; or (3) in the case of any criminal proceeding, they had reasonable cause to believe the act or omission was unlawful. Moreover, we have entered into separate indemnification agreements with each of our directors and executive officers. As a result, we and our stockholders may have more limited rights against these persons than might otherwise exist under common law. In addition, we may be obligated to fund the defense costs incurred by these persons in some cases. However, our charter also provides that we may not indemnify or hold harmless our directors, our advisor and its affiliates unless they have determined that the course of conduct that caused the loss or liability was in our best interests, they were acting on our behalf or performing services for us, the liability was not the result of negligence or misconduct by our non-independent directors, our advisor and its affiliates or gross negligence or willful misconduct by our independent directors, and the indemnification is recoverable only out of our net assets or the proceeds of insurance and not from our stockholders.
Maryland law prohibits certain business combinations, which may make it more difficult for us to be acquired and may limit our stockholders’ ability to dispose of their shares of our common stock.
Under Maryland law, “business combinations” between a Maryland corporation and an interested stockholder or an affiliate of an interested stockholder are prohibited for five years after the most recent date on which the interested stockholder becomes an interested stockholder. These business combinations include a merger, consolidation, share exchange or, in circumstances specified in the statute, an asset transfer or issuance or reclassification of equity securities. An interested stockholder is defined as:
•
any person who beneficially owns 10.0% or more of the voting power of the corporation’s outstanding voting stock; or
•
an affiliate or associate of the corporation who, at any time within the two-year period prior to the date in question, was the beneficial owner of 10.0% or more of the voting power of the then outstanding stock of the corporation.
A person is not an interested stockholder under the statute if the board of directors approved in advance the transaction by which he or she otherwise would have become an interested stockholder. However, in approving a transaction, the board of directors may provide that its approval is subject to compliance, at or after the time of approval, with any terms and conditions determined by the board.
After the five-year prohibition, any business combination between the Maryland corporation and an interested stockholder generally must be recommended by the board of directors of the corporation and approved by the affirmative vote of at least:
 
•
80.0% of the votes entitled to be cast by holders of outstanding shares of voting stock of the corporation; and
•
two-thirds of the votes entitled to be cast by holders of voting stock of the corporation other than shares of stock held by the interested stockholder with whom or with whose affiliate the business combination is to be effected or held by an affiliate or associate of the interested stockholder.
These super-majority vote requirements do not apply if the corporation’s common stockholders receive a minimum price, as defined under Maryland law, for their shares of our common stock in the form of cash or other consideration in the same form as previously paid by the interested stockholder for its shares of our common stock. The business combination statute permits various exemptions from its provisions, including business combinations that are exempted by the board of directors prior to the time that the interested stockholder becomes an interested stockholder. Our board of directors has adopted a resolution providing that any business combination between us and any other person is exempted from this statute, provided that such business combination is first approved by our board of directors. This resolution, however, may be altered or repealed in whole or in part at any time. If this resolution is repealed or our board of directors fails to first approve the business

32

combination, the business combination statute may discourage others from trying to acquire control of us and increase the difficulty of consummating any offer.
Our charter includes a provision that may discourage a stockholder from launching a tender offer for shares of our common stock.
Our charter requires that any tender offer made by a person, including any “mini-tender” offer, must comply with Regulation 14D of the Securities Exchange Act of 1934, as amended. The offeror must provide us notice of the tender offer at least ten business days before initiating the tender offer. If the offeror does not comply with these requirements, we will have the right to repurchase that person’s shares of our stock and any shares of our stock acquired in such tender offer. In addition, the non-complying offeror shall be responsible for all of our expenses in connection with that stockholders’ noncompliance. This provision of our charter may discourage a person from initiating a tender offer for shares of our common stock and prevent our stockholders from receiving a premium price for their shares of our common stock in such a transaction.
Our stockholders’ investment return may be reduced if we are required to register as an investment company under the Investment Company Act. To avoid registration as an investment company, we may not be able to operate our business successfully. If we become subject to registration under the Investment Company Act, we may not be able to continue our business.
We are not registered, and do not intend to register, as an investment company under the Investment Company Act. If for any reason, we were required to register as an investment company, we would have to comply with a variety of substantive requirements under the Investment Company Act imposing, among other things:
 
•
limitations on capital structure;
•
restrictions on specified investments;
•
prohibitions on transactions with affiliates; and
•
compliance with reporting, record keeping, voting, proxy disclosure and other rules and regulations that would significantly change our operations.
In order for us not to be subject to regulation under the Investment Company Act, we intend to engage, through our operating partnership and subsidiaries, primarily in the business of buying real estate. We expect that investments in real estate will represent the substantial majority of our total asset mix, which would not subject us to the Investment Company Act by virtue of the definition of “investment company” provided in Section 3(a)(1) of the Investment Company Act.
In the event that any of our subsidiaries are deemed to be an investment company pursuant to Section 3(a)(1) of the Investment Company Act, such subsidiaries would have to rely on the exclusion from the definition of “investment company” provided by Section 3(c)(5)(C) of the Investment Company Act. To rely upon Section 3(c)(5)(C) of the Investment Company Act such subsidiaries would have to invest at least 55.0% of its respective portfolio in “mortgage and other liens on and interests in real estate,” which we refer to as “qualifying real estate investments” and maintain an additional 25.0% of assets in qualifying real estate investments or other real estate-related assets. The remaining 20.0% of the portfolio’s assets can consist of miscellaneous assets. What we buy and sell is therefore limited to these criteria. How we classify our assets for purposes of the Investment Company Act will be based in large measure upon no-action letters issued by the SEC staff in the past and other SEC interpretive guidance. These no-action positions were issued in accordance with factual situations that may be substantially different from the factual situations we may face, and a number of these no-action positions were issued more than ten years ago. Pursuant to this guidance, and depending on the characteristics of the specific investments, certain mortgage loans, participations in mortgage loans, mortgage-backed securities, mezzanine loans, joint venture investments and the equity securities of other entities may not constitute qualifying real estate assets, and therefore, investments in these types of assets may be limited. The SEC may not concur with our classification of our assets. Future revisions to the Investment Company Act or further guidance from the SEC may cause us to lose our exclusion from registration or force us to re-evaluate our portfolio and our investment strategy. Such changes may prevent us from operating our business successfully.
We may determine to operate through our majority owned operating partnership or other wholly owned or majority owned subsidiaries. If so, our subsidiaries will be subject to investment restrictions so that the respective majority owned or wholly owned subsidiary does not come within the definition of an investment company, or cause us to come within the definition of an investment company, under the Investment Company Act.
To ensure that neither we, nor our operating partnership, nor any of our other wholly owned or majority owned subsidiaries are required to register as an investment company, each entity may be unable to sell assets we would otherwise want to sell and may need to sell assets we would otherwise wish to retain. In addition, we, our operating partnership or any of our other wholly owned or majority owned subsidiaries may be required to acquire additional income- or loss-generating assets

33

that we might not otherwise acquire or forego opportunities to acquire interests in companies that we would otherwise want to acquire. Although we intend to monitor our portfolio periodically and prior to each acquisition, any of these entities may not be able to maintain an exclusion from registration as an investment company. If we, our operating partnership or any of our other subsidiaries are required to register as an investment company but fail to do so, the unregistered entity would be prohibited from engaging in our business, and criminal and civil actions could be brought against such entity. In addition, the contracts of such entity would be unenforceable unless a court required enforcement, and a court could appoint a receiver to take control of the entity and liquidate its business.
As part of our advisor’s obligations under the Advisory Agreement, our advisor agrees to refrain from taking any action which, in its sole judgment made in good faith, would subject us to regulation under the Investment Company Act. Failure to maintain an exclusion from registration under the Investment Company Act would require us to significantly restructure our business plan. For example, because affiliate transactions generally are prohibited under the Investment Company Act, we would not be able to enter into transactions with any of our affiliates if we are required to register as an investment company, and we may be required to terminate the Advisory Agreement and any other agreements with affiliates, which could have a material adverse effect on our ability to operate our business and pay distributions.
Risks Related to Investments in Real Estate
Changes in international, national, regional or local economic, demographic or real estate market conditions may adversely affect our results of operations and our ability to pay distributions to our stockholders or reduce the value of their investment.
We are subject to risks generally incidental to the ownership of real estate, including changes in international, national, regional or local economic, demographic or real estate market conditions. We are unable to predict future changes in international, national, regional or local economic, demographic or real estate market conditions. For example, a recession or rise in interest rates could make it more difficult for us to lease real properties or dispose of them. In addition, rising interest rates could also make alternative interest-bearing and other investments more attractive, and therefore, potentially lower the relative value of our existing real estate investments. These conditions, or others we cannot predict, may adversely affect our results of operations, our ability to pay distributions to our stockholders or reduce the value of their investment.
If we acquire real estate at a time when the real estate market is experiencing substantial influxes of capital investment and competition for income-producing properties, such real estate investments may not appreciate or may decrease in value.
Although the real estate market has experienced severe dislocations in recent years, in the future the market may experience a substantial influx of capital from investors. Any substantial flow of capital, combined with significant competition for income-producing real estate, may result in inflated purchase prices for such assets. To the extent we purchase real estate in such an environment in the future, we will be subject to the risk that the value of such investments may not appreciate or may decrease significantly below the amount we paid for such investment.
We may obtain only limited warranties when we purchase a property and would have only limited recourse in the event our due diligence did not identify any issues that lower the value of our property.
The seller of a property often sells such property in its “as is” condition on a “where is” basis and “with all faults,” without any warranties of merchantability or fitness for a particular use or purpose. In addition, purchase and sale agreements may contain only limited warranties, representations and indemnifications that will only survive for a limited period after the closing. The purchase of properties with limited warranties increases the risk that we may lose some or all of our invested capital in the property, as well as the loss of real estate revenue from that property.
Acquiring or attempting to acquire multiple properties in a single transaction may adversely affect our operations.
From time to time, we may attempt to acquire multiple properties in a single transaction. Portfolio acquisitions are more complex and expensive than single property acquisitions, and the risk that a multiple-property acquisition does not close may be greater than in a single-property acquisition. Portfolio acquisitions may also result in us owning investments in geographically dispersed markets, placing additional demands on our ability to manage the properties in the portfolio. In addition, a seller may require that a group of properties be purchased as a package even though we may not want to purchase one or more properties in the portfolio. In these situations, if we are unable to identify another person or entity to acquire the unwanted properties, we may be required to operate or attempt to dispose of these properties. To acquire multiple properties in a single transaction, we may be required to accumulate a large amount of cash. We would expect the returns that we earn on such cash to be less than the ultimate returns on real property; therefore, accumulating such cash could reduce our funds available for distributions to our stockholders. Any of the foregoing events may have an adverse effect on our operations.

34

Uninsured losses relating to real estate and lender requirements to obtain insurance may reduce our stockholders’ returns.
There are types of losses relating to real estate, generally catastrophic in nature, such as losses due to wars, acts of terrorism, earthquakes, floods, hurricanes, pollution or environmental matters, for which we do not intend to obtain insurance unless we are required to do so by mortgage lenders. If any of our properties incurs a casualty loss that is not fully covered by insurance, the value of our assets will be reduced by any such uninsured loss. In addition, other than any reserves we may establish, we have no source of funding to repair or reconstruct any uninsured damaged property, and we cannot assure our stockholders that any such sources of funding will be available to us for such purposes in the future. Also, to the extent we must pay unexpectedly large amounts for uninsured losses, we could suffer reduced earnings that would result in less cash to be distributed to our stockholders. In cases where we are required by mortgage lenders to obtain casualty loss insurance for catastrophic events or terrorism, such insurance may not be available, or may not be available at a reasonable cost, which could inhibit our ability to finance or refinance our properties. Additionally, if we obtain such insurance, the costs associated with owning a property would increase and could have a material adverse effect on the net income from the property, and, thus, the cash available for distribution to our stockholders.
Terrorist attacks and other acts of violence or war may affect the markets in which we operate and have a material adverse effect on our financial condition, results of operations and ability to pay distributions to our stockholders.
Terrorist attacks may negatively affect our operations and our stockholders’ investment. We may acquire real estate assets located in areas that are susceptible to attack. These attacks may directly impact the value of our assets through damage, destruction, loss or increased security costs. Although we may obtain terrorism insurance, we may not be able to obtain sufficient coverage to fund any losses we may incur. Risks associated with potential acts of terrorism could sharply increase the premiums we pay for coverage against property and casualty claims. Further, certain losses resulting from these types of events are uninsurable or not insurable at reasonable costs.
More generally, any terrorist attack, other act of violence or war, including armed conflicts, could result in increased volatility in, or damage to, the U.S. and worldwide financial markets and economy, all of which could adversely affect our tenants’ ability to pay rent on their leases or our ability to borrow money or issue capital stock at acceptable prices, which could have a material adverse effect on our financial condition, results of operations and ability to pay distributions to our stockholders.
Dramatic increases in insurance rates could adversely affect our cash flows and our ability to pay distributions to our stockholders.
We may not be able to obtain insurance coverage at reasonable rates due to high premium and/or deductible amounts. As a result, our cash flows could be adversely impacted due to these higher costs, which would adversely affect our ability to pay distributions to our stockholders.
Delays in the acquisition, development and construction of real properties may have adverse effects on our results of operations and our ability to pay distributions to our stockholders.
Delays we encounter in the selection, acquisition and development of real properties could adversely affect our stockholders’ returns. Where properties are acquired prior to the start of construction or during the early stages of construction, it will typically take several months to complete construction and rent available space. If we engage in development or construction projects, we will be subject to uncertainties associated with re-zoning for development, environmental concerns of governmental entities and/or community groups, and our builder’s ability to build in conformity with plans, specifications, budgeted costs, and timetables. If a builder fails to perform, we may resort to legal action to rescind the purchase or the construction contract or to compel performance. A builder’s performance may also be affected or delayed by conditions beyond the builder’s control. Therefore, our stockholders could suffer delays in the receipt of cash distributions attributable to those particular real properties. Delays in completion of construction could give tenants the right to terminate preconstruction leases for space at a newly developed project. We may incur additional risks when we make periodic progress payments or other advances to builders prior to the completion of construction. These and other such factors can result in increased costs of a project or loss of our investment. In addition, we will be subject to normal lease-up risks relating to newly constructed projects. We also must rely on real estate revenue and expense projections and estimates of the fair market value of property upon completion of construction when agreeing upon a price at the time we acquire the property. If our projections are inaccurate, we may pay too much for a property, and our return on our investment could suffer.
While we do not currently intend to do so, we may invest in unimproved real property. Returns from development of unimproved properties are also subject to risks associated with re-zoning the land for development and environmental concerns of governmental entities and/or community groups. Although we intend to limit any investment in unimproved real property to real property we intend to develop, our stockholders’ investment, nevertheless, is subject to the risks associated with investments in unimproved real property.

35

If we contract with a development company for newly developed property, our earnest money deposit made to the development company may not be fully refunded.
We have and in the future may acquire one or more properties under development. We anticipate that if we do acquire properties that are under development, we will be obligated to pay a substantial earnest money deposit at the time of contracting to acquire such properties, and that we will be required to close the purchase of the property upon completion of the development of the property. We may enter into such a contract with the development company even if at the time we enter into the contract, we have not yet raised sufficient proceeds from any future indebtedness or possible future equity offerings to enable us to close the purchase of such property. However, we may not be required to close a purchase from the development company, and may be entitled to a refund of our earnest money, in the following circumstances:
 
•
the development company fails to develop the property;
•
all or a specified portion of the pre-leased tenants fail to take possession under their leases for any reason; or
•
we are unable to raise sufficient proceeds from any future indebtedness or possible future equity offerings to pay the purchase price at closing.
The obligation of the development company to refund our earnest money deposit will be unsecured, and we may not be able to obtain a refund of such earnest money deposit from it under these circumstances since the development company may be an entity without substantial assets or operations.
Uncertain market conditions relating to the future disposition of properties could cause us to sell our properties at a loss in the future.
We intend to hold our various real estate investments until such time as our advisor entities determines that a sale or other disposition appears to be advantageous to achieve our investment objectives. Our advisor, through our sub-advisor and subject to the oversight and approval of our board of directors, may exercise its discretion as to whether and when to sell a property, and we will have no obligation to sell properties at any particular time. We generally intend to hold properties for an extended period of time, and we cannot predict with any certainty the various market conditions affecting real estate investments that will exist at any particular time in the future. Because of the uncertainty of market conditions that may affect the future disposition of our properties, we cannot assure our stockholders that we will be able to sell our properties at a profit in the future. Additionally, we may incur prepayment penalties in the event we sell a property subject to a mortgage earlier than we otherwise had planned. Accordingly, the extent to which our stockholders will receive cash distributions and realize potential appreciation on our real estate investments will, among other things, be dependent upon fluctuating market conditions.
Our inability to sell a property when we desire to do so could adversely impact our ability to pay cash distributions to our stockholders.
The real estate market is affected by many factors, such as general economic conditions, availability of financing, interest rates, supply and demand, and other factors that are beyond our control. We cannot predict whether we will be able to sell any property for the price or on the terms set by us, or whether any price or other terms offered by a prospective purchaser would be acceptable to us. We may be required to expend funds to correct defects or to make improvements before a property can be sold. We may not have adequate funds available to correct such defects or to make such improvements. Moreover, in acquiring a property, we may agree to restrictions that prohibit the sale of that property for a period of time or impose other restrictions, such as a limitation on the amount of debt that can be placed or repaid on that property. We cannot predict the length of time needed to find a willing purchaser and to close the sale of a property. Our inability to sell a property when we desire to do so may cause us to reduce our selling price for the property. Any delay in our receipt of proceeds, or diminishment of proceeds, from the sale of a property could adversely impact our ability to pay distributions to our stockholders.
If we sell properties by providing financing to purchasers, defaults by the purchasers would adversely affect our cash flows from operations.
If we decide to sell any of our properties, we intend to use our best efforts to sell them for cash. However, in some instances we may sell our properties by providing financing to purchasers. When we provide financing to purchasers, we will bear the risk that the purchaser may default on its obligations under the financing, which could negatively impact cash flows from operations. Even in the absence of a purchaser default, the distribution of sale proceeds, or their reinvestment in other assets, will be delayed until the promissory notes or other property we may accept upon the sale are actually paid, sold, refinanced or otherwise disposed of. In some cases, we may receive initial down payments in cash and other property in the year of sale in an amount less than the selling price, and subsequent payments will be spread over a number of years. If any purchaser defaults under a financing arrangement with us, it could negatively impact our ability to pay cash distributions to our stockholders.

36

Our stockholders may not receive any profits resulting from the sale of one of our properties, or receive such profits in a timely manner, because we may provide financing to the purchaser of such property.
If we sell one of our properties during liquidation, our stockholders may experience a delay before receiving their share of the proceeds of such liquidation. In a forced or voluntary liquidation, we may sell our properties either subject to or upon the assumption of any then outstanding mortgage debt or, alternatively, may provide financing to purchasers. We may take a purchase money obligation secured by a mortgage as partial payment. We do not have any limitations or restrictions on our taking such purchase money obligations. To the extent we receive promissory notes or other property instead of cash from sales, such proceeds, other than any interest payable on those proceeds, will not be included in net sale proceeds until and to the extent the promissory notes or other property are actually paid, sold, refinanced or otherwise disposed of. In many cases, we will receive initial down payments in the year of sale in an amount less than the selling price and subsequent payments will be spread over a number of years. Therefore, our stockholders may experience a delay in the distribution of the proceeds of a sale until such time.
We face possible liability for environmental cleanup costs and damages for contamination related to properties we acquire, which could substantially increase our costs and reduce our liquidity and cash distributions to our stockholders.
Because we own and operate real estate, we are subject to various international, federal, state and local environmental laws, ordinances and regulations. Under these laws, ordinances and regulations, a current or previous owner or operator of real estate may be liable for the cost of removal or remediation of hazardous or toxic substances on, under or in such property. The costs of removal or remediation could be substantial. Such laws often impose liability whether or not the owner or operator knew of, or was responsible for, the presence of such hazardous or toxic substances. Environmental laws also may impose restrictions on the manner in which property may be used or businesses may be operated, and these restrictions may require substantial expenditures. Environmental laws provide for sanctions in the event of noncompliance and may be enforced by governmental agencies or, in certain circumstances, by private parties. Certain environmental laws and common law principles could be used to impose liability for release of and exposure to hazardous substances, including the release of asbestos-containing materials into the air, and third parties may seek recovery from owners or operators of real estate for personal injury or property damage associated with exposure to released hazardous substances. In addition, new or more stringent laws or stricter interpretations of existing laws could change the cost of compliance or liabilities and restrictions arising out of such laws. The cost of defending against these claims, complying with environmental regulatory requirements, conducting remediation of any contaminated property, or of paying personal injury claims could be substantial, which would reduce our liquidity and cash available for distribution to our stockholders. In addition, the presence of hazardous substances on a property or the failure to meet environmental regulatory requirements may materially impair our ability to use, lease or sell a property, or to use the property as collateral for borrowing.
Our real estate investments are concentrated in medical office buildings and other healthcare-related facilities, making us more vulnerable economically than if our investments were diversified.
As a REIT, we invest primarily in real estate. Within the real estate industry, we have acquired and will continue to acquire or selectively develop and own medical office buildings and healthcare-related facilities. We are subject to risks inherent in concentrating investments in real estate. These risks resulting from a lack of diversification become even greater as a result of our business strategy to invest to a substantial degree in healthcare-related facilities.
A downturn in the commercial real estate industry generally could significantly adversely affect the value of our properties. A downturn in the healthcare industry could negatively affect our lessees’ ability to make lease payments to us and our ability to pay distributions to our stockholders. These adverse effects could be more pronounced than if we diversified our investments outside of real estate or if our portfolio did not include a substantial concentration in medical office buildings and healthcare-related facilities.
A high concentration of our properties in a particular geographic area would magnify the effects of downturns in that geographic area.
Although we intend to continue to acquire real estate throughout the U.S. and internationally, a significant portion of our portfolio is located in the United Kingdom and the southern and midwest regions of the U.S. Any adverse situation that disproportionately effects those geographic areas would have a magnified adverse effect on our portfolio.
Certain of our properties may not have efficient alternative uses, so the loss of a tenant may cause us not to be able to find a replacement or cause us to spend considerable capital to adapt the property to an alternative use.
Some of the properties we have acquired and will seek to acquire are specialized medical facilities. If we or our tenants terminate the leases for these properties or our tenants lose their regulatory authority to operate such properties, we may not be able to locate suitable replacement tenants to lease the properties for their specialized uses. Alternatively, we may be required to

37

spend substantial amounts to adapt the properties to other uses. Any loss of revenues or additional capital expenditures required as a result may have a material adverse effect on our business, financial condition and results of operations and our ability to pay distributions to our stockholders.
Our medical office buildings, healthcare-related facilities and tenants may be unable to compete successfully.
Our medical office buildings and healthcare-related facilities often face competition from nearby hospitals and other medical office buildings that provide comparable services. Some of those competing facilities are owned by governmental agencies and supported by tax revenues, and others are owned by nonprofit corporations and may be supported to a large extent by endowments and charitable contributions. These types of support are not available to our buildings.
Similarly, our tenants face competition from other medical practices in nearby hospitals and other medical facilities. Our tenants’ failure to compete successfully with these other practices could adversely affect their ability to make rental payments, which could adversely affect our rental revenues. Further, from time to time and for reasons beyond our control, referral sources, including physicians and managed care organizations, may change their lists of hospitals or physicians to which they refer patients. This could adversely affect our tenants’ ability to make rental payments, which could adversely affect our rental revenues.
Any reduction in rental revenues resulting from the inability of our medical office buildings and healthcare-related facilities and our tenants to compete successfully may have a material adverse effect on our business, financial condition and results of operations and our ability to pay distributions to our stockholders.
A proposed change in GAAP for leases could reduce the overall demand to lease our properties.
The existing accounting standards for leases require lessees to classify their leases as either capital or operating leases. Under a capital lease, both the leased asset, which represents the tenant’s right to use the property, and the contractual lease obligation are recorded on the tenant’s balance sheet if one of the following criteria are met: (i) the lease transfers ownership of the property to the lessee by the end of the lease term; (ii) the lease contains a bargain purchase option; (iii) the non-cancellable lease term is more than 75.0% of the useful life of the asset; or (iv) if the present value of the minimum lease payments equals 90.0% or more of the leased property’s fair value. If the terms of the lease do not meet these criteria, the lease is considered an operating lease, and no leased asset or contractual lease obligation is recorded by the tenant.
In order to address concerns raised by the SEC regarding the transparency of contractual lease obligations under the existing accounting standards for operating leases, the Financial Accounting Standards Board, or the FASB, and the International Accounting Standards Board, or the IASB, initiated a joint project to develop new guidelines to lease accounting. The FASB and IASB, or collectively, the Boards, issued an Exposure Draft on August 17, 2010 and a Revised Exposure Draft on May 16, 2013, or collectively, the Exposure Drafts, which propose substantial changes to the current lease accounting standards, primarily by eliminating the concept of operating lease accounting. As a result, a lease asset and obligation will be recorded on the tenant’s balance sheet for all lease arrangements. In addition, the Exposure Drafts will impact the method in which contractual lease payments will be recorded. In order to mitigate the effect of the proposed lease accounting, tenants may seek to negotiate certain terms within new lease arrangements or modify terms in existing lease arrangements, such as shorter lease terms or fewer extension options, which would generally have less impact on tenant balance sheets. Also, tenants may reassess their lease-versus-buy strategies. This could result in a greater renewal risk, a delay in investing proceeds from this offering, or shorter lease terms, all of which may negatively impact our operations and ability to pay distributions.
After receiving extensive comments on the Exposure Drafts, the Boards are considering all feedback received and are re-deliberating all significant issues through early 2014.
Our costs associated with complying with the Americans with Disabilities Act may reduce our cash available for distributions.
The properties we acquire may be subject to the ADA. Under the ADA, all places of public accommodation are required to comply with federal requirements related to access and use by disabled persons. The ADA has separate compliance requirements for “public accommodations” and “commercial facilities” that generally require that buildings and services be made accessible and available to people with disabilities. The ADA’s requirements could require removal of access barriers and could result in the imposition of injunctive relief, monetary penalties or, in some cases, an award of damages. We attempt to acquire properties that comply with the ADA or place the burden on the seller or other third party, such as a tenant, to ensure compliance with the ADA. However, we cannot assure our stockholders that we will be able to acquire properties or allocate responsibilities in this manner. If we cannot, our funds used for ADA compliance may reduce cash available for distributions and the amount of distributions to our stockholders.

38

Increased operating expenses could reduce cash flows from operations and funds available to acquire investments or pay distributions.
Any property that we have acquired or may acquire will be subject to operating risks common to real estate in general, any or all of which may negatively affect us. If any property is not fully occupied or if rents are being paid in an amount that is insufficient to cover operating expenses, we could be required to expend funds with respect to that property for operating expenses. The properties will be subject to increases in tax rates, utility costs, insurance costs, repairs and maintenance costs, administrative costs and other operating expenses. While we expect that many of our property leases will require the tenants to pay all or a portion of these expenses, some of our leases or future leases may not be negotiated on that basis, in which event we may have to pay these costs. If we are unable to lease properties on terms that require the tenants to pay all or some of the properties’ operating expenses, if our tenants fail to pay these expenses as required or if expenses we are required to pay exceed our expectations, we could have less funds available for future acquisitions or cash available for distributions to our stockholders.
Our operating properties are subject to real and personal property taxes that may increase in the future, which could adversely affect our cash flows.
Our operating properties are subject to real and personal property taxes that may increase as tax rates change and as the operating properties are assessed or reassessed by taxing authorities. Some of our leases generally provide that the property taxes or increases therein are charged to the tenants as an expense related to the operating properties that they occupy, while other leases will generally provide that we are responsible for such taxes. In any case, as the owner of the properties, we will be ultimately responsible for the payment of taxes to the applicable government authorities. If real property taxes increase, our tenants may be unable to make the required tax payments, ultimately requiring us to pay the taxes even if otherwise stated under the terms of the lease. If we fail to pay any such taxes, the applicable taxing authority may place a lien on the operating property and the operating property may be subject to a tax sale. In addition, we are generally responsible for real property taxes related to any vacant space.
Costs of complying with governmental laws and regulations related to environmental protection and human health and safety may be high.
All real property investments and the operations conducted in connection with such investments are subject to international, federal, state and local laws and regulations relating to environmental protection and human health and safety. Some of these laws and regulations may impose joint and several liability on customers, owners or operators for the costs to investigate or remediate contaminated properties, regardless of fault or whether the acts causing the contamination were legal.
Under various international, federal, state and local environmental laws, a current or previous owner or operator of real property may be liable for the cost of removing or remediating hazardous or toxic substances on such real property. Such laws often impose liability whether or not the owner or operator knew of, or was responsible for, the presence of such hazardous or toxic substances. In addition, the presence of hazardous substances, or the failure to properly remediate those substances, may adversely affect our ability to sell, rent or pledge such real property as collateral for future borrowings. Environmental laws also may impose restrictions on the manner in which real property may be used or businesses may be operated. Some of these laws and regulations have been amended so as to require compliance with new or more stringent standards as of future dates. Compliance with new or more stringent laws or regulations or stricter interpretation of existing laws may require us to incur material expenditures. Future laws, ordinances or regulations may impose material environmental liability. Additionally, our tenants’ operations, the existing condition of land when we buy it, operations in the vicinity of our real properties, such as the presence of underground storage tanks, or activities of unrelated third parties may affect our real properties. In addition, there are various local, state, international and federal fire, health, life-safety and similar regulations with which we may be required to comply, and which may subject us to liability in the form of fines or damages for noncompliance. In connection with the acquisition and ownership of our real properties, we may be exposed to such costs in connection with such regulations. The cost of defending against environmental claims, of any damages or fines we must pay, of compliance with environmental regulatory requirements or of remediating any contaminated real property could materially and adversely affect our business, lower the value of our assets or results of operations and, consequently, lower the amounts available for distribution to our stockholders.

Ownership of property outside the U.S. may subject us to different or greater risks than those associated with our domestic operations.
We have operations in the United Kingdom. International development, ownership, and operating activities involve risks that are different from those we face with respect to our domestic properties and operations. These risks include, but are not limited to, any international currency gain recognized with respect to changes in exchange rates may not qualify under the 75% gross income test or the 95% gross income test that we must satisfy annually in order to maintain our status as a REIT;

39

challenges with respect to the repatriation of foreign earnings and cash; changes in foreign political, regulatory, and economic conditions, including regionally, nationally, and locally; challenges in managing international operations; challenges of complying with a wide variety of foreign laws and regulations, including those relating to real estate, corporate governance, operations, taxes, employment and legal proceedings; foreign ownership restrictions with respect to operations in countries; diminished ability to legally enforce our contractual rights in foreign countries; differences in lending practices and the willingness of domestic or foreign lenders to provide financing; regional or country-specific business cycles and economic instability; and changes in applicable laws and regulations in the U.S. that affect foreign operations. In addition, we have limited investing experience in international markets. If we are unable to successfully manage the risks associated with international expansion and operations, our results of operations and financial condition may be adversely affected.

Investments in properties or other real estate-related investments outside the U.S. would subject us to foreign currency risks, which may adversely affect distributions and our REIT status.
We generate a portion of our revenue in such foreign currencies as the United Kingdom Pound Sterling. Revenues generated from any properties or other real estate-related investments we acquire or ventures we enter into relating to transactions involving assets located in markets outside the U.S. likely will be denominated in the local currency. Therefore, any investments we make outside the U.S. may subject us to foreign currency risk due to potential fluctuations in exchange rates between foreign currencies and the U.S. Dollar. As a result, changes in exchange rates of any such foreign currency to U.S. Dollars may affect our revenues, operating margins and distributions and may also affect the book value of our assets and the amount of stockholders' equity.
Changes in foreign currency exchange rates used to value a REIT's foreign assets may be considered changes in the value of the REIT's assets. These changes may adversely affect our status as a REIT. Further, bank accounts in a foreign currency which are not considered cash or cash equivalents may adversely affect our status as a REIT.
Risks Related to the Healthcare Industry
The healthcare industry is heavily regulated and new laws or regulations, changes to existing laws or regulations, loss of licensure or failure to obtain licensure could result in the inability of our tenants to make rent payments to us.
The healthcare industry is heavily regulated by international, federal, state and local governmental bodies. Our tenants generally are subject to laws and regulations covering, among other things, licensure, certification for participation in government programs, and relationships with physicians and other referral sources. Changes in these laws and regulations could negatively affect the ability of our tenants to make lease payments to us and our ability to pay distributions to our stockholders.
Many of our medical properties and their tenants may require a license or certificate of need, or CON, to operate. Failure to obtain a license or CON, or loss of a required license or CON would prevent a facility from operating in the manner intended by the tenant. These events could materially adversely affect our tenants’ ability to make rent payments to us. State and local laws also may regulate expansion, including the addition of new beds or services or acquisition of medical equipment, and the construction of healthcare-related facilities, by requiring a CON or other similar approval. State CON laws are not uniform throughout the U.S. and are subject to change; therefore, this may adversely impact our tenants’ ability to provide services in different states. We cannot predict the impact of state CON laws on our development of facilities or the operations of our tenants.
In addition, state CON laws often materially impact the ability of competitors to enter into the marketplace of our facilities. The repeal of CON laws could allow competitors to freely operate in previously closed markets. This could negatively affect our tenants’ abilities to make rent payments to us.
In limited circumstances, loss of state licensure or certification or closure of a facility could ultimately result in loss of authority to operate the facility and require new CON authorization to re-institute operations. As a result, a portion of the value of the facility may be reduced, which would adversely impact our business, financial condition and results of operations and our ability to pay distributions to our stockholders.

Reductions in reimbursement from third party payors, including Medicare, Medicaid and international government sponsored programs, could adversely affect the profitability of our tenants and hinder their ability to make rent payments to us.
Sources of revenue for our tenants may include the federal Medicare program, state Medicaid programs, international government sponsored programs, private insurance carriers and health maintenance organizations, among others. Efforts by such payors to reduce healthcare costs will likely continue, which may result in reductions or slower growth in reimbursement for certain services provided by some of our tenants. In addition, the healthcare billing rules and regulations are complex, and the failure of any of our tenants to comply with various laws and regulations could jeopardize their ability to continue

40

participating in Medicare, Medicaid and other U.S. and international government sponsored payment programs. Moreover, the U.S. state and federal governmental healthcare programs are subject to reductions by state and federal legislative actions. The American Taxpayer Relief Act of 2012 prevented the reduction in physician reimbursement of Medicare from being implemented in 2013. Therefore, the reduction of 27.0% for Medicare reimbursement to physicians that is related to the sustainable growth rate adjustment has been delayed until March 31, 2014. However, this is merely a delay in the implementation of the Medicare payment reduction to physicians and it may be implemented in 2014, which will adversely impact our U.S. tenants’ ability to make rental payments. At this time, Congress has not repealed the sustainable growth rate adjustment, but the House Energy and Commerce and Ways and Means Panels and the Senate Finance Committee have passed bills to repeal the sustainable growth rate.
The healthcare industry continues to face various challenges, including increased government and private payor pressure on healthcare providers to control or reduce costs. It is possible that our tenants will continue to experience a shift in payor mix away from fee-for-service payors, resulting in an increase in the percentage of revenues attributable to managed care payors, and general industry trends that include pressures to control healthcare costs. Our tenants located in some international areas may also be limited to a single national payor system and any changes to the reimbursement by the national payor may adversely impact our international tenants’ ability to operate. Pressures to control healthcare costs and a shift in the U.S. away from traditional health insurance reimbursement to managed care plans have resulted in an increase in the number of U.S. patients whose healthcare coverage is provided under managed care plans, such as health maintenance organizations and preferred provider organizations. In 2014, in the U.S., state insurance exchanges will be implemented which will provide a new mechanism for individuals to obtain insurance. At this time, the number of payers that are participating in the state insurance exchanges varies, and in some regions there are very limited insurance plans available for individuals to choose from when purchasing insurance. In addition, not all healthcare providers will maintain participation agreements with the payers that are participating in the state health insurance exchange. Therefore, it is possible that our tenants may incur a change in their reimbursement if the tenant does not have a participation agreement with the state insurance exchange payers and a large number of individuals elect to purchase insurance from the state insurance exchange. Further, the rates of reimbursement from the state insurance exchange payers to healthcare providers will vary greatly. The rates of reimbursement will be subject to negotiation between the healthcare provider and the payer, which may vary based upon the market, the healthcare provider’s quality metrics, the number of providers participating in the area and the patient population, among other factors. Therefore, it is uncertain whether healthcare providers will incur a decrease in reimbursement from the state insurance exchange, which may impact a tenant’s ability to pay rent.
In addition, the U.S. healthcare legislation passed in 2010 included new payment models with new shared savings programs and demonstration programs that include bundled payment models and payments contingent upon reporting on satisfaction of quality benchmarks. The new payment models will likely change how physicians are paid for services. These changes could have a material adverse effect on the financial condition of some or all of our U.S. tenants. The financial impact on our tenants could restrict their ability to make rent payments to us, which would have a material adverse effect on our business, financial condition and results of operations and our ability to pay distributions to our stockholders.
Some tenants of our medical office buildings and healthcare-related facilities will be subject to fraud and abuse laws, the violation of which by a tenant may jeopardize the tenant’s ability to make rent payments to us.
There are various federal and state laws prohibiting fraudulent and abusive business practices by healthcare providers who participate in, receive payments from or are in a position to make referrals in connection with government-sponsored healthcare programs, including the Medicare and Medicaid programs. Our lease arrangements with certain tenants may also be subject to these fraud and abuse laws. In order to support compliance with the fraud and abuse laws, our lease agreements may be required to satisfy the Stark Law exception and the Anti-Kickback Statute safe harbor for lease arrangements, which impacts the terms and conditions that may be negotiated in the lease arrangements.
These laws include:
 
•
the Federal Anti-Kickback Statute, which prohibits, among other things, the offer, payment, solicitation or receipt of any form of remuneration in return for, or to induce, the referral of any item or service reimbursed by Medicare or Medicaid;
•
the Federal Physician Self-Referral Prohibition, which, subject to specific exceptions, restricts physicians from making referrals for specifically designated health services for which payment may be made under Medicare or Medicaid programs to an entity with which the physician, or an immediate family member, has a financial relationship;
•
the False Claims Act, which prohibits any person from knowingly presenting false or fraudulent claims for payment to the federal government, including claims paid by the Medicare and Medicaid programs; and

41

•
the Civil Monetary Penalties Law, which authorizes the U.S. Department of Health and Human Services to impose monetary penalties for certain fraudulent acts.
Each of these laws includes criminal and/or civil penalties for violations that range from punitive sanctions, damage assessments, penalties, imprisonment, denial of Medicare and Medicaid payments and/or exclusion from the Medicare and Medicaid programs. Certain laws, such as the False Claims Act, allow for individuals to bring whistleblower actions on behalf of the government for violations thereof. Additionally, states in which the facilities are located may have similar fraud and abuse laws. Investigation by a federal or state governmental body for violation of fraud and abuse laws or imposition of any of these penalties upon one of our tenants could jeopardize that tenant’s ability to operate or to make rent payments, which may have a material adverse effect on our business, financial condition and results of operations and our ability to pay distributions to our stockholders.
Adverse trends in healthcare provider operations may negatively affect our lease revenues and our ability to pay distributions to our stockholders.
The healthcare industry is currently experiencing:
 
•
changes in the demand for and methods of delivering healthcare services;
•
changes in third party reimbursement policies;
•
significant unused capacity in certain areas, which has created substantial competition for patients among healthcare providers in those areas;
•
increased expense for uninsured patients;
•
increased competition among healthcare providers;
•
increased liability insurance expense;
•
continued pressure by private and governmental payors to reduce payments to providers of services;
•
increased scrutiny of billing, referral and other practices by federal and state authorities;
•
changes in federal and state healthcare program payment models; and
•
increased emphasis on compliance with privacy and security requirements related to personal health information.
These factors may adversely affect the economic performance of some or all of our tenants and, in turn, our lease revenues and our ability to pay distributions to our stockholders.
Our healthcare-related tenants may be subject to significant legal actions that could subject them to increased operating costs and substantial uninsured liabilities, which may affect their ability to pay their rent payments to us.
As is typical in the healthcare industry, our healthcare-related tenants may often become subject to claims that their services have resulted in patient injury or other adverse effects. Many of these tenants may have experienced an increasing trend in the frequency and severity of professional liability and general liability insurance claims and litigation asserted against them. The insurance coverage maintained by these tenants may not cover all claims made against them nor continue to be available at a reasonable cost, if at all. In some states, insurance coverage for the risk of punitive damages arising from professional liability and general liability claims and/or litigation may not, in certain cases, be available to these tenants due to state law prohibitions or limitations of availability. As a result, these types of tenants of our medical office buildings and healthcare-related facilities operating in these states may be liable for punitive damage awards that are either not covered or are in excess of their insurance policy limits. We also believe that there has been, and will continue to be, an increase in governmental investigations of certain healthcare providers, particularly in the area of Medicare/Medicaid false claims, as well as an increase in enforcement actions resulting from these investigations. Insurance is not available to cover such losses. Any adverse determination in a legal proceeding or governmental investigation, whether currently asserted or arising in the future, could have a material adverse effect on a tenant’s financial condition. If a tenant is unable to obtain or maintain insurance coverage, if judgments are obtained in excess of the insurance coverage, if a tenant is required to pay uninsured punitive damages, or if a tenant is subject to an uninsurable government enforcement action, the tenant could be exposed to substantial additional liabilities, which may affect the tenant’s ability to pay rent, which in turn could have a material adverse effect on our business, financial condition and results of operations and our ability to pay distributions to our stockholders.
Comprehensive healthcare reform legislation, the effects of which are not yet known, could materially adversely affect our business, financial condition and results of operations and our ability to pay distributions to our stockholders.
On March 23, 2010, the President signed into law the Patient Protection and Affordable Care Act of 2010, or the Patient Protection and Affordable Care Act, and on March 30, 2010, the President signed into law the Health Care and Education

42

Reconciliation Act of 2010, or the Reconciliation Act, which in part modified the Patient Protection and Affordable Care Act. Together, the two acts will serve as the primary vehicle for comprehensive healthcare reform in the U.S. The acts are intended to reduce the number of individuals in the U.S. without health insurance and effect significant other changes to the ways in which healthcare is organized, delivered and reimbursed. Included within the legislation is a limitation on physician-owned hospitals from expanding, unless the facility satisfies very narrow federal exceptions to this limitation. Therefore, if our tenants are physicians that own and refer to a hospital, the hospital would be limited in its operations and expansion potential, which may limit the hospital’s services and resulting revenues and may impact the owner’s ability to make rental payments. The legislation will become effective through a phased approach, beginning in 2010 and concluding in 2018, although several provisions of the legislation have been delayed, and additional delays are being considered. At this time, the effects of healthcare reform, its success or delay in implementation and its impact on our properties are not yet known but could materially adversely affect our business, financial condition, results of operations and ability to pay distributions to our stockholders.
Risks Related to Debt Financing
Increases in interest rates could increase the amount of our debt payments, and therefore, negatively impact our operating results.
Interest we will pay on our debt obligations will reduce cash available for distributions. Whenever we incur variable rate debt, increases in interest rates would increase our interest costs, which would reduce our cash flows and our ability to pay distributions to our stockholders. If we need to repay existing debt during periods of rising interest rates, we could be required to liquidate one or more of our investments in properties at times which may not permit realization of the maximum return on such investments.
To the extent we borrow at fixed rates or enter into fixed interest rate swaps, we will not benefit from reduced interest expense if interest rates decrease.
We are exposed to the effects of interest rate changes primarily as a result of borrowings used to maintain liquidity and fund expansion and refinancing of our real estate investment portfolio and operations. To limit the impact of interest rate changes on earnings, prepayment penalties and cash flows and to lower overall borrowing costs while taking into account variable interest rate risk, we have and may continue to borrow at fixed rates or variable rates depending upon prevailing market conditions. We have and may continue to also enter into derivative financial instruments such as interest rate swaps and caps in order to mitigate our interest rate risk on a related financial instrument, and therefore we will not benefit from reduced interest expense if interest rates decrease.
Hedging activity may expose us to risks.
When we use derivative financial instruments to hedge against interest rate fluctuations, we are exposed to credit risk and legal enforceability risks. In this context, credit risk is the failure of the counterparty to perform under the terms of the derivative contract. If the fair value of a derivative contract is positive, the counterparty owes us, which creates credit risk for us. Legal enforceability risks encompass general contractual risks, including the risk that the counterparty will breach the terms of, or fail to perform its obligations under, the derivative contract. If we are unable to manage these risks effectively, our results of operations, financial condition and ability to pay distributions to our stockholders will be adversely affected.
Lenders may require us to enter into restrictive covenants relating to our operations, which could limit our ability to pay distributions to our stockholders.
When providing financing, a lender may impose restrictions on us that affect our ability to incur additional debt and affect our distribution and operating strategies. We have and may continue to enter into loan documents that contain covenants that limit our ability to further mortgage the property, discontinue insurance coverage, or replace our advisor entities. These or other limitations may adversely affect our flexibility and our ability to achieve our investment objectives.
Interest-only indebtedness may increase our risk of default and ultimately may reduce our funds available for distribution to our stockholders.
We have and may continue to finance or refinance our properties using interest-only mortgage indebtedness. During the interest-only period, the amount of each scheduled payment will be less than that of a traditional amortizing mortgage loan. The principal balance of the mortgage loan will not be reduced (except in the case of prepayments) because there are no scheduled monthly payments of principal during this period. After the interest-only period, we will be required either to make scheduled payments of amortized principal and interest or to make a lump-sum or “balloon” payment at maturity. These required principal or balloon payments will increase the amount of our scheduled payments and may increase our risk of default under the related mortgage loan. If the mortgage loan has an adjustable interest rate, the amount of our scheduled payments also may increase at

43

a time of rising interest rates. Increased payments and substantial principal or balloon maturity payments will reduce the funds available for distribution to our stockholders because cash otherwise available for distribution will be required to pay principal and interest associated with these mortgage loans.
If we enter into financing arrangements involving balloon payment obligations, it may adversely affect our ability to refinance or sell properties on favorable terms, and to pay distributions to our stockholders.
Some of our current and future financing arrangements will require us to make a lump-sum or “balloon” payment at maturity. Our ability to make a balloon payment at maturity is uncertain and may depend upon our ability to obtain additional financing or our ability to sell the particular property. At the time the balloon payment is due, we may or may not be able to refinance the balloon payment on terms as favorable as the original loan or sell the particular property at a price sufficient to make the balloon payment. The refinancing or sale could affect the rate of return to our stockholders and the projected time of disposition of our assets. In an environment of increasing mortgage rates, if we place mortgage debt on properties, we run the risk of being unable to refinance such debt if mortgage rates are higher at a time a balloon payment is due. In addition, payments of principal and interest made to service our debts, including balloon payments, may leave us with insufficient cash to pay the distributions that we are required to pay to maintain our qualification as a REIT. Any of these results would have a significant, negative impact on our stockholders’ investment.
Risks Related to Real Estate-Related Investments
The mortgage loans in which we may invest and the mortgage loans underlying the mortgage-backed securities in which we may invest may be impacted by unfavorable real estate market conditions, which could decrease their value.
If we acquire investments in mortgage loans or mortgage-backed securities, such investments will involve special risks relating to the particular borrower or issuer of the mortgage-backed securities and we will be at risk of loss on those investments, including losses as a result of defaults on mortgage loans. These losses may be caused by many conditions beyond our control, including economic conditions affecting real estate values, tenant defaults and lease expirations, interest rate levels and the other economic and liability risks associated with real estate. If we acquire property by foreclosure following defaults under our mortgage loan investments, we will have the economic and liability risks as the owner described above. We do not know whether the values of the property securing any of our real estate-related investments will remain at the levels existing on the dates we initially make the related investment. If the values of the underlying properties drop, our risk will increase and the values of our interests may decrease.
Delays in liquidating defaulted mortgage loan investments could reduce our investment returns.
If there are defaults under our mortgage loan investments, we may not be able to foreclose on or obtain a suitable remedy with respect to such investments. Specifically, we may not be able to repossess and sell the underlying properties quickly, which could reduce the value of our investment. For example, an action to foreclose on a property securing a mortgage loan is regulated by state statutes and rules and is subject to many of the delays and expenses of lawsuits if the defendant raises defenses or counterclaims. Additionally, in the event of default by a mortgagor, these restrictions, among other things, may impede our ability to foreclose on or sell the mortgaged property or to obtain proceeds sufficient to repay all amounts due to us on the mortgage loan.
The commercial mortgage-backed securities in which we may invest are subject to several types of risks.
Commercial mortgage-backed securities are bonds which evidence interests in, or are secured by, a single commercial mortgage loan or a pool of commercial mortgage loans. Accordingly, the mortgage-backed securities in which we may invest are subject to all the risks of the underlying mortgage loans.
In a rising interest rate environment, the value of commercial mortgage-backed securities may be adversely affected when payments on underlying mortgages do not occur as anticipated, resulting in the extension of the security’s effective maturity and the related increase in interest rate sensitivity of a longer-term instrument. The value of commercial mortgage-backed securities may also change due to shifts in the market’s perception of issuers and regulatory or tax changes adversely affecting the mortgage securities markets as a whole. In addition, commercial mortgage-backed securities are subject to the credit risk associated with the performance of the underlying mortgage properties.
Commercial mortgage-backed securities are also subject to several risks created through the securitization process. Subordinate commercial mortgage-backed securities are paid interest-only to the extent that there are funds available to make payments. To the extent the collateral pool includes a large percentage of delinquent loans, there is a risk that interest payments on subordinate commercial mortgage-backed securities will not be fully paid. Subordinate securities of commercial mortgage-backed securities are also subject to greater credit risk than those commercial mortgage-backed securities that are more highly rated.

44

The mezzanine loans in which we may invest would involve greater risks of loss than senior loans secured by income-producing real estate.
We may invest in mezzanine loans that take the form of subordinated loans secured by second mortgages on the underlying real estate or loans secured by a pledge of the ownership interests of either the entity owning the real estate or the entity that owns the interest in the entity owning the real estate. These types of investments involve a higher degree of risk than long-term senior mortgage lending secured by income-producing real estate because the investment may become unsecured as a result of foreclosure by the senior lender. In the event of a bankruptcy of the entity providing the pledge of its ownership interests as security, we may not have full recourse to the assets of such entity, or the assets of the entity may not be sufficient to satisfy our mezzanine loan. If a borrower defaults on our mezzanine loan or debt senior to our loan, or in the event of a borrower bankruptcy, our mezzanine loan will be satisfied only after the senior debt. As a result, we may not recover some or all of our investment. In addition, mezzanine loans may have higher loan-to-value ratios than conventional mortgage loans, resulting in less equity in the real estate and increasing the risk of loss of principal.
Real estate-related equity securities in which we may invest are subject to specific risks relating to the particular issuer of the securities and may be subject to the general risks of investing in real estate or real estate-related assets.
We may invest in the common and preferred stock of both publicly traded and private unaffiliated real estate companies, which involves a higher degree of risk than debt securities due to a variety of factors, including the fact that such investments are subordinate to creditors and are not secured by the issuer’s property. Our investments in real estate-related equity securities will involve special risks relating to the particular issuer of the equity securities, including the financial condition and business outlook of the issuer. Issuers of real estate-related equity securities generally invest in real estate or real estate-related assets and are subject to the inherent risks associated with acquiring real estate-related investments discussed in these risk factors, including risks relating to rising interest rates.
We expect a portion of our real estate-related investments to be illiquid and we may not be able to adjust our portfolio in response to changes in economic and other conditions.
We may acquire real estate-related investments in connection with privately negotiated transactions which are not registered under the relevant securities laws, resulting in a prohibition against their transfer, sale, pledge or other disposition except in a transaction that is exempt from the registration requirements of, or is otherwise in accordance with, those laws. As a result, our ability to vary our portfolio in response to changes in economic and other conditions may be relatively limited. The mezzanine and bridge loans we may purchase will be particularly illiquid investments due to their short life, their unsuitability for securitization and the greater difficulty of recoupment in the event of a borrower’s default.
Interest rate and related risks may cause the value of our real estate-related investments to be reduced.
Interest rate risk is the risk that fixed income securities such as preferred and debt securities, and to a lesser extent dividend paying common stocks, will decline in value because of changes in market interest rates. Generally, when market interest rates rise, the market value of such securities will decline, and vice versa. Our investment in such securities means that the net asset value and market price of the common stock may tend to decline if market interest rates rise.
During periods of rising interest rates, the average life of certain types of securities may be extended because of slower than expected principal payments. This may lock in a below-market interest rate, increase the security’s duration and reduce the value of the security. This is known as extension risk. During periods of declining interest rates, an issuer may be able to exercise an option to prepay principal earlier than scheduled, which is generally known as call or prepayment risk. If this occurs, we may be forced to reinvest in lower yielding securities. This is known as reinvestment risk. Preferred and debt securities frequently have call features that allow the issuer to repurchase the security prior to its stated maturity. An issuer may redeem an obligation if the issuer can refinance the debt at a lower cost due to declining interest rates or an improvement in the credit standing of the issuer. These risks may reduce the value of our real estate-related investments.
If we liquidate prior to the maturity of our real estate-related investments, we may be forced to sell those investments on unfavorable terms or at a loss.
Our board of directors may choose to effect a liquidity event in which we liquidate our assets, including our real estate-related investments. If we liquidate those investments prior to their maturity, we may be forced to sell those investments on unfavorable terms or at a loss. For instance, if we are required to liquidate mortgage loans at a time when prevailing interest rates are higher than the interest rates of such mortgage loans, we would likely sell such loans at a discount to their stated principal values.

45

Risks Related to Joint Ventures
The terms of joint venture agreements or other joint ownership arrangements into which we have entered and may enter could impair our operating flexibility and our results of operations.
In connection with the purchase of real estate, we may enter into joint ventures with third parties, including affiliates of our advisor entities. We may also purchase or develop properties in co-ownership arrangements with the sellers of the properties, developers or other persons. These structures involve participation in the investment by other parties whose interests and rights may not be the same as ours. Our joint venture partners may have rights to take some actions over which we have no control and may take actions contrary to our interests. Joint ownership of an investment in real estate may involve risks not associated with direct ownership of real estate, including the following:
 
•
a venture partner may at any time have economic or other business interests or goals which become inconsistent with our business interests or goals, including inconsistent goals relating to the sale of properties held in a joint venture or the timing of the termination and liquidation of the venture;
•
a venture partner might become bankrupt and such proceedings could have an adverse impact on the operation of the partnership or joint venture;
•
actions taken by a venture partner might have the result of subjecting the property to liabilities in excess of those contemplated; and
•
a venture partner may be in a position to take action contrary to our instructions or requests or contrary to our policies or objectives, including our policy with respect to qualifying and maintaining our qualification as a REIT.
Under certain joint venture arrangements, neither venture partner may have the power to control the venture, and an impasse could occur, which might adversely affect the joint venture and decrease potential returns to our stockholders. If we have a right of first refusal or buy/sell right to buy out a venture partner, we may be unable to finance such a buy-out or we may be forced to exercise those rights at a time when it would not otherwise be in our best interest to do so. If our interest is subject to a buy/sell right, we may not have sufficient cash, available borrowing capacity or other capital resources to allow us to purchase an interest of a venture partner subject to the buy/sell right, in which case we may be forced to sell our interest when we would otherwise prefer to retain our interest. In addition, we may not be able to sell our interest in a joint venture on a timely basis or on acceptable terms if we desire to exit the venture for any reason, particularly if our interest is subject to a right of first refusal of our venture partner.
We may structure our joint venture relationships in a manner which may limit the amount we participate in the cash flows or appreciation of an investment.
We may enter into joint venture agreements, the economic terms of which may provide for the distribution of income to us otherwise than in direct proportion to our ownership interest in the joint venture. For example, while we and a co-venturer may invest an equal amount of capital in an investment, the investment may be structured such that we have a right to priority distributions of cash flows up to a certain target return while the co-venturer may receive a disproportionately greater share of cash flows than we are to receive once such target return has been achieved. This type of investment structure may result in the co-venturer receiving more of the cash flows, including appreciation, of an investment than we would receive. If we do not accurately judge the appreciation prospects of a particular investment or structure the venture appropriately, we may incur losses on joint venture investments or have limited participation in the profits of a joint venture investment, either of which could reduce our ability to pay cash distributions to our stockholders.
Federal Income Tax Risks
Failure to maintain our qualification as a REIT for federal income tax purposes would subject us to federal income tax on our taxable income at regular corporate rates, which would substantially reduce our ability to pay distributions to our stockholders.
We qualified and elected to be taxed as a REIT under the Code beginning with our taxable year ended December 31, 2010. To continue to maintain our qualification as a REIT, we must meet various requirements set forth in the Code concerning, among other things, the ownership of our outstanding common stock, the nature of our assets, the sources of our income and the amount of our distributions to our stockholders. The REIT qualification requirements are extremely complex, and interpretations of the federal income tax laws governing qualification as a REIT are limited. Accordingly, we cannot be certain that we will be successful in operating so as to maintain our qualification as a REIT. At any time, new laws, interpretations or court decisions may change the federal tax laws relating to, or the federal income tax consequences of, qualification as a REIT. It is possible that future economic, market, legal, tax or other considerations may cause our board of directors to determine that

46

it is not in our best interest to maintain our qualification as a REIT or revoke our REIT election, which it may do without stockholder approval.
If we fail to maintain our qualification as a REIT for any taxable year, we will be subject to federal income tax on our taxable income at corporate rates. In addition, we would generally be disqualified from treatment as a REIT for the four taxable years following the year of losing our REIT status. Losing our REIT status would reduce our net earnings available for investment or distribution to our stockholders because of the additional tax liability. In addition, distributions would no longer qualify for the distributions paid deduction, and we would no longer be required to pay distributions. If this occurs, we might be required to borrow funds or liquidate some investments in order to pay the applicable tax.
As a result of all these factors, our failure to maintain our qualification as a REIT could impair our ability to expand our business and raise capital, and would substantially reduce our ability to pay distributions to our stockholders.
To maintain our qualification as a REIT and to avoid the payment of federal income and excise taxes, we may be forced to borrow funds, use proceeds from the issuance of securities, or sell assets to pay distributions, which may result in our distributing amounts that may otherwise be used for our operations.
To obtain the favorable tax treatment accorded to REITs, we normally will be required each year to distribute to our stockholders at least 90.0% of our annual taxable income, determined without regard to the deduction for distributions paid and by excluding net capital gains. We will be subject to federal income tax on our undistributed taxable income and net capital gain and to a 4.0% nondeductible excise tax on any amount by which distributions we pay with respect to any calendar year are less than the sum of (1) 85.0% of our ordinary income, (2) 95.0% of our capital gain net income and (3) 100% of our undistributed income from prior years. These requirements could cause us to distribute amounts that otherwise would be spent on acquisitions of properties and it is possible that we might be required to borrow funds, use proceeds from the issuance of securities or sell assets in order to distribute enough of our taxable income to maintain our qualification as a REIT and to avoid the payment of federal income and excise taxes.
Our investment strategy may cause us to incur penalty taxes, lose our REIT status, or own and sell properties through taxable REIT subsidiaries, each of which would diminish the return to our stockholders.
In light of our investment strategy, it is possible that one or more sales of our properties may be “prohibited transactions” under provisions of the Code. If we are deemed to have engaged in a “prohibited transaction” (i.e., we sell a property held by us primarily for sale in the ordinary course of our trade or business), all income that we derive from such sale would be subject to a 100% tax. The Code sets forth a safe harbor for REITs that wish to sell property without risking the imposition of the 100% tax. A principal requirement of the safe harbor is that the REIT must hold the applicable property for not less than two years prior to its sale. Given our investment strategy, it is entirely possible, if not likely, that the sale of one or more of our properties will not fall within the prohibited transaction safe harbor.
If we desire to sell a property pursuant to a transaction that does not fall within the safe harbor, we may be able to avoid the 100% penalty tax if we acquired the property through a TRS or acquired the property and transferred it to a TRS for a non-tax business purpose prior to the sale (i.e., for a reason other than the avoidance of taxes). However, there may be circumstances that prevent us from using a TRS in a transaction that does not qualify for the safe harbor. Additionally, even if it is possible to effect a property disposition through a TRS, we may decide to forego the use of a TRS in a transaction that does not meet the safe harbor based on our own internal analysis, the opinion of counsel or the opinion of other tax advisors that the disposition will not be subject to the 100% penalty tax. In cases where a property disposition is not effected through a TRS, the IRS could successfully assert that the disposition constitutes a prohibited transaction, in which event all of the net income from the sale of such property will be payable as a tax and none of the proceeds from such sale will be distributable by us to our stockholders or available for investment by us.
If we acquire a property that we anticipate will not fall within the safe harbor from the 100% penalty tax upon disposition, then we may acquire such property through a TRS in order to avoid the possibility that the sale of such property will be a prohibited transaction and subject to the 100% penalty tax. If we already own such a property directly or indirectly through an entity other than a TRS, we may contribute the property to a TRS if there is another, non-tax-related business purpose for the contribution of such property to the TRS. Following the transfer of the property to a TRS, the TRS will operate the property and may sell such property and distribute the net proceeds from such sale to us, and we may distribute the net proceeds distributed to us by the TRS to our stockholders. Though a sale of the property by a TRS likely would eliminate the danger of the application of the 100% penalty tax, the TRS itself would be subject to a tax at the federal level, and potentially at the state and local levels, on the gain realized by it from the sale of the property as well as on the income earned while the property is operated by the TRS. This tax obligation would diminish the amount of the proceeds from the sale of such property that would be distributable to our stockholders. As a result, the amount available for distribution to our stockholders would be substantially less than if the REIT had not operated and sold such property through the TRS and such transaction was not

47

characterized as a prohibited transaction. The maximum federal income tax rate currently is 35.0%. International, federal, state and local corporate income tax rates may be increased in the future, and any such increase would reduce the amount of the net proceeds available for distribution by us to our stockholders from the sale of property through a TRS after the effective date of any increase in such tax rates.
If we own too many properties through one or more of our TRSs, then we may lose our status as a REIT. If we fail to maintain our qualification as a REIT for any taxable year, we will be subject to federal income tax on our taxable income at corporate rates. In addition, we would generally be disqualified from treatment as a REIT for the four taxable years following the year of losing our REIT status. Losing our REIT status would reduce our net earnings available for investment or distribution to stockholders because of the additional tax liability. In addition, distributions to stockholders would no longer qualify for the distributions paid deduction, and we would no longer be required to pay distributions. If this occurs, we might be required to borrow funds or liquidate some investments in order to pay the applicable tax. As a REIT, the value of the securities we hold in all of our TRSs may not exceed 25.0% of the value of all of our assets at the end of any calendar quarter. If the IRS were to determine that the value of our interests in all of our TRSs exceeded 25.0% of the value of total assets at the end of any calendar quarter, then we would fail to qualify as a REIT. If we determine it to be in our best interest to own a substantial number of our properties through one or more TRSs, then it is possible that the IRS may conclude that the value of our interests in our TRSs exceeds 25.0% of the value of our total assets at the end of any calendar quarter, and therefore, cause us to fail to qualify as a REIT. Additionally, as a REIT, no more than 25.0% of our gross income with respect to any year may be from sources other than real estate. Distributions paid to us from a TRS are considered to be non-real estate income. Therefore, we may fail to qualify as a REIT if distributions from all of our TRSs, when aggregated with all other non-real estate income with respect to any one year, are more than 25.0% of our gross income with respect to such year. We will use all reasonable efforts to structure our activities in a manner intended to satisfy the requirements for our qualification as a REIT. Our failure to maintain our qualification as a REIT would adversely affect our stockholders’ return on their investment.
Our stockholders may have a current tax liability on distributions they elect to reinvest in shares of our common stock.
If our stockholders participate in the DRIP, they will be deemed to have received, and for income tax purposes will be taxed on, the amount reinvested in shares of our common stock to the extent the amount reinvested was not a tax-free return of capital. As a result, unless our stockholders are a tax-exempt entity, they may have to use funds from other sources to pay their tax liability on the value of the shares of common stock received.
Legislative or regulatory action with respect to taxes could adversely affect the returns to our investors.
In recent years, numerous legislative, judicial and administrative changes have been made in the provisions of the federal and state income tax laws applicable to investments similar to an investment in shares of our common stock. Additional changes to the tax laws are likely to continue to occur, and we cannot assure our stockholders that any such changes will not adversely affect the taxation of a stockholder. Any such changes could have an adverse effect on an investment in our stock or on the market value or the resale potential of our assets. Our stockholders are urged to consult with their own tax advisor with respect to the impact of recent legislation on their investment in our stock and the status of legislative, regulatory or administrative developments and proposals and their potential effect on an investment in shares of our common stock.
In certain circumstances, we may be subject to federal and state income taxes as a REIT, which would reduce our cash available for distribution to our stockholders.
Even if we continue to qualify as a REIT, we may be subject to international income taxes, federal income taxes or state taxes. For example, net income from a “prohibited transaction” will be subject to a 100% tax. We may not be able to make sufficient distributions to avoid excise taxes applicable to REITs. We may also decide to retain capital gains we earn from the sale or other disposition of our property and pay income tax directly on such income. In that event, our stockholders would be treated as if they earned that income and paid the tax on it directly. However, our stockholders that are tax-exempt, such as charities or qualified pension plans, would have no benefit from their deemed payment of such tax liability. We may also be subject to international, state and local taxes on our income or property, either directly or at the level of the companies through which we indirectly own our assets. Any international, federal or state taxes we pay will reduce our cash available for distribution to our stockholders.
Distributions to tax-exempt stockholders may be classified as UBTI.
Neither ordinary nor capital gain distributions with respect to the shares of our common stock nor gain from the sale of the shares of our common stock should generally constitute unrelated business taxable income, or UBTI, to a tax-exempt stockholder. However, there are certain exceptions to this rule. In particular:
 
•
part of the income and gain recognized by certain qualified employee pension trusts with respect to our common stock may be treated as UBTI if the shares of our common stock are predominately held by qualified employee

48

pension trusts, and we are required to rely on a special look-through rule for purposes of meeting one of the REIT share ownership tests, and we are not operated in a manner to avoid treatment of such income or gain as UBTI;
•
part of the income and gain recognized by a tax exempt stockholder with respect to the shares of our common stock would constitute UBTI if the stockholder incurs debt in order to acquire the shares of our common stock; and
•
part or all of the income or gain recognized with respect to the shares of our common stock by social clubs, voluntary employee benefit associations, supplemental unemployment benefit trusts and qualified group legal services plans which are exempt from federal income taxation under Sections 501(c)(7), (9), (17) or (20) of the Internal Revenue Code may be treated as UBTI.
Complying with the REIT requirements may cause us to forego otherwise attractive opportunities.
To maintain our qualification as a REIT for federal income tax purposes, we must continually satisfy tests concerning, among other things, the sources of our income, the nature and diversification of our assets, the amounts we distribute to our stockholders and the ownership of shares of our common stock. We may be required to pay distributions to our stockholders at disadvantageous times or when we do not have funds readily available for distribution, or we may be required to liquidate otherwise attractive investments in order to comply with the REIT tests. Thus, compliance with the REIT requirements may hinder our ability to operate solely on the basis of maximizing profits.
Foreign purchasers of shares of our common stock may be subject to FIRPTA tax upon the sale of their shares of our common stock and upon payment of a capital gain dividend.
A foreign person disposing of a U.S. real property interest, including shares of stock of a U.S. corporation whose assets consist principally of U.S. real property interests, is generally subject to the Foreign Investment in Real Property Tax Act of 1980, as amended, or FIRPTA, on the gain recognized on the disposition. Such FIRPTA tax does not apply, however, to the disposition of stock in a REIT if the REIT is “domestically controlled.” A REIT is “domestically controlled” if less than 50.0% of the REIT’s stock, by value, has been owned directly or indirectly by persons who are not qualifying U.S. persons during a continuous five-year period ending on the date of disposition or, if shorter, during the entire period of the REIT’s existence. We cannot assure our stockholders that we will qualify as a “domestically controlled” REIT. If we were to fail to so qualify, gain realized by foreign investors on a sale of shares of our common stock would be subject to FIRPTA tax, unless the shares of our common stock were traded on an established securities market and the foreign investor did not at any time during a specified testing period directly or indirectly own more than 5.0% of the value of our outstanding common stock. A foreign stockholder also may be subject to FIRPTA upon the payment of any capital gain dividends by us, which dividend is attributable to gain from sales or exchanges of U.S. real property interests.
Employee Benefit Plan, IRA, and Other Tax-Exempt Investor Risks
We, and our stockholders that are employee benefit plans, individual retirement accounts, or IRAs, annuities described in Sections 403(a) or (b) of the Internal Revenue Code, Archer MSAs, health savings accounts, or Coverdell education savings accounts (referred to generally as Benefit Plans and IRAs) will be subject to risks relating specifically to our having such Benefit Plan and IRA stockholders, which risks are discussed below.
If our stockholders fail to meet the fiduciary and other standards under ERISA or the Code as a result of an investment in shares of our common stock, our stockholders could be subject to criminal and civil penalties.
There are special considerations that apply to Benefit Plans or IRAs investing in shares of our common stock. If our stockholders are investing the assets of a Benefit Plan or IRA in us, they should consider:
 
•
whether their investment is consistent with the applicable provisions of the Employee Retirement Income Security Act of 1974, as amended, or ERISA, and the Code, or any other applicable governing authority in the case of a government plan;
•
whether their investment is made in accordance with the documents and instruments governing their Benefit Plan or IRA, including their Benefit Plan or IRA’s investment policy;
•
whether their investment satisfies the prudence, diversification and other requirements of Sections 404(a)(1)(B) and 404(a)(1)(C) of ERISA;
•
whether their investment will impair the liquidity needs and distribution requirements of the Benefit Plan or IRA;
•
whether their investment will constitute a prohibited transaction under Section 406 of ERISA or Section 4975 of the Code;
•
whether their investment will produce or result in UBTI, as defined in Sections 511 through 514 of the Code, to the Benefit Plan or IRA; and

49

•
their need to value the assets of the Benefit Plan or IRA annually in accordance with ERISA and the Code.
In addition to considering their fiduciary responsibilities under ERISA and the prohibited transaction rules of ERISA and the Code, a Benefit Plan or IRA purchasing shares of our common stock should consider the effect of the plan asset regulations of the U.S. Department of Labor. To avoid our assets from being considered plan assets under those regulations, our charter prohibits “benefit plan investors” from owning 25.0% or more of the shares of our common stock prior to the time that the common stock qualifies as a class of publicly-offered securities, within the meaning of the ERISA plan asset regulations. However, we cannot assure our stockholders that those provisions in our charter will be effective in limiting benefit plan investor ownership to less than the 25.0% limit. For example, the limit could be unintentionally exceeded if a benefit plan investor misrepresents its status as a benefit plan. Even if our assets are not considered to be plan assets, a prohibited transaction could occur if we or any of our affiliates is a fiduciary (within the meaning of ERISA and/or the Code) with respect to a Benefit Plan or IRA purchasing shares of our common stock, and, therefore, in the event any such persons are fiduciaries (within the meaning of ERISA and/or the Code) of our stockholders’ Benefit Plan or IRA, they should not purchase shares of our common stock unless an administrative or statutory exemption applies to their purchase.
Item 1B. Unresolved Staff Comments.
Not applicable.
Item 2. Properties.
As of December 31, 2013, our principal executive offices are located at 18191 Von Karman Avenue, Suite 300, Irvine, California 92612. We do not have an address separate from our advisor entities or our co-sponsors. Since we pay our advisor entities fees for their services, we do not pay rent for the use of their space.
Real Estate Investments
As of December 31, 2013, we had completed 72 acquisitions, 53 of which were acquisitions of medical office buildings, seven of which were acquisitions of hospitals, seven of which were acquisitions of skilled nursing facilities, two of which were acquisitions of both skilled nursing and senior housing facilities, two of which were acquisitions of senior housing facilities and one of which was a senior housing facility owned and operated utilizing a RIDEA structure. The aggregate purchase price of these properties was $2,785,711,000 and was comprised of 279 buildings and 10,565,000 square feet of GLA.
The following table presents certain additional information about our properties as of December 31, 2013:
Acquisition(1)
 
Property  Location
 
Type of  Property
 
GLA
(Sq Ft)
 
% of
GLA
 
Date  Acquired
 
Purchase
Price
 
Annualized
Base
Rent(2)
 
% of
Annualized
Base Rent
 
Leased Percentage(3)
 
Annual Rent
Per Leased
Sq Ft(4)
Lacombe Medical Office Building
 
Lacombe, LA
 
Medical Office
 
34,000
 
0.3
%
 
03/05/10
 
$
6,970,000

 
$
197,000

 
0.1
%
 
100
%
 
$
5.76

Center for Neurosurgery and Spine
 
Sartell, MN
 
Medical Office
 
35,000
 
0.3

 
03/31/10
 
6,500,000

 
596,000

 
0.2

 
100
%
 
$
17.26

Parkway Medical Center
 
Beachwood, OH
 
Medical Office
 
88,000
 
0.8

 
04/12/10
 
10,900,000

 
1,857,000

 
0.8

 
94.8
%
 
$
22.24

Highlands Ranch Medical Pavilion
 
Highlands Ranch,
CO
 
Medical Office
 
37,000
 
0.4

 
04/30/10
 
8,400,000

 
718,000

 
0.3

 
89.3
%
 
$
21.83

Muskogee Long-Term Acute Care Hospital
 
Muskogee, OK
 
Hospital
 
37,000
 
0.4

 
05/27/10
 
11,000,000

 
1,021,000

 
0.4

 
100
%
 
$
27.26

St. Vincent Medical Office Building
 
Cleveland, OH
 
Medical Office
 
51,000
 
0.5

 
06/25/10
 
10,100,000

 
1,099,000

 
0.4

 
80.3
%
 
$
26.57

Livingston Medical Arts Pavilion
 
Livingston, TX
 
Medical Office
 
29,000
 
0.3

 
06/28/10
 
6,350,000

 
475,000

 
0.2

 
71.6
%
 
$
23.05

Pocatello East Medical Office Building
 
Pocatello, ID
 
Medical Office
 
76,000
 
0.7

 
07/27/10
 
15,800,000

 
1,532,000

 
0.6

 
100
%
 
$
20.05

Monument Long-Term Acute Care Hospital Portfolio
 
Cape Girardeau,
Joplin and Columbia,
MO; and Athens,
GA
 
Hospital
 
115,000
 
1.1

 
08/12/10,
08/31/10,
10/29/10
and
01/31/11
 
41,695,000

 
3,944,000

 
1.6

 
100
%
 
$
34.31


50

Acquisition(1)
 
Property  Location
 
Type of  Property
 
GLA
(Sq Ft)
 
% of
GLA
 
Date  Acquired
 
Purchase
Price
 
Annualized
Base
Rent(2)
 
% of
Annualized
Base Rent
 
Leased Percentage(3)
 
Annual Rent
Per Leased
Sq Ft(4)
Virginia Skilled Nursing Facility Portfolio
 
Charlottesville,
Bastian,
Lebanon,  Fincastle,
Low Moor,
Midlothian and
Hot Springs, VA
 
Skilled Nursing
 
232,000
 
2.2
%
 
09/16/10
 
$
45,000,000

 
$
4,598,000

 
1.9
%
 
100
%
 
$
19.83

Sylva Medical Office Building
 
Sylva, NC
 
Medical Office
 
45,000
 
0.4

 
11/15/10
 
11,400,000

 
1,051,000

 
0.4

 
100
%
 
$
23.25

Surgical Hospital of Humble
 
Humble, TX
 
Hospital
 
30,000
 
0.3

 
12/10/10
 
13,100,000

 
1,190,000

 
0.5

 
100
%
 
$
39.18

Lawton Medical Office Building Portfolio
 
Lawton, OK
 
Medical Office
 
62,000
 
0.6

 
12/22/10
 
11,550,000

 
995,000

 
0.4

 
100
%
 
$
15.95

Ennis Medical Office Building
 
Ennis, TX
 
Medical Office
 
30,000
 
0.3

 
12/22/10
 
7,100,000

 
624,000

 
0.3

 
94.8
%
 
$
22.01

St. Anthony North Medical Office Building
 
Westminster, CO
 
Medical Office
 
60,000
 
0.6

 
03/29/11
 
11,950,000

 
1,128,000

 
0.5

 
90.5
%
 
$
20.63

Loma Linda Pediatric Specialty Hospital
 
Loma Linda, CA
 
Skilled  Nursing
 
34,000
 
0.3

 
03/31/11
 
13,000,000

 
1,354,000

 
0.6

 
100
%
 
$
39.52

Yuma Skilled Nursing Facility
 
Yuma, AZ
 
Skilled  Nursing
 
40,000
 
0.4

 
04/13/11
 
11,000,000

 
1,259,000

 
0.5

 
100
%
 
$
31.74

Hardy Oak Medical Office Building
 
San Antonio, TX
 
Medical Office
 
42,000
 
0.4

 
04/14/11
 
8,070,000

 
632,000

 
0.3

 
85.8
%
 
$
17.50

Lakewood Ranch Medical Office Building
 
Bradenton, FL
 
Medical Office
 
58,000
 
0.5

 
04/15/11
 
12,500,000

 
1,203,000

 
0.5

 
92.6
%
 
$
22.56

Dixie-Lobo Medical Office Building Portfolio
 
Alice, Lufkin,
Victoria and
Wharton, TX;
Carlsbad and
Hobbs, NM; Hope,
AR; and Lake
Charles, LA
 
Medical Office
 
156,000
 
1.5

 
05/12/11
 and
 05/02/13
 
30,100,000

 
2,876,000

 
1.2

 
100
%
 
$
18.44

Milestone Medical Office Building Portfolio
 
Jersey City, NJ and
Bryant and Benton,
AR
 
Medical Office
 
179,000
 
1.7

 
05/26/11
 
44,050,000

 
3,330,000

 
1.4

 
79.4
%
 
$
23.42

Philadelphia SNF Portfolio
 
Philadelphia, PA
 
Skilled  Nursing
 
392,000
 
3.7

 
06/30/11
 
75,000,000

 
13,080,000

 
5.4

 
100
%
 
$
33.39

Maxfield Medical Office Building
 
Sarasota, FL
 
Medical Office
 
41,000
 
0.4

 
07/11/11
 
7,200,000

 
667,000

 
0.3

 
90.5
%
 
$
17.94

Lafayette Physical Rehabilitation Hospital
 
Lafayette, LA
 
Hospital
 
26,000
 
0.2

 
09/30/11
 
12,100,000

 
1,097,000

 
0.5

 
100
%
 
$
41.52

Sierra Providence East Medical Plaza I
 
El Paso, TX
 
Medical Office
 
60,000
 
0.6

 
12/22/11
 
7,840,000

 
714,000

 
0.3

 
90.0
%
 
$
13.11

Southeastern SNF Portfolio
 
Conyers, Covington, Snellville, Gainsville and Atlanta, GA; Memphis and Millington, TN; Shreveport, LA; and Mobile, AL
 
Skilled  Nursing
 
454,000
 
4.3

 
01/10/12
 
166,500,000

 
16,134,000

 
6.6

 
100.0
%
 
$
35.56

FLAGS MOB Portfolio
 
Boynton Beach, FL; Austell, GA; Okatie, SC; and Tempe, AZ
 
Medical Office
 
177,000
 
1.7

 

01/27/12
and
03/23/12
 
33,800,000

 
2,699,000

 
1.1

 
80.0
%
 
$
19.09

Spokane MOB
 
Spokane, WA
 
Medical Office
 
96,000
 
0.9

 
01/31/12
 
32,500,000

 
2,380,000

 
1.0

 
96.6
%
 
$
25.74


51

Acquisition(1)
 
Property  Location
 
Type of  Property
 
GLA
(Sq Ft)
 
% of
GLA
 
Date  Acquired
 
Purchase
Price
 
Annualized
Base
Rent(2)
 
% of
Annualized
Base Rent
 
Leased Percentage(3)
 
Annual Rent
Per Leased
Sq Ft(4)
Centre Medical Plaza
 
Chula Vista, CA
 
Medical Office
 
75,000
 
0.7
%
 
04/26/12
 
$
24,600,000

 
$
2,557,000

 
1.1
%
 
96
%
 
$
35.59

Gulf Plains MOB Portfolio
 
Amarillo and Houston, TX
 
Medical Office
 
88,000
 
0.8

 
04/26/12
 
19,250,000

 
1,668,000

 
0.7

 
100
%
 
$
18.96

Midwestern MOB Portfolio
 
Champaign, Lemont, Naperville and Urbana, IL
 
Medical Office
 
150,000
 
1.4

 
05/22/12,
07/19/12
and
08/14/12
 
30,060,000

 
2,822,000

 
1.2

 
88.4
%
 
$
21.31

Texarkana MOB
 
Texarkana, TX
 
Medical Office
 
32,000
 
0.3

 
06/14/12
 
6,500,000

 
558,000

 
0.2

 
100
%
 
$
17.66

Greeley MOB
 
Greeley, CO
 
Medical Office
 
58,000
 
0.5

 
06/22/12
 
13,200,000

 
1,156,000

 
0.5

 
100
%
 
$
19.92

Columbia MOB
 
Columbia, SC
 
Medical Office
 
43,000
 
0.4

 
06/26/12
 
6,900,000

 
809,000

 
0.3

 
87.4
%
 
$
21.41

Ola Nalu MOB Portfolio
 
Huntsville, AL; New Port Richey, FL; Hilo, HI; Warsaw, IN; Las Vegas, NM; and Rockwall, San Angelo and Schertz, TX
 
Medical Office
 
272,000
 
2.6

 
06/29/12
and
07/12/12
 
71,000,000

 
6,116,000

 
2.5

 
97.8
%
 
$
23.00

Silver Star MOB Portfolio
 
Killeen, Temple, Rowlett, Desoto and Frisco, TX
 
Medical Office
 
147,000
 
1.4

 
07/19/12,
09/05/12
and
09/27/12
 
35,400,000

 
2,716,000

 
1.1

 
93.3
%
 
$
19.75

Shelbyville MOB
 
Shelbyville, TN
 
Medical Office
 
31,000
 
0.3

 
07/26/12
 
6,800,000

 
530,000

 
0.2

 
95.1
%
 
$
17.92

Jasper MOB
 
Jasper, GA
 
Medical Office
 
57,000
 
0.5

 
08/08/12
and
09/27/12
 
13,800,000

 
1,153,000

 
0.5

 
100
%
 
$
20.13

Pacific Northwest Senior Care Portfolio
 
Bend, Corvallis, Grants Pass, Prineville, Redmond and Salem, OR; and North Bend, Olympia and Tacoma, WA
 
Skilled Nursing and Senior Housing
 
394,000
 
3.7

 
08/24/12
 and
 05/31/13
 
64,804,000

 
6,263,000

 
2.6

 
100
%
 
$
15.91

East Tennessee MOB Portfolio
 
Knoxville, TN
 
Medical Office
 
167,000
 
1.6

 
09/14/12
 
51,200,000

 
4,053,000

 
1.7

 
100
%
 
$
24.26

Los Angeles Hospital Portfolio
 
Los Angeles, Gardena and Norwalk, CA
 
Hospital
 
296,000
 
2.8

 
09/27/12
 
85,000,000

 
8,667,000

 
3.6

 
100
%
 
$
29.32

Bellaire Hospital
 
Houston, TX
 
Hospital
 
161,000
 
1.5

 
11/09/12
 
23,250,000

 
2,124,000

 
0.9

 
100
%
 
$
13.19

Massachusetts Senior Care Portfolio
 
Dalton and Hyde Park, MA
 
Skilled Nursing
 
104,000
 
1.0

 
12/10/12
 
24,350,000

 
2,240,000

 
0.9

 
100
%
 
$
21.54

St. Petersburg Medical Office Building
 
St.Petersburg, FL
 
Medical Office
 
53,000
 
0.5

 
12/20/12
 
10,400,000

 
933,000

 
0.4

 
87.1
%
 
$
20.16

Bessemer Medical Office Building
 
Bessemer, AL
 
Medical Office
 
100,000
 
0.9

 
12/20/12
 
25,000,000

 
1,958,000

 
0.8

 
91.3
%
 
$
21.50

Santa Rosa Medical Office Building
 
Santa Rosa, CA
 
Medical Office
 
102,000
 
1.0

 
12/20/12
 
18,200,000

 
2,491,000

 
1.0

 
90
%
 
$
27.32

North Carolina ALF Portfolio
 
Fayetteville, Fuquay-Varina, Knightdale, Lincolnton and Monroe, NC
 
Senior Housing
 
185,000
 
1.8

 
12/21/12
 
75,000,000

 
5,400,000

 
2.2

 
100
%
 
$
29.15

Falls of Neuse Raleigh Medical Office Building
 
Raleigh, NC
 
Medical Office
 
77,000
 
0.7

 
12/31/12
 
21,000,000

 
1,633,000

 
0.7

 
100
%
 
$
21.28

Central Indiana MOB Portfolio
 
Avon, Bloomington, Carmel, Fishers, Indianapolis, Lafayette, Muncie and Noblesville, IN
 
Medical Office
 
594,000
 
5.7

 
12/31/12,
03/28/13,
04/26/13
and
05/20/13
 
122,780,000

 
12,745,000

 
5.2

 
93.5
%
 
$
22.96


52

Acquisition(1)
 
Property  Location
 
Type of  Property
 
GLA
(Sq Ft)
 
% of
GLA
 
Date  Acquired
 
Purchase
Price
 
Annualized
Base
Rent(2)
 
% of
Annualized
Base Rent
 
Leased Percentage(3)
 
Annual Rent
Per Leased
Sq Ft(4)
A & R Medical Office Building Portfolio
 
Ruston, LA and Abilene, TX
 
Medical Office
 
183,000
 
1.7
%
 
02/20/13
 
$
31,750,000

 
$
2,459,000

 
1.0
%
 
100.0
%
 
$
13.43

Greeley Northern Colorado MOB Portfolio
 
Greeley, CO
 
Medical Office
 
101,000
 
1.0

 
02/28/13
 
15,050,000

 
1,295,000

 
0.5

 
89.1
%
 
$
14.34

St. Anthony North Denver MOB II
 
Westminister, CO
 
Medical Office
 
28,000
 
0.3

 
03/22/13
 
4,100,000

 
393,000

 
0.2

 
86.8
%
 
$
16.14

Eagles Landing GA MOB
 
Stockbridge, GA
 
Medical Office
 
45,000
 
0.4

 
03/28/13
 
12,400,000

 
950,000

 
0.4

 
100
%
 
$
20.96

Eastern Michigan MOB Portfolio
 
Novi and West Bloomfield, MI
 
Medical Office
 
94,000
 
0.9

 
03/28/13
 
21,600,000

 
1,833,000

 
0.8

 
84.8
%
 
$
22.92

Pennsylvania SNF Portfolio
 
Milton and Watsontown, PA
 
Skilled Nursing
 
75,000
 
0.7

 
04/30/13
 
13,000,000

 
1,251,000

 
0.5

 
100
%
 
$
16.67

Rockwall MOB II
 
Rockwall, TX
 
Medical Office
 
18,000
 
0.2

 
05/23/13
 
5,400,000

 
401,000

 
0.2

 
100
%
 
$
22.88

Pittsfield Skilled Nursing Facility
 
Pittsfield, MA
 
Skilled Nursing
 
42,000
 
0.4

 
05/29/13
 
15,750,000

 
1,535,000

 
0.5

 
100
%
 
$
36.50

Des Plaines Surgical Center
 
Des Plaines, IL
 
Medical Office
 
47,000
 
0.4

 
05/31/13
 
10,050,000

 
838,000

 
0.3

 
92.5
%
 
$
19.47

Winn MOB Portfolio
 
Decatur, GA
 
Medical Office
 
65,000
 
0.6

 
06/03/13
 
9,850,000

 
771,000

 
0.3

 
78.9
%
 
$
15.04

Hinsdale MOB Portfolio
 
Hinsdale, IL
 
Medical Office
 
169,000
 
1.6

 
07/11/13
 
35,500,000

 
4,015,000

 
1.6

 
85.3
%
 
$
27.83

Johns Creek Medical Office Building
 
Johns Creek, GA
 
Medical Office
 
90,000
 
0.9

 
08/26/13
 
20,100,000

 
982,000

 
0.4

 
87.7
%
 
$
12.43

Winn MOB II
 
Decatur, GA
 
Medical Office
 
22,000
 
0.2

 
08/27/13
 
2,800,000

 
404,000

 
0.2

 
100
%
 
$
18.57

Greeley Cottonwood MOB
 
Greeley, CO
 
Medical Office
 
36,000
 
0.3

 
09/06/13
 
7,450,000

 
589,000

 
0.2

 
100
%
 
$
16.18

UK Senior Housing Portfolio
 
England, Scotland, and Jersey, UK
 
Senior Housing
 
962,000
 
9.1

 
09/11/13
 
472,167,000

 
35,780,000

 
14.8

 
100
%
 
$
37.20

Tiger Eye NY MOB Portfolio
 
Middletown, Rock Hill and Wallkill, NY
 
Medical Office
 
362,000
 
3.4

 
09/20/13
 and
 12/23/13
 
141,000,000

 
10,018,000

 
4.1

 
100
%
 
$
27.67

Salt Lake City LTACH
 
Murray, UT
 
Hospital
 
35,000
 
0.3

 
09/25/13
 
13,700,000

 
1,196,000

 
0.5

 
100
%
 
$
34.27

Lacombe MOB II
 
Lacombe, LA
 
Medical Office
 
43,000
 
0.4

 
09/27/13
 
5,500,000

 
437,000

 
0.2

 
59.0
%
 
$
17.25

Tennessee MOB Portfolio
 
Memphis and Hendersonville, TN
 
Medical Office
 
65,000
 
0.6

 
10/02/13
 
13,600,000

 
1,248,000

 
0.5

 
100
%
 
$
19.06

Central Indiana MOB Portfolio II
 
Greenfield and Indianapolis, IN
 
Medical Office
 
57,000
 
0.5

 
12/12/13
 
9,400,000

 
962,000

 
0.4

 
90.7
%
 
$
18.45

Kennestone East MOB Portfolio
 
Marietta, GA
 
Medical Office
 
52,000
 
0.5

 
12/13/13
 
13,775,000

 
968,000

 
0.4

 
82.7
%
 
$
22.58

Dux MOB Portfolio
 
Brownsburg, Evansville, Indianapolis, Lafayette, Munster, and St. John, IN; Escanaba, MI; Batavia, OH; and San Antonio, TX
 
Medical Office
 
700,000
 
6.7

 
12/19/13
 and
 12/20/13
 
181,800,000

 
12,265,000

 
5.1

 
94.4
%
 
$
18.57

Midwest CCRC Portfolio
 
Cincinnati, OH; Colorado Springs, CO; and Lincolnwood, IL
 
Senior Housing–RIDEA
 
1,372,000
 
13.0

 
12/20/13
 
310,000,000

 
24,918,000

 
10.3

 
(5
)
 
(5
)
Total/Weighted Average
 
 
 
 
 
10,565,000
 
100
%
 
 
 
$
2,785,711,000

 
$
242,550,000

 
100
%
 
95.8
%
 
$
24.72

 ________
(1)
We own 100% of our properties as of December 31, 2013.

53

(2)
With the exception of Midwest CCRC Portfolio, annualized base rent is based on contractual base rent from leases in effect as of December 31, 2013. Annualized base rent for Midwest CCRC Portfolio, which is operated utilizing a RIDEA structure, is based on annualized net operating income.
(3)
Leased percentage includes all leased space of the respective acquisition including master leases and excludes Midwest CCRC Portfolio, which is operated utilizing a RIDEA structure.
(4)
Average annual rent per leased square foot is based on leases in effect as of December 31, 2013 and excludes Midwest CCRC Portfolio, which is operated utilizing a RIDEA structure.
(5)
Resident occupancy for these 1,079 units was 93.6% as of December 31, 2013. Average annual rent per unit was $25,000 and was based on net operating income of $24,918,000 divided by the average occupied units of the facilities as of such period.
We own fee simple interests in all of our properties except for 42 buildings for which we own fee simple interests in the building and improvements of such properties subject to the respective ground leases.
The following information generally applies to our properties:
 
•
we believe all of our properties are adequately covered by insurance and are suitable for their intended purposes;
•
we have no plans for any material renovations, improvements or development with respect to any of our properties, except in accordance with planned budgets;
•
our properties are located in markets where we are subject to competition for attracting new tenants and retaining current tenants; and
•
depreciation is provided on a straight-line basis over the estimated useful lives of the buildings, 39 years, and over the shorter of the lease term or useful lives of the tenant improvements.
Lease Expirations
The following table presents the sensitivity of our annual base rent due to lease expirations for the next 10 years and thereafter at our properties, by number, square feet, percentage of leased area, annual base rent and percentage of annual rent of expiring leases as of December 31, 2013:
Year (1)
 
Number of Expiring
Leases
 
Total Sq. Ft. of
Expiring Leases
 
% of Leased Area
Represented by
Expiring Leases
 
Annual Base Rent 
Under Expiring Leases
 
% of Total 
Annual
Base Rent
Represented
by Expiring
Leases(2)
2014
 
123
 
475,000
 
5.4
%
 
$
10,608,000

 
3.9
%
2015
 
78
 
396,000
 
4.5

 
7,688,000

 
2.8

2016
 
94
 
557,000
 
6.3

 
13,005,000

 
4.8

2017
 
76
 
507,000
 
5.8

 
10,590,000

 
3.9

2018
 
79
 
582,000
 
6.6

 
13,037,000

 
4.8

2019
 
47
 
387,000
 
4.4

 
9,716,000

 
3.6

2020
 
53
 
408,000
 
4.6

 
10,108,000

 
3.7

2021
 
32
 
321,000
 
3.6

 
8,691,000

 
3.2

2022
 
26
 
223,000
 
2.5

 
5,112,000

 
1.9

2023
 
22
 
463,000
 
5.3

 
10,968,000

 
4.0

Thereafter
 
51
 
4,481,000
 
51.0

 
172,154,000

 
63.4

Total
 
681
 
8,800,000
 
100
%
 
$
271,677,000

 
100
%
 _______
(1)
Excludes Midwest CCRC Portfolio with annualized net operating income of $24,918,000, which is operated utilizing a RIDEA structure.
(2)
The annual rent percentage is based on the total annual contractual base rent based on leases in effect as of December 31, 2013.

54

Geographic Diversification/Concentration Table
The following table lists the states in which our properties are located and provides certain information regarding our portfolio’s geographic diversification/concentration as of December 31, 2013:
 
State/Country
 
Number of
Buildings
 
GLA (Sq Ft)
 
% of GLA
 
Annualized Base Rent(1)
 
% of
Annualized
Base Rent
Domestic:
 
 
 
 
 
 
 
 
 
 
Alabama
 
3
 
193,000
 
1.8
%
 
$
3,601,000

 
1.5
%
Arizona
 
2
 
99,000
 
0.9

 
1,870,000

 
0.8

Arkansas
 
5
 
121,000
 
1.1

 
1,354,000

 
0.6

California
 
11
 
506,000
 
4.8

 
15,068,000

 
6.2

Colorado
 
9
 
606,000
 
5.7

 
11,074,000

 
4.6

Florida
 
5
 
201,000
 
1.9

 
3,636,000

 
1.5

Georgia
 
21
 
674,000
 
6.5

 
17,612,000

 
7.3

Hawaii
 
1
 
23,000
 
0.2

 
777,000

 
0.3

Idaho
 
1
 
76,000
 
0.7

 
1,532,000

 
0.6

Illinois
 
8
 
708,000
 
6.7

 
13,341,000

 
5.5

Indiana
 
33
 
1,214,000
 
11.5

 
23,059,000

 
9.5

Louisiana
 
6
 
296,000
 
2.8

 
5,638,000

 
2.3

Massachusetts
 
8
 
146,000
 
1.4

 
3,776,000

 
1.6

Michigan
 
3
 
137,000
 
1.3

 
2,719,000

 
1.1

Minnesota
 
2
 
35,000
 
0.3

 
596,000

 
0.2

Missouri
 
3
 
84,000
 
0.8

 
2,770,000

 
1.1

New Jersey
 
1
 
68,000
 
0.6

 
2,024,000

 
0.8

New Mexico
 
3
 
53,000
 
0.5

 
1,064,000

 
0.4

New York
 
6
 
362,000
 
3.4

 
10,018,000

 
4.1

North Carolina
 
7
 
307,000
 
2.9

 
8,084,000

 
3.3

Ohio
 
28
 
944,000
 
8.9

 
17,255,000

 
7.1

Oklahoma
 
3
 
100,000
 
0.9

 
2,016,000

 
0.8

Oregon
 
11
 
283,000
 
2.7

 
4,535,000

 
1.9

Pennsylvania
 
7
 
467,000
 
4.4

 
14,331,000

 
5.9

South Carolina
 
2
 
90,000
 
0.9

 
1,552,000

 
0.6

Tennessee
 
7
 
334,000
 
3.2

 
8,726,000

 
3.7

Texas
 
27
 
1,002,000
 
9.5

 
18,840,000

 
7.8

Utah
 
1
 
35,000
 
0.4

 
1,196,000

 
0.5

Virginia
 
7
 
232,000
 
2.2

 
4,598,000

 
1.9

Washington
 
4
 
207,000
 
2.0

 
4,108,000

 
1.7

     Total Domestic
 
235
 
9,603,000
 
90.9

 
206,770,000

 
85.2

United Kingdom
 
44
 
962,000
 
9.1

 
35,780,000

 
14.8

Total
 
279
 
10,565,000
 
100
%
 
$
242,550,000

 
100
%
 _______
(1)
With the exception of Midwest CCRC Portfolio, annualized base rent is based on contractual base rent from leases in effect as of December 31, 2013. Annualized base rent for Midwest CCRC Portfolio, which is operated utilizing a RIDEA structure, is based on annualized net operating income.


55

Indebtedness
For a discussion of our indebtedness, see Note 7, Mortgage Loans Payable, Net, Note 8, Derivative Financial Instruments, and Note 9, Line of Credit, to the Consolidated Financial Statements that are a part of this Annual Report on Form 10-K.
Item 3. Legal Proceedings.
None.
Item 4. Mine Safety Disclosures.
Not applicable.

56

PART II
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.
Market Information
There is no established public trading market for shares of our common stock.
To assist the members of the Financial Industry Regulatory Authority, or FINRA, and their associated persons that participated in the offering and sale of shares of our common stock, we disclose in each annual report distributed to stockholders a per share estimated value of the shares, the method by which it was developed, and the date of the data used to develop the estimated value. In addition, we will prepare annual statements of estimated share values to assist fiduciaries of retirement plans subject to the annual reporting requirements of ERISA in the preparation of their reports relating to an investment in shares of our common stock. For these purposes, our advisor entities’ estimated value of the shares is $10.22 per share as of December 31, 2013. The basis for this valuation is the fact that the most recent public offering price for shares of our common stock in our primary offering was $10.22 per share (ignoring purchase price discounts for certain categories of purchasers). However, there is no public trading market for the shares of our common stock at this time, and there can be no assurance that stockholders could receive $10.22 per share if such a market did exist and they sold their shares of our common stock or that they will be able to receive such amount for their shares of our common stock in the future. Unless otherwise required pursuant to applicable regulations, until 18 months after the termination of our follow-on offering, we intend to continue to use the offering price of shares of our common stock in our most recent offering as the estimated per share value reported in our Annual Reports on Form 10-K distributed to stockholders. Beginning 18 months after the termination of our follow-on offering, or such earlier time as required by applicable regulations, the value of the properties and our other assets will be determined in a manner deemed appropriate by our board of directors, unless another valuation methodology is required by applicable regulations, and we will disclose the resulting estimated per share value in our Annual Reports on Form 10-K distributed to stockholders.
Stockholders
As of March 7, 2014, we had approximately 65,406 stockholders of record.
Distributions
Our board of directors authorized, on a quarterly basis, a daily distribution to our stockholders of record as of the close of business on each day of the quarterly periods from January 1, 2012 and ending on March 31, 2014. For distributions declared for each record date in the January 2012 through October 2012 periods, the distributions were calculated based on 365 days in the calendar year and were equal to $0.001808219 per day per share of common stock, which is equal to an annualized distribution rate of 6.6%, assuming a purchase price of $10.00 per share. For distributions declared for each record date in the November 2012 through March 2014 periods, the distributions are calculated based on 365 days in the calendar year and are equal to $0.001863014 per day per share of common stock, which is equal to an annualized distribution rate of 6.65%, assuming a purchase price of $10.22 per share. These distributions are aggregated and paid in cash or shares of our common stock pursuant to the DRIP monthly in arrears. The distributions declared for each record date are paid only from legally available funds.
The amount of the distributions to our stockholders is determined quarterly by our board of directors and is dependent on a number of factors, including funds available for payment of distributions, our financial condition, capital expenditure requirements and annual distribution requirements needed to maintain our qualification as a REIT under the Code. We did not establish any limit on the amount of offering proceeds, and we have not established any limit on the amount of proceeds from any future offerings, that may be used to fund distributions, except that, in accordance with our organizational documents and Maryland law, we may not make distributions that would: (i) cause us to be unable to pay our debts as they become due in the usual course of business; (ii) cause our total assets to be less than the sum of our total liabilities plus senior liquidation preferences; or (iii) jeopardize our ability to maintain our qualification as a REIT.

57

The distributions paid for the years ended December 31, 2013 and 2012, along with the amount of distributions reinvested pursuant to the DRIP and the sources of our distributions as compared to cash flows from operations were as follows:
 
Years Ended December 31,
 
2013
 
2012
Distributions paid in cash
$
57,642,000

 
 
 
$
22,972,000

 
 
Distributions reinvested
67,905,000

 
 
 
22,622,000

 
 
 
$
125,547,000

 
 
 
$
45,594,000

 
 
Sources of distributions:
 
 
 
 
 
 
 
Cash flows from operations
$
42,748,000

 
34.0
%
 
$
23,462,000

 
51.5
%
Offering proceeds
82,799,000

 
66.0

 
22,132,000

 
48.5

 
$
125,547,000

 
100
%
 
$
45,594,000

 
100
%
Under GAAP, acquisition related expenses are expensed, and therefore, subtracted from cash flows from operations. However, these expenses are paid from offering proceeds.
Our distributions of amounts in excess of our current and accumulated earnings and profits have resulted in a return of capital to our stockholders, and all or any portion of a distribution to our stockholders may be paid from offering proceeds. The payment of distributions from our offering proceeds could reduce the amount of capital we ultimately invest in assets and negatively impact the amount of income available for future distributions.
As of December 31, 2013, we had an amount payable of $2,285,000 to our sub-advisor or its affiliates primarily comprised of asset and property management fees and lease commissions, which will be paid from cash flows from operations in the future as they become due and payable by us in the ordinary course of business consistent with our past practice.
As of December 31, 2013, no amounts due to our advisor entities or its affiliates had been deferred, waived or forgiven. Our advisor entities and their affiliates have no obligations to defer, waive or forgive amounts due to them. In the future, if our advisor entities or their affiliates do not defer, waive or forgive amounts due to them, this would negatively affect our cash flows from operations, which could result in us paying distributions, or a portion thereof, using borrowed funds. As a result, the amount of proceeds available for investment and operations would be reduced, or we may incur additional interest expense as a result of borrowed funds.
The distributions paid for the years ended December 31, 2013 and 2012, along with the amount of distributions reinvested pursuant to the DRIP and the sources of our distributions as compared to FFO were as follows:
 
Years Ended December 31,
 
2013
 
2012
Distributions paid in cash
$
57,642,000

 
 
 
$
22,972,000

 
 
Distributions reinvested
67,905,000

 
 
 
22,622,000

 
 
 
$
125,547,000

 
 
 
$
45,594,000

 
 
Sources of distributions:
 
 
 
 
 
 
 
FFO
$
85,154,000

 
67.8
%
 
$
—

 
—
%
Offering proceeds
40,393,000

 
32.2

 
45,594,000

 
100

 
$
125,547,000

 
100
%
 
$
45,594,000

 
100
%
The payment of distributions from sources other than FFO may reduce the amount of proceeds available for investment and operations or cause us to incur additional interest expense as a result of borrowed funds. For a further discussion of FFO, a non-GAAP financial measure, including a reconciliation of our GAAP net income (loss) to FFO, see Funds from Operations, Modified Funds from Operations and Normalized Modified Funds from Operations in Item 6. Selected Financial Data.

58

Securities Authorized for Issuance under Equity Compensation Plans
We adopted our incentive plan, pursuant to which our board of directors or a committee of our independent directors may make grants of options, restricted shares of common stock, stock purchase rights, stock appreciation rights or other awards to our independent directors, employees and consultants. The maximum number of shares of our common stock that may be issued pursuant to our incentive plan is 2,000,000. For a further discussion of our incentive plan, see Note 13, Equity — 2009 Incentive Plan, to the Consolidated Financial Statements that are a part of this Annual Report on Form 10-K. The following table provides information regarding our incentive plan as of December 31, 2013:
 
Plan Category
 
Number of Securities
to be Issued upon
Exercise of
Outstanding Options,
Warrants and Rights
 
Weighted Average
Exercise Price of
Outstanding Options,
Warrants and Rights
 
Number of Securities
Remaining
Available for
Future Issuance
Equity compensation plans approved by security holders(1)
 
—

 
—

 
1,932,500

Equity compensation plans not approved by security holders
 
—

 
—

 
—

Total
 
—

 
 
 
1,932,500

________ 
(1)
On October 21, 2009, we granted an aggregate of 15,000 shares of our restricted common stock, as defined in our incentive plan, to our independent directors in connection with their initial election to our board of directors, of which 20.0% vested on the grant date and 20.0% will vest on each of the first four anniversaries of the date of grant. On each of June 8, 2010, June 14, 2011, November 7, 2012 and December 5, 2013, in connection with their re-election, we granted an aggregate of 7,500, 7,500, 15,000 and 15,000 shares, respectively, of our restricted common stock, as defined in our incentive plan, to our independent directors, which will vest over the same period described above. In addition, on November 7, 2012, we granted an aggregate of 7,500 shares of restricted common stock, as defined in our incentive plan, to our independent directors in consideration of the directors' determination of market compensation for independent directors of similar publicly registered real estate investment trusts. These shares of restricted common stock will vest under the same period described above. The fair value of each share at the date of grant was estimated at $10.00 or $10.22 per share, as applicable based on the then most recent price paid to acquire a share of our common stock in our offerings; and with respect to the initial 20.0% of shares of our restricted common stock that vested on the date of grant, expensed as compensation immediately, and with respect to the remaining shares of our restricted common stock, amortized on a straight-line basis over the vesting period. Shares of our restricted common stock may not be sold, transferred, exchanged, assigned, pledged, hypothecated or otherwise encumbered. Such restrictions expire upon vesting. Shares of our restricted common stock have full voting rights and rights to distributions. Such shares are not shown in the chart above as they are deemed outstanding shares of our common stock; however, such grants reduce the number of securities remaining available for future issuance.
Recent Sales of Unregistered Securities
On December 5, 2013, in connection with the re-election of our independent directors, we issued an aggregate of 15,000 shares of restricted common stock to our independent directors pursuant to our incentive plan in a private transaction exempt from registration pursuant to Section 4(2) of the Securities Act. Each of these restricted common stock awards vested 20.0% on the grant date and 20.0% will vest on each of the first four anniversaries of the date of grant.
In December 2013, as compensation for services rendered in connection with the investigation, selection and acquisition of our properties, we issued an aggregate of 88,271 shares of our common stock to our advisor entities and their affiliates for acquisition fees in an amount equal to 0.15% of the contract purchase price, at $9.20 per share, the then most recent price paid to acquire a share of our common stock in our follow-on offering, net of selling commissions and dealer manager fees. The acquisition fees paid in shares of our common stock were issued through a private transaction exempt from registration pursuant to Section 4(2) of the Securities Act and Regulation D of the Securities Act and Rule 506 promulgated thereunder.
Use of Public Offering Proceeds
Follow-On Offering
On February 14, 2013, pursuant to our Registration Statement on Form S-11 (File No. 333-181928), we commenced our follow-on offering of up to $1,650,000,000 of shares of our common stock in which we initially offered to the public up to $1,500,000,000 of shares of our common stock for $10.22 per share in our primary offering and up to $150,000,000 of shares of our common stock for $9.71 per share pursuant to the DRIP. We reserved the right to reallocate the shares of common stock we offered in our follow-on offering between the primary offering and the DRIP. As such, during our follow-on offering, we

59

reallocated an aggregate $107,200,000 of shares from the DRIP to the primary offering. Accordingly, we offered to the public up to $1,607,200,000 of shares of our common stock in our primary offering and up to $42,800,000 of shares of our common stock pursuant to the DRIP. Griffin Securities served as the dealer manager of our follow-on offering.
On October 30, 2013, we terminated our follow-on offering. As of December 31, 2013, we had received and accepted subscriptions in our follow-on offering for 157,622,743 shares of our common stock, or $1,604,996,000, and a total of $42,713,000 in distributions were reinvested and 4,398,862 shares of our common stock were issued pursuant to the DRIP.
As of December 31, 2013 we had incurred other offering expenses of $2,755,000 to our advisor entities and their respective affiliates in connection with our follow-on offering. In addition, as of December 31, 2013, we had incurred selling commissions of $107,191,000 and dealer manager fees of $47,825,000 to Griffin Securities, an unaffiliated entity. Such commissions, fees and reimbursements were charged to stockholders’ equity as such amounts were reimbursed from the gross proceeds of our follow-on offering. The cost of raising funds in our follow-on offering as a percentage of gross proceeds received in our follow-on offering was 9.8% as of December 31, 2013. As of December 31, 2013, net offering proceeds in our follow-on offering were $1,489,938,000, including proceeds from the DRIP and after deducting offering expenses.
As of December 31, 2013, $28,000 remained payable to our sub-advisor or its affiliates for costs related to our follow-on offering.
As of December 31, 2013, we had used $1,338,689,000 in proceeds from our follow-on offering to acquire properties from unaffiliated parties, $20,791,000 to subsequently repay borrowings from unaffiliated parties incurred in connection with our acquisitions, $22,422,000 to acquire real-estate related investments from unaffiliated parties, $38,220,000 to pay acquisition related expenses to affiliated parties, $9,258,000 to pay acquisition related expenses to unaffiliated parties, $3,992,000 for lender required restricted cash accounts to unaffiliated parties and $2,722,000 for deferred financing costs to unaffiliated parties.
Purchase of Equity Securities by the Issuer and Affiliated Purchasers
Our share repurchase plan allows for repurchases of shares of our common stock by us when certain criteria are met. Share repurchases will be made at the sole discretion of our board of directors. All repurchases are subject to a one-year holding period, except for repurchases made in connection with a stockholder’s death or “qualifying disability,” as defined in our share repurchase plan. Funds for the repurchase of shares of our common stock will come exclusively from the cumulative proceeds we receive from the sale of shares of our common stock pursuant to the DRIP.
The prices per share at which we will repurchase shares of our common stock will range, depending on the length of time the stockholder held such shares, from 92.5% to 100% of the price paid per share to acquire such shares from us. However, if shares of our common stock are to be repurchased in connection with a stockholder’s death or qualifying disability, the repurchase price will be no less than 100% of the price paid to acquire the shares of our common stock from us.
During the three months ended December 31, 2013, we repurchased shares of our common stock as follows:
Period
 
(a)
Total Number of
Shares Purchased
 
(b)
Average Price
Paid per Share
 
(c)
Total Number of Shares
Purchased As Part of
Publicly Announced
Plan or Program(1)
 
(d)
Maximum Approximate
Dollar Value
of Shares that May
Yet Be Purchased
Under the
Plans or Programs
October 1, 2013 to October 31, 2013
 
154,296

 
$
9.71

 
154,296

 
(2
)
November 1, 2013 to November 30, 2013
 
—

 
$
—

 
—

 
(2
)
December 1, 2013 to December 31, 2013
 
—

 
$
—

 
—

 
(2
)
Total
 
154,296

 
$
9.71

 
154,296

 
 
 _________
(1)
Our board of directors adopted a share repurchase plan effective August 24, 2009, which was amended and restated on November 6, 2012 primarily to revise the per share repurchase price.
(2)
Subject to funds being available, we will limit the number of shares of our common stock repurchased during any calendar year to 5.0% of the weighted average number of shares of our common stock outstanding during the prior calendar year; provided however, shares of our common stock subject to a repurchase requested upon the death of a stockholder will not be subject to this cap.

60

Item 6. Selected Financial Data.
The following should be read with Part I, Item 1A. Risk Factors and Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations and our accompanying consolidated financial statements and the notes thereto. Our historical results are not necessarily indicative of results for any future period.
The following selected financial data is derived from our consolidated financial statements in Part IV, Item 15. Exhibits, Financial Statement Schedules that is a part of this Annual Report on Form 10-K. 
 
 
December 31,
Selected Financial Data
 
2013
 
2012

2011

2010
 
2009
BALANCE SHEET DATA:
 

 





 
 
Total assets
 
$
2,928,726,000

 
$
1,454,629,000


$
499,152,000

 
$
203,996,000

 
$
13,809,000

Mortgage loans payable, net
 
$
329,476,000

 
$
291,052,000


$
80,466,000

 
$
58,331,000

 
$
—

Lines of credit
 
$
68,000,000

 
$
200,000,000


$
—

 
$
11,800,000

 
$
—

Stockholders' equity
 
$
2,383,025,000

 
$
860,307,000


$
397,357,000

 
$
125,240,000

 
$
13,283,000

 
 
 
 
 
 
 
 
 
 
 
 
 
Years Ended December 31,
 
Period from
January 7, 2009
(Date of Inception)
through
December 31, 2009
 
 
2013
 
2012
 
2011
 
2010
 
STATEMENT OF OPERATIONS DATA:
 

 





 
 
Total revenues
 
$
204,403,000

 
$
100,728,000


$
40,457,000


$
8,682,000

 
$
—

Net income (loss)
 
$
9,065,000

 
$
(63,244,000
)
 
$
(5,774,000
)
 
$
(7,423,000
)
 
$
(282,000
)
Net income (loss) attributable to controlling interest
 
$
9,051,000

 
$
(63,247,000
)

$
(5,776,000
)

$
(7,424,000
)
 
$
(281,000
)
Net income (loss) per common share attributable to controlling interest — basic and diluted(1)
 
$
0.05

 
$
(0.85
)

$
(0.19
)

$
(0.99
)
 
$
(1.51
)
STATEMENT OF CASH FLOWS DATA:
 

 





 
 
Net cash provided by (used in) operating activities
 
$
42,748,000

 
$
23,462,000


$
9,264,000


$
(2,881,000
)
 
$
(40,000
)
Net cash used in investing activities
 
$
(1,437,605,000
)
 
$
(730,304,000
)

$
(223,689,000
)

$
(186,342,000
)
 
$
—

Net cash provided by financing activities
 
$
1,337,919,000

 
$
756,843,000


$
253,089,000


$
181,468,000

 
$
13,813,000

OTHER DATA:
 

 





 
 
Distributions declared
 
$
135,900,000

 
$
49,346,000

 
$
20,037,000


$
4,866,000

 
$
—

Distributions declared per share
 
$
0.68

 
$
0.66


$
0.65


$
0.66

 
$
—

Funds from operations(2)
 
$
85,154,000

 
$
(24,851,000
)

$
9,040,000

 
$
(3,837,000
)
 
$
(281,000
)
Modified funds from operations(2)
 
$
109,266,000

 
$
44,987,000


$
17,577,000


$
2,909,000

 
$
(263,000
)
Normalized modified funds from operations(2)
 
$
109,266,000

 
$
49,219,000

 
$
17,577,000

 
$
2,909,000

 
$
(263,000
)
Net operating income(3)
 
$
161,016,000

 
$
79,597,000


$
32,127,000

 
$
6,481,000

 
$
—

 _______
(1)
Net income (loss) per common share is based upon the weighted average number of shares of our common stock outstanding. Distributions by us of our current and accumulated earnings and profits for federal income tax purposes are taxable to stockholders as ordinary income. Distributions in excess of these earnings and profits generally are treated as a non-taxable reduction of the stockholders’ basis in the shares of our common stock to the extent thereof (a return of capital for tax purposes) and, thereafter, as taxable gain. These distributions in excess of earnings and profits will have the effect of deferring taxation of the distributions until the sale of the stockholders’ common stock.
(2)
Funds from Operations, Modified Funds from Operations and Normalized Modified Funds from Operations:
Due to certain unique operating characteristics of real estate companies, the National Association of Real Estate Investment Trusts, or NAREIT, an industry trade group, has promulgated a measure known as FFO, which we believe to be an appropriate supplemental measure to reflect the operating performance of a REIT. The use of FFO is

61

recommended by the REIT industry as a supplemental performance measure. FFO is not equivalent to our net income (loss) as determined under GAAP.
We define FFO, a non-GAAP measure, consistent with the standards established by the White Paper on FFO approved by the Board of Governors of NAREIT, as revised in February 2004, or the White Paper. The White Paper defines FFO as net income (loss) computed in accordance with GAAP, excluding gains or losses from sales of property and asset impairment writedowns, plus depreciation and amortization, and after adjustments for unconsolidated partnerships and joint ventures. Adjustments for unconsolidated partnerships and joint ventures are calculated to reflect FFO. Our FFO calculation complies with NAREIT’s policy described above.
The historical accounting convention used for real estate assets requires straight-line depreciation of buildings and improvements, which implies that the value of real estate assets diminishes predictably over time, which is the case if such assets are not adequately maintained or repaired and renovated as required by relevant circumstances and/or as requested or required by lessees for operational purposes in order to maintain the value disclosed. We believe that, since real estate values historically rise and fall with market conditions, including inflation, interest rates, the business cycle, unemployment and consumer spending, presentations of operating results for a REIT using historical accounting for depreciation may be less informative. In addition, we believe it is appropriate to disregard impairment charges, as this is a fair value adjustment that is largely based on market fluctuations and assessments regarding general market conditions which can change over time. An asset will only be evaluated for impairment if certain impairment indications exist, and if the carrying, or book value, exceeds the total estimated undiscounted future cash flows (including net rental and lease revenues, net proceeds on the sale of the property, and any other ancillary cash flows at a property or group level under GAAP) from such asset an impairment charge would be recognized. Testing for impairment charges is a continuous process and is analyzed on a quarterly basis. Investors should note, however, that determinations of whether impairment charges have been incurred are based partly on anticipated operating performance, because estimated undiscounted future cash flows from a property, including estimated future net rental and lease revenues, net proceeds on the sale of the property, and certain other ancillary cash flows, are taken into account in determining whether an impairment charge has been incurred. While impairment charges are excluded from the calculation of FFO as described above, investors are cautioned that due to the fact that impairments are based on estimated future undiscounted cash flows and that we intend to have a relatively limited term of our operations, it could be difficult to recover any impairment charges through the eventual sale of the property.
Historical accounting for real estate involves the use of GAAP. Any other method of accounting for real estate such as the fair value method cannot be construed to be any more accurate or relevant than the comparable methodologies of real estate valuation found in GAAP. Nevertheless, we believe that the use of FFO, which excludes the impact of real estate related depreciation and amortization and impairments, provides a more complete understanding of our performance to investors and to our management, and when compared year over year, reflects the impact on our operations from trends in occupancy rates, rental rates, operating costs, general and administrative expenses, and interest costs, which may not be immediately apparent from net income (loss).
However, FFO and modified funds from operations, or MFFO, as described below, should not be construed to be more relevant or accurate than the current GAAP methodology in calculating net income (loss) or in its applicability in evaluating our operating performance. The method utilized to evaluate the value and performance of real estate under GAAP should be construed as a more relevant measure of operational performance and considered more prominently than the non-GAAP FFO and MFFO measures and the adjustments to GAAP in calculating FFO and MFFO.
Changes in the accounting and reporting rules under GAAP that were put into effect and other changes to GAAP accounting for real estate subsequent to the establishment of NAREIT’s definition of FFO have prompted an increase in cash-settled expenses, specifically acquisition fees and expenses, as items that are expensed as operating expenses under GAAP. We believe these fees and expenses do not affect our overall long-term operating performance. Publicly registered, non-listed REITs typically have a significant amount of acquisition activity and are substantially more dynamic during their initial years of investment and operation. While other start up entities may also experience significant acquisition activity during their initial years, we believe that publicly registered, non-listed REITs are unique in that they have a limited life with targeted exit strategies within a relatively limited time frame after the acquisition activity ceases. We will use the proceeds raised in our offerings to acquire properties, and we intend to begin the process of achieving a liquidity event (i.e., listing of our shares of common stock on a national securities exchange, a merger or sale, the sale of all or substantially all of our assets, or another similar transaction) within five years after the completion of our offering stage, which is generally comparable to other publicly registered, non-listed REITs. Thus, we do not intend to continuously purchase assets and intend to have a limited life. Due to the above factors and other unique features of publicly registered, non-listed REITs, the Investment Program Association, or the IPA, an industry trade group, has standardized a measure known as MFFO, which the IPA has recommended as a supplemental measure for

62

publicly registered, non-listed REITs and which we believe to be another appropriate supplemental measure to reflect the operating performance of a publicly registered, non-listed REIT having the characteristics described above. MFFO is not equivalent to our net income (loss) as determined under GAAP, and MFFO may not be a useful measure of the impact of long-term operating performance on value if we do not continue to operate with a limited life and targeted exit strategy, as currently intended. We believe that, because MFFO excludes acquisition fees and expenses that affect our operations only in periods in which properties are acquired and that we consider more reflective of investing activities, as well as other non-operating items included in FFO, MFFO can provide, on a going forward basis, an indication of the sustainability (that is, the capacity to continue to be maintained) of our operating performance after the period in which we are acquiring our properties and once our portfolio is in place. By providing MFFO, we believe we are presenting useful information that assists investors and analysts to better assess the sustainability of our operating performance after our offering stage has been completed and our properties have been acquired. We also believe that MFFO is a recognized measure of sustainable operating performance by the publicly registered, non-listed REIT industry. Further, we believe MFFO is useful in comparing the sustainability of our operating performance after our offering stage and acquisitions are completed with the sustainability of the operating performance of other real estate companies that are not as involved in acquisition activities. Investors are cautioned that MFFO should only be used to assess the sustainability of our operating performance after our offering stage has been completed and properties have been acquired, as it excludes acquisition fees and expenses that have a negative effect on our operating performance during the periods in which properties are acquired.
We define MFFO, a non-GAAP measure, consistent with the IPA’s Guideline 2010-01, Supplemental Performance Measure for Publicly Registered, Non-Listed REITs: Modified Funds from Operations, or the Practice Guideline, issued by the IPA in November 2010. The Practice Guideline defines MFFO as FFO further adjusted for the following items included in the determination of GAAP net income (loss): acquisition fees and expenses; amounts relating to deferred rent receivables and amortization of above and below market leases and liabilities (which are adjusted in order to reflect such payments from a GAAP accrual basis to closer to an expected to be received cash basis of disclosing the rent and lease payments); accretion of discounts and amortization of premiums on debt investments; mark-to-market adjustments included in net income (loss); gains or losses included in net income (loss) from the extinguishment or sale of debt, hedges, foreign exchange, derivatives or securities holdings where trading of such holdings is not a fundamental attribute of the business plan; unrealized gains or losses resulting from consolidation from, or deconsolidation to, equity accounting; and after adjustments for consolidated and unconsolidated partnerships and joint ventures, with such adjustments calculated to reflect MFFO on the same basis. The accretion of discounts and amortization of premiums on debt investments, unrealized gains and losses on hedges, foreign exchange, derivatives or securities holdings, unrealized gains and losses resulting from consolidations, as well as other listed cash flow adjustments are adjustments made to net income (loss) in calculating cash flows from operations and, in some cases, reflect gains or losses which are unrealized and may not ultimately be realized. We are responsible for managing interest rate, hedge and foreign exchange risk, and we do not rely on another party to manage such risk. Inasmuch as interest rate and foreign currency rate hedges are not a fundamental part of our operations, we believe it is appropriate to exclude such gains and losses in calculating MFFO, as such gains and losses are based on market fluctuations and may not be directly related or attributable to our operations.
Our MFFO calculation complies with the IPA’s Practice Guideline described above. In calculating MFFO, we exclude acquisition related expenses (which includes gains and losses on contingent consideration), amortization of above and below market leases, amortization of closing costs and origination fees, fair value adjustments of derivative financial instruments, gains or losses on foreign currency transactions, gains or losses from the extinguishment of debt, change in deferred rent receivables and the adjustments of such items related to noncontrolling interests. The other adjustments included in the IPA’s Practice Guideline are not applicable to us for years ended December 31, 2013, 2012, 2011, and 2010 and for the period from January 7, 2009 (Date of Inception) through December 31, 2009. Acquisition fees and expenses are paid in cash by us, and we have not set aside or put into escrow any specific amount of proceeds from our offerings to be used to fund acquisition fees and expenses. The purchase of real estate and real estate-related investments, and the corresponding expenses associated with that process, is a key operational feature of our business plan in order to generate operating revenues and cash flows to make distributions to our stockholders. However, we do not intend to fund acquisition fees and expenses in the future from operating revenues and cash flows, nor from the sale of properties and subsequent re-deployment of capital and concurrent incurring of acquisition fees and expenses. Acquisition fees and expenses include payments to our advisor entities or their affiliates and third parties. Such fees and expenses will not be reimbursed by our advisor entities or their affiliates and third parties, and therefore if there are no further proceeds from the sale of shares of our common stock to fund future acquisition fees and expenses, such fees and expenses will need to be paid from either additional debt, operational earnings or cash flows, net proceeds from the sale of properties, or from ancillary cash flows. Acquisition related expenses under GAAP are considered operating expenses and as expenses included in the determination of net income (loss) and income (loss) from continuing operations, both of which are performance measures under GAAP. All paid and accrued acquisition fees and expenses will have negative

63

effects on returns to investors, the potential for future distributions, and cash flows generated by us, unless earnings from operations or net sales proceeds from the disposition of other properties are generated to cover the purchase price of the property, these fees and expenses and other costs related to such property. In the future, we may pay acquisition fees or reimburse acquisition expenses due to our advisor entities and their affiliates, or a portion thereof, with net proceeds from borrowed funds, operational earnings or cash flows, net proceeds from the sale of properties, or ancillary cash flows. As a result, the amount of proceeds available for investment and operations would be reduced, or we may incur additional interest expense as a result of borrowed funds. Nevertheless, our advisor entities or their affiliates will not accrue any claim on our assets if acquisition fees and expenses are not paid from the proceeds of our offerings.
Further, under GAAP, certain contemplated non-cash fair value and other non-cash adjustments are considered operating non-cash adjustments to net income (loss) in determining cash flows from operations. In addition, we view fair value adjustments of derivatives and gains and losses from dispositions of assets as items which are unrealized and may not ultimately be realized or as items which are not reflective of on-going operations and are therefore typically adjusted for when assessing operating performance.
We use MFFO and the adjustments used to calculate it in order to evaluate our performance against other publicly registered, non-listed REITs which intend to have limited lives with short and defined acquisition periods and targeted exit strategies shortly thereafter. As noted above, MFFO may not be a useful measure of the impact of long-term operating performance if we do not continue to operate in this manner. We believe that our use of MFFO and the adjustments used to calculate it allow us to present our performance in a manner that reflects certain characteristics that are unique to publicly registered, non-listed REITs, such as their limited life, limited and defined acquisition period and targeted exit strategy, and hence that the use of such measures may be useful to investors. For example, acquisition fees and expenses are intended to be funded from the proceeds of our offerings and other financing sources and not from operations. By excluding expensed acquisition fees and expenses, the use of MFFO provides information consistent with management’s analysis of the operating performance of the properties. Additionally, fair value adjustments, which are based on the impact of current market fluctuations and underlying assessments of general market conditions, but can also result from operational factors such as rental and occupancy rates, may not be directly related or attributable to our current operating performance. By excluding such charges that may reflect anticipated and unrealized gains or losses, we believe MFFO provides useful supplemental information.
Presentation of this information is intended to provide useful information to investors as they compare the operating performance of different REITs, although it should be noted that not all REITs calculate FFO and MFFO the same way, so comparisons with other REITs may not be meaningful. Furthermore, FFO and MFFO are not necessarily indicative of cash flow available to fund cash needs and should not be considered as an alternative to net income (loss) or income (loss) from continuing operations as an indication of our performance, as an alternative to cash flows from operations, which is an indication of our liquidity, or indicative of funds available to fund our cash needs including our ability to make distributions to our stockholders. FFO and MFFO should be reviewed in conjunction with other measurements as an indication of our performance. MFFO has limitations as a performance measure in offerings such as our offerings where the price of a share of common stock is a stated value and there is no net asset value determination during the offering stage and for a period thereafter. MFFO may be useful in assisting management and investors in assessing the sustainability of operating performance in future operating periods, and in particular, after the offering and acquisition stages are complete and net asset value is disclosed. FFO and MFFO are not useful measures in evaluating net asset value because impairments are taken into account in determining net asset value but not in determining FFO and MFFO.
Neither the SEC, NAREIT nor any other regulatory body has passed judgment on the acceptability of the adjustments that we use to calculate FFO or MFFO. In the future, the SEC, NAREIT or another regulatory body may decide to standardize the allowable adjustments across the publicly registered, non-listed REIT industry and we would have to adjust our calculation and characterization of FFO or MFFO.
In addition, we are presenting normalized MFFO, or Normalized MFFO, to adjust MFFO for the costs associated with the purchase during the third quarter of 2012 from an unaffiliated third party of the rights to any subordinated distribution that may have been owed to our former sponsor. We believe that adjusting for the purchase of the subordinated distribution provides useful information because such payment may not be reflective of on-going operations. For a further discussion of the subordinated distribution purchase, see Item 7. Management's Discussion and Analysis — Results of Operations — Subordinated Distribution Purchase.

64

The following is a reconciliation of net income (loss), which is the most directly comparable GAAP financial measure, to FFO, MFFO and Normalized MFFO for the years ended December 31, 2013, 2012, 2011 and 2010 and for the period from January 7, 2009 (Date of Inception) through December 31, 2009:
 
Years Ended December 31,
 
Period from
January 7, 2009
(Date of Inception)
through
December 31, 2009
 
2013
 
2012
 
2011
 
2010
 
Net income (loss)
$
9,065,000

 
$
(63,244,000
)
 
$
(5,774,000
)
 
$
(7,423,000
)
 
$
(282,000
)
Add:
 
 
 
 
 
 
 
 
 
Depreciation and amortization — consolidated properties
76,188,000

 
38,407,000

 
14,826,000

 
3,591,000

 
—

Less:
 
 
 
 
 
 
 
 
 
Net (income) loss attributable to noncontrolling interests
(14,000
)
 
(3,000
)
 
(2,000
)
 
(1,000
)
 
1,000

Depreciation and amortization related to noncontrolling interests
(85,000
)
 
(11,000
)
 
(10,000
)
 
(4,000
)
 
—

FFO
$
85,154,000

 
$
(24,851,000
)
 
$
9,040,000

 
$
(3,837,000
)
 
$
(281,000
)
 
 
 
 
 
 
 
 
 
 
Acquisition related expenses(1)
$
25,501,000

 
$
75,608,000

 
$
10,389,000

 
$
7,099,000

 
$
18,000

Amortization of above and below market leases(2)
1,910,000

 
1,283,000

 
298,000

 
79,000

 
—

Amortization of closing costs and origination fees(3)
107,000

 
15,000

 
—

 
—

 
—

(Gain) loss in fair value of derivative financial instruments(4)
(344,000
)
 
(24,000
)
 
366,000

 
143,000

 
—

Foreign currency and derivative loss(4)(5)
11,312,000

 
—

 
—

 
—

 
 
(Gain) loss on extinguishment of debt(6)
(127,000
)
 
35,000

 
44,000

 
—

 
—

Adjustments for noncontrolling interests(7)
(23,000
)
 
2,000

 
2,000

 
1,000

 
—

Change in deferred rent receivables(8)
(14,224,000
)
 
(7,081,000
)
 
(2,562,000
)
 
(576,000
)
 
—

MFFO
$
109,266,000

 
$
44,987,000

 
$
17,577,000

 
$
2,909,000

 
$
(263,000
)
 
 
 
 
 
 
 
 
 
 
Subordinated distribution purchase(9)
—

 
4,232,000

 
—

 
—

 
—

Normalized MFFO
$
109,266,000

 
$
49,219,000

 
$
17,577,000

 
$
2,909,000

 
$
(263,000
)
Weighted average common shares outstanding — basic and diluted
199,793,355

 
74,122,982

 
30,808,725

 
7,471,184

 
186,330

Net income (loss) per common share — basic and diluted
$
0.05

 
$
(0.85
)
 
$
(0.19
)
 
$
(0.99
)
 
$
(1.51
)
FFO per common share — basic and diluted
$
0.43

 
$
(0.34
)
 
$
0.29

 
$
(0.51
)
 
$
(1.51
)
MFFO per common share — basic and diluted
$
0.55

 
$
0.61

 
$
0.57

 
$
0.39

 
$
(1.41
)
Normalized MFFO per common share — basic and diluted
$
0.55

 
$
0.66

 
$
0.57

 
$
0.39

 
$
(1.41
)
_________
(1)
In evaluating investments in real estate, we differentiate the costs to acquire the investment from the operations derived from the investment. Such information would be comparable only for publicly registered, non-listed REITs that have completed their acquisition activity and have other similar operating characteristics. By excluding expensed acquisition related expenses, we believe MFFO provides useful supplemental information that is comparable for each type of real estate investment and is consistent with management’s analysis of the investing and operating performance of our properties. Acquisition fees and expenses include payments to our former advisor, our advisor entities or their affiliates and third parties. Acquisition related expenses under GAAP are considered operating expenses and as expenses included in the determination of net income (loss) and income (loss) from continuing operations, both of which are performance measures under GAAP. All paid and accrued acquisition fees and expenses will have negative effects on returns to investors, the potential for future distributions, and cash flows generated by us, unless earnings from operations or net sales proceeds from the disposition of other properties are generated to cover the purchase price of the property, these fees and expenses and other costs related to such property.

65


(2)
Under GAAP, above and below market leases are assumed to diminish predictably in value over time and amortized, similar to depreciation and amortization of other real estate related assets that are excluded from FFO. However, because real estate values and market lease rates historically rise or fall with market conditions, including inflation, interest rates, the business cycle, unemployment and consumer spending, we believe that by excluding charges relating to the amortization of above and below market leases, MFFO may provide useful supplemental information on the performance of the real estate.

(3)
Under GAAP, direct loan origination fees and costs are amortized over the term of the notes receivable as an adjustment to the yield on the notes receivable. This may result in income recognition that is different than the contractual cash flows under the notes receivable. By adjusting for the amortization of the closing costs and origination fees related to our real estate notes receivable, MFFO may provide useful supplemental information on the realized economic impact of the notes receivable terms, providing insight on the expected contractual cash flows of such notes receivable, and aligns results with our analysis of operating performance.

(4)
Under GAAP, we are required to record our derivative financial instruments at fair value at each reporting period. We believe that adjusting for the change in fair value of our derivative financial instruments is appropriate because such adjustments may not be reflective of on-going operations and reflect unrealized impacts on value based only on then current market conditions, although they may be based upon general market conditions. The need to reflect the change in fair value of our derivative financial instruments is a continuous process and is analyzed on a quarterly basis in accordance with GAAP.

(5)
We believe that adjusting for the change in foreign currency exchange rates provides useful information because such adjustments may not be reflective of on-going operations.

(6)
We believe that adjusting for the gain or loss on extinguishment of debt provides useful information because such gain or loss on extinguishment of debt may not be reflective of on-going operations.

(7)
Includes all adjustments to eliminate the noncontrolling interests' share of the adjustments described in Notes (1) - (6) and (8) to convert our FFO to MFFO.

(8)
Under GAAP, rental revenue is recognized on a straight-line basis over the terms of the related lease (including rent holidays). This may result in income recognition that is significantly different than the underlying contract terms. By adjusting for the change in deferred rent receivables, excluding the impact of foreign currency translation adjustments, MFFO may provide useful supplemental information on the realized economic impact of lease terms, providing insight on the expected contractual cash flows of such lease terms, and aligns results with our analysis of operating performance.

(9)
We believe that adjusting for the purchase of the subordinated distribution provides useful information because such payment may not be reflective of on-going operations.
(3)
Net Operating Income:
Net operating income is a non-GAAP financial measure that is defined as net income (loss), computed in accordance with GAAP, generated from properties before general and administrative expenses, subordinated distribution purchase, acquisition related expenses, depreciation and amortization, interest expense, foreign currency and derivative loss, interest income and income tax benefit. We believe that net operating income is useful for investors as it provides an accurate measure of the operating performance of our operating assets because net operating income excludes certain items that are not associated with the management of the properties. Additionally, we believe that net operating income is a widely accepted measure of comparative operating performance in the real estate community. However, our use of the term net operating income may not be comparable to that of other real estate companies as they may have different methodologies for computing this amount.

66

The following is a reconciliation of net (income) loss, which is the most directly comparable GAAP financial measure, to net operating income for the years ended December 31, 2013, 2012, 2011 and 2010 and for the period from January 7, 2009 (Date of Inception) through December 31, 2009:
 
Years Ended December 31,
 
Period from
January 7, 2009
(Date of Inception)
through
December 31, 2009
 
2013
 
2012
 
2011
 
2010
 
Net income (loss)
$
9,065,000

 
$
(63,244,000
)
 
$
(5,774,000
)
 
$
(7,423,000
)
 
$
(282,000
)
General and administrative
22,519,000

 
11,067,000

 
5,992,000

 
1,670,000

 
268,000

Subordinated distribution purchase
—

 
4,232,000

 
—

 
—

 
—

Acquisition related expenses
25,501,000

 
75,608,000

 
10,389,000

 
7,099,000

 
18,000

Depreciation and amortization
76,188,000

 
38,407,000

 
14,826,000

 
3,591,000

 
—

Interest expense
17,765,000

 
13,542,000

 
6,711,000

 
1,559,000

 
—

Foreign currency and derivative loss
11,312,000

 
—

 
—

 
—

 
—

Interest income
(329,000
)
 
(15,000
)
 
(17,000
)
 
(15,000
)
 
(4,000
)
Income tax benefit
(1,005,000
)
 
—

 
—

 
—

 
—

Net operating income
$
161,016,000

 
$
79,597,000

 
$
32,127,000

 
$
6,481,000

 
$
—


67

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
The use of the words “we,” “us” or “our” refers to Griffin-American Healthcare REIT II, Inc. and its subsidiaries, including Griffin-American Healthcare REIT II Holdings, LP, except where the context otherwise requires.
The following discussion should be read in conjunction with our accompanying consolidated financial statements and notes thereto appearing elsewhere in this Annual Report on Form 10-K. Such consolidated financial statements and information have been prepared to reflect our financial position as of December 31, 2013 and 2012, together with our results of operations for the years ended December 31, 2013, 2012 and 2011 and cash flows for the years ended December 31, 2013, 2012 and 2011.
Forward-Looking Statements
Historical results and trends should not be taken as indicative of future operations. Our statements contained in this report that are not historical facts are forward-looking. Actual results may differ materially from those included in the forward-looking statements. Forward-looking statements, which are based on certain assumptions and describe future plans, strategies and expectations, are generally identifiable by use of the words “expect,” “project,” “may,” “will,” “should,” “could,” “would,” “intend,” “plan,” “anticipate,” “estimate,” “believe,” “continue,” “predict,” “potential” or the negative of such terms and other comparable terminology. Our ability to predict results or the actual effect of future plans or strategies is inherently uncertain. Factors which could have a material adverse effect on our operations and future prospects on a consolidated basis include, but are not limited to: changes in economic conditions generally and the real estate market specifically; legislative and regulatory changes, including changes to laws governing the taxation of real estate investment trusts, or REITs; changes in interest and foreign currency exchange rates; competition in the real estate industry; the supply and demand for operating properties in our proposed market areas; changes in accounting principles generally accepted in the United States of America, or GAAP, policies and guidelines applicable to REITs; the availability of properties to acquire; our ability to acquire properties pursuant to our investment strategy; the availability of capital and debt financing; and our ongoing relationship with American Healthcare Investors LLC, or American Healthcare Investors, and Griffin Capital Corporation, or Griffin Capital, or our co-sponsors, and their affiliates. These risks and uncertainties should be considered in evaluating forward-looking statements and undue reliance should not be placed on such statements. Additional information concerning us and our business, including additional factors that could materially affect our financial results, is included herein and in our other filings with the United States Securities and Exchange Commission, or the SEC.
Overview and Background
Griffin-American Healthcare REIT II, Inc., a Maryland corporation, was incorporated as Grubb & Ellis Healthcare REIT II, Inc. on January 7, 2009 and therefore we consider that our date of inception. We were initially capitalized on February 4, 2009. Our board of directors adopted an amendment to our charter, which was filed with the Maryland State Department of Assessments and Taxation on January 3, 2012, to change our name from Grubb & Ellis Healthcare REIT II, Inc. to Griffin-American Healthcare REIT II, Inc. We invest in a diversified portfolio of real estate properties, focusing primarily on medical office buildings and healthcare-related facilities. We may also originate and acquire secured loans and real estate-related investments. We also operate healthcare-related facilities utilizing the structure permitted by the REIT Investment Diversification and Empowerment Act of 2007, which is commonly referred to as a "RIDEA" structure (the provisions of the Internal Revenue Code of 1986, as amended, or the Code, authorizing the RIDEA structure were enacted as part of the Housing and Economic Recovery Act of 2008). We generally seek investments that produce current income. We qualified to be taxed as a REIT under the Code for federal income tax purposes beginning with our taxable year ended December 31, 2010 and we intend to continue to be taxed as a REIT.
On August 24, 2009, we commenced a best efforts initial public offering, or our initial offering, of up to $3,285,000,000 of shares of our common stock. Until November 6, 2012, we offered to the public up to $3,000,000,000 of shares of our common stock for $10.00 per share in our primary offering and $285,000,000 of shares of our common stock pursuant to our distribution reinvestment plan, or the DRIP, for $9.50 per share. On November 7, 2012, we began selling shares of our common stock in our initial offering at $10.22 per share in our primary offering and issuing shares pursuant to the DRIP for $9.71 per share.
On February 14, 2013, we terminated our initial offering. As of February 14, 2013, we had received and accepted subscriptions in our initial offering for 123,179,064 shares of our common stock, or $1,233,333,000, and a total of $40,167,000 in distributions were reinvested and 4,205,920 shares of our common stock were issued pursuant to the DRIP.
On February 14, 2013, we commenced a best efforts follow-on public offering, or our follow-on offering, of up to $1,650,000,000 of shares of our common stock, in which we initially offered to the public up to $1,500,000,000 of shares of our common stock for $10.22 per share in our primary offering and $150,000,000 of shares of our common stock for $9.71 per share pursuant to the DRIP. We reserved the right to reallocate the shares of common stock we offered in our follow-on offering

68

between the primary offering and the DRIP. As such, during our follow-on offering, we reallocated an aggregate of $107,200,000 of shares from the DRIP to the primary offering. Accordingly, we offered to the public up to $1,607,200,000 of shares of our common stock in our primary offering and up to $42,800,000 of shares of our common stock pursuant to the DRIP.
On October 30, 2013, we terminated our follow-on offering. As of December 31, 2013, we had received and accepted subscriptions in our follow-on offering for 157,622,743 shares of our common stock, or $1,604,996,000, and a total of $42,713,000 in distributions were reinvested and 4,398,862 shares of our common stock were issued pursuant to the DRIP.
On September 9, 2013, we filed a Registration Statement on Form S-3 under the Securities Act of 1933, as amended, to register a maximum of $100,000,000 of additional shares of our common stock pursuant to our distribution reinvestment plan, or the Secondary DRIP. The Registration Statement on Form S-3 was automatically effective with the SEC upon its filing; however, we did not commence offering shares pursuant to the Secondary DRIP until October 30, 2013 following the termination of our follow-on offering. As of December 31, 2013, a total of $18,448,000 in distributions were reinvested and 1,899,892 shares of our common stock were issued pursuant to the Secondary DRIP.
We conduct substantially all of our operations through Griffin-American Healthcare REIT II Holdings, LP, or our operating partnership. On January 3, 2012, our operating partnership filed an Amendment to the Certificate of Limited Partnership with the Delaware Department of State to change its name from Grubb & Ellis Healthcare REIT II Holdings, LP to Griffin-American Healthcare REIT II Holdings, LP. Until January 6, 2012, we were externally advised by Grubb & Ellis Healthcare REIT II Advisor, LLC, or our former advisor, pursuant to an advisory agreement, as amended and restated, or the G&E Advisory Agreement, between us and our former advisor. From August 24, 2009 through January 6, 2012, our former advisor supervised and managed our day-to-day operations and selected the properties and real estate-related investments we acquired, subject to the oversight and approval of our board of directors. Our former advisor also provided marketing, sales and client services on our behalf and engaged affiliated entities to provide various services to us. Our former advisor was managed by and was a wholly owned subsidiary of Grubb & Ellis Equity Advisors, LLC, or GEEA, which was a wholly owned subsidiary of Grubb & Ellis Company, or Grubb & Ellis, or our former sponsor.
On November 7, 2011, our independent directors determined that it was in the best interests of our company and its stockholders to transition advisory and dealer manager services rendered to us by affiliates of Grubb & Ellis and to engage American Healthcare Investors and Griffin Capital as replacement co-sponsors. As a result, on November 7, 2011, we notified our former advisor that we terminated the G&E Advisory Agreement. Pursuant to the G&E Advisory Agreement, either party could terminate the G&E Advisory Agreement without cause or penalty; however, certain rights and obligations of the parties would survive during a 60-day transition period and beyond.
In addition, on November 7, 2011, we notified Grubb & Ellis Capital Corporation, our former dealer manager, that we terminated the Amended and Restated Dealer Manager Agreement dated June 1, 2011 between us and Grubb & Ellis Capital Corporation, or the G&E Dealer Manager Agreement, in accordance with the terms thereof. Until January 6, 2012, Grubb & Ellis Capital Corporation remained a non-exclusive agent of our company and distributor of shares of our common stock.
As a result of the co-sponsorship arrangement, an affiliate of Griffin Capital, Griffin-American Healthcare REIT Advisor, LLC, or Griffin-American Advisor, or our advisor, began serving as our advisor on January 7, 2012 pursuant to an advisory agreement, or the Advisory Agreement, that took effect upon the expiration of the 60-day transition period provided for in the G&E Advisory Agreement. The Advisory Agreement had an initial one-year term, but was subject to successive one year renewals upon mutual consent of the parties. On January 6, 2014, the Advisory Agreement was renewed pursuant to the mutual consent of the parties for a term of six months and expires on July 6, 2014. Our advisor delegates advisory duties to Griffin-American Healthcare REIT Sub-Advisor, LLC, or Griffin-American Sub-Advisor, or our sub-advisor. Griffin-American Sub-Advisor is jointly owned by our co-sponsors. Our advisor, through our sub-advisor, uses its best efforts, subject to the oversight, review and approval of our board of directors, to, among other things, research, identify, review and make investments in and dispositions of properties, real estate-related investments and securities on our behalf consistent with our investment policies and objectives. Our advisor performs its duties and responsibilities under the Advisory Agreement as our fiduciary. Our sub-advisor performs its duties and responsibilities pursuant to a sub-advisory agreement with our advisor and also acts as our fiduciary. Collectively, we refer to our advisor and our sub-advisor as our advisor entities. Griffin Capital Securities, Inc., or Griffin Securities, or our dealer manager, an affiliate of Griffin Capital, serves as our dealer manager pursuant to a dealer manager agreement, or the Dealer Manager Agreement, that also became effective on January 7, 2012. We are not affiliated with Griffin Capital, Griffin-American Advisor or Griffin Securities; however, we are affiliated with Griffin-American Sub-Advisor and American Healthcare Investors.
American Healthcare Investors and Griffin Capital paid the majority of the expenses we incurred in connection with the transition to our co-sponsors.

69

We currently operate through five reportable business segments — medical office buildings, hospitals, skilled nursing facilities, senior housing and senior housing–RIDEA. As of December 31, 2013, we had completed 72 acquisitions comprising 279 buildings and approximately 10,565,000 square feet of gross leasable area, or GLA, for an aggregate purchase price of $2,785,711,000.
Investment Strategy
We have and we intend to continue to invest in a diversified portfolio of real estate properties, focusing primarily on medical office buildings and healthcare-related facilities. We also may originate or acquire real estate-related investments such as mortgage, mezzanine, bridge and other loans, common and preferred stock of, or other interests in, public or private unaffiliated real estate companies, commercial mortgage-backed securities, and certain other securities, including collateralized debt obligations and foreign securities. We generally seek investments that produce current income. In order to maintain our exemption from regulation as an investment company under the Investment Company Act of 1940, as amended, or the Investment Company Act, we may be required to limit our investments in certain types of real estate-related investments.
We seek to maximize long-term stockholder value by generating sustainable growth in cash flows and portfolio value. In order to achieve these objectives, we may invest using a number of investment structures which may include direct acquisitions, joint ventures, leveraged investments, issuing securities for property and direct and indirect investments in real estate. In order to maintain our exemption from regulation as an investment company under the Investment Company Act, we may be required to limit our investments in certain types of real estate-related investments.
In addition, when and as determined appropriate by our advisor entities, our portfolio may also include properties in various stages of development other than those producing current income. These stages include, without limitation, unimproved land both with and without entitlements and permits, property to be redeveloped and repositioned, newly constructed properties and properties in lease-up or other stabilization scenarios, all of which have limited or no relevant operating histories and no current income. Our advisor entities will make this determination based upon a variety of factors, including the available risk adjusted returns for such properties when compared with other available properties, the appropriate diversification of the portfolio, and our objectives of realizing both current income and capital appreciation upon the ultimate sale of properties.
For each of our investments, regardless of property type, we seek to invest in properties with the following attributes:
 
•
Quality. We seek to acquire properties that are suitable for their intended use with a quality of construction that is capable of sustaining the property’s investment potential for the long-term, assuming funding of budgeted maintenance, repairs and capital improvements.
•
Location. We seek to acquire properties that are located in established or otherwise appropriate markets for comparable properties, with access and visibility suitable to meet the needs of its occupants.
•
Market; Supply and Demand. We focus on local or regional markets that have potential for stable and growing property level cash flows over the long-term. These determinations are based in part on an evaluation of local and regional economic, demographic and regulatory factors affecting the property. For instance, we favor markets that indicate a growing population and employment base or markets that exhibit potential limitations on additions to supply, such as barriers to new construction. Barriers to new construction include lack of available land and stringent zoning restrictions. In addition, we generally seek to limit our investments in areas that have limited potential for growth.
•
Predictable Capital Needs. We seek to acquire properties where the future expected capital needs can be reasonably projected in a manner that would enable us to meet our objectives of growth in cash flows and preservation of capital and stability.
•
Cash Flows. We seek to acquire properties where the current and projected cash flows, including the potential for appreciation in value, would enable us to meet our overall investment objectives. We evaluate cash flows as well as expected growth and the potential for appreciation.
We will not invest more than 10.0% of the proceeds available for investment from our initial offering and our follow-on offering, or our offerings, in unimproved or non-income producing properties or in other investments relating to unimproved or non-income producing property. A property will be considered unimproved or non-income producing property for purposes of this limitation if it: (1) is not acquired for the purpose of producing rental or other operating income; or (2) has no development or construction in process at the date of acquisition or planned in good faith to commence within one year of the date of acquisition.

70

We will not invest more than 10.0% of the proceeds available for investment from our offerings in commercial mortgage-backed securities. In addition, we will not invest more than 10.0% of the proceeds available for investment from our offerings in equity securities of public or private real estate companies.
We are not limited as to the geographic area where we may acquire properties. We are not specifically limited in the number or size of properties we may acquire or on the percentage of our assets that we may invest in a single property or investment. The number and mix of properties and real estate-related investments we will acquire will depend upon real estate and market conditions and other circumstances existing at the time we are acquiring our properties and making our investments, and the amount of debt financing available.
Critical Accounting Policies
We believe that our critical accounting policies are those that require significant judgments and estimates such as those related to revenue recognition, tenant receivables, allowance for uncollectible accounts, capitalization of expenditures, depreciation of assets, impairment of real estate, properties held for sale, accounting for property acquisition and qualification as a REIT. These estimates are made and evaluated on an on-going basis using information that is available as well as various other assumptions believed to be reasonable under the circumstances.
Use of Estimates
The preparation of our consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. These estimates are made and evaluated on an on-going basis using information that is currently available as well as various other assumptions believed to be reasonable under the circumstances. Actual results could differ from those estimates, perhaps in material adverse ways, and those estimates could be different under different assumptions or conditions.
Revenue Recognition, Tenant Receivables and Allowance for Uncollectible Accounts
We recognize revenue in accordance with Financial Accounting Standards Board, or FASB, Accounting Standards Codification, or ASC, Topic 605, Revenue Recognition, or ASC Topic 605. ASC Topic 605 requires that all four of the following basic criteria be met before revenue is realized or realizable and earned: (1) there is persuasive evidence that an arrangement exists; (2) delivery has occurred or services have been rendered; (3) the seller’s price to the buyer is fixed and determinable; and (4) collectability is reasonably assured.
In accordance with ASC Topic 840, Leases, minimum annual rental revenue is recognized on a straight-line basis over the term of the related lease (including rent holidays). Differences between real estate revenue recognized and cash amounts contractually due from tenants under the lease agreements are recorded to deferred rent receivable or deferred rent liability, as applicable. Tenant reimbursement revenue, which is comprised of additional amounts recoverable from tenants for common area maintenance expenses and certain other recoverable expenses, is recognized as revenue in the period in which the related expenses are incurred. Tenant reimbursements are recognized and presented in accordance with ASC Subtopic 605-45, Revenue Recognition — Principal Agent Consideration, or ASC Subtopic 605-45. ASC Subtopic 605-45 requires that these reimbursements be recorded on a gross basis, as we are generally the primary obligor with respect to purchasing goods and services from third-party suppliers, have discretion in selecting the supplier and have credit risk. We recognize lease termination fees at such time when there is a signed termination letter agreement, all of the conditions of the agreement have been met and the tenant is no longer occupying the property. Resident fees and services revenue is recorded when services are rendered and includes resident room and care charges, community fees and other resident charges.
Tenant receivables and unbilled deferred rent receivables are carried net of an allowance for uncollectible amounts. An allowance is maintained for estimated losses resulting from the inability of certain tenants to meet the contractual obligations under their lease agreements. We maintain an allowance for deferred rent receivables arising from the straight line recognition of rents. Such allowance is charged to bad debt expense which is included in general and administrative in our accompanying consolidated statements of operations. Our determination of the adequacy of these allowances is based primarily upon evaluations of historical loss experience, the tenant’s financial condition, security deposits, letters of credit, lease guarantees and current economic conditions and other relevant factors.
Capitalization of Expenditures and Depreciation of Assets
The cost of operating properties includes the cost of land and completed buildings and related improvements. Expenditures that increase the service life of properties are capitalized and the cost of maintenance and repairs is charged to expense as incurred. The cost of building and improvements is depreciated on a straight-line basis over the estimated useful lives. The cost of improvements is depreciated on a straight-line basis over the shorter of the lease term or useful life. Furniture,

71

fixtures and equipment, if any, is depreciated over the estimated useful lives. When depreciable property is retired or disposed of, the related costs and accumulated depreciation is removed from the accounts and any gain or loss is reflected in operations.
As part of the leasing process, we may provide the lessee with an allowance for the construction of leasehold improvements. These leasehold improvements are capitalized and recorded as tenant improvements, and depreciated over the shorter of the useful life of the improvements or the lease term. If the allowance represents a payment for a purpose other than funding leasehold improvements, or in the event we are not considered the owner of the improvements, the allowance is considered to be a lease inducement and is recognized over the lease term as a reduction of rental revenue on a straight-line basis. Factors considered during this evaluation include, among other things, who holds legal title to the improvements as well as other controlling rights provided by the lease agreement and provisions for substantiation of such costs (e.g. unilateral control of the tenant space during the build-out process). Determination of the appropriate accounting for the payment of a tenant allowance is made on a lease-by-lease basis, considering the facts and circumstances of the individual tenant lease. Recognition of rental revenue commences when the lessee is given possession of the leased space upon completion of tenant improvements when we are the owner of the leasehold improvements. However, when the leasehold improvements are owned by the tenant, the lease inception date (and the date on which recognition of lease revenue commences) is the date the tenant obtains possession of the leased space for purposes of constructing its leasehold improvements.
Impairment
We carry our operating properties at historical cost less accumulated depreciation. We assess the impairment of an operating property when events or changes in circumstances indicate that its carrying value may not be recoverable. Indicators we consider important and that we believe could trigger an impairment review include, among others, the following:
 
•
significant negative industry or economic trends;
•
a significant underperformance relative to historical or projected future operating results; and
•
a significant change in the extent or manner in which the asset is used or significant physical change in the asset.
In the event that the carrying amount of an operating property exceeds the sum of the future undiscounted cash flows expected to result from the use and eventual disposition of the property, we would recognize an impairment loss to the extent the carrying amount exceeded the estimated fair value of the property. The estimation of expected future net cash flows is inherently uncertain and relies on subjective assumptions dependent upon future and current market conditions and events that affect the ultimate value of the property. It requires us to make assumptions related to discount rates, future rental rates, tenant allowances, operating expenditures, property taxes, capital improvements, occupancy levels and the estimated proceeds generated from the future sale of the property.
Properties Held for Sale
We will account for our properties held for sale in accordance with ASC Topic 360, Property, Plant, and Equipment, or ASC Topic 360, which addresses financial accounting and reporting for the impairment or disposal of long-lived assets and requires that, in a period in which a component of an entity either has been disposed of or is classified as held for sale, the statements of operations for current and prior periods shall report the results of operations of the component as discontinued operations.
In accordance with ASC Topic 360, at such time as a property is held for sale, such property is carried at the lower of (1) its carrying amount or (2) fair value less costs to sell. In addition, a property being held for sale ceases to be depreciated. We will classify operating properties as property held for sale in the period in which all of the following criteria are met:
 
•
management, having the authority to approve the action, commits to a plan to sell the asset;
•
the asset is available for immediate sale in its present condition subject only to terms that are usual and customary for sales of such assets;
•
an active program to locate a buyer and other actions required to complete the plan to sell the asset has been initiated;
•
the sale of the asset is probable and the transfer of the asset is expected to qualify for recognition as a completed sale within one year;
•
the asset is being actively marketed for sale at a price that is reasonable in relation to its current fair value; and
•
given the actions required to complete the plan to sell the asset, it is unlikely that significant changes to the plan would be made or that the plan would be withdrawn.

72

Property Acquisitions
In accordance with ASC Topic 805, Business Combinations, or ASC Topic 805, we determine whether a transaction is a business combination, which requires that the assets acquired and liabilities assumed constitute a business. If the assets acquired are not a business, we account for the transaction as an asset acquisition. Under both methods, we recognize the identifiable assets acquired and liabilities assumed. In addition, for transactions that are business combinations, we evaluate the existence of intangible assets and liabilities. We immediately expense acquisition related expenses associated with business combinations and capitalize acquisition related expenses associated with an asset acquisition.
We, with assistance from independent valuation specialists, measure the fair value of tangible and identified intangible assets and liabilities, as applicable, based on their respective fair values for acquired properties. The determination of the fair value of land is based upon comparable sales data. In cases where a leasehold interest in the land is acquired, the value of the leasehold interest is determined by discounting the difference between the contract ground lease payments and a market ground lease payment back to a present value as of the acquisition date. The market ground lease payment is estimated as a percentage of the land value. The fair value of buildings is based upon our determination of the value as if it were to be replaced and vacant using cost data and discounted cash flow models similar to those used by independent appraisers. We would also recognize the fair value of furniture, fixtures and equipment on the premises, if any, as well as the above or below market rent, the value of in-place leases, the value of in-place lease costs, tenant relationships, master leases and above or below market debt and derivative financial instruments assumed. Factors considered by us include an estimate of carrying costs during the expected lease-up periods considering current market conditions and costs to execute similar leases.
The value of the above or below market component of the acquired in-place leases is determined based upon the present value (using a discount rate which reflects the risks associated with the acquired leases) of the difference (if greater than 10.0%) between the level payment equivalent of the contract rent paid pursuant to the lease, and our estimate of market rent payments taking into account rent steps throughout the lease. In the case of leases with options, unless an option rent is more than 5.0% below market rent, it is not assumed to be exercised. The amounts related to above market leases are included in identified intangible assets, net in our accompanying consolidated balance sheets and are amortized against real estate revenue over the remaining non-cancelable lease term of the acquired leases with each property. The amounts related to below market leases are included in identified intangible liabilities, net in our accompanying consolidated balance sheets and are amortized to real estate revenue over the remaining non-cancelable lease term plus any below market renewal options of the acquired leases with each property.
The value of in-place lease costs and the value of tenant relationships is based on management's evaluation of the specific characteristics of the tenant's lease and our overall relationship with the tenants. Characteristics considered by us in allocating these values include the nature and extent of the credit quality and expectations of lease renewals, among other factors. The amounts related to in-place lease costs are included in identified intangible assets, net in our accompanying consolidated balance sheets and are amortized to depreciation and amortization expense over the average remaining non-cancelable lease term of the acquired leases with each property. The amounts related to the value of tenant relationships are included in identified intangible assets, net in our accompanying consolidated balance sheets and are amortized to depreciation and amortization expense over the average remaining non-cancelable lease term of the acquired leases plus the market renewal lease term. The value of a master lease, in which a previous owner or a tenant is relieved of specific rental obligations as additional space is leased, is determined by discounting the expected real estate revenue associated with the master lease space over the assumed lease-up period.
The value of above or below market debt is determined based upon the present value of the difference between the cash flow stream of the assumed mortgage and the cash flow stream of a market rate mortgage at the time of assumption. The value of above or below market debt is included in mortgage loans payable, net in our accompanying consolidated balance sheets and is amortized to interest expense over the remaining term of the assumed mortgage.
The value of derivative financial instruments is determined in accordance with ASC Topic 820, Fair Value Measurements and Disclosures, or ASC Topic 820, and is included in derivative financial instruments in our accompanying consolidated balance sheets.
The values of contingent consideration assets and liabilities are analyzed at the time of acquisition. For contingent purchase options, the fair market value of the asset is compared to the specified option price at the exercise date. If the option price is below market, it is assumed to be exercised and the difference between the fair market value and the option price is discounted to the present value at the time of acquisition.
The fair values are subject to change based on information received within one year of the purchase related to one or more events identified at the time of purchase which confirm the value of an asset or liability received in an acquisition of property.

73

Qualification as a REIT
We qualified and elected to be taxed as a REIT under the Code beginning with our taxable year ended December 31, 2010. To maintain our qualification as a REIT, we must meet certain organizational and operational requirements, including a requirement to currently distribute at least 90.0% of our annual taxable income, excluding net capital gains, to stockholders. As a REIT, we generally will not be subject to federal income tax on taxable income that we distribute to our stockholders.
If we fail to maintain our qualification as a REIT in any taxable year, we will then be subject to federal income taxes on our taxable income at regular corporate rates and will not be permitted to qualify for treatment as a REIT for federal income tax purposes for four years following the year during which qualification is lost unless the Internal Revenue Service grants us relief under certain statutory provisions. Such an event could have a material adverse effect on our net income and net cash available for distribution to our stockholders.
Recently Issued Accounting Pronouncements
For a discussion of recently issued accounting pronouncements, see Note 2, Summary of Significant Accounting Policies — Recently Issued Accounting Pronouncements, to the Consolidated Financial Statements that are a part of this Annual Report on Form 10-K.
Acquisitions in 2014, 2013, 2012 and 2011
For a discussion of acquisitions in 2014, 2013, 2012 and 2011 see Note 3, Real Estate Investments, Net and Note 22, Subsequent Events – Property Acquisitions, to the Consolidated Financial Statements that are a part of this Annual Report on Form 10-K.
Factors Which May Influence Results of Operations
We are not aware of any material trends or uncertainties, other than national economic conditions affecting real estate generally, that may reasonably be expected to have a material impact, favorable or unfavorable, on revenues or income from the acquisition, management and operation of properties other than those listed in Part I, Item 1A. Risk Factors, of this Annual Report on Form 10-K.
Revenue
The amount of revenue generated by our properties depends principally on our ability to maintain the occupancy rates of currently leased space and to lease currently available space and space available from lease terminations at the then existing rental rates. Negative trends in one or more of these factors could adversely affect our revenue in future periods.
Scheduled Lease Expirations
Excluding Midwest CCRC Portfolio, which is operated utilizing a RIDEA structure, as of December 31, 2013, our consolidated properties were 95.8% leased and during 2014, 5.4% of the leased GLA is scheduled to expire. Midwest CCRC Portfolio was 93.6% leased as of December 31, 2013 and substantially all of our leases with residents at Midwest CCRC Portfolio are for a term of one year or less. Our leasing strategy focuses on negotiating renewals for leases scheduled to expire during the remainder of the year. In the future, if we are unable to negotiate renewals, we will try to identify new tenants or collaborate with existing tenants who are seeking additional space to occupy.
Excluding our senior housing facilities operated utilizing a RIDEA structure, as of December 31, 2013, our remaining weighted average lease term was 9.5 years.
Sarbanes-Oxley Act
The Sarbanes-Oxley Act of 2002, as amended, or the Sarbanes-Oxley Act, and related laws, regulations and standards relating to corporate governance and disclosure requirements applicable to public companies have increased the costs of compliance with corporate governance, reporting and disclosure practices. These costs may have a material adverse effect on our results of operations and could impact our ability to pay distributions at current rates to our stockholders. Furthermore, we expect that these costs will increase in the future due to our continuing implementation of compliance programs mandated by these requirements. Any increased costs may affect our ability to distribute funds to our stockholders. As part of our compliance with the Sarbanes-Oxley Act, we have provided management’s assessment of our internal control over financial reporting as of December 31, 2013 and will continue to comply with such regulations.
In addition, these laws, rules and regulations create new legal bases for potential administrative enforcement, civil and criminal proceedings against us in the event of non-compliance, thereby increasing the risks of liability and potential sanctions against us. We expect that our efforts to comply with these laws and regulations will continue to involve significant and

74

potentially increasing costs, and that our failure to comply with these laws could result in fees, fines, penalties or administrative remedies against us.
Results of Operations
Comparison of the Years Ended December 31, 2013, 2012 and 2011
Our operating results for the years ended December 31, 2013, 2012 and 2011 are primarily comprised of income derived from our portfolio of properties and acquisition related expenses in connection with the acquisitions of such properties.
In general, we expect all amounts to increase in the future based on a full year of operations as well as increased activity as we acquire additional real estate investments. Our results of operations are not indicative of those expected in future periods.
As of December 31, 2013, we operated through five reportable business segments — medical office buildings, hospitals, skilled nursing facilities, senior housing and senior housing–RIDEA. Prior to December 2013, we operated through 4 reportable segments; however, with the acquisition of our first senior housing facilities owned and operated utilizing a RIDEA structure in December 2013, we felt it useful to segregate our operations into 5 reporting segments to assess the performance of our business in the same way that management intends to review our performance and make operating decisions. Prior to June 2013, our senior housing segment was referred to as our assisted living facilities segment. Prior to August 2012, we operated through 3 reportable business segments; however, with the addition of our first senior housing facilities in August 2012, we felt it was useful to segregate our operations into 4 reporting segments to assess the performance of our business in the same way that management intended to review our performance and make operating decisions.
Except where otherwise noted, the change in our results of operations is primarily due to our 279 buildings as of December 31, 2013, as compared to 143 buildings as of December 31, 2012, and 56 buildings as of December 31, 2011. As of December 31, 2013, 2012 and 2011, we owned the following types of properties:
 
December 31,
 
2013
 
2012
 
2011
 
Number of
Buildings
 
Aggregate
Purchase Price
 
Leased
%
 
Number of
Buildings
 
Aggregate
Purchase Price
 
Leased
%
 
Number of
Buildings
 
Aggregate
Purchase Price
 
Leased
%
Medical office buildings
139

 
$
1,300,295,000

 
93.0
%
 
78

 
$
670,370,000

 
93.7
%
 
33

 
$
216,730,000

 
92.9
%
Senior housing
59

 
578,103,000

 
100
%
 
15

 
105,936,000

 
100
%
 
—

 
—

 
—
%
Skilled nursing facilities
41

 
397,468,000

 
100
%
 
37

 
362,145,000

 
100
%
 
16

 
144,000,000

 
100
%
Senior housing–RIDEA
26

 
310,000,000

 
(1
)
 
—

 
—

 
—
%
 
—

 
—

 
—
%
Hospitals
14

 
199,845,000

 
100
%
 
13

 
186,145,000

 
100
%
 
7

 
77,895,000

 
100
%
Total/weighted average(2)
279

 
$


 
95.8
%
 
143

 
$


 
96.6
%
 
56

 
$


 
96.1
%
_________
(1)
The leased percentage for these 1079 resident units was 0.936 as of December 31, 2013.
(2)
Leased percentage excludes Midwest CCRC Portfolio, which is operated utilizing a RIDEA structure.
Real Estate Revenue
For the years ended December 31, 2013, 2012 and 2011, real estate revenue was 202096000., 100728000 and 40457000, respectively, and was primarily comprised of base rent of $157,638,000, $78,548,000 and $31,506,000, respectively, and expense recoveries of $28,547,000, $15,036,000 and $6,175,000, respectively. For the year ended December 31, 2013, real estate revenue derived from our real estate investments in the United Kingdom was $12,979,000, or 6.4% of total real estate revenue.

75

Real estate revenue by operating segment consisted of the following for the periods then ended:
 
Years Ended December 31,
 
2013
 
2012
 
2011
Medical office buildings
$


 
$


 
$


Skilled nursing facilities
49381000

 
37432000

 
11327000

Hospitals
23563000

 
12280000

 
7651000

Senior housing
22492000

 
1035000

 
0

Total
$


 
$


 
$


Resident Fees and Services
For the year ended December 31, 2013, resident fees and services was 2307000. and related to revenue earned from our operations of senior housing facilities operated utilizing a RIDEA structure acquired in December 2013. We did not own or operate any real estate investments utilizing a RIDEA structure prior to December 2013.
Rental Expenses
For the years ended December 31, 2013, 2012 and 2011, rental expenses were 43387000., 21131000 and 8330000, respectively. Rental expenses consisted of the following for the periods then ended:
 
Years Ended December 31,
 
2013
 
2012
 
2011
Real estate taxes
$
16,760,000

 
$
9,948,000

 
$
3,709,000

Building maintenance
9,066,000

 
3,299,000

 
1,582,000

Utilities
7,921,000

 
3,204,000

 
1,361,000

Property management fees — affiliates
4418000

 
2,158,000

 
843,000

Administration
2,240,000

 
744,000

 
319,000

Insurance
872,000

 
452,000

 
180,000

Amortization of leasehold interests
208,000

 
243,000

 
139,000

RIDEA operating management fees
115,000

 
—

 
—

Other
1,787,000

 
1,083,000

 
197,000

Total
$


 
$


 
$


Rental expenses and rental expenses as a percentage of total revenue by operating segment consisted of the following for the periods then ended:
 
Years Ended December 31,
 
2013
 
2012
 
2011
Medical office buildings
$


 
0.3241327583

 
$


 
0.3334467097

 
$


 
0.3061129475

Skilled nursing facilities
3392000

 
0.068690387

 
2853000

 
0.076218209

 
1030000

 
0.0909331685

Hospitals
3124000

 
0.132580741

 
1516000

 
0.1234527687

 
725000

 
0.0947588551

Senior housing
800000

 
0.035568202

 
96000

 
0.0927536232

 
—

 
0

Senior housing–RIDEA
1499000

 
0.6497615951

 
—

 
—
%
 
—

 
—
%
Total/weighted average
$


 
0.2122620509

 
$


 
0.2097827814

 
$


 
0.2058976197

Overall, the percentage of rental expenses as a percentage of revenue in 2013 was slightly higher than in 2012 due to the acquisition of senior housing facilities operated utilizing a RIDEA structure, which accounted for 1.1% of total revenues. We anticipate that the percentage of rental expenses to revenue will increase when we have a full year of operations from our properties operated utilizing a RIDEA structure. Overall, as compared to 2011, the percentage of rental expenses as a

76

percentage of revenue in 2012 remained consistent as the percentage of medical office buildings in the portfolio remained consistent between 2011 and 2012.
General and Administrative
For the years ended December 31, 2013, 2012 and 2011, general and administrative was 22519000., 11067000 and 5992000, respectively. General and administrative consisted of the following for the periods then ended: 
 
Years Ended December 31,
 
2013
 
2012
 
2011
Asset management fees — affiliates
$


 
$
6,727,000

 
$
2,929,000

Transfer agent services
2,349,000

 
1,119,000

 
—

Professional and legal fees
1,988,000

 
1,495,000

 
1,466,000

Franchise taxes
1,519,000

 
306,000

 
170,000

Bad debt expense
1,182,000

 
82,000

 
261,000

Bank charges
525,000

 
233,000

 
115,000

Board of directors fees
425,000

 
316,000

 
377,000

Directors’ and officers’ liability insurance
310,000

 
206,000

 
164,000

Postage & delivery
230,000

 
120,000

 
99,000

Restricted stock compensation
133000

 
115000

 
66000

Transfer agent services — former affiliate
—

 
10,000

 
311,000

Other
107,000

 
338,000

 
34,000

Total
$


 
$


 
$


The increase in general and administrative in 2013 as compared to 2012 was primarily the result of purchasing additional properties in 2013 and 2012 and thus incurring higher asset management fees and franchise taxes, as well as incurring higher fees for transfer agent services due to an increase in the number of our investors in connection with the increased equity raise pursuant to our public offerings. We expect general and administrative to continue to increase in 2014 as we purchase additional properties in 2014.
The increase in general and administrative in 2012 as compared to 2011 was primarily the result of purchasing properties in 2012 and 2011 and thus incurring higher asset management fees, as well as incurring higher fees for transfer agent services due to an increase in the number of our investors.
Subordinated Distribution Purchase
For the year ended December 31, 2012, we recorded a charge of $4,232,000, which pertained to a settlement agreement we and our operating partnership entered into on September 14, 2012 with BGC Partners, Inc., or BGC Partners, to transfer certain assets held by BGC Partners to us, including 200 units of limited partnership interest held in our operating partnership and any rights to the payment of any subordinated distribution that may have been owed to our former advisor and its affiliates, including our former sponsor, for consideration of $4,300,000. Of the $4,300,000 paid by us, $4,232,000 is reflected in our accompanying consolidated statements of operations and comprehensive income (loss) for the year ended December 31, 2012, and $68,000 is in satisfaction of all remaining payments owed by us to our former advisor and its affiliates, including our former sponsor, under the G&E Advisory Agreement.
Acquisition Related Expenses
For the years ended December 31, 2013, 2012 and 2011, we incurred acquisition related expenses of 25501000., 75608000 and 10389000, respectively.
For the year ended December 31, 2013, acquisition related expense related primarily to expenses associated with our acquisitions completed during the period, including acquisition fees of $20,910,000 incurred to our advisor entities. For the year ended December 31, 2012, acquisition related expenses related primarily to the unrealized/realized gains and losses on our contingent consideration arrangements of $50,250,000 and expenses associated with our acquisitions completed during the period, including acquisition fees of $21,336,000 incurred to our former advisor, our advisor entities or their respective

77

affiliates. The decrease in acquisition related expenses for the year ended December 31, 2013 as compared to the year ended December 31, 2012 was primarily due to $50,250,000 of net unrealized/realized loss on contingent consideration in 2012, which was primarily due to one tenant's significant improvement in its specified rent coverage ratio for the six and twelve months ended December 31, 2012. For a further discussion, see Note 14, Fair Value Measurements — Assets and Liabilities Reported at Fair Value — Contingent Consideration, to the Consolidated Financial Statements that are a part of this Annual Report on Form 10-K.
For the year ended December 31, 2011, acquisition related expenses related primarily to expenses associated with our acquisitions completed during the period, including acquisition fees of 6739000 incurred to our former advisor or its affiliates. The increase in acquisition related expenses for the year ended December 31, 2012 as compared to the year ended December 31, 2011 is due to purchasing $810,971,000 in acquisitions in 2012 as compared to $245,183,000 in acquisitions in 2011, as well as the unrealized/realized gains and losses on our contingent consideration arrangements.
Depreciation and Amortization
For the years ended December 31, 2013, 2012 and 2011, depreciation and amortization was 76188000., 38407000 and 14826000, respectively, and consisted primarily of depreciation on our operating properties of $50,178,000, $25,125,000 and $9,919,000, respectively, and amortization on our identified intangible assets of $25,680,000, $13,183,000 and $4,878,000 respectively.
Interest Expense
For the years ended December 31, 2013, 2012 and 2011, interest expense including gain (loss) in fair value of derivative financial instruments was 17765000, 13542000 and 6711000, respectively. Interest expense consisted of the following for the periods then ended: 
 
Years Ended December 31,
 
2013
 
2012
 
2011
Interest expense — mortgage loans payable and derivative financial instruments
$
16,192,000

 
$
10,935,000

 
$
4,065,000

Interest expense — lines of credit
1,677,000

 
1,866,000

 
1,016,000

Amortization of debt discount and (premium), net
(2,209,000
)
 
(1,023,000
)
 
(47,000
)
Amortization of deferred financing costs — lines of credit
1,734,000

 
1,021,000

 
661,000

Amortization of deferred financing costs — mortgage loans payable
842,000

 
732,000

 
606,000

(Gain) loss on extinguishment of debt — write-off of deferred financing costs and debt premium
--127000

 
35000

 
44000

(Gain) loss in fair value of derivative financial instruments
(344,000
)
 
(24,000
)
 
366,000

Total
$


 
$


 
$


Foreign Currency and Derivative Loss
For the year ended December 31, 2013, we had 11312000 in net losses resulting from foreign currency transactions as compared to $0 in 2012 and 2011. The net losses on foreign currency transactions in 2013 were primarily due to an unrealized loss of 16489000 on our foreign currency forward contract, partially offset by the gains recognized in closing the acquisition of UK Senior Housing Portfolio in the amount of $4,295,000 and re-measurement of real estate notes receivable denominated in United Kingdom Pound Sterling, or GBP, as of December 31, 2013 of $519,000. For a further discussion of our foreign currency forward contract, including a discussion regarding the fair value measurements, see Note 8, Derivative Financial Instruments and Note 14, Fair Value Measurements — Assets and Liabilities Reported at Fair Value, to the Consolidated Financial Statements that are a part of this Annual Report on Form 10-K.
The significant fluctuations in foreign currency exchange rates between GBP and U.S. Dollars, or USD, have material effects on our results of operations and financial position.

78

Interest Income
For the years ended December 31, 2013, 2012 and 2011, we had interest income of 329000, 15000 and 17000, respectively, related to interest earned on funds held in cash accounts. Higher interest income in 2013 as compared to 2012 and 2011 was due to higher average cash balances in 2013 due to the close out of our follow-on offering.
Income Tax Benefit
For the year ended December 31, 2013, we had an income tax benefit of $1,005,000 as compared to $0 in 2012 and 2011. The income tax benefit in 2013 was primarily due to the -1205000 decrease in our foreign deferred tax liabilities on our real estate investments located in the United Kingdom, offset by 152000 of foreign income taxes incurred on the 2013 operations of our real estate investments located in the United Kingdom and $48,000 of U.S. federal and state income tax expense incurred on our senior housing facilities owned and operated utilizing a RIDEA structure. For a further discussion of our income taxes, see Note 15, Income Taxes and Distributions, to the Consolidated Financial Statements that are a part of this Annual Report on Form 10-K.
Liquidity and Capital Resources
Our sources of funds will primarily consist of operating cash flows and borrowings. We terminated our follow-on offering on October 30, 2013. Our ability to raise funds is dependent on general economic conditions, general market conditions for REITs and our operating performance. Our principal demands for funds are for acquisitions of real estate and real estate-related investments, payment of operating expenses and interest on our current and future indebtedness and payment of distributions to our stockholders.
Our total capacity to purchase real estate and real estate-related investments is a function of our current cash position, our borrowing capacity on our unsecured revolving line of credit with Bank of America, N.A., or Bank of America, or our unsecured line of credit, as well as any future indebtedness that we may incur and any possible future equity offerings. As of December 31, 2013, our cash on hand was $37,955,000 and we had $382,000,000 available on our unsecured line of credit. We believe that these resources will be sufficient to satisfy our cash requirements for the foreseeable future, and we do not anticipate a need to raise funds from other sources within the next 12 months.
We estimate that we will require approximately $16,810,000 to pay interest on our outstanding indebtedness in 2014, based on interest rates in effect as of December 31, 2013. In addition, we estimate that we will require $15,363,000 to pay principal on our outstanding indebtedness in 2014. We also require resources to make certain payments to our advisor entities and their affiliates. See Note 12, Related Party Transactions, to the Consolidated Financial Statements that are a part of this Annual Report on Form 10-K, for a further discussion of our payments to our advisor entities and their affiliates.
Our advisor entities evaluate potential additional investments and engage in negotiations with real estate sellers, developers, brokers, investment managers, lenders and others on our behalf. When we acquire a property, our advisor entities prepare a capital plan that contemplates the estimated capital needs of that investment. In addition to operating expenses, capital needs may also include costs of refurbishment, tenant improvements or other major capital expenditures. The capital plan also sets forth the anticipated sources of the necessary capital, which may include a line of credit or other loans established with respect to the investment, operating cash generated by the investment, additional equity investments from us or joint venture partners or, when necessary, capital reserves. Any capital reserve would be established from proceeds from sales of other investments, borrowings, operating cash generated by other investments or other cash on hand. In some cases, a lender may require us to establish capital reserves for a particular investment. The capital plan for each investment will be adjusted through ongoing, regular reviews of our portfolio or as necessary to respond to unanticipated additional capital needs.
Other Liquidity Needs
In the event that there is a shortfall in net cash available due to various factors, including, without limitation, the timing of distributions or the timing of the collection of receivables, we may seek to obtain capital to pay distributions by means of secured or unsecured debt financing through one or more third parties, or our advisor entities or their affiliates. There are currently no limits or restrictions on the use of proceeds from our advisor entities or their affiliates which would prohibit us from making the proceeds available for distribution. We may also pay distributions from cash from capital transactions, including, without limitation, the sale of one or more of our properties.
Based on the properties we owned as of December 31, 2013, we estimate that our expenditures for capital improvements and tenant improvements will require up to $27,317,000 within the next 12 months. As of December 31, 2013, we had

79

$10,250,000 of restricted cash in loan impounds and reserve accounts for capital expenditures, some of which may be used to fund our estimated expenditures for capital improvements and tenant improvements. We cannot provide assurance, however, that we will not exceed these estimated expenditure and distribution levels or be able to obtain additional sources of financing on commercially favorable terms or at all.
If we experience lower occupancy levels, reduced rental rates, reduced revenues as a result of asset sales, or increased capital expenditures and leasing costs compared to historical levels due to competitive market conditions for new and renewal leases, the effect would be a reduction of net cash provided by operating activities. If such a reduction of net cash provided by operating activities is realized, we may have a cash flow deficit in subsequent periods. Our estimate of net cash available is based on various assumptions which are difficult to predict, including the levels of leasing activity and related leasing costs. Any changes in these assumptions could impact our financial results and our ability to fund working capital and unanticipated cash needs.
Cash Flows
Operating
Cash flows provided by operating activities for the years ended December 31, 2013, 2012 and 2011, were $42,748,000, $23,462,000 and $9,264,000, respectively. For the years ended December 31, 2013, 2012 and 2011, cash flows provided by operating activities primarily related to the cash flows provided by our property operations, offset by the payment of acquisition related expenses and general and administrative expenses. In addition, for the year ended December 31, 2013, we paid $51,198,000 to a settle contingent consideration obligation that was paid from cash flows from operating activities.
We anticipate cash flows from operating activities to increase as we purchase additional properties.
Investing
Cash flows used in investing activities for the years ended December 31, 2013, 2012 and 2011, were $1,437,605,000, $730,304,000 and $223,689,000, respectively. For the year ended December 31, 2013, cash flows used in investing activities related primarily to the acquisition of our properties in the amount of $1,402,189,000, advances of $23,745,000 on our real estate notes receivable, capital expenditures of $5,521,000, an increase in restricted cash in the amount of $3,992,000 and an increase in real estate and escrow deposits of $1,801,000. For the year ended December 31, 2012, cash flows used in investing activities related primarily to the acquisition of our properties in the amount of $719,369,000, restricted cash in the amount of $6,691,000, advances of $5,213,000 on our real estate notes receivable and capital expenditures of $3,713,000, partially offset by a decrease of $4,650,000 in real estate and escrow deposits for the acquisition of real estate. For the year ended December 31, 2011, cash flows used in investing activities related primarily to the acquisition of our properties in the amount of $213,856,000, the payment of $6,901,000 in real estate and escrow deposits for the acquisition of real estate and capital expenditures of $3,459,000.
We continue to acquire additional real estate and real estate-related investments, but generally anticipate that cash flows used in investing activities will decrease in 2014 as compared to 2013.
Financing
Cash flows provided by financing activities for the years ended December 31, 2013, 2012 and 2011, were $1,337,919,000, $756,843,000 and $253,089,000, respectively. For the year ended December 31, 2013, such cash flows related primarily to funds raised from investors in our offerings in the amount of $1,740,028,000, offset by net payments on our unsecured line of credit in the amount of $132,000,000, the payment of offering costs of $171,689,000 in connection with our offerings and distributions to our common stockholders of $57,642,000. Additional cash outflows primarily related to principal payments on our mortgage loans payable in the amount of $21,866,000, share repurchases of $8,938,000 and payments on contingent consideration obligations of $4,888,000. Of the $21,866,000 in payments on our mortgage loans payable, $16,563,000 reflects the early extinguishment of mortgage loans secured by Hardy Oak Medical Office Building and Centre Medical Plaza. For a further discussion of our unsecured line of credit, see Note 9, Line of Credit, to the Consolidated Financial Statements that are a part of this Annual Report on Form 10-K.
For the year ended December 31, 2012, such cash flows related primarily to funds raised from investors in our initial offering in the amount of $618,734,000, net borrowings under our secured revolving credit facilities with Bank of America and KeyBank National Association, or KeyBank, and our unsecured line of credit with Bank of America, or collectively the lines of credit, in the amount of $200,000,000 and borrowings on our mortgage loans payable in the amount of $71,602,000, partially offset by principal payments on our mortgage loans payable in the amount of $30,280,000, the payment of offering costs of $66,419,000 in connection with our initial offering and distributions to our common stockholders of $22,972,000. Additional cash outflows primarily related to deferred financing costs of $5,079,000 in connection with the debt financing for our

80

acquisitions and our lines of credit, payments on contingent consideration obligations of $4,590,000 and share repurchases of $4,153,000. For a further discussion of our lines of credit, see Note 9, Line of Credit, to the Consolidated Financial Statements that are a part of this Annual Report on Form 10-K. Of the $30,280,000 in payments on our mortgage loans payable, $26,669,000 reflects the early extinguishment of mortgage loans secured by Virginia Skilled Nursing Facility Portfolio and Highlands Ranch Medical Pavilion and the repayment of a bridge loan on Southeastern SNF Portfolio (Snellville).
For the year ended December 31, 2011, such cash flows related primarily to funds raised from investors in our initial offering in the amount of $325,444,000 and borrowings on our mortgage loans payable in the amount of $43,700,000, partially offset by principal payments on our mortgage loans payable in the amount of $55,429,000, the payment of offering costs of $35,297,000 in connection with our initial offering, net payments under our lines of credit in the amount of $11,800,000 and distributions of $9,375,000. Additional cash outflows primarily related to deferred financing costs of $2,851,000 in connection with the debt financing for our acquisitions and our lines of credit and share repurchases of $1,198,000. For a further discussion of our lines of credit, see Note 9, Line of Credit, to the Consolidated Financial Statements that are a part of this Annual Report on Form 10-K. Of the $55,429,000 in payments on our mortgage loans payable, $7,500,000 reflects the early extinguishment of a mortgage loan payable on Surgical Hospital of Humble using excess cash on hand, $23,132,000 reflects the early extinguishment of mortgage loans secured by Dixie-Lobo Medical Office Building Portfolio using borrowings from our secured revolving line of credit with Bank of America and $22,039,000 reflects early payments made on a bridge loan on Virginia Skilled Nursing Facility Portfolio using borrowings on our secured revolving line of credit with KeyBank.
Overall, we anticipate cash flows from financing activities to decrease in the future since we terminated our initial offering on February 14, 2013 and our follow-on offering on October 30, 2013. However, we anticipate borrowings under our unsecured line of credit and other indebtedness to increase as we acquire additional real estate and real estate-related investments.
Distributions
The income tax treatment for distributions reportable for the years ended December 31, 2013, 2012 and 2011, was as follows:
 
Years Ended December 31,
 
2013
 
2012
 
2011
Ordinary income
$
70,200,000

 
56
%
 
$
25,001,000

 
55
%
 
$
9,276,000

 
51
%
Capital gain
—

 
—

 
—

 
—

 
—

 
—

Return of capital
55,329,000

 
44

 
20,575,000

 
45

 
8,912,000

 
49

 
$
125,529,000

 
100
%
 
$
45,576,000

 
100
%
 
$
18,188,000

 
100
%
Amounts listed above do not include distributions paid on nonvested shares of our restricted common stock which have been separately reported.
See Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities — Distributions, for a further discussion of our distributions.
Financing
We anticipate that our aggregate borrowings, both secured and unsecured, will not exceed 45.0% of all of our properties’ and other real estate-related assets’ combined fair market values, as defined, as determined at the end of each calendar year beginning with our first full year of operations. For these purposes, the fair market value of each asset will be equal to the purchase price paid for the asset or, if the asset was appraised subsequent to the date of purchase, then the fair market value will be equal to the value reported in the most recent independent appraisal of the asset. Our policies do not limit the amount we may borrow with respect to any individual investment. As of December 31, 2013, our borrowings were 13.2% of the combined fair market value of all of our real estate and real estate-related investments.
Under our charter, we have a limitation on borrowing that precludes us from borrowing in excess of 300% of our net assets without the approval of a majority of our independent directors. Net assets for purposes of this calculation are defined to be our total assets (other than intangibles), valued at cost prior to deducting depreciation, amortization, bad debt and other non-cash reserves, less total liabilities. Generally, the preceding calculation is expected to approximate 75.0% of the aggregate cost of our real estate and real estate-related investments before depreciation, amortization, bad debt and other similar non-cash reserves. In addition, we may incur mortgage debt and pledge some or all of our real properties as security for that debt to obtain funds to acquire additional real estate or for working capital. We may also borrow funds to satisfy the REIT tax qualification requirement that we distribute at least 90.0% of our annual taxable income, excluding net capital gains, to our

81

stockholders. Furthermore, we may borrow if we otherwise deem it necessary or advisable to ensure that we maintain our qualification as a REIT for federal income tax purposes. As of March 13, 2014 and December 31, 2013, our leverage did not exceed 300% of the value of our net assets.
Mortgage Loans Payable, Net
For a discussion of our mortgage loans payable, net, see Note 7, Mortgage Loans Payable, Net, to the Consolidated Financial Statements that are a part of this Annual Report on Form 10-K.
Lines of Credit
For a discussion of our lines of credit, see Note 9, Line of Credit, to the Consolidated Financial Statements that are a part of this Annual Report on Form 10-K.
REIT Requirements
In order to maintain our qualification as a REIT for federal income tax purposes, we are required to make distributions to our stockholders of at least 90.0% of our annual taxable income, excluding net capital gains. In the event that there is a shortfall in net cash available due to factors including, without limitation, the timing of such distributions or the timing of the collection of receivables, we may seek to obtain capital to pay distributions by means of secured debt financing through one or more unaffiliated parties. We may also pay distributions from cash from capital transactions including, without limitation, the sale of one or more of our properties or from the proceeds of our offerings.
Commitments and Contingencies
For a discussion of our commitments and contingencies, see Note 11, Commitments and Contingencies, to the Consolidated Financial Statements that are a part of this Annual Report on Form 10-K.
Debt Service Requirements
Our principal liquidity need is the payment of principal and interest on our outstanding indebtedness. As of December 31, 2013, we had $299,680,000 ($313,646,000, net of discount and premium) of fixed rate debt and $16,042,000 ($15,830,000, net of discount) of variable rate debt outstanding secured by our properties. As of December 31, 2013, we also had $68,000,000 outstanding under our unsecured line of credit.
We are required by the terms of certain loan documents to meet certain covenants, such as occupancy ratios, leverage ratios, net worth ratios, debt service coverage ratios, liquidity ratios, operating cash flow to fixed charges ratios, distribution ratios and reporting requirements. As of December 31, 2013, we were in compliance with all such covenants and requirements on our mortgage loans payable and our unsecured line of credit and we expect to remain in compliance with all such requirements for the next 12 months. As of December 31, 2013, the weighted average effective interest rate on our outstanding debt, factoring in our fixed rate interest rate swaps, was 4.51% per annum.

82

Contractual Obligations
The following table provides information with respect to (i) the maturity and scheduled principal repayment of our secured mortgage loans payable and our unsecured line of credit, (ii) interest payments on our mortgage loans payable, unsecured line of credit and fixed rate interest rate swaps, and (iii) obligations under our ground leases, as of December 31, 2013:
 
Payments Due by Period
 
Less than 1 Year
(2014)
 
1-3 Years
(2015-2016)
 
4-5 Years
(2017-2018)
 
More than 5 Years
(after 2018)
 
Total
Principal payments — fixed rate debt
$
12,530,000

  
$
85,290,000

 
$
58,643,000

 
$
143,217,000

 
$
299,680,000

Interest payments — fixed rate debt
14,779,000

  
24,380,000

 
15,944,000

 
56,790,000

 
111,893,000

Principal payments — variable rate debt
2,833,000

(1)
75,009,000

 
6,200,000

 
—

 
84,042,000

Interest payments — variable rate debt (based on rates in effect as of December 31, 2013)
1,769,000

  
1,347,000

 
213,000

 
—

 
3,329,000

Interest payments — fixed rate interest rate swaps (based on rates in effect as of December 31, 2013)
121,000

  
60,000

 
—

 
—

 
181,000

Ground and other lease obligations
997,000

  
2,025,000

 
2,087,000

 
52,331,000

 
57,440,000

Total
$
33,029,000

  
$
188,111,000

 
$
83,087,000

 
$
252,338,000

 
$
556,565,000

 ________
(1)
Our variable rate mortgage loan payable in the outstanding principal amount of $2,483,000 ($2,271,000, net of discount) secured by Center for Neurosurgery and Spine as of December 31, 2013, had a fixed rate interest rate swap, thereby effectively fixing our interest rate on this mortgage loan payable to an effective interest rate of 6.00% per annum. This mortgage loan payable is due August 15, 2021; however, the principal balance is immediately due upon written request from the seller and seller's confirmation that it shall pay any interest rate swap termination amount that is applicable. Assuming the seller does not exercise such right, interest payments, using the 6.00% per annum effective interest rate, would be $141,000, $225,000, $148,000 and $75,000 in 2014, 2015-2016, 2017-2018 and thereafter, respectively.
The table above does not reflect any payments expected under our contingent consideration obligations in the estimated amount of $4,675,000, the majority of which we expect to pay in the next twelve months. For a further discussion of our contingent consideration obligations, see Note 14, Fair Value Measurements — Assets and Liabilities Reported at Fair Value — Contingent Consideration, to the Consolidated Financial Statements that are a part of this Annual Report on Form 10-K.
In addition, based on the currency exchange rate as of December 31, 2013, approximately $96,225,000 remained available for future funding under our real estate notes receivable, subject to certain conditions set forth in the applicable loan agreements. These amounts do not have fixed funding dates, but may be funded in any future year, subject to certain conditions set forth in the applicable loan agreements. We anticipate funding the majority of these commitments in the next three years. There are various maturity dates depending upon the timing of advances, however, the maturity dates of the real estate notes receivable will be no later than March 10, 2022. For a further discussion of the real estate notes receivable, see Note 4, Real Estate Notes Receivable, Net, to the Consolidated Financial Statements that are a part of this Annual Report on Form 10-K.
Off-Balance Sheet Arrangements
As of December 31, 2013, we had no off-balance sheet transactions, nor do we currently have any such arrangements or obligations.
Inflation
We are exposed to inflation risk as income from future long-term leases will be the primary source of our cash flows from operations. There are provisions in the majority of our tenant leases that will protect us from the impact of inflation. These provisions include negotiated rental increases, reimbursement billings for operating expense pass-through charges, and real estate tax and insurance reimbursements on a per square foot allowance. However, due to the long-term nature of the anticipated leases, among other factors, the leases may not re-set frequently enough to cover inflation.
Related Party Transactions
For a discussion of related party transactions, see Note 12, Related Party Transactions, to the Consolidated Financial Statements that are a part of this Annual Report on Form 10-K.

83

Subsequent Events
For a discussion of subsequent events, see Note 22, Subsequent Events, to the Consolidated Financial Statements that are a part of this Annual Report on Form 10-K.
Item 7A. Quantitative and Qualitative Disclosures About Market Risk.
Market risk includes risks that arise from changes in interest rates, foreign currency exchange rates, commodity prices, equity prices and other market changes that affect market sensitive instruments. There were no material changes in our market risk exposures between the years ended December 31, 2013 and 2012, except that we are now exposed to foreign currency exchange rate risks as noted below. In pursuing our business plan, we expect that the primary market risks to which we will be exposed are interest rate risk and foreign currency exchange rate risk as noted below.
We have entered into, and in the future may continue to enter into, derivative instruments for which we have not and may not elect hedge accounting treatment. Because we have not elected to apply hedge accounting treatment to these derivatives, changes in the fair value of interest rate derivative financial instruments are recorded as a component of interest expense in gain (loss) in fair value of derivative financial instruments in our accompanying consolidated statements of operations and comprehensive income (loss) and changes in the fair value of foreign currency derivative financial instruments are recorded in foreign currency and derivative loss in our accompanying consolidated statements of operations and comprehensive income (loss). Derivatives are recorded on our accompanying consolidated balance sheets at their fair value of $(16,940,000) as of December 31, 2013. We do not enter into derivative transactions for speculative purposes.
Interest Rate Risk
We are exposed to the effects of interest rate changes primarily as a result of long-term debt used to acquire properties and other permitted investments. We are also exposed to the effects of changes in interest rates as a result of our investments in real estate notes receivable. Our interest rate risk is monitored using a variety of techniques. Our interest rate risk management objectives are to limit the impact of interest rate changes on earnings, prepayment penalties and cash flows and to lower overall borrowing costs while taking into account variable interest rate risk. To achieve our objectives, we may borrow or lend at fixed or variable rates.
We also may continue to enter into derivative financial instruments such as interest rate swaps in order to mitigate our interest rate risk on a related financial instrument. To the extent we do, we are exposed to credit risk and market risk. Credit risk is the failure of the counterparty to perform under the terms of the derivative contract. When the fair value of an interest rate swap is positive, the counterparty owes us, which creates credit risk for us. When the fair value of an interest rate swap is negative, we owe the counterparty and, therefore, it does not possess credit risk. It is our policy to enter into these transactions with the same party providing the underlying financing. In the alternative, we will seek to minimize the credit risk associated with interest rate swaps by entering into transactions with what we believe are high-quality counterparties. We believe the likelihood of realized losses from counterparty non-performance is remote. Market risk is the adverse effect on the value of a financial instrument that results from a change in interest rates. We manage the market risk associated with interest rate swaps by establishing and monitoring parameters that limit the types and degree of market risk that may be undertaken.

84

The table below presents, as of December 31, 2013, the principal amounts and weighted average interest rates by year of expected maturity to evaluate the expected cash flows and sensitivity to interest rate changes.
 
Expected Maturity Date
 
2014
 
2015
 
2016
 
2017
 
2018
 
Thereafter
 
Total
 
Fair Value
Assets
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fixed rate notes receivable — principal payments
$
—

 
$
—

 
$
—

 
$
10,182,000

 
$
—

 
$
—

 
$
10,182,000

 
$
10,361,000

Weighted average interest rate on maturing notes receivable
—
%
 
—
%
 
—
%
 
7.50
%
 
—
%
 
—
%
 
7.50
%
 
—

Variable rate notes receivable — principal payments
$
—

 
$
2,002,000

 
$
—

 
$
6,411,000

 
$
—

 
$
—

 
$
8,413,000

 
$
8,527,000

Weighted average interest rate on maturing notes receivable (based on rates in effect as of December 31, 2013)
—
%
 
7.25
%
 
—
%
 
7.50
%
 
—
%
 
—
%
 
7.44
%
 
—

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fixed rate debt — principal payments
$
12,530,000

 
$
41,621,000

 
$
43,669,000

 
$
24,574,000

 
$
34,069,000

 
$
143,217,000

 
$
299,680,000

 
$
309,202,000

Weighted average interest rate on maturing debt
5.49
%
 
5.44
%
 
5.83
%
 
4.98
%
 
5.91
%
 
4.36
%
 
5.00
%
 
—

Variable rate debt — principal payments
$
2,833,000

 
$
68,359,000

 
$
6,650,000

 
$
205,000

 
$
5,995,000

 
$
—

 
$
84,042,000

 
$
83,971,000

Weighted average interest rate on maturing debt (based on rates in effect as of December 31, 2013)
1.45
%
 
2.32
%
 
3.02
%
 
2.57
%
 
2.57
%
 
—
%
 
2.37
%
 
—

Real Estate Notes Receivable
As of December 31, 2013, the carrying value of our real estate notes receivable was $18,888,000, which approximates the fair value. As we expect to hold our fixed rate notes receivable to maturity and the amounts due under such notes would be limited to the outstanding principal balance and any accrued and unpaid interest, we do not expect that fluctuations in interest rates, and the resulting change in fair value of our fixed rate notes receivable, would have a significant impact on our operations. Conversely, movements in interest rates on our variable rate notes receivable may change our future earnings and cash flows, but not significantly affect the fair value of those instruments.
The weighted average effective interest rate on our outstanding real estate notes receivable was 7.47% per annum based on rates in effect as of December 31, 2013. A decrease in the variable interest rate on our real estate notes receivable constitutes a market risk. As of December 31, 2013, a 0.50% decrease in the market rates of interest would have no impact on our future earnings and cash flows due to interest rate floors on our variable rate real estate notes receivable.
Mortgage Loans Payable and Line of Credit
Mortgage loans payable were $315,722,000 ($329,476,000, net of discount and premium) as of December 31, 2013. As of December 31, 2013, we had 43 fixed rate and three variable rate mortgage loans payable with effective interest rates ranging from 1.27% to 6.60% per annum and a weighted average effective interest rate of 4.87% per annum. As of December 31, 2013, we had $299,680,000 ($313,646,000, net of discount and premium) of fixed rate debt, or 94.9% of mortgage loans payable, at a weighted average effective interest rate of 5.00% per annum and $16,042,000 ($15,830,000, net of discount) of variable rate debt, or 5.1% of mortgage loans payable, at a weighted average effective interest rate of 2.57% per annum. In addition, as of December 31, 2013, we had $68,000,000 outstanding under our unsecured line of credit, at a weighted-average interest rate of 2.32% per annum.
As of December 31, 2013, the weighted average effective interest rate on our outstanding debt, factoring in our fixed rate interest rate swaps, was 4.51% per annum. $2,483,000 of our variable rate mortgage loans payable is due August 15, 2021; however, the principal balance is immediately due upon written request from the seller and seller's confirmation that it shall pay any interest rate swap termination amount that is applicable, and as such, the $2,483,000 principal balance is reflected in the 2014 column above.
An increase in the variable interest rate on our unsecured line of credit and our variable rate mortgage loans payable constitutes a market risk. As of December 31, 2013, we have fixed rate interest rate swaps on all of our variable rate mortgage loans payable. As of December 31, 2013, a 0.50% increase in the market rates of interest would have increased our overall interest expense on our unsecured line of credit by $345,000, or 1.9%.

85

Foreign Currency Exchange Rate Risk
Foreign currency exchange rate risk is the possibility that our financial results could be better or worse than planned because of changes in foreign currency exchange rates.
Our primary exposure to foreign currency exchange rates relates to the translation of the net income and net investment
in our foreign subsidiaries from GBP into USD, especially to the extent we wish to repatriate funds to the United States. To mitigate our foreign currency exchange rate exposure, we intend to borrow funds in the functional currency of the borrowing entity, when appropriate. We also use foreign currency forward contracts to manage foreign currency exchange rate risk associated with the projected net operating income or net equity of our foreign subsidiaries. Hedging arrangements involve risks, such as the risk that counterparties may fail to honor their obligations under these arrangements and the risk of fluctuation in the relative value of the foreign currency. The funds required to settle such arrangements could be significant depending on the stability and movement of foreign currency rates. The failure to hedge effectively against exchange rate changes may materially adversely affect our results of operations and financial position. We may experience fluctuations in our earnings as a result of changes in foreign currency exchange rates. Based solely on our results for the year ended December 31, 2013, if foreign currency exchange rates were to increase or decrease by 100 basis points, our net income from these investments would decrease or increase, as applicable, by approximately $105,000 for the same period.

In September 2013, we entered into a foreign currency forward contract that matures in September 2014 with an aggregate notional amount of £180,000,000 ($280,908,000 using the contract currency exchange rate of 1.5606) to hedge approximately 55.7%, as of December 31, 2013, of our net investment in the United Kingdom at a fixed GBP rate in USD. Based on a sensitivity analysis, a strengthening or weakening of the USD against the GBP by 10% would result in a $28,091,000 positive or negative change in our cash flows upon settlement of the forward contract. We did not designate this derivative financial instrument as a hedge and therefore the change in fair value of this derivative financial instrument is recorded in foreign currency and derivative loss in our consolidated statements of operations and comprehensive income (loss). We may enter into similar agreements in the future to further hedge our investment in the United Kingdom or other jurisdictions.
Other Market Risk
In addition to changes in interest rates, the value of our future investments is subject to fluctuations based on changes in local and regional economic conditions and changes in the creditworthiness of tenants, which may affect our ability to refinance our debt if necessary.
Item 8. Financial Statements and Supplementary Data.
See the index at Part IV, Item 15. Exhibits, Financial Statement Schedules.
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.
None.
Item 9A. Controls and Procedures.
(a) Evaluation of disclosure controls and procedures. We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports under the Securities Exchange Act of 1934, as amended, or the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the rules and forms, and that such information is accumulated and communicated to us, including our chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosure.
As required by Rules 13a-15(b) and 15d-15(b) of the Exchange Act, an evaluation as of December 31, 2013 was conducted under the supervision and with the participation of our management, including our chief executive officer and chief financial officer, of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act). Based on this evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures, as of December 31, 2013, were effective.
(b) Management’s Annual Report on Internal Control over Financial Reporting. Our management is responsible for establishing and maintaining adequate internal control over our financial reporting, as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f). Under the supervision, and with the participation, of our management, including our chief executive officer and chief financial officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in Internal Control-Integrated Framework issued in 1992 by the Committee of Sponsoring Organizations of the Treadway Commission, or COSO.

86

Based on our evaluation under the Internal Control-Integrated Framework issued in 1992, our management concluded that our internal control over financial reporting was effective as of December 31, 2013.
(c) Changes in internal control over financial reporting. There were no changes in internal control over financial reporting that occurred during the fiscal quarter ended December 31, 2013 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Item 9B. Other Information.
None.

87

PART III
Item 10. Directors, Executive Officers and Corporate Governance.
The following table and biographical descriptions set forth certain information with respect to the individuals who are our executive officers and directors:
Name
Age*
 
Position
Jeffrey T. Hanson
43
 
Chief Executive Officer and Chairman of the Board of Directors
Danny Prosky
48
 
President and Chief Operating Officer and Director
Shannon K S Johnson
36
 
Chief Financial Officer
Mathieu B. Streiff
38
 
Executive Vice President, General Counsel
Stefan K. L. Oh
43
 
Senior Vice President — Acquisitions
Cora Lo
39
 
Secretary
Patrick R. Leardo
66
 
Independent Director
Gerald W. Robinson
66
 
Independent Director
Gary E. Stark
58
 
Independent Director
__________
* As of March 13, 2014
There are no family relationships among any directors and executive officers.
Jeffrey T. Hanson has served as our Chief Executive Officer and Chairman of the Board of Directors since January 2009. He is also one of the founders and owners of American Healthcare Investors, an investment management firm that serves as one of our co-sponsors and owns a majority interest in our sub-advisor. Since November 2011, Mr. Hanson has also served as an Executive Vice President of our sub-advisor. Mr. Hanson has also served as the Chief Executive Officer and Chairman of the Board of Directors of Griffin-American Healthcare REIT III, Inc., or GA Healthcare REIT III, since January 2013. He served as the Chief Executive Officer of Grubb & Ellis Healthcare REIT II Advisor, LLC, or Grubb & Ellis Healthcare REIT II Advisor, from January 2009 to November 2011 and as the Chief Executive Officer and President of GEEA, from June 2009 to November 2011. He also served as the Executive Vice President, Investment Programs, of Grubb & Ellis from December 2007 to November 2011 and served in various capacities within the Grubb & Ellis organization from July 2006 to November 2011. Grubb & Ellis filed for Chapter 11 bankruptcy protection on February 20, 2012. From 1997 to July 2006, prior to Grubb & Ellis’ merger with NNN Realty Advisors, Inc. in December 2007, Mr. Hanson served as Senior Vice President with Grubb & Ellis’ Institutional Investment Group in the firm’s Newport Beach office. While with that entity, he managed investment sale assignments throughout the Western U.S., with a significant focus on leading acquisitions and dispositions on healthcare-related properties, for major private and institutional clients. During that time, he also served as a member of the Grubb & Ellis President’s Counsel and Institutional Investment Group Board of Advisors. Mr. Hanson received a B.S. degree in Business from the University of Southern California with an emphasis in Real Estate Finance.
Our board of directors selected Mr. Hanson to serve as a director because he is our Chief Executive Officer and has served in various executive roles with a focus on property management and property acquisitions. Mr. Hanson has profound insight into the development, marketing, finance and operations aspects of our company. He has expansive knowledge of the real estate and healthcare industries and relationships with chief executives and other senior management at real estate and healthcare companies. Our board of directors believes that Mr. Hanson brings a unique and valuable perspective to our board of directors. As of March 7, 2014, Mr. Hanson owns, either individually or collectively with his wife, approximately 510,550 shares of our common stock and is the largest stockholder of our company.
Danny Prosky has served as our director, President and Chief Operating Officer since January 2009. He is also one of the founders and owners of American Healthcare Investors, which serves as one of our co-sponsors and owns a majority interest in our sub-advisor. Since November 2011, Mr. Prosky has also served as an Executive Vice President of our sub-advisor. He has also served as President, Chief Operating Officer of GA Healthcare REIT III since January 2013 and as that company's director from January 2013 to January 2014. He served as the President and Chief Operating Officer of Grubb & Ellis Healthcare REIT II Advisor from January 2009 to November 2011 and as Executive Vice President and Secretary of GEEA Property Management, Inc. from June 2011 to November 2011. He also served as the Executive Vice President, Healthcare Real Estate of GEEA from September 2009 to November 2011, having served in various capacities within the Grubb & Ellis organization from March 2006 to November 2011, and was responsible for all healthcare-related property acquisitions, management and dispositions. He served as the Executive Vice President — Acquisitions of Grubb & Ellis Healthcare REIT, Inc. (now known as Healthcare Trust of America, Inc.) from April 2008 to June 2009, having served as its Vice President – Acquisitions from

88

September 2006 to April 2008. Mr. Prosky previously worked for Health Care Property Investors, Inc., a publicly traded healthcare REIT, where he served as the Assistant Vice President – Acquisitions & Dispositions from February 2005 to March 2006 and as Assistant Vice President – Asset Management from November 1999 to February 2005. From 1992 to 1999, he served as the Manager, Financial Operations, Multi-Tenant Facilities for American Health Properties, Inc. Mr. Prosky received a B.S. degree in Finance from the University of Colorado and an M.S. degree in Management from Boston University.
Our board of directors selected Mr. Prosky to serve as a director because he is our President and Chief Operating Officer and his primary focus has been on the acquisition and operation of healthcare and healthcare-related properties. He has significant knowledge of, and relationships within, the real estate and healthcare industries, due in part to the 14 years he worked at Health Care Property Investors, Inc. and American Health Properties, Inc. Our board of directors believes that his executive experience in the real estate industry coupled with his deep knowledge of our company’s strategies and operations bring strong financial and operational expertise to our board of directors.
Shannon K S Johnson has served as our Chief Financial Officer since January 2009. Ms. Johnson has also served as the Senior Vice President, Accounting and Finance of American Healthcare Investors since January 2012. She has also served as Chief Financial Officer of GA Healthcare REIT III since January 2013. Ms. Johnson served as the Financial Reporting Manager for Grubb & Ellis Realty Investors, LLC, or Grubb & Ellis Realty Investors, an indirect wholly-owned subsidiary of Grubb & Ellis, from January 2006 to January 2012. Ms. Johnson served as Chief Financial Officer of Grubb & Ellis Healthcare REIT, Inc. (now known as Healthcare Trust of America, Inc.) and Grubb & Ellis Apartment REIT, Inc. (now known as Landmark Apartment Trust of America, Inc.) from August 2006 to March 2009 and from April 2006 to November 2010, respectively. From June 2002 to January 2006, Ms. Johnson gained public accounting and auditing experience while employed as an auditor with PricewaterhouseCoopers LLP. Prior to joining PricewaterhouseCoopers LLP, from September 1999 to June 2002, Ms. Johnson worked as an auditor with Arthur Andersen LLP, where she worked on the audits of a variety of public and private entities. Ms. Johnson is a Certified Public Accountant in the State of California and received a B.A. degree in Business-Economics and a minor in Accounting from the University of California, Los Angeles, where she graduated summa cum laude.
Mathieu B. Streiff has served as our Executive Vice President, General Counsel since September 2013 and served as Executive Vice President from January 2012 to September 2013. He is also one of the founders and owners of American Healthcare Investors, which serves as one of our co-sponsors and owns a majority interest in our sub-advisor. Since November 2011, Mr. Streiff has also served as an Executive Vice President of our sub-advisor. Mr. Streiff also served as Executive Vice President of GA Healthcare REIT III from January 2013 to July 2013, and has served as Executive Vice President, General Counsel of GA Healthcare REIT III since July 2013. He served as General Counsel, Executive Vice President and Secretary of Grubb & Ellis from October 2010 to June 2011. Grubb & Ellis filed for Chapter 11 bankruptcy protection on February 20, 2012. Mr. Streiff joined Grubb & Ellis Realty Investors in March 2006 as the firm’s real estate counsel responsible for structuring and negotiating property acquisitions, financings, joint ventures and disposition transactions. He was promoted to Chief Real Estate Counsel and Senior Vice President, Investment Operations in March 2009 and served in that position until October 2010. In this role, his responsibility was expanded to include the structuring and strategic management of the company’s securitized real estate investment platforms. From September 2002 until March 2006, Mr. Streiff was an associate in the real estate department of Latham & Watkins LLP in New York. Mr. Streiff received a B.S. degree in Environmental Economics and Policy from the University of California, Berkeley and a J.D. degree from Columbia University Law School. He is a member of the New York State Bar Association.
Stefan K.L. Oh has served as our Senior Vice President — Acquisitions since January 2009. Mr. Oh has also served as the Senior Vice President, Acquisitions of American Healthcare Investors since January 2012. He has also served as Senior Vice President — Acquisitions of GA Healthcare REIT III since January 2013. Mr. Oh served as the Senior Vice President, Healthcare Real Estate of GEEA from January 2010 to January 2012, having served in the same capacity for Grubb & Ellis Realty Investors since June 2007, where he was responsible for the acquisition and management of healthcare real estate. Prior to joining Grubb & Ellis, from August 1999 to June 2007, Mr. Oh worked for Health Care Property Investors, Inc., where he served as Director of Asset Management and later as Director of Acquisitions. From 1997 to 1999, he worked as an auditor and project manager for Ernst & Young AB in Stockholm, Sweden and from 1993 to 1997 as an auditor within Ernst & Young LLP’s EYKL Real Estate Group in Los Angeles, California. Mr. Oh received a B.S. degree in Accounting from Pepperdine University and is a Certified Public Accountant in the State of California (inactive).
Cora Lo has served as our Secretary since November 2010, having previously served as our Assistant Secretary since March 2009. Ms. Lo has also served as the Senior Vice President, Securities Counsel of American Healthcare Investors since January 2012. She has also served as Secretary of GA Healthcare REIT III since January 2013. Ms. Lo served as Senior Corporate Counsel for Grubb & Ellis from December 2007 to January 2012, having served as Senior Corporate Counsel and Securities Counsel for Grubb & Ellis Realty Investors since January 2007 and December 2005, respectively. She also served as the Assistant Secretary of Grubb & Ellis Apartment REIT, Inc. (now known as Landmark Apartment Trust of America, Inc.) from June 2008 to November 2010. From September 2002 to December 2005, Ms. Lo served as General Counsel of I/OMagic

89

Corporation, a publicly traded company. Prior to 2002, Ms. Lo practiced as a private attorney specializing in corporate and securities law. Ms. Lo also interned at the SEC, Division of Enforcement in 1998. Ms. Lo received a B.A. degree in Political Science from the University of California, Los Angeles and received a J.D. degree from Boston University. Ms. Lo is a member of the California State Bar Association.
Patrick R. Leardo has served as one of our independent directors and chairman of the audit committee of our board of directors since August 2009. Mr. Leardo has also served as chairman of the special committee of our board of directors since November 2013. Mr. Leardo has also served as the Managing Member of Domain Capital Advisors, LLC, a registered investment advisor, since July 2008. From May 1986 to June 2008, Mr. Leardo served in various management roles at PricewaterhouseCoopers LLP, including serving as the partner in charge of the Global Real Estate Advisory practice. Prior to the merger of PriceWaterhouse and Coopers & Lybrand in 1998, Mr. Leardo was also the Real Estate Industry Chairman for Coopers & Lybrand’s real estate activities, coordinating all lines of service including audit, tax and consulting. Mr. Leardo’s industry memberships include the Pension Real Estate Association, National Realty Committee, Urban Land Institute, or ULI, and the National Association of Real Estate Investment Trusts, or NAREIT. He also holds the prestigious Counselor of Real Estate designation and was honored by the Royal Institute of Chartered Surveyors as a Fellow in May 2006. He completed a term as a Trustee of ULI and has also been appointed as a Governor of ULI. Mr. Leardo has also served as a Board Trustee for the American Seniors Housing Association, a member of the board of directors of Edens & Avant, a $2.5 billion market cap private REIT and a Board Trustee for Roanoke College located in Salem, Virginia. Mr. Leardo received a B.S. degree in Economics from Upsala College.
Our board of directors selected Mr. Leardo to serve as a director in part due to his financial and accounting expertise, particularly in the real estate industry. Our board of directors believes that his experience as a partner at a public accounting firm, as well as his previous service on the board of directors of a REIT, will bring value to us, particularly in his role as the audit committee chairman and audit committee financial expert. With his extensive background in finance, accounting and business operations, Mr. Leardo has a unique portfolio of business skills.
Gerald W. Robinson has served as one of our independent directors since August 2009. Mr. Robinson has also served as the Executive Vice President of Pacific Life Insurance Company since January 1994 and as Chairman and Chief Executive Officer of Pacific Select Distributors, Inc. since March 1994. Prior to 1994, Mr. Robinson served in various executive positions in the life insurance industry, including positions with Home Life Insurance Company, Anchor National Life Insurance Company and Private Ledger Financial Services. During Mr. Robinson’s career, he has supervised and been a member of due diligence committees responsible for the approval of all products offered by broker-dealers for sale through registered representatives including real estate limited partnership, REIT and mortgage-based products. In addition, while at Pacific Life Insurance Company, Mr. Robinson was a member of the investment committee, which was responsible for the purchase and disposition of all assets of the insurance company which included numerous forms of real estate, mortgage and REIT investments. Mr. Robinson is a Certified Financial Planner and a Chartered Life Underwriter and received a B.S. degree in Business Administration from Central Michigan University.
Our board of directors selected Mr. Robinson to serve as a director due to his strong relationships and understanding of the financial network through which we offered our shares of common stock in our offerings. Mr. Robinson’s vast experience in capital markets and business operations enhances his ability to contribute insight on achieving business success in a diverse range of economic conditions and competitive environments. Our board of directors believes that this experience will bring valuable knowledge and insight to our company.
Gary E. Stark has served as one of our independent directors since August 2009. From February 2010 through March 2011, Mr. Stark acted as the chief operating officer of Whitten LLC, a healthcare company operating a luxury assisted living and memory care facility in La Habra, California. Since December 2007, Mr. Stark has been the owner and managing member of Chateau DHAL Management, LLC, a healthcare management company that operated an assisted living facility exclusively dedicated to qualifying low income individuals with assisted living needs in Kansas City, Kansas. Since May 2005, Mr. Stark has been the owner and managing member of Chateau Healthcare Management, LLC, a healthcare management company that operated luxury assisted living, senior residential care, memory care and Alzheimer’s care facilities in Overland Park and Mission, Kansas. From November 2002 to July 2005, Mr. Stark co-owned Grace Long Term Care, LLC, a healthcare management company operating skilled nursing and assisted living facilities. Mr. Stark served as a private consultant from August 2001 to March 2004 to Health Care Property Investors, Inc. Mr. Stark also served as a Vice President and General Counsel of Nationwide Health Properties, Inc., a publicly traded healthcare REIT, from March 1992 to August 2001. Prior to 2001, Mr. Stark also served as Vice President of Legal Affairs/General Counsel of Life Care Centers of America, Inc., one of the largest privately owned sub-acute/long-term care providers in the U.S., and as General Counsel of Care Enterprises, Inc., a publicly traded healthcare corporation engaged in sub-acute/long-term care, ancillary healthcare services and products. Mr. Stark received a B.A. degree in Economics from the University of California, Irvine and received a J.D. degree from the University of California, Hastings College of Law. Mr. Stark is a member of the California State Bar Association.

90

Our board of directors selected Mr. Stark to serve as a director due to his knowledge of the healthcare industry and his previous relationships with publicly traded REITs. Mr. Stark’s extensive knowledge of our company’s business sector combined with his executive experience at numerous other real estate companies focused on the healthcare industry is a significant asset to our company. Our board of directors believes that Mr. Stark’s experience will result in assisting us in developing our long-term strategy in the healthcare industry.

Each of our directors and executive officers has stated that there is no arrangement or understanding of any kind between him or her and any other person pursuant to which he or she was selected as a director or executive officer.
Committees of our Board of Directors
Our board of directors has established an audit committee and a special committee and may establish other committees it deems appropriate to address specific areas in more depth than may be possible at a full board meeting, provided that the majority of the members of each committee are independent directors.
Audit Committee. We have established an audit committee which consists of all of our independent directors, with Mr. Leardo serving as the audit committee financial expert. Our audit committee’s primary function is to assist the board of directors in fulfilling its oversight responsibilities by reviewing the financial information to be provided to the stockholders and others, the system of internal controls which management has established, and the audit and financial reporting process. The audit committee: (1) makes recommendations to our board of directors concerning the engagement of an independent registered public accounting firm; (2) reviews the plans and results of the audit engagement with our independent registered public accounting firm; (3) approves audit and non-audit professional services (including the fees and terms thereof) provided by, and the independence of, our independent registered public accounting firm; and (4) consults with our independent registered public accounting firm regarding the adequacy of our internal controls. We expect that pursuant to our audit committee charter, the audit committee will always be comprised solely of independent directors.
Special Committee. During the fiscal year ended December 31, 2013, our board of directors established a special committee which consists of all of our independent directors. The special committee was formed to consider and evaluate strategic alternatives for our company. Mr. Leardo serves as the chairman of the special committee.
Compensation Committee. We currently do not have, but we may have in the future, a compensation committee comprised of a minimum of three directors, including at least two independent directors, to establish compensation strategies and programs for our directors and executive officers. However, at a later date, the compensation committee may exercise all powers of our board of directors in connection with establishing and implementing compensation matters. Stock-based compensation plans will be administered by the board of directors if the members of the compensation committee do not qualify as “non-employee directors” within the meaning of the Exchange Act.
Nominating and Corporate Governance Committee. We do not have a separate nominating and corporate governance committee. We believe that our board of directors is qualified to perform the functions typically delegated to a nominating and corporate governance committee and that the formation of a separate committee is not necessary at this time. Instead, the full board of directors performs functions similar to those which might otherwise normally be delegated to such a committee, including, among other things, developing a set of corporate governance principles, adopting a code of ethics, adopting objectives with respect to conflicts of interest, monitoring our compliance with corporate governance requirements of state and federal law, establishing criteria for prospective members of the board of directors, conducting candidate searches and interviews, overseeing and evaluating the board of directors and our management, evaluating from time to time the appropriate size and composition of the board of directors and recommending, as appropriate, increases, decreases and changes to the composition of the board of directors and formally proposing the slate of directors to be elected at each annual meeting of our stockholders.
Code of Business Conduct and Ethics
We have adopted our Code of Business Conduct and Ethics, or Code of Ethics, which contains general guidelines for conducting our business and is designed to help our directors, employees and independent consultants resolve ethical issues in an increasingly complex business environment. Our Code of Ethics applies to our principal executive officer, principal financial officer, principal accounting officer, controller and persons performing similar functions and all members of our board of directors. Our Code of Ethics covers topics including, but not limited to, conflicts of interest, confidentiality of information and compliance with laws and regulations. Stockholders may request a copy of our Code of Ethics, which will be provided without charge, by writing to: Griffin-American Healthcare REIT II, Inc., 18191 Von Karman Avenue, Suite 300,
Irvine, California 92612, Attention: Secretary. Our Code of Ethics is also available on our website,

91

http://www.healthcarereit2.com/corporate-governance. If, in the future, we amend, modify or waive a provision in our Code of Ethics, we may, rather than filing a Current Report on Form 8-K, satisfy the disclosure requirement by posting such information on our website, as necessary.
Section 16(a) Beneficial Ownership Reporting Compliance
Section 16(a) of the Exchange Act requires each director, officer and individual beneficially owning more than 10.0% of a registered security of the company to file with the SEC, within specified time frames, initial statements of beneficial ownership (Form 3) and statements of changes in beneficial ownership (Forms 4 and 5) of common stock of the company. These specified time frames require the reporting of changes in ownership within two business days of the transaction giving rise to the reporting obligation. Reporting persons are required to furnish us with copies of all Section 16(a) forms filed with the SEC. Based solely on a review of the copies of such forms furnished to us during and with respect to the fiscal year ended December 31, 2013 or written representations that no additional forms were required, to the best of our knowledge, all required Section 16(a) filings were timely and correctly made by reporting persons during 2013.
Our Co-Sponsors
American Healthcare Investors
American Healthcare Investors is an investment management firm that specializes in the acquisition and management of healthcare-related real estate. The company was founded and is majority owned by Jeffrey T. Hanson, our Chief Executive Officer, Chairman of the Board of Directors, and our largest individual stockholder; Danny Prosky, our President and Chief Operating Officer and a director; and Mathieu B. Streiff, our Executive Vice President, General Counsel. Nationally recognized real estate executives, Messrs. Hanson, Prosky and Streiff have directly overseen in excess of $18.0 billion in combined acquisition and disposition transactions, more than $8.0 billion of which has been healthcare-related.
For biographical information regarding Messrs. Hanson, Prosky and Streiff, see “— Directors, Executive Officers and Corporate Governance” above.
Griffin Capital
Griffin Capital is a privately-owned real estate company with an eight-year track record sponsoring real estate investment vehicles and managing institutional capital. Led by senior executives, each with more than two decades of real estate experience who have collectively closed more than 650 transactions representing over $16.0 billion in transaction value, Griffin Capital has acquired or constructed over 26.0 million square feet of space since its formation in 1995, and as of December 31, 2013, owns, manages, and/or sponsors a portfolio of more than 24.2 million square feet located in 32 states, representing more than $4.5 billion in asset value. We are not affiliated with Griffin Capital.
Our Advisor
We rely on our advisor, Griffin-American Advisor, a subsidiary of Griffin Capital, to manage our day-to-day activities and to implement our investment strategy. We and our advisor are parties to the Advisory Agreement, pursuant to which our advisor performs its duties and responsibilities as our fiduciary. We are not affiliated with Griffin-American Advisor.
Pursuant to the Advisory Agreement, our advisor, through our sub-advisor, uses its best efforts, subject to the oversight, review and approval of our board of directors, to perform the following duties pursuant to the terms of the Advisory Agreement:
 
•
participate in formulating an investment strategy and asset allocation framework consistent with achieving our investment objectives;
•
research, identify, review and recommend to our board of directors for approval of real estate and real estate-related acquisitions and dispositions consistent with our investment policies and objectives;
•
structure and negotiate the terms and conditions of transactions pursuant to which acquisitions and dispositions of real properties will be made;
•
actively oversee and manage our real estate and real estate-related investment portfolio for purposes of meeting our investment objectives;
•
manage our day-to-day affairs, including financial accounting and reporting, investor relations, marketing, informational systems and other administrative services on our behalf;
•
select joint venture partners, structure corresponding agreements and oversee and monitor these relationships;

92

•
arrange for financing and refinancing of our assets; and
•
recommend to our board of directors when appropriate various transactions which would provide liquidity to our stockholders (such as listing the shares of our common stock on a national securities exchange, liquidating our portfolio, or the sale or merger of our company).
The above summary is provided to illustrate the material functions for which our advisor is responsible and it is not intended to include all of the services that may be provided to us by our advisor, our sub-advisor or third parties.
Our Sub-Advisor
With our consent, Griffin-American Advisor has delegated all advisory duties and compensation therefore to Griffin-American Sub-Advisor, a sub-advisor jointly owned by Griffin-American Advisor and American Healthcare Investors. Our advisor and our sub-advisor are parties to a sub-advisory agreement, pursuant to which our sub-advisor has agreed to perform its duties and responsibilities as our fiduciary. We are affiliated with Griffin-American Sub-Advisor and American Healthcare Investors, as described elsewhere in this Annual Report on Form 10-K.
The following table sets forth information with respect to our sub-advisor’s executive officers:
Name
Age*
 
Position
Jeffrey T. Hanson
43
 
Executive Vice President
Danny Prosky
48
 
Executive Vice President
Mathieu B. Streiff
38
 
Executive Vice President
Kevin A. Shields
55
 
Executive Vice President
Michael J. Escalante
53
 
Executive Vice President
__________
* As of March 13, 2014
For biographical information regarding Messrs. Hanson, Prosky and Streiff, see “— Directors, Executive Officers and Corporate Governance” above.
Kevin A. Shields has served as an Executive Vice President of our sub-advisor since November 2011. Mr. Shields also has served as the Chairman of the Board of Directors of Griffin Capital since its formation in 1995 and has served as its Chief Executive Officer since September 2010, after serving as its President from 1995 to September 2010. Mr. Shields has served as an executive officer and the Chairman of the Board of Directors of Griffin Capital Essential Asset REIT, Inc., or GC REIT, a publicly registered, non-traded real estate investment trust also sponsored by Griffin Capital, since the company’s formation in August 2008. He currently serves as the Chief Executive Officer and Chairman of the Board of Directors of GC REIT. Additionally, Mr. Shields is the Chairman and sole stockholder of Griffin Securities. Since November 2011, Mr. Shields has also served as the Chief Executive Officer of Griffin-American Healthcare REIT Advisor, LLC. Before founding Griffin Capital, from 1993 to 1994, Mr. Shields was a Senior Vice President and head of the Structured Real Estate Finance Group at Jefferies & Company, Inc., a Los Angeles-based investment bank. During his tenure at Jefferies, Mr. Shields focused on originating structured lease bond products with a particular emphasis on sub-investment grade lessees. From 1992 to 1993, Mr. Shields was the President and Principal of Terrarius Incorporated, a firm engaged in the restructuring of real estate debt and equity on behalf of financial institutions, corporations, partnerships and developers. Prior to founding Terrarius, from 1986 to 1992, Mr. Shields served as a Vice President in the Real Estate Finance Department of Salomon Brothers Inc. in both New York and Los Angeles. During his tenure at Salomon Brothers, Mr. Shields initiated, negotiated, drafted and closed engagement, purchase and sale and finance agreements. Over the course of his 30-year real estate investment-banking career, Mr. Shields has structured and closed over 200 transactions totaling in excess of $8 billion of real estate acquisitions, financings and dispositions. Mr. Shields holds a J.D. degree, an M.B.A. and a B.S. degree in Finance and Real Estate from the University of California at Berkeley. Mr. Shields is a Registered Securities Principal of Griffin Securities, and holds Series 7, 63, 24 and 27 licenses, and is also a licensed California Real Estate Broker.
Our board of directors has agreed to invite Mr. Shields to attend, in a nonvoting observer capacity, meetings of the board of directors for the sole purpose of permitting Mr. Shields and his affiliates, Griffin Capital, Griffin Securities, and Griffin-American Advisor, to have current information with respect to the affairs of our company and the actions taken by our board of directors.
Michael J. Escalante has served as an Executive Vice President of our sub-advisor since November 2011. He has also served as Chief Investment Officer of Griffin Capital since June 2006, where he is responsible for overseeing all acquisition and disposition activities. Mr. Escalante has served as Vice President and Chief Investment Officer of GC REIT since the

93

company’s formation in August 2008. Since November 2011, Mr. Escalante has also served as the Chief Investment Officer of Griffin-American Healthcare REIT Advisor, LLC. With more than 25 years of real estate-related investment experience, he has been responsible for completing in excess of $4.0 billion of commercial real estate transactions throughout the western United States, or U.S. Prior to joining Griffin Capital in June 2006, Mr. Escalante founded Escalante Property Ventures in March 2005, a real estate investment management company, to invest in value-added and development-oriented infill properties within California and other western states. From 1997 to March 2005, Mr. Escalante served eight years at Trizec Properties, Inc., or Trizec, one of the largest publicly-traded U.S. office REITs, with his final position being Executive Vice President – Capital Transactions and Portfolio Management. While at Trizec, Mr. Escalante was directly responsible for all capital transaction activity for the western U.S., which included the acquisition of several prominent office projects. Mr. Escalante’s work experience at Trizec also included significant hands-on operations experience as the REIT’s western U.S. regional director with bottom-line responsibility for asset and portfolio management of a 4.6 million square foot office/retail portfolio (11 projects/23 buildings) and associated administrative support personnel (110 total/65 company employees). Prior to joining Trizec, from 1987 to 1997, Mr. Escalante held various acquisitions, asset management and portfolio management positions with The Yarmouth Group, an international investment advisor. Mr. Escalante holds an M.B.A. from the University of California at Los Angeles, and a B.S. in Commerce from the University of Santa Clara, which is located in California. Mr. Escalante is a full member of Urban Land Institute and active in many civic organizations.
Investment Committee
Our sub-advisor has established an investment committee to review all advisory recommendations made by our sub-advisor to our board of directors. A majority of all members of the investment committee must approve the recommendations of the sub-advisor before such recommendations are provided to our board of directors for approval. The investment committee is comprised of five persons, two of which are designated by our advisor and three of which are designated by American Healthcare Investors. Our advisor has initially designated Messrs. Shields and Escalante as members of the investment committee, and American Healthcare Investors has initially designated Messrs. Hanson, Prosky and Streiff as members of the investment committee. Members of our sub-advisor’s investment committee are not separately compensated for their service as members of the investment committee, nor are members of our investment committee reimbursed for their expenses associated with the investment committee.
Item 11. Executive Compensation.
Executive Compensation
We have no employees. Our executive officers are all employees of affiliates of our advisor entities and are compensated by these entities for their services to us. Our day-to-day management is performed by our advisor entities and their affiliates. We pay these entities fees and reimburse expenses pursuant to the Advisory Agreement. We do not currently intend to pay any compensation directly to our executive officers. As a result, we do not have, and our board of directors has not considered, a compensation policy or program for our executive officers and has not included a Compensation Discussion and Analysis, a Compensation Committee Report or a resolution subject to a stockholder advisory vote to approve the compensation of our executive officers in this Annual Report on Form 10-K.
Compensation Committee Interlocks and Insider Participation
Other than Mr. Hanson and Mr. Prosky, no member of our board of directors during the year ended December 31, 2013 has served as an officer, and no member of our board of directors served as an employee, of Griffin-American Healthcare REIT II, Inc. or any of our subsidiaries. In addition, during the year ended December 31, 2013, none of our executive officers served as a director or member of a compensation committee (or other board committee performing equivalent functions) of any entity that has one or more executive officers serving as a member of our board of directors or compensation committee.
Option/SAR Grants in Last Fiscal Year
No option grants were made to our officers or directors for the year ended December 31, 2013.
Director Compensation
For the year ended December 31, 2013, our independent directors received the following forms of compensation:
 
•
Annual Retainer. Effective as of the first quarter of 2013, our independent directors received an aggregate annual retainer of $50,000, which was paid on a quarterly basis at the commencement of each quarter for which an individual served as an independent director. Effective as of the first quarter of 2013, the chairman of the Audit Committee received an additional aggregate annual retainer of $5,000, which is paid on a quarterly basis at the

94

commencement of each quarter for which an individual serves as the chairman of the Audit Committee. Effective as of November 1, 2013, our independent directors receive a monthly fee of $7,500, which is paid on a monthly basis at the commencement of each month for which an individual serves as a member of the special committee.
•
Meeting Fees. Effective as of the first quarter of 2013, our independent directors receive $1,500 for each board of directors meeting attended in person or by telephone, $500 for each audit committee meeting attended in person or by telephone and $1,500 for each special committee meeting attended in person or by telephone, which was paid monthly in arrears. The chairman of each committee, other than the Audit Committee chairman, also may receive additional compensation. If a board of directors meeting is held on the same day as an audit committee meeting, an additional fee will not be paid for attending the audit committee meeting.
•
Equity Compensation. Effective as of the first quarter of 2013, in connection with their initial election to our board of directors, each independent director receives 5,000 shares of restricted common stock pursuant to our incentive plan, and an additional 5,000 shares of restricted common stock pursuant to our incentive plan in connection with his or her subsequent election each year, provided that such person is an independent director as of the date of his or her re-election and continually served as an independent director during such period. The restricted shares vest as to 20.0% of the shares on the date of grant and on each anniversary thereafter over four years from the date of grant.
•
Other Compensation. We reimburse our directors for reasonable out-of-pocket expenses incurred in connection with attendance at meetings, including committee meetings, of our board of directors. Such reimbursement is paid monthly. Our independent directors do not receive other benefits from us.
Our non-independent directors do not receive any compensation from us.
The following table sets forth certain information with respect to our director compensation for the year ended December 31, 2013: 
Name
 
Fees
Earned or
Paid in
Cash($)(1)
 
Stock
Awards
($)(2)
 
Option
Awards ($)
 
Non-Equity Incentive Plan
Compensation
($)
 
Change in Pension
Value and
Nonqualified  Deferred
Compensation
Earnings ($)
 
All Other
Compensation ($)
 
Total ($)
Jeffrey T. Hanson(3)
 
—

 
—

 
—

 
—

 
—

 
—

 
—

Danny Prosky(3)
 
—

 
—

 
—

 
—

 
—

 
—

 
—

Patrick R. Leardo
 
142,000

 
51,100

 
—

 
—

 
—

 
—

 
193,100

Gerald W. Robinson
 
137,000

 
51,100

 
—

 
—

 
—

 
—

 
188,100

Gary E. Stark
 
146,000

 
51,100

 
—

 
—

 
—

 
—

 
197,100

___________ 
(1)
Consists of the amounts described below.
Director
 
Role
 
Annual Retainer
($)
 
Meeting Fees
($)
 
Additional
Special  Payments
($)
Hanson
 
Chairman of the Board of Directors
 
—

 
—

 
—

Prosky
 
Director
 
—

 
—

 
—

Leardo
 
Chairman, Audit Committee and Special Committee
 
70,000

 
72,000

 
—

Robinson
 
Member, Audit Committee and Special Committee
 
65,000

 
72,000

 
—

Stark
 
Member, Audit Committee and Special Committee
 
65,000

 
72,000

 
9,000

(2)
The amounts in this column represent the aggregate grant date fair value of the awards granted for the year ended December 31, 2013, as determined in accordance with ASC Topic 718, Compensation — Stock Compensation, or ASC Topic 718. The following table shows the shares of restricted common stock awarded to each director for the year ended December 31, 2013, and the aggregate grant date fair value for each award (computed in accordance with ASC Topic 718):

95

Director
 
Grant Date
 
Number of Shares
of Restricted
Common Stock
 
Full Grant Date Fair Value of Award ($)
Hanson
 
—

 
—

 
—

Prosky
 
—

 
—

 
—

Leardo
 
12/5/2013

 
5,000

 
51,100

Robinson
 
12/5/2013

 
5,000

 
51,100

Stark
 
12/5/2013

 
5,000

 
51,100

The following table shows the aggregate number of shares of nonvested restricted common stock held by each director as of December 31, 2013:
Director
 
Number of Shares of Nonvested Restricted Common Stock
Hanson
 
—

Prosky
 
—

Leardo
 
10,000

Robinson
 
10,000

Stark
 
10,000


(3)
Mr. Hanson and Mr. Prosky are not independent directors.
2009 Incentive Plan
For a discussion of our incentive plan, see Note 13, Equity — 2009 Incentive Plan, to the Consolidated Financial Statements that are a part of this Annual Report on Form 10-K.
Amendment and Termination of the 2009 Incentive Plan
Unless otherwise provided in an award certificate, upon the death or disability of a participant, or upon a change in control, all of such participant’s outstanding awards pursuant to our incentive plan will become fully vested. Our incentive plan will automatically expire on the tenth anniversary of the date on which it was adopted, unless extended or earlier terminated by our board of directors. Our board of directors may terminate our incentive plan at any time, but such termination will have no adverse impact on any award that is outstanding at the time of such termination. Our board of directors may amend our incentive plan at any time, but any amendment would be subject to stockholder approval if, in the reasonable judgment of our board of directors, stockholder approval would be required by any law, regulation or rule applicable to the plan. No termination or amendment of our incentive plan may, without the written consent of the participant, reduce or diminish the value of an outstanding award determined as if the award had been exercised, vested, cashed in or otherwise settled on the date of such amendment or termination. Our board of directors may amend or terminate outstanding awards, but those amendments may require consent of the participant and, unless approved by our stockholders or otherwise permitted by the antidilution provisions of the plan, the exercise price of an outstanding option may not be reduced, directly or indirectly, and the original term of an option may not be extended.
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.
Principal Stockholders
The following table shows, as of March 7, 2014, the number of shares of our common stock beneficially owned by (1) any person who is known by us to be the beneficial owner of more than 5.0% of the outstanding shares of our common stock; (2) our directors; (3) our named executive officers; and (4) all of our directors and executive officers as a group. The percentage of common stock beneficially owned is based on 292,698,141 shares of our common stock outstanding as of March 7, 2014. Beneficial ownership is determined in accordance with the rules of the SEC and generally includes securities over which a person has voting or investment power and securities that a person has the right to acquire within 60 days.

96

 
Name of Beneficial Owners(1)
 
Number of Shares
of Common Stock
Beneficially Owned
 
Percentage
Jeffrey T. Hanson(2)
 
670,284

 
*
Shannon K S Johnson
 
27,368

 
*
Danny Prosky(2)
 
375,734

 
*
Patrick R. Leardo(3)
 
71,817

 
*
Gerald W. Robinson(3)
 
49,680

 
*
Gary E. Stark(3)
 
49,680

 
*
All directors and officers as a group (9 persons)(2)(3)
 
1,231,548

 
*
_________
* Represents less than 1.0% of our outstanding common stock.
 
(1)
The address of each beneficial owner listed is c/o Griffin-American Healthcare REIT II, Inc., 18191 Von Karman Avenue, Suite 300, Irvine, California 92612.
(2)
Includes 157,734 shares of our common stock owned directly by American Healthcare Investors, of which Messrs. Hanson, Prosky and Streiff are principals. Each of Messrs. Hanson, Prosky and Streiff disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
(3)
Includes restricted and unrestricted shares of common stock.
None of the above shares have been pledged as security.
Securities Authorized for Issuance Under Equity Compensation Plans
See Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities — Securities Authorized for Issuance under Equity Compensation Plans, for a discussion of our incentive plan.
Item 13. Certain Relationships and Related Transactions, and Director Independence.
Relationships Among Our Affiliates
As of December 31, 2013, some of our executive officers and our non-independent directors are also executive officers and employees and/or holders of direct or indirect interests in our advisor entities.
Fees and Expenses Paid to Affiliates
For a discussion of fees and expenses paid to affiliates, see Note 12, Related Party Transactions, to the Consolidated Financial Statements that are a part of this Annual Report on Form 10-K.
Executive Stock Purchase Plans
Effective January 1, 2013, our Chief Executive Officer and Chairman of the Board of Directors, Jeffrey T. Hanson; our President, Chief Operating Officer and Director, Danny Prosky; our Executive Vice President, General Counsel, Mathieu B. Streiff; our Chief Financial Officer, Shannon K S Johnson; our Senior Vice President of Acquisitions, Stefan K.L. Oh; and our Secretary, Cora Lo, each adopted an executive stock purchase plan, or the Executive Stock Purchase Plans, whereby each executive irrevocably agreed to invest 100%, 50.0%, 50.0%, 15.0%, 15.0% and 10.0% respectively, of all of their net after-tax salary and cash bonus compensation that was earned on or after January 1, 2013 as employees of American Healthcare Investors directly into our company by purchasing shares of our common stock. The shares were purchased pursuant to our offerings at a price of $9.20 per share, the then most recent price paid to acquire a share of our common stock in our offerings, net of selling commissions and the dealer manager fee. The Executive Stock Purchase Plans each were to terminate on the earlier of (i) December 31, 2013, (ii) the termination of our offerings, (iii) any suspension of our offerings by our board of directors or a regulatory body, or (iv) the date upon which the number of shares of our common stock owned by such person, when combined with all their other investments in our common stock, exceeds the ownership limits set forth in our charter. In connection with the termination of our follow-on offering on October 30, 2013, the Executive Stock Purchase Plans also terminated.

97

For the year ended December 31, 2013, our executive officers invested the following amounts and we issued the following shares of our common stock pursuant to the applicable stock purchase plan:
 
 
 
 
Year Ended December 31, 2013
Officer's Name
 
Title
 
Amount
 
Shares
Jeffrey T. Hanson
 
Chairman of the Board of Directors and Chief Executive Officer
 
$
184,000

 
20,010

Danny Prosky
 
President and Chief Operating Officer
 
105,000

 
11,396

Mathieu B. Streiff
 
Executive Vice President, General Counsel
 
100,000

 
10,886

Shannon K S Johnson
 
Chief Financial Officer
 
16,000

 
1,735

Stefan K.L. Oh
 
Senior Vice President of Acquisitions
 
14,000

 
1,547

Cora Lo
 
Secretary
 
9,000

 
998

 
 
 
 
$
428,000

 
46,572

For a further discussion, see Note 12, Related Party Transactions — Executive Stock Purchase Plans, to the Consolidated Financial Statements that are a part of this Annual Report on Form 10-K.
Certain Conflict Resolution Restrictions and Procedures
In order to reduce or eliminate certain potential conflicts of interest, our charter and the Advisory Agreement contain restrictions and conflict resolution procedures relating to (1) transactions we enter into with our advisor entities, our directors or their respective affiliates, (2) certain future offerings and (3) allocation of properties among affiliated entities. Each of the restrictions and procedures that apply to transactions with our advisor entities and their affiliates will also apply to any transaction with any entity or real estate program advised, managed or controlled by our advisor entities and their affiliates. These restrictions and procedures include, among others, the following:
 
•
Except as otherwise disclosed in our prospectus for our follow-on offering, we will not accept goods or services from our advisor entities or their affiliates unless a majority of our directors, including a majority of our independent directors, not otherwise interested in the transactions, approve such transactions as fair and reasonable to us and on terms and conditions not less favorable to us than those available from unaffiliated third parties.
•
We will not purchase or lease any asset (including any property) in which our advisor entities, any of our directors or any of their respective affiliates has an interest without a determination by a majority of our directors, including a majority of our independent directors, not otherwise interested in such transaction, that such transaction is fair and reasonable to us and at a price to us no greater than the cost of the property to our advisor entities, such director or directors or any such affiliate, unless there is substantial justification for any amount that exceeds such cost and such excess amount is determined to be reasonable. In no event will we acquire any such asset at an amount in excess of its appraised value. We will not sell or lease assets to our advisor entities, any of our directors or any of their respective affiliates unless a majority of our directors, including a majority of our independent directors, not otherwise interested in the transaction, determine the transaction is fair and reasonable to us, which determination will be supported by an appraisal obtained from a qualified, independent appraiser selected by a majority of our independent directors.
Director Independence
We have a five-member board of directors. Our charter provides that a majority of the directors must be “independent directors.” Two of our directors, Jeffrey T. Hanson and Danny Prosky, are affiliated with us and we do not consider them to be independent directors. Our three remaining directors qualify as “independent directors” as defined in our charter in compliance with the requirements of the North American Securities Administrators Association’s Statement of Policy Regarding Real Estate Investment Trusts. As defined in our charter, the term “independent director” means a director who is not on the date of determination, and within the last two years from the date of determination has not been, directly or indirectly associated with our co-sponsors or our advisor entities by virtue of: (i) ownership of an interest in our co-sponsors, our advisor entities or any of their affiliates, other than in us; (ii) employment by our co-sponsors, our advisor entities or any of their affiliates; (iii) service as an officer or director of our co-sponsors, our advisor entities or any of their affiliates, other than as our director or a director of any other REIT organized by our co-sponsors or advised by our advisor entities; (iv) performance of services, other than as a director for us; (v) service as a director or trustee of more than three REITs organized by our co-sponsors or advised by our advisor entities; or (vi) maintenance of a material business or professional relationship with our co-sponsors, our advisor entities or any of their affiliates. A business or professional relationship is considered “material” if the aggregate gross income derived by a director from our co-sponsors, our advisor entities and their affiliates (excluding fees for serving as our director or

98

director of another REIT or real estate program that is organized, advised or managed by our advisor or its affiliates) exceeds five percent of either the director’s annual gross income during either of the last two years or the director’s net worth on a fair market value basis. An indirect association with our co-sponsors or our advisor entities shall include circumstances in which a director’s spouse, parent, child, sibling, mother- or father-in-law, son- or daughter-in-law or brother- or sister-in-law is or has been associated with our co-sponsors, our advisor entities, any of their affiliates or with us.
While our stock is not listed on the New York Stock Exchange, each of our independent directors would also qualify as independent under the rules of the New York Stock Exchange and our Audit Committee members would qualify as independent under the New York Stock Exchange’s rules applicable to Audit Committee members.
Item 14. Principal Accounting Fees and Services.
Ernst & Young has served as our independent registered public accounting firm and audited our consolidated financial statements since February 4, 2009.
The following table lists the fees for services billed by our independent registered public accounting firm in 2013 and 2012:
Services
 
2013
 
2012
Audit fees(1)
 
$
921,000

 
$
831,000

Audit-related fees(2)
 
—

 
—

Tax fees(3)
 
121,000

 
79,000

All other fees
 
—

 
—

Total
$
1,042,000

 
$
910,000

________ 
(1)
Audit fees billed in 2013 and 2012 consisted of fees related to the audit of our annual consolidated financial statements, reviews of our quarterly consolidated financial statements, and statutory and regulatory audits, consents and other services related to filings with the SEC, including filings related to our offerings. These amounts include fees paid by our advisor entities for costs in connection with our offerings.
(2)
Audit-related fees relate to financial accounting and reporting consultations, assurance and related services.
(3)
Tax services consist of tax compliance and tax planning and advice.
The Audit Committee pre-approves all auditing services and permitted non-audit services (including the fees and terms thereof) to be performed for us by our independent registered public accounting firm, subject to the de minimis exceptions for non-audit services described in Section 10A(i)(1)(b) of the Exchange Act and the rules and regulations of the SEC. All services rendered by Ernst & Young for the year ended December 31, 2013 were pre-approved in accordance with the policies and procedures described above.

99

PART IV
Item 15. Exhibits, Financial Statement Schedules.
(a)(1) Financial Statements:
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
 

(a)(2) Financial Statement Schedule:
The following financial statement schedule for the year ended December 31, 2013 is submitted herewith:
All schedules other than the one listed above have been omitted as the required information is inapplicable or the information is presented in our consolidated financial statements or related notes.
(a)(3) Exhibits:
The exhibits listed on the Exhibit Index (following the signatures section of this report) are included, or incorporated by reference, in this annual report.
(b) Exhibits:
See Item 15(a)(3) above.
(c) Financial Statement Schedule: 
See Item 15(a)(2) above.


100

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors and Stockholders of
Griffin-American Healthcare REIT II, Inc.
We have audited the accompanying consolidated balance sheets of Griffin-American Healthcare REIT II, Inc. (the “Company”) as of December 31, 2013 and 2012, and the related consolidated statements of operations and comprehensive income (loss), equity and cash flows for each of the three years in the period ended December 31, 2013. Our audits also included the financial statement schedule listed in the Index at Item 15(a). These financial statements and schedule are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements and schedule based on our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. We were not engaged to perform an audit of the Company’s internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in all material respects, the consolidated financial position of Griffin-American Healthcare REIT II, Inc. at December 31, 2013 and 2012 and the consolidated results of its operations and its cash flows for each of the three years in the period ended December 31, 2013 in conformity with U.S. generally accepted accounting principles. Also, in our opinion, the financial statement schedule, when considered in relation to the basic financial statements taken as a whole, presents fairly in all material respects the information set forth therein.
/s/ Ernst & Young LLP
Irvine, California
March 13, 2014


101

GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
CONSOLIDATED BALANCE SHEETS
As of December 31, 2013 and 2012
 
 
December 31,
 
2013
 
2012
ASSETS
Real estate investments, net
$
2,523,699,000

 
$
1,112,295,000

Real estate notes receivable, net
18,888,000

 
5,182,000

Cash and cash equivalents
37,955,000

 
94,683,000

Accounts and other receivables, net
6,906,000

 
6,920,000

Restricted cash
12,972,000

 
8,980,000

Real estate and escrow deposits
4,701,000

 
2,900,000

Identified intangible assets, net
285,667,000

 
204,147,000

Other assets, net
37,938,000

 
19,522,000

Total assets
$
2,928,726,000

 
$
1,454,629,000

 
 
 
 
LIABILITIES AND EQUITY
Liabilities:
 
 
 
Mortgage loans payable, net
$
329,476,000

 
$
291,052,000

Line of credit
68,000,000

 
200,000,000

Accounts payable and accrued liabilities
42,717,000

 
20,030,000

Accounts payable due to affiliates
2,407,000

 
1,807,000

Derivative financial instruments
16,940,000

 
795,000

Identified intangible liabilities, net
11,693,000

 
5,156,000

Security deposits, prepaid rent and other liabilities
72,262,000

 
75,043,000

Total liabilities
543,495,000

 
593,883,000

 
 
 
 
Commitments and contingencies (Note 11)

 

 
 
 
 
Equity:
 
 
 
Stockholders’ equity:
 
 
 
Preferred stock, $0.01 par value; 200,000,000 shares authorized; none issued and outstanding
—

 
—

Common stock, $0.01 par value; 1,000,000,000 shares authorized; 290,003,240 and 113,199,988 shares issued and outstanding as of December 31, 2013 and 2012, respectively
2,900,000

 
1,132,000

Additional paid-in capital
2,635,175,000

 
1,010,152,000

Accumulated deficit
(277,826,000
)
 
(150,977,000
)
Accumulated other comprehensive income
22,776,000

 
—

Total stockholders’ equity
2,383,025,000

 
860,307,000

Noncontrolling interests (Note 13)
2,206,000

 
439,000

Total equity
2,385,231,000

 
860,746,000

Total liabilities and equity
$
2,928,726,000

 
$
1,454,629,000

The accompanying notes are an integral part of these consolidated financial statements.


102


GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
For the Years Ended December 31, 2013, 2012 and 2011
 
 
 
 
 
 
 
Years Ended December 31,
 
2013
 
2012
 
2011
Revenues:
 
 
 
 
 
Real estate revenue
$
202,096,000

 
$
100,728,000

 
$
40,457,000

Resident fees and services
2,307,000

 
—

 
—

Total revenues
204,403,000

 
100,728,000

 
40,457,000

Expenses:
 
 
 
 
 
Rental expenses
43,387,000

 
21,131,000

 
8,330,000

General and administrative
22,519,000

 
11,067,000

 
5,992,000

Subordinated distribution purchase (Note 2)
—

 
4,232,000

 
—

Acquisition related expenses
25,501,000

 
75,608,000

 
10,389,000

Depreciation and amortization
76,188,000

 
38,407,000

 
14,826,000

Total expenses
167,595,000

 
150,445,000

 
39,537,000

Income (loss) from operations
36,808,000

 
(49,717,000
)
 
920,000

Other income (expense):
 
 
 
 
 
Interest expense (including amortization of deferred financing costs and debt discount/premium):
 
 
 
 
 
Interest expense
(18,109,000
)
 
(13,566,000
)
 
(6,345,000
)
Gain (loss) in fair value of derivative financial instruments
344,000

 
24,000

 
(366,000
)
Foreign currency and derivative loss
(11,312,000
)
 
—

 
—

Interest income
329,000

 
15,000

 
17,000

Income (loss) before income taxes
8,060,000

 
(63,244,000
)
 
(5,774,000
)
Income tax benefit
1,005,000

 
—

 
—

Net income (loss)
9,065,000

 
(63,244,000
)
 
(5,774,000
)
Less: Net income attributable to noncontrolling interests
(14,000
)
 
(3,000
)
 
(2,000
)
Net income (loss) attributable to controlling interest
$
9,051,000

 
$
(63,247,000
)
 
$
(5,776,000
)
Net income (loss) per common share attributable to controlling interest — basic and diluted
$
0.05

 
$
(0.85
)
 
$
(0.19
)
Weighted average number of common shares outstanding — basic and diluted
199,793,355

 
74,122,982

 
30,808,725

 
 
 
 
 
 
Net income (loss)
$
9,065,000

 
$
(63,244,000
)
 
$
(5,774,000
)
Other comprehensive income:
 
 
 
 
 
Gains on intra-entity foreign currency transactions that are of a long-term investment nature
22,059,000

 
—

 
—

Foreign currency translation adjustments
739,000

 
—

 
—

Total other comprehensive income
22,798,000

 
—

 
—

Comprehensive income (loss)
31,863,000

 
(63,244,000
)
 
(5,774,000
)
Less: Comprehensive income attributable to noncontrolling interests
(36,000
)
 
(3,000
)
 
(2,000
)
Comprehensive income (loss) attributable to controlling interest
$
31,827,000

 
$
(63,247,000
)
 
$
(5,776,000
)

The accompanying notes are an integral part of these consolidated financial statements.

103

GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
CONSOLIDATED STATEMENTS OF EQUITY
For the Years Ended December 31, 2013, 2012 and 2011
 
Stockholders’ Equity
 
 
 
 
 
Common Stock
 
 
 
 
 
 
 
 
 
 
 
 
 
Number
of
Shares
 
Amount
 
Additional
Paid-In Capital
 
Accumulated
Deficit
 
Accumulated Other Comprehensive Income
 
Total Stockholders' Equity
 
Noncontrolling
Interests
 
Total Equity
BALANCE — December 31, 2010
15,452,668

 
$
154,000

 
$
137,657,000

 
$
(12,571,000
)
 
$
—

 
$
125,240,000

 
$
122,000

 
$
125,362,000

Issuance of common stock
32,609,245

 
327,000

 
325,117,000

 
—

 
—

 
325,444,000

 
—

 
325,444,000

Offering costs — common stock
—

 
—

 
(35,199,000
)
 
—

 
—

 
(35,199,000
)
 
—

 
(35,199,000
)
Issuance of vested and nonvested restricted common stock
7,500

 
—

 
15,000

 
—

 
—

 
15,000

 
—

 
15,000

Issuance of common stock under the DRIP
928,058

 
9,000

 
8,808,000

 
—

 
—

 
8,817,000

 
—

 
8,817,000

Repurchase of common stock
(127,802
)
 
(1,000
)
 
(1,197,000
)
 
—

 
—

 
(1,198,000
)
 
—

 
(1,198,000
)
Amortization of nonvested common stock compensation
—

 
—

 
51,000

 
—

 
—

 
51,000

 
—

 
51,000

Distributions to noncontrolling interest
—

 
—

 
—

 
—

 
—

 
—

 
(1,000
)
 
(1,000
)
Distributions declared
—

 
—

 
—

 
(20,037,000
)
 
—

 
(20,037,000
)
 
—

 
(20,037,000
)
Net (loss) income
—

 
—

 
—

 
(5,776,000
)
 
—

 
(5,776,000
)
 
2,000

 
(5,774,000
)
BALANCE — December 31, 2011
48,869,669

 
$
489,000

 
$
435,252,000

 
$
(38,384,000
)
 
$
—

 
$
397,357,000

 
$
123,000

 
$
397,480,000

Issuance of common stock
62,360,749

 
623,000

 
622,856,000

 
—

 
—

 
623,479,000

 
—

 
623,479,000

Offering costs — common stock
—

 
—

 
(66,538,000
)
 
—

 
—

 
(66,538,000
)
 
—

 
(66,538,000
)
Issuance of vested and nonvested restricted common stock
22,500

 
—

 
45,000

 
—

 
—

 
45,000

 
—

 
45,000

Issuance of common stock under the DRIP
2,374,407

 
24,000

 
22,598,000

 
—

 
—

 
22,622,000

 
—

 
22,622,000

Repurchase of common stock
(427,337
)
 
(4,000
)
 
(4,149,000
)
 
—

 
—

 
(4,153,000
)
 
—

 
(4,153,000
)
Amortization of nonvested common stock compensation
—

 
—

 
70,000

 
—

 
—

 
70,000

 
—

 
70,000

Issuance of limited partnership units
—

 
—

 
83,000

 
—

 
—

 
83,000

 
323,000

 
406,000

Offering costs — limited partnership units
—

 
—

 
(65,000
)
 
—

 
—

 
(65,000
)
 
—

 
(65,000
)
Contribution from noncontrolling interest
—

 
—

 
—

 
—

 
—

 
—

 
2,000

 
2,000

Distributions to noncontrolling interest
—

 
—

 
—

 
—

 
—

 
—

 
(12,000
)
 
(12,000
)
Distributions declared
—

 
—

 
—

 
(49,346,000
)
 
—

 
(49,346,000
)
 
—

 
(49,346,000
)
Net (loss) income
—

 
—

 
—

 
(63,247,000
)
 
—

 
(63,247,000
)
 
3,000

 
(63,244,000
)
BALANCE — December 31, 2012
113,199,988

 
$
1,132,000

 
$
1,010,152,000

 
$
(150,977,000
)
 
$
—

 
$
860,307,000

 
$
439,000

 
$
860,746,000

Issuance of common stock
170,720,092

 
1,707,000

 
1,736,847,000

 
—

 
—

 
1,738,554,000

 
—

 
1,738,554,000

Offering costs — common stock
—

 
—

 
(171,075,000
)
 
—

 
—

 
(171,075,000
)
 
—

 
(171,075,000
)
Issuance of vested and nonvested restricted common stock
15,000

 
—

 
31,000

 
—

 
—

 
31,000

 
—

 
31,000

Issuance of common stock under the DRIP
6,993,254

 
70,000

 
67,835,000

 
—

 
—

 
67,905,000

 
—

 
67,905,000

Repurchase of common stock
(925,094
)
 
(9,000
)
 
(8,929,000
)
 
—

 
—

 
(8,938,000
)
 
—

 
(8,938,000
)
Amortization of nonvested common stock compensation
—

 
—

 
102,000

 
—

 
—

 
102,000

 
—

 
102,000

Issuance of limited partnership units
—

 
—

 
288,000

 
—

 
—

 
288,000

 
1,983,000

 
2,271,000

Offering costs — limited partnership units
—

 
—

 
(25,000
)
 
—

 
—

 
(25,000
)
 
—

 
(25,000
)
Distributions to noncontrolling interests
—

 
—

 
—

 
—

 
—

 
—

 
(142,000
)
 
(142,000
)
Purchase of noncontrolling interest
—

 
—

 
(51,000
)
 
—

 
—

 
(51,000
)
 
(110,000
)
 
(161,000
)
Distributions declared
—

 
—

 
—

 
(135,900,000
)
 
—

 
(135,900,000
)
 
—

 
(135,900,000
)
Net income
—

 
—

 
—

 
9,051,000

 
—

 
9,051,000

 
14,000

 
9,065,000

Other comprehensive income
—

 
—

 
—

 
—

 
22,776,000

 
22,776,000

 
22,000

 
22,798,000

BALANCE — December 31, 2013
290,003,240

 
$
2,900,000

 
$
2,635,175,000

 
$
(277,826,000
)
 
$
22,776,000

 
$
2,383,025,000

 
$
2,206,000

 
$
2,385,231,000

The accompanying notes are an integral part of these consolidated financial statements.

104
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS
For the Years Ended December 31, 2013, 2012 and 2011

 
 
 
 
 
 
 
Years Ended December 31,
 
2013
 
2012
 
2011
CASH FLOWS FROM OPERATING ACTIVITIES
 
 
 
 
 
Net income (loss)
$
9,065,000

 
$
(63,244,000
)
 
$
(5,774,000
)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
 
 
 
 
 
Depreciation and amortization (including deferred financing costs, above/below market leases, leasehold interests, above market leasehold interests, debt discount/premium, closing costs and origination fees)
78,652,000

 
40,714,000

 
16,528,000

Contingent consideration related to acquisition of real estate
(51,198,000
)
 
8,000

 
—

Deferred rent
(15,081,000
)
 
(7,105,000
)
 
(2,716,000
)
Stock based compensation
133,000

 
115,000

 
66,000

Acquisition fees paid in stock
1,218,000

 
1,079,000

 
—

Bad debt expense
1,182,000

 
82,000

 
261,000

Unrealized foreign currency gain
(723,000
)
 
—

 
—

Change in fair value of contingent consideration
134,000

 
50,250,000

 
—

Changes in fair value of derivative financial instruments
16,145,000

 
(24,000
)
 
366,000

Changes in operating assets and liabilities:
 
 
 
 
 
Accounts and other receivables
(3,604,000
)
 
(1,676,000
)
 
(1,508,000
)
Accounts receivable due from affiliate
—

 
121,000

 
—

Other assets
(3,672,000
)
 
(1,469,000
)
 
(468,000
)
Accounts payable and accrued liabilities
9,243,000

 
6,643,000

 
2,489,000

Accounts payable due to affiliates
796,000

 
969,000

 
326,000

Security deposits, prepaid rent and other liabilities
458,000

 
(3,001,000
)
 
(306,000
)
Net cash provided by operating activities
42,748,000

 
23,462,000

 
9,264,000

CASH FLOWS FROM INVESTING ACTIVITIES
 
 
 
 
 
Acquisition of real estate operating properties
(1,402,189,000
)
 
(719,369,000
)
 
(213,856,000
)
Advances on real estate notes receivable
(23,745,000
)
 
(5,213,000
)
 
—

Closing costs and origination fees on real estate notes receivable, net
(447,000
)
 
32,000

 
—

Capital expenditures
(5,521,000
)
 
(3,713,000
)
 
(3,459,000
)
Proceeds from sale of land
90,000

 
—

 
—

Restricted cash
(3,992,000
)
 
(6,691,000
)
 
527,000

Real estate and escrow deposits
(1,801,000
)
 
4,650,000

 
(6,901,000
)
Net cash used in investing activities
(1,437,605,000
)
 
(730,304,000
)
 
(223,689,000
)
CASH FLOWS FROM FINANCING ACTIVITIES
 
 
 
 
 
Borrowings on mortgage loans payable
—

 
71,602,000

 
43,700,000

Payments on mortgage loans payable
(21,866,000
)
 
(30,280,000
)
 
(55,429,000
)
Borrowings under the lines of credit
154,900,000

 
794,855,000

 
284,551,000

Payments under the lines of credit
(286,900,000
)
 
(594,855,000
)
 
(296,351,000
)
Proceeds from issuance of common stock
1,740,028,000

 
618,734,000

 
325,444,000

Deferred financing costs
(2,773,000
)
 
(5,079,000
)
 
(2,851,000
)
Contingent consideration related to acquisition of real estate
(4,888,000
)
 
(4,590,000
)
 
—

Return of contingent consideration related to acquisition of real estate
—

 
2,000

 
—

Repurchase of common stock
(8,938,000
)
 
(4,153,000
)
 
(1,198,000
)
Contribution from noncontrolling interest to our operating partnership
—

 
2,000

 
—

Distributions to noncontrolling interests
(126,000
)
 
(12,000
)
 
(1,000
)
Purchase of noncontrolling interest
(155,000
)
 
—

 
—

Security deposits
(1,943,000
)
 
9,000

 
(104,000
)
Payment of offering costs — common stock
(171,689,000
)
 
(66,419,000
)
 
(35,297,000
)
Payment of offering costs — limited partnership units
(89,000
)
 
(1,000
)
 
—

Distributions paid
(57,642,000
)
 
(22,972,000
)
 
(9,375,000
)
Net cash provided by financing activities
1,337,919,000

 
756,843,000

 
253,089,000


105
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS — (Continued)
For the Years Ended December 31, 2013, 2012 and 2011

 
 
 
 
 
 
 
Years Ended December 31,
 
2013
 
2012
 
2011
NET CHANGE IN CASH AND CASH EQUIVALENTS
(56,938,000
)
 
50,001,000

 
38,664,000

EFFECT OF FOREIGN CURRENCY TRANSLATION ON CASH AND CASH EQUIVALENTS
210,000

 
—

 
—

CASH AND CASH EQUIVALENTS — Beginning of period
94,683,000

 
44,682,000

 
6,018,000

CASH AND CASH EQUIVALENTS — End of period
$
37,955,000

 
$
94,683,000

 
$
44,682,000

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
 
 
 
 
 
Cash paid for:
 
 
 
 
 
Interest
$
17,332,000

 
$
11,897,000

 
$
5,199,000

Income taxes
$
283,000

 
$
42,000

 
$
—

SUPPLEMENTAL DISCLOSURE OF NONCASH ACTIVITIES:
 
 
 
 
 
Investing Activities:
 
 
 
 
 
Accrued capital expenditures
$
1,513,000

 
$
1,063,000

 
$
396,000

Accrued acquisition fees — real estate notes receivable
$
—

 
$
16,000

 
$
—

Tenant improvement overage
$
555,000

 
$
823,000

 
$
—

Receivable for sale of land
$
4,000

 
$
—

 
$
—

Settlement of real estate note receivable
$
10,882,000

 
$
—

 
$
—

The following represents the increase in certain assets and liabilities in connection with our acquisitions of operating properties:
 
 
 
 
 
Other assets
$
747,000

 
$
520,000

 
$
451,000

Mortgage loans payable, net
$
62,712,000

 
$
170,282,000

 
$
33,941,000

Accounts payable and accrued liabilities
$
4,196,000

 
$
1,384,000

 
$
315,000

Security deposits, prepaid rent and other liabilities
$
52,090,000

 
$
20,506,000

 
$
7,766,000

Financing Activities:
 
 
 
 
 
Issuance of common stock under the DRIP
$
67,905,000

 
$
22,622,000

 
$
8,817,000

Issuance of common stock for acquisitions
$
974,000

 
$
—

 
$
—

Distributions declared but not paid — common stock
$
16,744,000

 
$
6,391,000

 
$
2,639,000

Distributions declared but not paid — limited partnership units
$
16,000

 
$
—

 
$
—

Issuance of limited partnership units
$
2,271,000

 
$
406,000

 
$
—

Payable for purchase of noncontrolling interest
$
6,000

 
$
—

 
$
—

Accrued offering costs — common stock
$
32,000

 
$
277,000

 
$
527,000

Accrued offering costs — limited partnership units
$
—

 
$
64,000

 
$
—

Receivable from transfer agent
$
—

 
$
3,298,000

 
$
—

Accrued deferred financing costs
$
2,000

 
$
67,000

 
$
12,000

The accompanying notes are an integral part of these consolidated financial statements.


106

GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
For the Years Ended December 31, 2013, 2012 and 2011
The use of the words “we,” “us” or “our” refers to Griffin-American Healthcare REIT II, Inc. and its subsidiaries, including Griffin-American Healthcare REIT II Holdings, LP, except where the context otherwise requires.
1. Organization and Description of Business
Griffin-American Healthcare REIT II, Inc., a Maryland corporation, was incorporated as Grubb & Ellis Healthcare REIT II, Inc. on January 7, 2009 and therefore we consider that our date of inception. We were initially capitalized on February 4, 2009. Our board of directors adopted an amendment to our charter, which was filed with the Maryland State Department of Assessments and Taxation on January 3, 2012, to change our name from Grubb & Ellis Healthcare REIT II, Inc. to Griffin-American Healthcare REIT II, Inc. We invest in a diversified portfolio of real estate properties, focusing primarily on medical office buildings and healthcare-related facilities. We may also originate and acquire secured loans and real estate-related investments. We also operate healthcare-related facilities utilizing the structure permitted by the REIT Investment Diversification and Empowerment Act of 2007, which is commonly referred to as a "RIDEA" structure (the provisions of the Internal Revenue Code of 1986, as amended, or the Code, authorizing the RIDEA structure were enacted as part of the Housing and Economic Recovery Act of 2008). We generally seek investments that produce current income. We qualified to be taxed as a real estate investment trust, or REIT, under the Code for federal income tax purposes beginning with our taxable year ended December 31, 2010 and we intend to continue to be taxed as a REIT.
On August 24, 2009, we commenced a best efforts initial public offering, or our initial offering, of up to $3,285,000,000 of shares of our common stock. Until November 6, 2012, we offered to the public up to $3,000,000,000 of shares of our common stock for $10.00 per share in our primary offering and $285,000,000 of shares of our common stock pursuant to our distribution reinvestment plan, or the DRIP, for $9.50 per share. On November 7, 2012, we began selling shares of our common stock in our initial offering at $10.22 per share in our primary offering and issuing shares pursuant to the DRIP for $9.71 per share.
On February 14, 2013, we terminated our initial offering. As of February 14, 2013, we had received and accepted subscriptions in our initial offering for 123,179,064 shares of our common stock, or $1,233,333,000, and a total of $40,167,000 in distributions were reinvested and 4,205,920 shares of our common stock were issued pursuant to the DRIP.
On February 14, 2013, we commenced a best efforts follow-on public offering, or our follow-on offering, of up to $1,650,000,000 of shares of our common stock, in which we initially offered to the public up to $1,500,000,000 of shares of our common stock for $10.22 per share in our primary offering and $150,000,000 of shares of our common stock for $9.71 per share pursuant to the DRIP. We reserved the right to reallocate the shares of common stock we offered in our follow-on offering between the primary offering and the DRIP. As such, during our follow-on offering, we reallocated an aggregate of $107,200,000 of shares from the DRIP to the primary offering. Accordingly, we offered to the public up to $1,607,200,000 of shares of our common stock in our primary offering and up to $42,800,000 of shares of our common stock pursuant to the DRIP.
On October 30, 2013, we terminated our follow-on offering. As of December 31, 2013, we had received and accepted subscriptions in our follow-on offering for 157,622,743 shares of our common stock, or $1,604,996,000, and a total of $42,713,000 in distributions were reinvested and 4,398,862 shares of our common stock were issued pursuant to the DRIP.
On September 9, 2013, we filed a Registration Statement on Form S-3 under the Securities Act of 1933, as amended, or the Securities Act, to register a maximum of $100,000,000 of additional shares of our common stock pursuant to our distribution reinvestment plan, or the Secondary DRIP. The Registration Statement on Form S-3 was automatically effective with the Securities and Exchange Commission, or the SEC, upon its filing; however, we did not commence offering shares pursuant to the Secondary DRIP until October 30, 2013 following the termination of our follow-on offering. As of December 31, 2013, a total of $18,448,000 in distributions were reinvested and 1,899,892 shares of our common stock were issued pursuant to the Secondary DRIP.
We conduct substantially all of our operations through Griffin-American Healthcare REIT II Holdings, LP, or our operating partnership. On January 3, 2012, our operating partnership filed an Amendment to the Certificate of Limited Partnership with the Delaware Department of State to change its name from Grubb & Ellis Healthcare REIT II Holdings, LP to Griffin-American Healthcare REIT II Holdings, LP. Until January 6, 2012, we were externally advised by Grubb & Ellis Healthcare REIT II Advisor, LLC, or our former advisor, pursuant to an advisory agreement, as amended and restated, or the G&E Advisory Agreement, between us and our former advisor. From August 24, 2009 through January 6, 2012, our former advisor supervised and managed our day-to-day operations and selected the properties and real estate-related investments we

107
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)



acquired, subject to the oversight and approval of our board of directors. Our former advisor also provided marketing, sales and client services on our behalf and engaged affiliated entities to provide various services to us. Our former advisor was managed by and was a wholly owned subsidiary of Grubb & Ellis Equity Advisors, LLC, or GEEA, which was a wholly owned subsidiary of Grubb & Ellis Company, or Grubb & Ellis, or our former sponsor.
On November 7, 2011, our independent directors determined that it was in the best interests of our company and its stockholders to transition advisory and dealer manager services rendered to us by affiliates of Grubb & Ellis and to engage American Healthcare Investors LLC, or American Healthcare Investors, and Griffin Capital Corporation, or Griffin Capital, as replacement co-sponsors, or our co-sponsors. As a result, on November 7, 2011, we notified our former advisor that we terminated the G&E Advisory Agreement. Pursuant to the G&E Advisory Agreement, either party could terminate the G&E Advisory Agreement without cause or penalty; however, certain rights and obligations of the parties would survive during a 60-day transition period and beyond.
In addition, on November 7, 2011, we notified Grubb & Ellis Capital Corporation, our former dealer manager, that we terminated the Amended and Restated Dealer Manager Agreement dated June 1, 2011 between us and Grubb & Ellis Capital Corporation, or the G&E Dealer Manager Agreement, in accordance with the terms thereof. Until January 6, 2012, Grubb & Ellis Capital Corporation remained a non-exclusive agent of our company and distributor of shares of our common stock.
As a result of the co-sponsorship arrangement, an affiliate of Griffin Capital, Griffin-American Healthcare REIT Advisor, LLC, or Griffin-American Advisor, or our advisor, began serving as our advisor on January 7, 2012 pursuant to an advisory agreement, or the Advisory Agreement, that took effect upon the expiration of the 60-day transition period provided for in the G&E Advisory Agreement. The Advisory Agreement had an initial one-year term, but was subject to successive one year renewals upon mutual consent of the parties. On January 6, 2014, the Advisory Agreement was renewed pursuant to the mutual consent of the parties for a term of six months and expires on July 6, 2014. Our advisor delegates advisory duties to Griffin-American Healthcare REIT Sub-Advisor, LLC, or Griffin-American Sub-Advisor, or our sub-advisor. Griffin-American Sub-Advisor is jointly owned by our co-sponsors. Our advisor, through our sub-advisor, uses its best efforts, subject to the oversight, review and approval of our board of directors, to, among other things, research, identify, review and make investments in and dispositions of properties, real estate-related investments and securities on our behalf consistent with our investment policies and objectives. Our advisor performs its duties and responsibilities under the Advisory Agreement as our fiduciary. Our sub-advisor performs its duties and responsibilities pursuant to a sub-advisory agreement with our advisor and also acts as our fiduciary. Collectively, we refer to our advisor and our sub-advisor as our advisor entities. Griffin Capital Securities, Inc., or Griffin Securities, or our dealer manager, an affiliate of Griffin Capital, serves as our dealer manager pursuant to a dealer manager agreement, or the Dealer Manager Agreement, that also became effective on January 7, 2012. We are not affiliated with Griffin Capital, Griffin-American Advisor or Griffin Securities; however, we are affiliated with Griffin-American Sub-Advisor and American Healthcare Investors.
American Healthcare Investors and Griffin Capital paid the majority of the expenses we incurred in connection with the transition to our co-sponsors.
We currently operate through five reportable business segments — medical office buildings, hospitals, skilled nursing facilities, senior housing and senior housing–RIDEA. As of December 31, 2013, we had completed 72 acquisitions comprising 279 buildings and approximately 10,565,000 square feet of gross leasable area, or GLA, for an aggregate purchase price of $2,785,711,000.
2. Summary of Significant Accounting Policies
The summary of significant accounting policies presented below is designed to assist in understanding our consolidated financial statements. Such consolidated financial statements and the accompanying notes thereto are the representations of our management, who are responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America, or GAAP, in all material respects, and have been consistently applied in preparing our accompanying consolidated financial statements.
Basis of Presentation

Our accompanying consolidated financial statements include our accounts and those of our operating partnership, the wholly owned subsidiaries of our operating partnership and all non-wholly owned subsidiaries and any variable interest entities, or VIEs, as defined in Financial Accounting Standards Boards, or FASB, Accounting Standards Codification, or ASC, Topic 810, Consolidation, or ASC Topic 810, which we have concluded should be consolidated pursuant to ASC Topic 810.

108
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)



We operate and intend to continue to operate in an umbrella partnership REIT structure in which our operating partnership, or wholly owned subsidiaries of our operating partnership, will own substantially all of the properties acquired on our behalf. We are the sole general partner of our operating partnership and as of December 31, 2013 and 2012, we owned greater than a 99.90% and 99.96%, respectively, general partnership interest therein. On January 4, 2012, our advisor contributed $2,000 to acquire 200 limited partnership units of our operating partnership and as such, as of December 31, 2013 and 2012, owns less than a 0.01% noncontrolling limited partnership interest in our operating partnership. Until September 14, 2012, our former advisor was a limited partner of our operating partnership and as of December 31, 2011, owned less than a 0.01% noncontrolling limited partnership interest in our operating partnership. On September 14, 2012, we entered into an agreement whereby we purchased all of the limited partnership interests held by our former advisor in our operating partnership. Between December 31, 2012 and July 16, 2013, 12 investors contributed their interests in 15 buildings in exchange for 281,600 limited partnership units in our operating partnership. As of December 31, 2013 and 2012, these investors collectively owned less than a 0.10% and 0.04%, respectively, noncontrolling limited partnership interest in our operating partnership. Because we are the sole general partner and a limited partner of our operating partnership and have unilateral control over its management and major operating decisions, the accounts of our operating partnership are consolidated in our consolidated financial statements. All significant intercompany accounts and transactions are eliminated in consolidation.
In preparing our accompanying consolidated financial statements, management has evaluated subsequent events through the financial statement issuance date. We believe that the disclosures contained herein are adequate to prevent the information presented from being misleading.
Use of Estimates
The preparation of our consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. These estimates are made and evaluated on an on-going basis using information that is currently available as well as various other assumptions believed to be reasonable under the circumstances. Actual results could differ from those estimates, perhaps in material adverse ways, and those estimates could be different under different assumptions or conditions.
Cash and Cash Equivalents
Cash and cash equivalents consist of all highly liquid investments with a maturity of three months or less when purchased.
Restricted Cash
Restricted cash is primarily comprised of lender required accounts for tenant improvements, capital improvements, property taxes and insurance, which are restricted as to use or withdrawal.
Revenue Recognition, Tenant Receivables and Allowance for Uncollectible Accounts
We recognize revenue in accordance with ASC Topic 605, Revenue Recognition, or ASC Topic 605. ASC Topic 605 requires that all four of the following basic criteria be met before revenue is realized or realizable and earned: (1) there is persuasive evidence that an arrangement exists; (2) delivery has occurred or services have been rendered; (3) the seller’s price to the buyer is fixed and determinable; and (4) collectability is reasonably assured.
In accordance with ASC Topic 840, Leases, minimum annual rental revenue is recognized on a straight-line basis over the term of the related lease (including rent holidays). Differences between real estate revenue recognized and cash amounts contractually due from tenants under the lease agreements are recorded to deferred rent receivable or deferred rent liability, as applicable. Tenant reimbursement revenue, which is comprised of additional amounts recoverable from tenants for common area maintenance expenses and certain other recoverable expenses, is recognized as revenue in the period in which the related expenses are incurred. Tenant reimbursements are recognized and presented in accordance with ASC Subtopic 605-45, Revenue Recognition — Principal Agent Consideration, or ASC Subtopic 605-45. ASC Subtopic 605-45 requires that these reimbursements be recorded on a gross basis, as we are generally the primary obligor with respect to purchasing goods and services from third-party suppliers, have discretion in selecting the supplier and have credit risk. We recognize lease termination fees at such time when there is a signed termination letter agreement, all of the conditions of such agreement have been met and the tenant is no longer occupying the property. Resident fees and services revenue is recorded when services are rendered and includes resident room and care charges, community fees and other resident charges.

109
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)



Tenant receivables and unbilled deferred rent receivables are carried net of an allowance for uncollectible amounts. An allowance is maintained for estimated losses resulting from the inability of certain tenants to meet the contractual obligations under their lease agreements. We maintain an allowance for deferred rent receivables arising from the straight line recognition of rents. Such allowance is charged to bad debt expense which is included in general and administrative in our accompanying consolidated statements of operations and comprehensive income (loss). Our determination of the adequacy of these allowances is based primarily upon evaluations of historical loss experience, the tenant's financial condition, security deposits, letters of credit, lease guarantees and current economic conditions and other relevant factors.
As of December 31, 2013, 2012 and 2011, we had $323,000, $78,000 and $112,000, respectively, in allowance for uncollectible accounts which was determined necessary to reduce receivables to our estimate of the amount recoverable. For the years ended December 31, 2013, 2012 and 2011, $55,000, $0 and $0, respectively, net, of our receivables were directly written off to bad debt expense. For the years ended 2013, 2012 and 2011, $25,000, $92,000 and $0, respectively, of our receivables were written off against the allowance for uncollectible accounts. As of December 31, 2013, 2012 and 2011, we did not have an allowance for uncollectible accounts for deferred rent receivables. For the years ended December 31, 2013, 2012 and 2011, $857,000, $24,000 and $154,000, respectively, of our deferred rent receivables were directly written off to bad debt expense.
Real Estate Investments, Net
We carry our operating properties at historical cost less accumulated depreciation. The cost of operating properties includes the cost of land and completed buildings and related improvements. Expenditures that increase the service life of properties are capitalized and the cost of maintenance and repairs is charged to expense as incurred. The cost of buildings and capital improvements is depreciated on a straight-line basis over the estimated useful lives of the buildings and capital improvements, up to 39 years, and the cost for tenant improvements is depreciated over the shorter of the lease term or useful life, ranging from two months to 22.5 years. Furniture, fixtures and equipment is depreciated over the estimated useful life, ranging from five years to 10 years. When depreciable property is retired, replaced or disposed of, the related costs and accumulated depreciation will be removed from the accounts and any gain or loss will be reflected in earnings.
As part of the leasing process, we may provide the lessee with an allowance for the construction of leasehold improvements. These leasehold improvements are capitalized and recorded as tenant improvements and depreciated over the shorter of the useful life of the improvements or the lease term. If the allowance represents a payment for a purpose other than funding leasehold improvements, or in the event we are not considered the owner of the improvements, the allowance is considered to be a lease inducement and is recognized over the lease term as a reduction of rental revenue on a straight-line basis. Factors considered during this evaluation include, among other things, who holds legal title to the improvements as well as other controlling rights provided by the lease agreement and provisions for substantiation of such costs (e.g. unilateral control of the tenant space during the build-out process). Determination of the appropriate accounting for the payment of a tenant allowance is made on a lease-by-lease basis, considering the facts and circumstances of the individual tenant lease. Recognition of lease revenue commences when the lessee is given possession of the leased space upon completion of tenant improvements when we are the owner of the leasehold improvements. However, when the leasehold improvements are owned by the tenant, the lease inception date (and the date on which recognition of lease revenue commences) is the date the tenant obtains possession of the leased space for purposes of constructing its leasehold improvements.

We assess the impairment of an operating property when events or changes in circumstances indicate that its carrying amount may not be recoverable. Impairment losses are recorded on an operating property when indicators of impairment are present and the carrying amount exceeds the sum of the future undiscounted cash flows expected to result from the use and eventual disposition of the property. We would recognize an impairment loss to the extent the carrying amount exceeded the estimated fair value of the property. For the years ended December 31, 2013, 2012 and 2011, there were no impairment losses recorded.
Property Acquisitions

In accordance with ASC Topic 805, Business Combinations, or ASC Topic 805, we determine whether a transaction is a business combination, which requires that the assets acquired and liabilities assumed constitute a business. If the assets acquired are not a business, we account for the transaction as an asset acquisition. Under both methods, we recognize the identifiable assets acquired and liabilities assumed. In addition, for transactions that are business combinations, we evaluate the existence of intangible assets and liabilities. We immediately expense acquisition related expenses associated with business combinations and capitalize acquisition related expenses associated with an asset acquisition.
 

110
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)



We, with assistance from independent valuation specialists, measure the fair value of tangible and identified intangible assets and liabilities, as applicable, based on their respective fair values for acquired properties. The determination of the fair value of land is based upon comparable sales data. In cases where a leasehold interest in the land is acquired, the value of the leasehold interest is determined by discounting the difference between the contract ground lease payments and a market ground lease payment back to a present value as of the acquisition date. The market ground lease payment is estimated as a percentage of the land value. The fair value of buildings is based upon our determination of the value as if it were to be replaced and vacant using cost data and discounted cash flow models similar to those used by independent appraisers. We would also recognize the fair value of furniture, fixtures and equipment on the premises, if any, as well as the above or below market rent, the value of in-place leases, the value of in-place lease costs, tenant relationships, master leases and above or below market debt and derivative financial instruments assumed. Factors considered by us include an estimate of carrying costs during the expected lease-up periods considering current market conditions and costs to execute similar leases.

The value of the above or below market component of the acquired in-place leases is determined based upon the present value (using a discount rate which reflects the risks associated with the acquired leases) of the difference (if greater than 10.0%) between the level payment equivalent of the contract rent paid pursuant to the lease, and our estimate of market rent payments taking into account rent steps throughout the lease. In the case of leases with options, unless an option rent is more than 5.0% below market rent, it is not assumed to be exercised. The amounts related to above market leases are included in identified intangible assets, net in our accompanying consolidated balance sheets and are amortized against real estate revenue over the remaining non-cancelable lease term of the acquired leases with each property. The amounts related to below market leases are included in identified intangible liabilities, net in our accompanying consolidated balance sheets and are amortized to real estate revenue over the remaining non-cancelable lease term plus any below market renewal options of the acquired leases with each property.

The value of in-place lease costs and the value of tenant relationships is based on management's evaluation of the specific characteristics of the tenant's lease and our overall relationship with the tenants. Characteristics considered by us in allocating these values include the nature and extent of the credit quality and expectations of lease renewals, among other factors. The amounts related to in-place lease costs are included in identified intangible assets, net in our accompanying consolidated balance sheets and are amortized to depreciation and amortization expense over the average remaining non-cancelable lease term of the acquired leases with each property. The amounts related to the value of tenant relationships are included in identified intangible assets, net in our accompanying consolidated balance sheets and are amortized to depreciation and amortization expense over the average remaining non-cancelable lease term of the acquired leases plus the market renewal lease term. The value of a master lease, in which a previous owner or a tenant is relieved of specific rental obligations as additional space is leased, is determined by discounting the expected real estate revenue associated with the master lease space over the assumed lease-up period.

The value of above or below market debt is determined based upon the present value of the difference between the cash flow stream of the assumed mortgage and the cash flow stream of a market rate mortgage at the time of assumption. The value of above or below market debt is included in mortgage loans payable, net in our accompanying consolidated balance sheets and is amortized to interest expense over the remaining term of the assumed mortgage.

The value of derivative financial instruments is determined in accordance with ASC Topic 820, Fair Value Measurements and Disclosures, or ASC Topic 820, and is included in derivative financial instruments in our accompanying consolidated balance sheets. See Note 14, Fair Value Measurements, for a further discussion.

The values of contingent consideration assets and liabilities are analyzed at the time of acquisition. For contingent purchase options, the fair market value of the asset is compared to the specified option price at the exercise date. If the option price is below market, it is assumed to be exercised and the difference between the fair market value and the option price is discounted to the present value at the time of acquisition.

The fair values are subject to change based on information received within one year of the purchase related to one or more events identified at the time of purchase which confirm the value of an asset or liability received in an acquisition of property.



111
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)



Real Estate Notes Receivable, Net
Real estate notes receivable, net consists of mortgage loans collateralized by interests in real property. Interest income on our real estate notes receivable are recognized on an accrual basis over the life of the investment using the interest method. Direct loan origination fees and costs are amortized over the term of the loan as an adjustment to the yield on the loan. We record loans at cost. We evaluate the collectability of both interest and principal for each of our loans to determine whether they are impaired. A loan is considered impaired when, based on current information and events, it is probable that we will be unable to collect all amounts due according to the existing contractual terms. When a loan is considered to be impaired, the amount of the allowance is calculated by comparing the recorded investment to either the value determined by discounting the expected future cash flows using the loan's effective interest rate or to the fair value of the collateral if the loan is collateral dependent.
Derivative Financial Instruments
We are exposed to the effect of interest rate changes and foreign currency fluctuations in the normal course of business. We seek to mitigate these risks by following established risk management policies and procedures which include the occasional use of derivatives. Our primary strategy in entering into derivative contracts, such as fixed interest rate swaps, is to add stability to interest expense and to manage our exposure to interest rate movements by effectively converting a portion of our variable rate debt to fixed rate debt. We also use derivative instruments, such as foreign currency forward contracts, to mitigate the effects of the foreign currency fluctuations on future cash flows. We do not enter into derivative instruments for speculative purposes.
Derivatives are recognized as either assets or liabilities in our accompanying consolidated balance sheets and are measured at fair value in accordance with ASC Topic 815, Derivatives and Hedging, or ASC Topic 815. ASC Topic 815 establishes accounting and reporting standards for derivative instruments, including certain derivative instruments embedded in other contracts, and for hedging activities. Since our derivative instruments are not designated as hedge instruments, they do not qualify for hedge accounting under ASC Topic 815. Changes in the fair value of interest rate derivative financial instruments are recorded as a component of interest expense in gain (loss) in fair value of derivative financial instruments in our accompanying consolidated statements of operations and comprehensive income (loss). Changes in the fair value of foreign currency derivative financial instruments are recorded in foreign currency and derivative loss in our accompanying consolidated statements of operations and comprehensive income (loss).
See Note 8, Derivative Financial Instruments and Note 14, Fair Value Measurements, for a further discussion of our derivative financial instruments.
Fair Value Measurements
We follow ASC Topic 820 to account for the fair value of certain assets and liabilities. ASC Topic 820 defines fair value, establishes a framework for measuring fair value and expands disclosures about fair value measurements. ASC Topic 820 applies to reported balances that are required or permitted to be measured at fair value under existing accounting pronouncements; accordingly, the standard does not require any new fair value measurements of reported balances.
ASC Topic 820 emphasizes that fair value is a market-based measurement, not an entity-specific measurement. Therefore, a fair value measurement should be determined based on the assumptions that market participants would use in pricing the asset or liability. As a basis for considering market participant assumptions in fair value measurements, ASC Topic 820 establishes a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs that are classified within Levels 1 and 2 of the hierarchy) and the reporting entity’s own assumptions about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy).
Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that we have the ability to access. An active market is defined as a market in which transactions for the assets or liabilities occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2 inputs are inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs may include quoted prices for similar assets and liabilities in active markets, as well as inputs that are observable for the asset or liability (other than quoted prices), such as interest rates, foreign exchange rates and yield curves that are observable at commonly quoted intervals. Level 3 inputs are unobservable inputs for the asset or liability which are typically based on an entity’s own assumptions, as there is little, if any, related market activity. In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety. Our assessment of the

112
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)



significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability.
See Note 14, Fair Value Measurements, for a further discussion.
Real Estate and Escrow Deposits
Real estate and escrow deposits include funds held by escrow agents and others to be applied towards the purchase of real estate.
Other Assets, Net
Other assets consist primarily of deferred rent receivables, deferred financing costs, prepaid expenses and deposits and leasing commissions. Deferred financing costs include amounts paid to lenders and others to obtain financing. Such costs are amortized using the straight-line method over the term of the related loan, which approximates the effective interest rate method. Amortization of deferred financing costs is included in interest expense in our accompanying consolidated statements of operations and comprehensive income (loss). Leasing commissions are amortized using the straight-line method over the term of the related lease. Amortization of leasing commissions is included in depreciation and amortization in our accompanying consolidated statements of operations and comprehensive income (loss).
See Note 6, Other Assets, Net, for a further discussion.
Contingent Consideration

As of December 31, 2013 and 2012, included in security deposits, prepaid rent and other liabilities in our accompanying consolidated balance sheets is $4,675,000 and $60,204,000, respectively, of contingent consideration obligations in connection with our property acquisitions. Such amounts are due upon certain criteria being met within specified timeframes. For the years ended December 31, 2013, 2012 and 2011, we recorded a net loss on the change in fair value of contingent consideration obligations of $134,000, $50,250,000, and $0, respectively, which is included in acquisition related expenses in our accompanying consolidated statements of operations and comprehensive income (loss). See Note 14, Fair Value Measurements — Assets and Liabilities Reported at Fair Value — Contingent Consideration, for a further discussion.

Subordinated Distribution Purchase

On September 14, 2012, we and our operating partnership entered into an agreement, or the settlement agreement, with BGC Partners, Inc., or BGC Partners, which held 200 units of limited partnership interest in our operating partnership and would have been entitled to any subordinated distribution that would have been owed to our former advisor and its affiliates, including our former sponsor. Pursuant to the settlement agreement, BGC Partners transferred certain assets to us, including the 200 units of limited partnership interest held in our operating partnership and any rights to the payment of any subordinated distribution for consideration of $4,300,000. Notwithstanding these transfers to us, in the event of a listing event or other liquidity event, as both terms are defined in the partnership agreement for our operating partnership, or the operating partnership agreement, we will calculate a hypothetical deferred termination amount (as defined in the operating partnership agreement and based on assets acquired by us on or before January 10, 2012) for the payment of the subordinated distribution that would have been owed to our former advisor and its affiliates, including our former sponsor. If such calculation results in an amount that is greater than the $4,300,000 paid by us, then we will pay BGC Partners an amount equal to 10.0% of the difference between such calculation and the $4,300,000 paid by us. In connection with the settlement agreement, BGC Partners has agreed to release all known and unknown claims that they may have had against us and our operating partnership.

Of the $4,300,000 paid by us, $4,232,000 is reflected in subordinated distribution purchase in our accompanying consolidated statements of operations and comprehensive income (loss) for the year ended December 31, 2012 and $68,000 is in satisfaction of all remaining payments owed by us to our former advisor and its affiliates, including our former sponsor, under the G&E Advisory Agreement.
Stock Compensation
We follow ASC Topic 718, Compensation – Stock Compensation, or ASC Topic 718, to account for our stock compensation pursuant to the 2009 Incentive Plan, or our incentive plan. See Note 13, Equity — 2009 Incentive Plan, for a further discussion of grants under our incentive plan.

113
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)



Foreign Currency
We have real estate investments in the United Kingdom for which the functional currency is the United Kingdom Pound Sterling, or GBP. We translate the results of operations of our foreign real estate investments into U.S. Dollars, or USD, using the average rates of currency exchange in effect during the period, and we translate assets and liabilities using the currency exchange rate in effect at the end of the period. The resulting foreign currency translation adjustments are included in accumulated other comprehensive income, or AOCI, a component of stockholders' equity in our accompanying consolidated balance sheets.
Gains or losses resulting from foreign currency transactions are remeasured into USD at the rates of currency exchange prevailing on the date of the transactions. The effects of transaction gains/losses are generally included in foreign currency and derivative loss in our accompanying consolidated statements of operations and comprehensive income (loss). In addition to the unrealized loss we recorded on our foreign currency forward contract, we recorded $5,177,000 for the year ended December 31, 2013, in foreign currency transaction gains. See Note 8, Derivative Financial Instruments — Foreign Currency Forward Contract, for a further discussion of our foreign currency forward contract.
Income Taxes
We qualified and elected to be taxed as a REIT under the Code beginning with our taxable year ended December 31, 2010. To maintain our qualification as a REIT, we must meet certain organizational and operational requirements, including a requirement to currently distribute at least 90.0% of our annual taxable income, excluding net capital gains, to stockholders. As a REIT, we generally will not be subject to federal income tax on taxable income that we distribute to our stockholders.
If we fail to maintain our qualification as a REIT in any taxable year, we will then be subject to federal income taxes on our taxable income at regular corporate rates and will not be permitted to qualify for treatment as a REIT for federal income tax purposes for four years following the year during which qualification is lost unless the Internal Revenue Service, or the IRS, grants us relief under certain statutory provisions. Such an event could materially adversely affect our net income and net cash available for distribution to stockholders.
We follow ASC Topic 740, Income Taxes, to recognize, measure, present and disclose in our consolidated financial statements uncertain tax positions that we have taken or expect to take on a tax return. We recognize tax benefits of uncertain income tax positions that are subject to audit only if we believe it is more likely than not that the position would be sustained (including the impact of appeals, as applicable), assuming the applicable taxing authorities had full knowledge of the relevant facts and circumstances of our positions. As of December 31, 2013 and 2012, we did not have any tax benefits and liabilities for uncertain tax positions that we believe should be recognized in our consolidated financial statements.
Temporary differences between financial statement carrying amounts of existing assets and liabilities and their respective tax bases are recorded to deferred tax liabilities, which are included in security deposits, prepaid rent and other liabilities in our accompanying consolidated balance sheets. We measure deferred tax liabilities using the enacted tax rates expected to apply to taxable income in the periods in which the deductible or taxable temporary difference is expected to be realized or settled. The deferred tax liability is remeasured at each reporting period until it is fully recognized and any change in liability is recorded in income tax benefit (expense) in our accompanying consolidated statements of operations and comprehensive income (loss) in the period of change.
We may be subject to certain state and local income taxes on our income, property or net worth in some jurisdictions, and in certain circumstances we may also be subject to federal excise taxes on undistributed income. In addition, certain activities that we undertake are conducted by subsidiaries which we elected to be treated as taxable REIT subsidiaries, or TRSs, to allow us to provide services that would otherwise be considered impermissible for REITs. Also, we have real estate investments in the United Kingdom, which does not recognize REITs and does not accord REIT status under its tax laws. Accordingly, we recognize income tax benefit (expense) for the federal, state and local income taxes incurred by our TRSs and foreign income taxes for our real estate investments in the United Kingdom.
See Note 15, Income Taxes and Distributions, for a further discussion.
Segment Disclosure
ASC Topic 280, Segment Reporting, establishes standards for reporting financial and descriptive information about a public entity's reportable segments. As of December 31, 2013, we operated through five reportable business segments — medical office buildings, hospitals, skilled nursing facilities, senior housing and senior housing–RIDEA. Prior to December

114
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)



2013, we operated through four reportable segments; however, with the acquisition of our first senior housing facilities owned and operated utilizing a RIDEA structure in December 2013, we felt it useful to segregate our operations into five reporting segments to assess the performance of our business in the same way that management intends to review our performance and make operating decisions. Prior to June 2013, our senior housing segment was referred to as our assisted living facilities segment. Prior to August 2012, we operated through three reportable business segments; however, with the addition of our first senior housing facilities in August 2012, we felt it was useful to segregate our operations into four reporting segments to assess the performance of our business in the same way that management intended to review our performance and make operating decisions.
See Note 18, Segment Reporting, for a further discussion.
Square Feet of GLA and Other Measures
Square feet of GLA and other measures used to describe real estate investments included in our accompanying consolidated financial statements are presented on an unaudited basis.
Reclassifications
Contingent consideration related to acquisition of real estate for the year ended December 31, 2012 has been reclassified on our accompanying consolidated statements of cash flows to conform to the current year presentation. This reclassification has no effect on cash flows provided by operating activities.
Recently Issued Accounting Pronouncements
In February 2013, the FASB issued Accounting Standards Update, or ASU, 2013-02, Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income, or ASU 2013-02, to improve the transparency of amounts reclassified out of AOCI. The additional disclosure requirements in ASU 2013-02 include: (1) changes in AOCI balances by component and (2) presentation of significant amounts reclassified out of AOCI to net income (loss) by the specific line item of net income (loss)affected. For public entities, ASU 2013-02 is effective prospectively for interim and annual reporting periods beginning after December 15, 2012. We adopted ASU 2013-02 on January 1, 2013, which did not have a material impact on our consolidated financial statements.
3. Real Estate Investments, Net
Our real estate investments, net consisted of the following as of December 31, 2013 and 2012:
 
December 31,
 
2013
 
2012
Building and improvements
$
2,189,345,000

 
$
1,039,461,000

Land
414,179,000

 
106,735,000

Furniture, fixtures and equipment
6,410,000

 
2,669,000

 
2,609,934,000

 
1,148,865,000

Less: accumulated depreciation
(86,235,000
)
 
(36,570,000
)
 
$
2,523,699,000

 
$
1,112,295,000

Depreciation expense for the years ended December 31, 2013, 2012 and 2011 was $50,178,000, $25,125,000 and $9,919,000 respectively. In addition to the acquisitions discussed below, for the years ended December 31, 2013, 2012 and 2011, we had capital expenditures of $6,455,000, $4,208,000 and $3,148,000, respectively, on our medical office buildings, $68,000, $904,000 and $0, respectively, on our skilled nursing facilities, $0, $91,000 and $300,000, respectively, on our hospitals, and $3,000, $0 and $0, respectively, on our senior housing facilities. We did not have any capital expenditures on our senior housing–RIDEA facilities for the years ended December 31, 2013, 2012 and 2011. In addition, subsequent to the initial purchase of Dixie-Lobo Medical Office Building Portfolio, on May 2, 2013, we purchased the land under the building in Hope, Arkansas for a purchase price of $50,000 plus closing costs and acquisition fees, for which we previously owned a leasehold interest.
Until January 6, 2012, we reimbursed our former advisor or its affiliates and since January 7, 2012, we reimburse our advisor entities or their affiliates for acquisition expenses related to selecting, evaluating, acquiring and investing in properties.

115
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)



The reimbursement of acquisition expenses, acquisition fees and real estate commissions and other fees paid to unaffiliated parties will not exceed, in the aggregate, 6.0% of the contract purchase price or total development costs, unless fees in excess of such limits are approved by a majority of our directors, including a majority of our independent directors. As of December 31, 2013, such fees and expenses did not exceed 6.0% of the contract purchase price of our acquisitions, except with respect to our acquisition of land in the Dixie-Lobo Medical Office Building Portfolio noted above, and except with respect to our acquisition of Lakewood Ranch Medical Office Building, or the Lakewood Ranch property, and Philadelphia SNF Portfolio, both of which we acquired in 2011. Pursuant to our charter, prior to the acquisition of the land in the Dixie-Lobo Medical Office Building Portfolio, the Lakewood Ranch property and Philadelphia SNF Portfolio, our directors, including a majority of our independent directors, not otherwise interested in the transaction, approved the fees and expenses associated with the acquisitions in excess of the 6.0% limit and determined that such fees and expenses were commercially competitive, fair and reasonable to us. For a further discussion, see footnote (6) and footnote (7) to the table below under — Acquisitions in 2011.

Acquisitions in 2013
For the year ended December 31, 2013, we completed 23 property acquisitions comprising 136 buildings from unaffiliated parties. The aggregate purchase price of these properties was $1,461,065,000 and we incurred $37,771,000 to our advisor entities and their affiliates in acquisition fees in connection with these property acquisitions. The following is a summary of our property acquisitions for the year ended December 31, 2013:
Acquisition(1)
 
Location
 
Type
 
Date Acquired
 
Purchase
Price
 
Mortgage  Loans
Payable(2)
 
Line of
Credit(3)
 
Issuance of Limited Partnership Units(4)
 
Acquisition Fee(5)
 
A & R Medical Office Building Portfolio
 
Ruston, LA and Abilene, TX
 
Medical Office
 
02/20/13
 
$
31,750,000

 
$
—

 
$
29,000,000

 
$
—

 
$
826,000

 
Greeley Northern Colorado MOB Portfolio
 
Greeley, CO
 
Medical Office
 
02/28/13
 
15,050,000

 
—

 
15,000,000

 
—

 
391,000

 
St. Anthony North Denver MOB II
 
Westminster, CO
 
Medical Office
 
03/22/13
 
4,100,000

 
—

 
—

 
—

 
107,000

 
Eagles Landing GA MOB
 
Stockbridge, GA
 
Medical Office
 
03/28/13
 
12,400,000

 
—

 
12,300,000

 
—

 
322,000

 
Eastern Michigan MOB Portfolio
 
Novi and West Bloomfield, MI
 
Medical Office
 
03/28/13
 
21,600,000

 
—

 
21,600,000

 
—

 
562,000

 
Central Indiana MOB Portfolio(6)
 
Avon, Bloomington, Carmel, Fishers, Indianapolis, Muncie and Noblesville, IN
 
Medical Office
 
03/28/13,
 04/26/13
 and
 05/20/13
 
88,750,000

 
59,343,000

 
—

 
2,012,000

 
2,308,000

 
Pennsylvania SNF Portfolio
 
Milton and Watsontown, PA
 
Skilled Nursing
 
04/30/13
 
13,000,000

 
—

 
9,000,000

 
—

 
338,000

 
Rockwall MOB II
 
Rockwall, TX
 
Medical Office
 
05/23/13
 
5,400,000

 
—

 
—

 
—

 
140,000

 
Pittsfield Skilled Nursing Facility
 
Pittsfield, MA
 
Skilled Nursing
 
05/29/13
 
15,750,000

 
—

 
—

 
—

 
410,000

 
Des Plaines Surgical Center
 
Des Plaines, IL
 
Medical Office
 
05/31/13
 
10,050,000

 
—

 
—

 
—

 
261,000

 
Pacific Northwest Senior Care Portfolio(7)
 
Grants Pass, OR
 
Skilled Nursing
 
05/31/13
 
6,573,000

 
—

 
—

 
—

 
171,000

 
Winn MOB Portfolio
 
Decatur, GA
 
Medical Office
 
06/03/13
 
9,850,000

 
—

 
—

 
—

 
256,000

 
Hinsdale MOB Portfolio
 
Hinsdale, IL
 
Medical Office
 
07/11/13
 
35,500,000

 
—

 
—

 
—

 
923,000

 
Johns Creek Medical Office Building
 
Johns Creek, CA
 
Medical Office
 
08/26/13
 
20,100,000

 
—

 
—

 
—

 
523,000

 
Winn MOB II
 
Decatur, GA
 
Medical Office
 
08/27/13
 
2,800,000

 
—

 
—

 
—

 
73,000

 
Greeley Cottonwood MOB
 
Greeley, CO
 
Medical Office
 
09/06/13
 
7,450,000

 
—

 
—

 
—

 
194,000

 

116
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)



Acquisition(1)
 
Location
 
Type
 
Date Acquired
 
Purchase
Price
 
Mortgage  Loans
Payable(2)
 
Line of
Credit(3)
 
Issuance of Limited Partnership Units(4)
 
Acquisition Fee(5)
 
UK Senior Housing Portfolio(8)
 
England, Scotland and Jersey, UK
 
Senior Housing
 
09/11/13
 
$
472,167,000

 
$
—

 
$
—

 
$
—

 
12,276,000

 
Tiger Eye NY MOB Portfolio
 
Middletown, Rock Hill and Wallkill, NY
 
Medical Office
 
09/20/13
and
12/23/13
 
141,000,000

 
—

 
26,250,000

 
—

 
3,666,000

 
Salt Lake City LTACH
 
Murray, UT
 
Hospital
 
09/25/13
 
13,700,000

 
—

 
—

 
—

 
138,000

(9)
Lacombe MOB II
 
Lacombe, LA
 
Medical Office
 
09/27/13
 
5,500,000

 
—

 
—

 
—

 
143,000

 
Tennessee MOB Portfolio
 
Memphis and Hendersonville, TN
 
Medical Office
 
10/02/13
 
13,600,000

 
—

 
—

 
—

 
354,000

 
Central Indiana MOB Portfolio II
 
Greenfield and Indianapolis, IN
 
Medical Office
 
12/12/13
 
9,400,000

 
—

 
—

 
—

 
244,000

 
Kennestone East MOB Portfolio
 
Marietta, GA
 
Medical Office
 
12/13/13
 
13,775,000

 
—

 
—

 
—

 
358,000

 
Dux MOB Portfolio
 
Brownsburg, Evansville, Indianapolis, Lafayette, Munster, and St. John, IN; Escanaba, MI; Batavia, OH; and San Antonio, TX
 
Medical Office
 
12/19/13
and
12/20/13
 
181,800,000

 
—

 
—

 
—

 
4,727,000

 
Midwest CCRC Portfolio
 
Cincinnati, OH; Colorado Springs, CO; and Lincolnwood, IL
 
Senior Housing–RIDEA
 
12/20/13
 
310,000,000

 
—

 
32,000,000

 
—

 
8,060,000

 
Total
 
 
 
 
 
 
 
$
1,461,065,000

 
$
59,343,000

 
$
145,150,000

 
$
2,012,000

 
$
37,771,000

 
___________
(1)
We own 100% of our properties acquired in 2013.

(2)
Represents the balance of the mortgage loans payable assumed by us at the time of acquisition.

(3)
Represents borrowings under the unsecured revolving line of credit, as defined in Note 9, Line of Credit, at the time of acquisition. We periodically advance funds and pay down the unsecured revolving line of credit as needed. See Note 9, Line of Credit, for a further discussion.

(4)
Represents the value of our operating partnership's units issued as part of the consideration paid to acquire the property.

(5)
Unless otherwise noted, our advisor entities and their affiliates were paid, as compensation for services rendered in connection with the investigation, selection and acquisition of our properties, an acquisition fee of 2.60% of the contract purchase price which was paid as follows: (i) in shares of our common stock in an amount equal to 0.15% of the contract purchase price, at $9.20 per share, the then most recent price paid to acquire a share of our common stock in our initial offering or our follow-on offering, or our offerings, net of selling commissions and dealer manager fees, and (ii) the remainder in cash equal to 2.45% of the contract purchase price.

(6)
On March 28, 2013, April 26, 2013 and May 20, 2013, we added a total of 12 additional buildings to our existing Central Indiana MOB Portfolio. The other five buildings were purchased in 2012.

(7)
On May 31, 2013, we purchased the fourteenth skilled nursing facility comprising our existing Pacific Northwest Senior Care Portfolio. The other 13 facilities were purchased in 2012.

(8)
On September 11, 2013, we purchased UK Senior Housing Portfolio for a net contract purchase price of £298,500,000, or approximately $472,167,000, based on the currency exchange rate on the acquisition date.

117
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)




(9)
With respect to Salt Lake City LTACH, our advisor entities and their affiliates were paid an acquisition fee which was paid as follows: (i) in shares of our common stock in an amount equal to 0.15% of the contract purchase price, at $9.20 per share, the established offering price as of the date of closing, net of selling commissions and dealer manager fees, and (ii) in cash equal to 2.45% of the contract purchase price less $218,000 which was previously paid as an acquisition fee for the Salt Lake City Note. See Note 4, Real Estate Notes Receivable, Net, for a further discussion. The total acquisition fee paid for both the Salt Lake City Note and the purchase of Salt Lake City LTACH was 2.60% of the contract purchase price of Salt Lake City LTACH.

Acquisitions in 2012
For the year ended December 31, 2012, we completed 24 acquisitions comprising 87 buildings from unaffiliated parties. The aggregate purchase price of these properties was $885,971,000 and we incurred $23,286,000 to our former advisor and our advisor entities and their respective affiliates in acquisition fees in connection with these acquisitions. The following is a summary of our acquisitions for the year ended December 31, 2012:
Acquisition(1)
 
Location
 
Type
 
Date Acquired
 
Purchase
Price
 
Mortgage  Loans
Payable(2)
 
Lines of
Credit
 
Issuance of Limited Partnership Units(5)
 
Acquisition Fee(6)
Southeastern SNF Portfolio
 
Conyers, Covington, Snellvile, Gainsville and Atlanta, GA; Memphis and Millington, TN; Shreveport, LA; and Mobile, AL
 
Skilled Nursing
 
01/10/12
 
$
166,500,000

 
$
83,159,000

 
$
58,435,000

(3)
$
—

 
$
4,579,000

FLAGS MOB Portfolio
 
Boynton Beach, FL; Austell, GA; Okatie, SC; and Tempe, AZ
 
Medical Office
 
01/27/12
and
03/23/12
 
33,800,000

 
17,354,000

 
15,600,000

(3)
—

 
879,000

Spokane MOB
 
Spokane, WA
 
Medical Office
 
01/31/12
 
32,500,000

 
14,482,000

 
19,000,000

(3)
—

 
845,000

Centre Medical Plaza
 
Chula Vista, CA
 
Medical Office
 
04/26/12
 
24,600,000

 
11,933,000

 
6,000,000

(3)
—

 
640,000

Gulf Plains MOB Portfolio
 
Amarillo and Houston, TX
 
Medical Office
 
04/26/12
 
19,250,000

 
—

 
16,000,000

(3)
—

 
501,000

Midwestern MOB Portfolio
 
Champaign, Lemont, Naperville and Urbana, IL
 
Medical Office
 
05/22/12,
07/19/12
and
08/14/12
 
30,060,000

 
17,728,000

 
6,000,000

(3)
—

 
782,000

Texarkana MOB
 
Texarkana, TX
 
Medical Office
 
06/14/12
 
6,500,000

 
—

 
—

 
—

 
169,000

Greeley MOB
 
Greeley, CO
 
Medical Office
 
06/22/12
 
13,200,000

 
—

 
—

 
—

 
343,000

Columbia MOB
 
Columbia, SC
 
Medical Office
 
06/26/12
 
6,900,000

 
—

 
—

 
—

 
179,000

Ola Nalu MOB Portfolio
 
Huntsville, AL; New Port Richey, FL; Hilo, HI; Warsaw, IN; Las Vegas, NM; and Rockwall, San Angelo and Schertz, TX
 
Medical Office
 
06/29/12
and
07/12/12
 
71,000,000

 
—

 
64,000,000

(4)
—

 
1,846,000


118
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)



Acquisition(1)
 
Location
 
Type
 
Date Acquired
 
Purchase
Price
 
Mortgage  Loans
Payable(2)
 
Lines of
Credit
 
Issuance of Limited Partnership Units(5)
 
Acquisition Fee(6)
Silver Star MOB Portfolio
 
Killeen, Temple, Rowlett, Desoto and Frisco, TX
 
Medical Office
 
07/19/12,
09/05/12
and
09/27/12
 
$
35,400,000

 
$
—

 
$
32,750,000

(4)
$
—

 
$
920,000

Shelbyville MOB
 
Shelbyville, TN
 
Medical Office
 
07/26/12
 
6,800,000

 
—

 
6,800,000

(4)
—

 
177,000

Jasper MOB
 
Jasper, GA
 
Medical Office
 
08/08/12
and
09/27/12
 
13,800,000

 
6,275,000

 
—

 
—

 
359,000

Pacific Northwest Senior Care Portfolio
 
Bend, Corvallis, Grants Pass, Prineville, Redmond and Salem, OR; and North Bend, Olympia and Tacoma, WA
 
Skilled Nursing and Senior Housing
 
08/24/12
 
58,231,000

 
—

 
45,000,000

(4)
—

 
1,514,000

East Tennessee MOB Portfolio
 
Knoxville, TN
 
Medical Office
 
09/14/12
 
51,200,000

 
—

 
50,000,000

(4)
—

 
1,331,000

Los Angeles Hospital Portfolio
 
Los Angeles, Gardena and Norwalk, CA
 
Hospital
 
09/27/12
 
85,000,000

 
—

 
86,500,000

(4)
—

 
2,210,000

Bellaire Hospital
 
Houston, TX
 
Hospital
 
11/09/12
 
23,250,000

 
—

 
12,000,000

(4)
—

 
605,000

Massachusetts Senior Care Portfolio
 
Dalton and HydePark, MA
 
Skilled Nursing and Senior Housing
 
12/10/12
 
24,350,000

 
—

 
22,000,000

(4)
—

 
633,000

St. Petersburg Medical Office Building
 
St. Petersburg, FL
 
Medical Office
 
12/20/12
 
10,400,000

 
—

 
—

 
—

 
270,000

Bessemer Medical Office Building
 
Bessemer, AL
 
Medical Office
 
12/20/12
 
25,000,000

 
—

 
12,000,000

(4)
—

 
650,000

Santa Rosa Medical Office Building
 
Santa Rosa, CA
 
Medical Office
 
12/20/12
 
18,200,000

 
—

 
—

 
—

 
473,000

North Carolina ALF Portfolio
 
Fayetteville, Fuquay-Varina, Knightdale, Lincolnton and Monroe, NC
 
Senior Housing
 
12/21/12
 
75,000,000

 
—

 
73,000,000

(4)
—

 
1,950,000

Falls of Neuse Raleigh Medical Office Building
 
Raleigh, NC
 
Medical Office
 
12/31/12
 
21,000,000

 
—

 
—

 
—

 
546,000

Central Indiana MOB Portfolio
 
Carmel, Indianapolis and Lafayette, IN
 
Medical Office
 
12/31/12
 
34,030,000

 
5,462,000

 
—

 
406,000

 
885,000

Total
 
 
 
 
 
 
 
$
885,971,000

 
$
156,393,000

 
$
525,085,000

 
$
406,000

 
$
23,286,000

___________
(1)
We own 100% of our properties acquired in 2012.

(2)
Represents the balance of the mortgage loans payable assumed by us or newly placed on the property at the time of acquisition.

(3)
Represents borrowings under our secured revolving lines of credit with Bank of America, N.A., or Bank of America, and KeyBank National Association, or KeyBank, as defined in Note 9, Line of Credit, at the time of the respective acquisition. We periodically advanced funds and paid down our secured revolving lines of credit with Bank of America and KeyBank as needed. We currently have no amounts outstanding and terminated our secured revolving lines of credit with Bank of America and KeyBank as of June 5, 2012. See Note 9, Line of Credit, for a further discussion.

119
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)




(4)
Represents borrowings under our unsecured revolving line of credit, as defined in Note 9, Line of Credit, at the time of acquisition. We periodically advance funds and pay down our unsecured revolving line of credit as needed. See Note 9, Line of Credit, for a further discussion.

(5)
Represents the value of our operating partnership's units issued as part of the consideration paid to acquire the property.

(6)
Our former advisor or its affiliates were paid, as compensation for services rendered in connection with the investigation, selection and acquisition of our properties, an acquisition fee of 2.75% of the contract purchase price of Southeastern SNF Portfolio. Except with respect to Southeastern SNF Portfolio, our advisor entities and their affiliates were paid, as compensation for services rendered in connection with the investigation, selection and acquisition of our properties, an acquisition fee of 2.60% of the contract purchase price which was paid as follows: (i) in shares of our common stock in an amount equal to 0.15% of the contract purchase price, at $9.00 or $9.20 per share, as applicable, the then most recent price paid to acquire a share of our common stock in our initial offering, net of selling commissions and dealer manager fees, and (ii) the remainder in cash equal to 2.45% of the contract purchase price.
Acquisitions in 2011
For the year ended December 31, 2011, we completed 11 acquisitions comprising 31 buildings from unaffiliated parties. The aggregate purchase price of these properties was $245,183,000 and we paid $6,739,000 in acquisition fees to our former advisor or its affiliates in connection with these acquisitions. The following is a summary of our acquisitions for the year ended December 31, 2011:
Acquisition(1)
 
Location
 
Type
 
Date Acquired
 
Purchase
Price
 
Mortgage  Loans
Payable(2)
 
Lines of
Credit(3)
 
Acquisition Fee
to our Former  Advisor
or its Affiliates(4)
Monument Long-Term Acute Care Hospital Portfolio(5)
 
Columbia, MO
 
Hospital
 
01/31/11
 
$
12,423,000

 
$
—

 
$
11,000,000

 
$
336,000

St. Anthony North Medical Office Building
 
Westminster, CO
 
Medical Office
 
03/29/11
 
11,950,000

 
—

 
—

 
329,000

Loma Linda Pediatric Specialty Hospital
 
Loma Linda, CA
 
Skilled Nursing
 
03/31/11
 
13,000,000

 
—

 
8,700,000

 
358,000

Yuma Skilled Nursing Facility
 
Yuma, AZ
 
Skilled Nursing
 
04/13/11
 
11,000,000

 
—

 
9,000,000

 
303,000

Hardy Oak Medical Office Building
 
San Antonio, TX
 
Medical Office
 
04/14/11
 
8,070,000

 
5,253,000

 
—

 
222,000

Lakewood Ranch Medical Office Building(6)
 
Bradenton, FL
 
Medical Office
 
04/15/11
 
12,500,000

 
—

 
13,800,000

 
344,000

Dixie-Lobo Medical Office Building Portfolio
 
Alice, Lufkin,
Victoria
and Wharton,
TX; Carlsbad
and Hobbs, NM;
Hope, AR; and
Lake Charles,
LA
 
Medical Office
 
05/12/11
 
30,050,000

 
23,239,000

 
5,000,000

 
826,000

Milestone Medical Office Building Portfolio
 
Jersey City, NJ
and Bryant and
Benton, AR
 
Medical Office
 
05/26/11
 
44,050,000

 
5,000,000

 
31,115,000

 
1,211,000

Philadelphia SNF Portfolio(7)
 
Philadelphia, PA
 
Skilled Nursing
 
06/30/11
 
75,000,000

 
—

 
74,870,000

 
2,063,000

Maxfield Medical Office Building
 
Sarasota, FL
 
Medical Office
 
07/11/11
 
7,200,000

 
5,119,000

 
—

 
198,000

Lafayette Physical Rehabilitation Hospital
 
Lafayette, LA
 
Hospital
 
09/30/11
 
12,100,000

 
—

 
12,000,000

 
333,000

Sierra Providence East Medical Plaza I
 
El Paso, TX
 
Medical Office
 
12/22/11
 
7,840,000

 
—

 
—

 
216,000

Total
 
 
 
 
 
 
 
$
245,183,000

 
$
38,611,000

 
$
165,485,000

 
$
6,739,000

                 
(1)
We own 100% of our properties acquired in 2011.


120
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)



(2)
Represents the balance of the mortgage loans payable assumed by us or newly placed on the property at the time of acquisition.
(3)
Represents borrowings under our secured revolving lines of credit with Bank of America and KeyBank, as defined in Note 9, Line of Credit, at the time of acquisition. We periodically advanced funds and paid down our secured revolving lines of credit with Bank of America and KeyBank as needed. We currently have no amounts outstanding and terminated our secured revolving lines of credit with Bank of America and KeyBank as of June 5, 2012. See Note 9, Line of Credit, for a further discussion.
(4)
Our former advisor or its affiliates were paid, as compensation for services rendered in connection with the investigation, selection and acquisition of our properties, an acquisition fee of 2.75% of the contract purchase price for each property acquired.
(5)
On January 31, 2011, we purchased the fourth hospital comprising our existing Monument Long-Term Acute Care Hospital Portfolio, the other three of which were purchased in 2010.
(6)
We paid a loan defeasance fee of approximately $1,223,000, or the loan defeasance fee, related to the repayment of the seller’s loan that was secured by the Lakewood Ranch property and had an outstanding principal balance of approximately $7,561,000 at the time of repayment. As a result of the loan defeasance fee, the fees and expenses associated with the Lakewood Ranch property acquisition exceeded 6.0% of the contract purchase price of the Lakewood Ranch property. Pursuant to our charter, prior to the acquisition of the Lakewood Ranch property, our directors, including a majority of our independent directors, not otherwise interested in the transaction, approved the fees and expenses associated with the acquisition of the Lakewood Ranch property in excess of the 6.0% limit and determined that such fees and expenses were commercially competitive, fair and reasonable to us.
(7)
We paid a state and city transfer tax of approximately $1,479,000 related to the transfer of ownership in the acquisition of Philadelphia SNF Portfolio. Also, we paid additional closing costs of $1,500,000 related to the operator’s costs associated with the sale of the portfolio. As a result of the state and city transfer tax and additional closing costs, the fees and expenses associated with the acquisition of Philadelphia SNF Portfolio exceeded 6.0% of the contract purchase price of Philadelphia SNF Portfolio. Pursuant to our charter, prior to the acquisition of Philadelphia SNF Portfolio, our directors, including a majority of our independent directors, not otherwise interested in the transaction, approved the fees and expenses associated with the acquisition of Philadelphia SNF Portfolio in excess of the 6.0% limit and determined that such fees and expenses were commercially competitive, fair and reasonable to us.
4. Real Estate Notes Receivable, Net
Real estate notes receivable, net consisted of the following as of December 31, 2013 and 2012:
 
 
 
 
 
 
 
 
 
 
Outstanding Balance(2)
December 31,
 
 
Notes Receivable
Location of Related Property or Collateral
 
Origination Date
 
Maturity Date
 
Contractual Interest Rate(1)
 
Maximum Advances Available
 
2013
 
2012
 
Acquisition Fee(3)
Salt Lake City Note(4)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Murray, UT
 
10/05/12
 
10/05/13
 
5.25%
 
$
12,100,000

 
$
—

 
$
5,213,000

 
$
218,000

UK Development Facility(5)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
United Kingdom
 
09/11/13
 
various
 
7.50%
 
$
110,420,000

 
16,593,000

 
—

 
321,000

Kissito Note
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Roanoke, VA
 
09/20/13
 
03/19/15
 
7.25%
 
$
4,400,000

 
2,002,000

 
—

 
40,000

 
 
 
 
 
 
 
 
 
 
18,595,000

 
5,213,000

 
$
579,000

Unamortized closing costs and origination fees, net
 
 
 
 
 
 
 
 
 
293,000

 
(31,000
)
 
 
Real estate notes receivable, net
 
 
 
 
 
 
 
 
 
$
18,888,000

 
$
5,182,000

 
 
___________
(1)
Represents the per annum interest rate in effect as of December 31, 2013.

(2)
Outstanding balance represents the original principal balance, increased by any subsequent advances and decreased by any subsequent principal paydowns, and only requires monthly interest payments. The UK Development Facility is subject to certain prepayment restrictions if repaid on or before the maturity date.

121
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)




(3)
Our advisor entities and their affiliates were paid, as compensation for services in connection with real estate-related investments, an acquisition fee of 2.00% of the total amount advanced through December 31, 2013.

(4)
On September 25, 2013, we purchased the property securing the Salt Lake City Note and the note receivable was settled in full.

(5)
We entered into the UK Development Facility agreement on July 6, 2013, which was effective upon the acquisition of UK Senior Housing Portfolio on September 11, 2013. There are various maturity dates depending upon the timing of advances, however, the maturity date will be no later than March 10, 2022. Based on the currency exchange rate as of December 31, 2013, the maximum amount of advances available was £66,691,000, or approximately $110,420,000, and the outstanding balance as of December 31, 2013 was £10,022,000, or approximately $16,593,000.
Pursuant to certain terms and conditions which may or may not be satisfied, we have the option to purchase the properties securing the UK Development Facility and the Kissito Note. The following shows the change in the carrying amount of the real estate notes receivable for the years ended December 31, 2013 and 2012:
 
 
Amount
Real estate notes receivable, net — December 31, 2011
 
$
—

Additions:
 
 
Advances on real estate notes receivable
 
5,213,000

Deductions:
 
 
Closing costs and origination fees, net
 
(16,000
)
Amortization of closing costs and origination fees
 
(15,000
)
Real estate notes receivable, net — December 31, 2012
 
$
5,182,000

Additions:
 
 
Advances on real estate notes receivable
 
$
23,745,000

Closing costs and origination fees, net
 
431,000

Unrealized foreign currency gain from remeasurement
 
519,000

Deductions:
 
 
Amortization of closing costs and origination fees
 
(107,000
)
Settlement of real estate note receivable
 
(10,882,000
)
Real estate notes receivable, net — December 31, 2013
 
$
18,888,000


Amortization expense on closing costs and origination fees for the years ended December 31, 2013 and 2012 was recorded against real estate revenue in our accompanying consolidated statements of operations and comprehensive income (loss).

122
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)



5. Identified Intangible Assets, Net
Identified intangible assets, net consisted of the following as of December 31, 2013 and 2012:
 
December 31,
 
2013
 
2012
Tenant relationships, net of accumulated amortization of $11,128,000 and $4,662,000 as of December 31, 2013 and 2012, respectively (with a weighted average remaining life of 17.8 years and 20.5 years as of December 31, 2013 and 2012, respectively)
$
131,816,000

 
$
88,304,000

In-place leases, net of accumulated amortization of $23,364,000 and $11,532,000 as of December 31, 2013 and 2012, respectively (with a weighted average remaining life of 8.1 years and 10.6 years as of December 31, 2013 and 2012, respectively)
123,780,000

 
88,110,000

Leasehold interests, net of accumulated amortization of $658,000 and $400,000 as of December 31, 2013 and 2012, respectively (with a weighted average remaining life of 63.8 years and 63.1 years as of December 31, 2013 and 2012, respectively)
16,077,000

 
15,690,000

Above market leases, net of accumulated amortization of $3,466,000 and $1,805,000 as of December 31, 2013 and 2012, respectively (with a weighted average remaining life of 6.6 years and 9.4 years as of December 31, 2013 and 2012, respectively)
13,400,000

 
11,190,000

Defeasible interest, net of accumulated amortization of $29,000 and $14,000 as of December 31, 2013 and 2012, respectively (with a weighted average remaining life of 39.8 years and 40.8 years as of December 31, 2013 and 2012, respectively)
594,000

 
610,000

Master leases, net of accumulated amortization of $616,000 as of December 31, 2012 (with a weighted average remaining life of 0.6 years as of December 31, 2012)
—

 
243,000

 
$
285,667,000

 
$
204,147,000

    
Amortization expense for the years ended December 31, 2013, 2012 and 2011 was $28,658,000, $14,967,000 and $5,437,000, respectively, which included $2,704,000, $1,524,000 and $420,000, respectively, of amortization recorded against real estate revenue for above market leases and $274,000, $260,000 and $139,000, respectively, of amortization recorded to rental expenses for leasehold interests in our accompanying consolidated statements of operations and comprehensive income (loss).
The aggregate weighted average remaining life of the identified intangible assets is 15.7 and 18.9 years as of December 31, 2013 and 2012, respectively. As of December 31, 2013, estimated amortization expense on the identified intangible assets for each of the next five years ending December 31 and thereafter is as follows:
 
Year
 
Amount
2014
 
$
51,526,000

2015
 
24,670,000

2016
 
22,595,000

2017
 
20,829,000

2018
 
19,132,000

Thereafter
 
146,915,000

 
 
$
285,667,000


123
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)



6. Other Assets, Net
Other assets, net consisted of the following as of December 31, 2013 and 2012:
 
December 31,
 
2013
 
2012
Deferred rent receivables
$
24,494,000

 
$
10,219,000

Deferred financing costs, net of accumulated amortization of $3,627,000 and $1,276,000 as of December 31, 2013 and 2012, respectively
6,282,000

 
6,234,000

Prepaid expenses and deposits
2,485,000

 
1,353,000

Lease commissions, net of accumulated amortization of $393,000 and $122,000 as of December 31, 2013 and 2012, respectively
4,677,000

 
1,716,000

 
$
37,938,000

 
$
19,522,000

    
Amortization expense on lease commissions for the years ended December 31, 2013, 2012 and 2011 was $330,000, $99,000 and $29,000, respectively. Amortization expense on deferred financing costs for the years ended December 31, 2013, 2012 and 2011 was $2,661,000, $1,784,000 and $1,267,000, respectively. Amortization expense on deferred financing costs is recorded to interest expense in our accompanying consolidated statements of operations and comprehensive income (loss).
For the years ended December 31, 2013, 2012 and 2011, $86,000, $30,000 and $72,000, respectively, of the amortization expense on deferred financing costs was related to the write-off of deferred financing costs due to the early extinguishment of various mortgage loans.
Estimated amortization expense on deferred financing costs and lease commissions as of December 31, 2013 for each of the next five years ending December 31 and thereafter is as follows:
Year
 
Amount
2014
 
$
3,509,000

2015
 
2,020,000

2016
 
879,000

2017
 
709,000

2018
 
585,000

Thereafter
 
3,257,000

 
 
$
10,959,000

7. Mortgage Loans Payable, Net
Mortgage loans payable were $315,722,000 ($329,476,000, net of discount and premium) and $278,245,000 ($291,052,000, net of discount and premium) as of December 31, 2013 and 2012, respectively.
As of December 31, 2013, we had 43 fixed rate and three variable rate mortgage loans payable with effective interest rates ranging from 1.27% to 6.60% per annum and a weighted average effective interest rate of 4.87% per annum based on interest rates in effect as of December 31, 2013. The mortgage loans payable as of December 31, 2013 had maturity dates ranging from March 1, 2014 to September 1, 2047. As of December 31, 2013, we had $299,680,000 ($313,646,000, net of discount and premium) of fixed rate debt, or 94.9% of mortgage loans payable, at a weighted average effective interest rate of 5.00% per annum, and $16,042,000 ($15,830,000, net of discount) of variable rate debt, or 5.1% of mortgage loans payable, at a weighted average effective interest rate of 2.57% per annum.
As of December 31, 2012, we had 33 fixed rate and three variable rate mortgage loans payable with effective interest rates ranging from 1.31% to 6.60% per annum and a weighted average effective interest rate of 4.76% per annum based on interest rates in effect as of December 31, 2012. The mortgage loans payable as of December 31, 2012 had maturity dates ranging from March 1, 2014 to September 1, 2047. As of December 31, 2012, we had $261,612,000 ($274,659,000, net of discount and premium) of fixed rate debt, or 94.0% of mortgage loans payable, at a weighted average effective interest rate of 4.90% per annum, and $16,633,000 ($16,393,000, net of discount) of variable rate debt, or 6.0% of mortgage loans payable, at a weighted average effective interest rate of 2.60% per annum.

124
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)



We are required by the terms of certain loan documents to meet certain covenants, such as occupancy ratios, leverage ratios, net worth ratios, debt service coverage ratio, liquidity ratios, operating cash flow to fixed charges ratios, distribution ratios and reporting requirements. As of December 31, 2013 and 2012, we were in compliance with all such covenants and requirements.
Mortgage loans payable, net consisted of the following as of December 31, 2013 and 2012:
 
 
December 31,
 
 
2013
 
2012
Total fixed rate debt
 
$
299,680,000

 
$
261,612,000

Total variable rate debt
 
16,042,000

 
16,633,000

 
 
315,722,000

 
278,245,000

Less: discount
 
(216,000
)
 
(248,000
)
Add: premium
 
13,970,000

 
13,055,000

Mortgage loans payable, net
 
$
329,476,000

 
$
291,052,000

The following shows the change in mortgage loans payable, net for the year ended December 31, 2013:
 
 
Amount
Mortgage loans payable, net — December 31, 2011
 
$
80,466,000

Additions:
 
 
Borrowings on mortgage loans payable
 
71,602,000

Assumption of mortgage loans payable, net
 
170,282,000

Deductions:
 
 
Scheduled principal payments on mortgage loans payable
 
(3,611,000
)
Early extinguishment of mortgage loans payable
 
(26,669,000
)
Amortization of premium/discount on mortgage loans payable
 
(1,018,000
)
Mortgage loans payable, net — December 31, 2012
 
$
291,052,000

Additions:
 
 
Assumption of mortgage loans payable, net
 
$
62,712,000

Deductions:
 
 
Scheduled principal payments on mortgage loans payable
 
(5,303,000
)
Early extinguishment of mortgage loans payable
 
(16,563,000
)
Amortization of premium/discount on mortgage loans payable
 
(2,422,000
)
Mortgage loans payable, net — December 31, 2013
 
$
329,476,000

As of December 31, 2013, the principal payments due on our mortgage loans payable for each of the next five years ending December 31 and thereafter, is as follows:
Year
 
Amount
2014
 
$
15,363,000

2015
 
41,980,000

2016
 
50,319,000

2017
 
24,779,000

2018
 
40,064,000

Thereafter
 
143,217,000

 
 
$
315,722,000


125
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)



8. Derivative Financial Instruments
ASC Topic 815 establishes accounting and reporting standards for derivative instruments, including certain derivative instruments embedded in other contracts, and for hedging activities. We utilize derivatives such as fixed interest rate swaps to add stability to interest expense and to manage our exposure to interest rate movements. We also use derivative instruments, such as foreign currency forward contracts, to mitigate the effects of the foreign currency fluctuations on future cash flows. Consistent with ASC Topic 815, we record derivative financial instruments in our accompanying consolidated balance sheets as either an asset or a liability measured at fair value. ASC Topic 815 permits special hedge accounting if certain requirements are met. Hedge accounting allows for gains and losses on derivatives designated as hedges to be offset by the change in value of the hedged item or items or to be deferred in other comprehensive income (loss).
As of December 31, 2013, no derivatives were designated as hedges. Derivatives not designated as hedges are not speculative and are used to manage our exposure to interest rate movements and foreign currency fluctuations, but do not meet the strict hedge accounting requirements of ASC Topic 815. Changes in the fair value of interest rate derivative financial instruments are recorded as a component of interest expense in gain (loss) in fair value of derivative financial instruments in our accompanying consolidated statements of operations and comprehensive income (loss). Changes in the fair value of foreign currency derivative financial instruments are recorded in foreign currency and derivative loss in our accompanying consolidated statements of operations and comprehensive income (loss).
See Note 14, Fair Value Measurements, for a further discussion of the fair value of our derivative financial instruments.
Interest Rate Swaps
For the years ended December 31, 2013, 2012 and 2011, we recorded $344,000, $24,000 and $(366,000), respectively, as a decrease (increase) to interest expense in our accompanying consolidated statements of operations and comprehensive income (loss) related to the change in the fair value of our interest rate swaps.
The following table lists the interest rate swap contracts held by us as of December 31, 2013:
Notional Amount
 
Index
 
Interest Rate
 
Fair Value
 
Instrument
 
Maturity Date
$
2,483,000

 
one month LIBOR
 
6.00
%
 
$
(309,000
)
 
Swap
 
08/15/21
6,798,000

 
one month LIBOR
 
4.41
%
 
—

 
Swap
 
01/01/14
6,761,000

 
one month LIBOR
 
4.28
%
 
(39,000
)
 
Swap
 
05/01/14
6,784,000

 
one month LIBOR
 
4.11
%
 
(103,000
)
 
Swap
 
10/01/15
$
22,826,000

 
 
 
 
 
$
(451,000
)
 
 
 
 
The following table lists the interest rate swap contracts held by us as of December 31, 2012:
Notional Amount
 
Index
 
Interest Rate
 
Fair Value
 
Instrument
 
Maturity Date
$
2,731,000

 
one month LIBOR
 
6.00
%
 
$
(470,000
)
 
Swap
 
08/15/21
6,970,000

 
one month LIBOR
 
4.41
%
 
(89,000
)
 
Swap
 
01/01/14
6,932,000

 
one month LIBOR
 
4.28
%
 
(147,000
)
 
Swap
 
05/01/14
6,784,000

 
one month LIBOR
 
4.11
%
 
(89,000
)
 
Swap
 
10/01/15
$
23,417,000

 
 
 
 
 
$
(795,000
)
 
 
 
 
Foreign Currency Forward Contract
On September 9, 2013, we entered into a foreign currency forward contract to sell £180,000,000 at the fixed foreign currency exchange rate of 1.5606 on September 10, 2014. For the year ended December 31, 2013, we recorded an unrealized loss of $16,489,000 to foreign currency and derivative loss in our accompanying consolidated statements of operations and comprehensive income (loss) related to the change in the fair value of our foreign currency forward contract. As of December 31, 2013, the fair value of our foreign currency forward contract was $(16,489,000), which is included in security deposits, prepaid rent and other liabilities in our accompanying consolidated balance sheets. For the year ended December 31, 2012, we did not enter into any foreign currency forward contracts.

126
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)



9. Line of Credit
Bank of America, N.A.
On July 19, 2010, we entered into a loan agreement with Bank of America to obtain a secured revolving credit facility with an aggregate maximum principal amount of $25,000,000, or the Bank of America line of credit. On May 4, 2011, we modified the Bank of America line of credit to increase the aggregate maximum principal amount from $25,000,000 to $45,000,000, subject to certain borrowing base conditions. On June 5, 2012, we terminated and currently have no additional obligations under the Bank of America line of credit.
KeyBank National Association
On June 30, 2011, we entered into a loan agreement with KeyBank to obtain a secured revolving credit facility with an aggregate maximum principal amount of $71,500,000, or the KeyBank line of credit. On October 6, 2011, RBS Citizens, N.A., d/b/a Charter One, or Charter One, was added as a syndication agent to the KeyBank line of credit, whereby $35,750,000 of the aggregate maximum principal amount of the KeyBank line of credit was assigned to Charter One. On June 5, 2012, we terminated and currently have no additional obligations under the KeyBank line of credit.
Unsecured Revolving Line of Credit
On June 5, 2012, we, our operating partnership and certain of our subsidiaries, or the subsidiary guarantors, entered into a credit agreement, or the Credit Agreement, with Bank of America, as administrative agent, swingline lender and issuer of letters of credit; KeyBank, as syndication agent; Merrill Lynch, Pierce, Fenner & Smith Incorporated and KeyBanc Capital Markets as joint lead arrangers and joint book managers; and the lenders named therein, to obtain an unsecured revolving line of credit, with an aggregate maximum principal amount of $200,000,000, or our unsecured line of credit. The proceeds of loans made under our unsecured line of credit may be used for working capital, capital expenditures and other general corporate purposes (including, without limitation, property acquisitions and repayment of debt). Our operating partnership may obtain up to 10.0% of the maximum principal amount in the form of standby letters of credit and up to 15.0% of the maximum principal amount in the form of swingline loans.
On May 24, 2013, we entered into a Second Amendment to the Credit Agreement, or the Amendment, which increased the aggregate maximum principal amount of our unsecured line of credit to $450,000,000, with Bank of America, KeyBank National Association, RBS Citizens, N.A., and Comerica Bank, as existing lenders, and Barclays Bank PLC, Fifth Third Bank, Wells Fargo Bank, N.A., Credit Agricole Corporate and Investment Bank, and Sumitomo Mitsui Banking Corporation, as new lenders. The Amendment also revised the amount that may be obtained by our operating partnership in the form of swingline loans from up to 15.0% of the maximum principal amount to up to $50,000,000.
The maximum principal amount of the Credit Agreement, as amended, may be increased by up to $200,000,000, for a total principal amount of $650,000,000, subject to (a) the terms of the Credit Agreement, as amended, and (b) such additional financing amount being offered and provided by current lenders or additional lenders under the Credit Agreement, as amended.
At our option, loans under the Credit Agreement, as amended, bear interest at per annum rates equal to (a) (i) the Eurodollar Rate plus (ii) a margin ranging from 2.00% to 3.00% based on our consolidated leverage ratio, or (b) (i) the greater of: (x) the prime rate publicly announced by Bank of America, (y) the Federal Funds Rate (as defined in the Credit Agreement, as amended) plus 0.50% and (z) the one-month Eurodollar Rate (as defined in the Credit Agreement, as amended) plus 1.00%, plus (ii) a margin ranging from 1.00% to 2.00% based on our consolidated leverage ratio. Accrued interest under the Credit Agreement, as amended, is payable monthly. Our unsecured line of credit matures on June 5, 2015, and may be extended by one 12-month period subject to satisfaction of certain conditions, including payment of an extension fee.
We are required to pay a fee on the unused portion of the lenders' commitments under the Credit Agreement, as amended, at a per annum rate equal to 0.25% if the average daily used amount is greater than 50.0% of the commitments and 0.35% if the average daily used amount is less than 50.0% of the commitments.
The Credit Agreement, as amended, contains various affirmative and negative covenants that are customary for credit facilities and transactions of this type, including limitations on the incurrence of debt by our operating partnership and its subsidiaries and limitations on secured recourse indebtedness. The Credit Agreement, as amended, imposes the following financial covenants, which are specifically defined in the Credit Agreement, as amended: (a) a maximum consolidated leverage ratio; (b) a maximum consolidated secured leverage ratio; (c) a minimum consolidated tangible net worth covenant; (d) a minimum consolidated fixed charge coverage ratio; (e) a maximum dividend payout ratio; (f) a maximum consolidated unencumbered leverage ratio; and (g) a minimum consolidated unencumbered interest coverage ratio. As of December 31, 2013 and 2012, we were in compliance with all such covenants and requirements.

127
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)



The Credit Agreement, as amended, requires us to add additional subsidiaries as guarantors in the event the value of the assets owned by the subsidiary guarantors falls below a certain threshold as set forth in the Credit Agreement, as amended. In the event of default, the lenders have the right to terminate its obligations under the Credit Agreement, as amended, including the funding of future loans, and to accelerate the payment on any unpaid principal amount of all outstanding loans and interest thereon.
The actual amount of credit available under our unsecured line of credit at any given time is a function of, and is subject to, loan to value and debt service coverage ratios based on net operating income as contained in the Credit Agreement, as amended. Based on the value of our borrowing base properties, as such term is used in the Credit Agreement, as amended, our aggregate borrowing capacity under our unsecured line of credit was $450,000,000 and $200,000,000, respectively, as of December 31, 2013 and 2012. As of December 31, 2013 and 2012, borrowings outstanding under our unsecured line of credit totaled $68,000,000 and $200,000,000, respectively, and $382,000,000 and $0, respectively, remained available under our unsecured line of credit. The weighted average interest rate on borrowings outstanding as of December 31, 2013 and 2012 was 2.32% and 3.33%, respectively, per annum.
10. Identified Intangible Liabilities, Net
Identified intangible liabilities, net consisted of the following as of December 31, 2013 and 2012:
 
December 31,
 
2013
 
2012
Below market leases, net of accumulated amortization of $887,000 and $265,000 as of December 31, 2013 and 2012, respectively (with a weighted average remaining life of 7.8 years and 8.2 years as of December 31, 2013 and 2012, respectively)
$
6,884,000

 
$
3,006,000

Above market leasehold interests, net of accumulated amortization of $83,000 and $17,000 as of December 31, 2013 and 2012, respectively (with a weighted average remaining life of 70.0 years and 48.8 years as of December 31, 2013 and 2012, respectively)
4,809,000

 
2,150,000

 
$
11,693,000

 
$
5,156,000

Amortization expense on below market leases for the years ended December 31, 2013, 2012 and 2011 was $794,000, $241,000 and $122,000, respectively. Amortization expense on below market leases is recorded to real estate revenue in our accompanying consolidated statements of operations and comprehensive income (loss).
Amortization expense on above market leasehold interests for the years ended December 31, 2013, 2012 and 2011 was $66,000, $17,000 and $0, respectively. Amortization expense on above market leasehold interests is recorded against rental expenses in our accompanying consolidated statements of operations and comprehensive income (loss).
The aggregate weighted average remaining life of the identified intangible liabilities is 33.4 and 25.1 years as of December 31, 2013 and 2012, respectively. As of December 31, 2013, estimated amortization expense on below market leases and above market leasehold interests for each of the next five years ending December 31 and thereafter was as follows:
Year
 
Amount
2014
 
$
1,269,000

2015
 
1,188,000

2016
 
1,118,000

2017
 
962,000

2018
 
853,000

Thereafter
 
6,303,000

 
 
$
11,693,000

11. Commitments and Contingencies
Litigation
We are not presently subject to any material litigation nor, to our knowledge, is any material litigation threatened against us, which if determined unfavorably to us, would have a material adverse effect on our consolidated financial position, results of operations or cash flows.

128
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)



Environmental Matters
We follow a policy of monitoring our properties for the presence of hazardous or toxic substances. While there can be no assurance that a material environmental liability does not exist at our properties, we are not currently aware of any environmental liability with respect to our properties that would have a material effect on our consolidated financial position, results of operations or cash flows. Further, we are not aware of any material environmental liability or any unasserted claim or assessment with respect to an environmental liability that we believe would require additional disclosure or the recording of a loss contingency.
Other Organizational and Offering Expenses
Prior to January 7, 2012, other organizational and offering expenses in connection with our initial offering (other than selling commissions and the dealer manager fee) were paid by our former advisor or its affiliates. Other organizational and offering expenses included all expenses (other than selling commissions and the dealer manager fee which generally represented 7.0% and 3.0%, respectively, of our gross offering proceeds) to be paid by us in connection with our initial offering. These other organizational and offering expenses would only have become our liability to the extent they did not exceed 1.0% of the gross proceeds from the sale of shares of our common stock in our initial offering, other than shares of our common stock sold pursuant to the DRIP. During the period from January 7, 2012 until February 14, 2013, our other organizational and offering expenses in connection with our initial offering were being paid by our sub-advisor or its affiliates on our behalf. As of February 14, 2013 and December 31, 2012, our sub-advisor, our former advisor and their affiliates had not incurred expenses on our behalf in excess of 1.0% of the gross proceeds of our initial offering. We terminated our initial offering and commenced our follow-on offering on February 14, 2013.
Our other organizational and offering expenses incurred in connection with our follow-on offering (other than selling commissions and the dealer manager fee) were paid by our sub-advisor or its affiliates on our behalf. These other organizational and offering expenses included all expenses to be paid by us in connection with our follow-on offering. These expenses only became our liability to the extent these other organizational and offering expenses did not exceed 1.0% of the gross offering proceeds from the sale of shares of our common stock in our follow-on offering. As of December 31, 2012, our sub-advisor and its affiliates had incurred expenses on our behalf of $610,000, in excess of 1.0% of the gross proceeds related to our follow-on offering, and therefore, these expenses were not recorded in our accompanying consolidated financial statements as of December 31, 2012. On October 30, 2013, we terminated our follow-on offering. As of October 30, 2013, our sub-advisor and its affiliates had not incurred expenses on our behalf in excess of 1.0% of the gross proceeds of our follow-on offering.
When recorded by us, other organizational expenses were expensed as incurred, as applicable, and offering expenses were charged to stockholders' equity as such amounts are reimbursed to our former advisor, our sub-advisor or their affiliates from the gross proceeds of our offerings. See Note 12, Related Party Transactions — Offering Stage, for a further discussion of other organizational and offering expenses.
Other
Our other commitments and contingencies include the usual obligations of real estate owners and operators in the normal course of business, which include calls/puts to sell/acquire properties. In our view, these matters are not expected to have a material adverse effect on our consolidated financial position, results of operations or cash flows.
12. Related Party Transactions
Fees and Expenses Paid to Affiliates

Until January 6, 2012, all of our executive officers and our non-independent directors were also executive officers and employees and/or holders of a direct or indirect interest in our former advisor, our former sponsor, GEEA or other affiliated entities.
Effective as of August 24, 2009, we entered into the G&E Advisory Agreement with our former advisor, and effective as of June 22, 2009, we entered into the G&E Dealer Manager Agreement with Grubb & Ellis Securities, Inc., or Grubb & Ellis Securities. Until April 18, 2011, Grubb & Ellis Securities served as the dealer manager of our initial offering pursuant to the G&E Dealer Manager Agreement. Effective as of April 19, 2011, the G&E Dealer Manager Agreement with Grubb & Ellis Securities was assigned to, and assumed by, Grubb & Ellis Capital Corporation, a wholly owned subsidiary of our former sponsor. Therefore, references to the G&E Dealer Manager shall be deemed to refer to either Grubb & Ellis Securities or Grubb & Ellis Capital Corporation, or both, as applicable, unless otherwise specified.

129
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)



On November 7, 2011, we notified our former advisor of the termination of the G&E Advisory Agreement. Pursuant to the G&E Advisory Agreement, either party could terminate the G&E Advisory Agreement without cause or penalty, subject to a 60-day transition period; however, certain rights and obligations of the parties would survive during the 60-day transition period and beyond. As a result of a new advisory agreement that took effect on January 7, 2012 upon the expiration of the 60-day transition period provided for in the G&E Advisory Agreement, Griffin-American Advisor serves as our advisor and delegates advisory duties to Griffin-American Sub-Advisor.
In addition, on November 7, 2011, we notified Grubb & Ellis Capital Corporation of the termination of the G&E Dealer Manager Agreement. Pursuant to the G&E Dealer Manager Agreement, either party could terminate the G&E Dealer Manager Agreement, subject to a 60-day transition period. Until January 6, 2012, Grubb & Ellis Capital Corporation remained a non-exclusive agent of our company and distributor of shares of our common stock. As a result of the Dealer Manager Agreement that took effect on January 7, 2012 upon the expiration of the 60-day transition period provided for in the G&E Dealer Manager Agreement, Griffin Securities serves as our dealer manager. The terms of the Dealer Manager Agreement are substantially the same as the terms of the terminated G&E Dealer Manager Agreement.
Upon the termination of the G&E Advisory Agreement and G&E Dealer Manager Agreement and corresponding 60-day transition periods, after January 6, 2012, we are no longer affiliated with Grubb & Ellis and its affiliates. The G&E Advisory Agreement and the G&E Dealer Manager Agreement entitled our former advisor, G&E Dealer Manager and their affiliates to specified compensation for certain services, as well as reimbursement of certain expenses. In the aggregate, for the years ended December 31, 2012 and 2011, we incurred $5,481,000 and $46,699,000, respectively, in fees and expenses to our former advisor or its affiliates as detailed below.
We are affiliated with Griffin-American Sub-Advisor and American Healthcare Investors; however, we are not affiliated with Griffin Capital, Griffin-American Advisor or Griffin Securities. In the aggregate, for the years ended December 31, 2013 and 2012, we incurred $62,699,000 and $34,823,000, respectively, in fees and expenses to our affiliates as detailed below. As discussed above, our advisor, which is not our affiliate, delegates certain advisory duties pursuant to a sub-advisory agreement to our sub-advisor, which is our affiliate. Therefore, although certain obligations under the Advisory Agreement are contractually performed by or for our advisor, only such obligations pursuant to the sub-advisory agreement that are performed by or for our sub-advisor or its affiliates are disclosed in this related party transactions note.

Offering Stage
Initial Offering Selling Commissions
Until January 6, 2012, G&E Dealer Manager received selling commissions of up to 7.0% of the gross offering proceeds from the sale of shares of our common stock in our initial offering other than shares of our common stock sold pursuant to the DRIP. G&E Dealer Manager could have re-allowed all or a portion of these fees to participating broker-dealers. For the years ended December 31, 2012 and 2011, we incurred $512,000 and $22,196,000, respectively, in selling commissions to G&E Dealer Manager. Such commissions were charged to stockholders' equity as such amounts were paid to G&E Dealer Manager from the gross proceeds of our initial offering.
Effective as of January 7, 2012, selling commissions in connection with our initial offering were paid to Griffin Securities, an unaffiliated entity. See Note 13, Equity — Offering Costs, for a further discussion.
Initial Offering Dealer Manager Fee
Until January 6, 2012, G&E Dealer Manager received a dealer manager fee of up to 3.0% of the gross offering proceeds from the sale of shares of our common stock in our initial offering other than shares of our common stock sold pursuant to the DRIP. G&E Dealer Manager could have re-allowed all or a portion of these fees to participating broker-dealers. For the years ended December 31, 2012 and 2011, we incurred $227,000 and $9,742,000, respectively, in dealer manager fees to G&E Dealer Manager. Such fees were charged to stockholders' equity as such amounts were paid to G&E Dealer Manager from the gross proceeds of our initial offering.
Effective as of January 7, 2012, the dealer manager fee in connection with our initial offering was paid to Griffin Securities, an unaffiliated entity. See Note 13, Equity — Offering Costs, for a further discussion.

130
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)



Other Organizational and Offering Expenses
Other organizational expenses were expensed as incurred and offering expenses were charged to stockholders' equity as such amounts were paid from the gross proceeds of our offerings.
Initial Offering
Effective as of January 7, 2012, our other organizational and offering expenses were paid by our sub-advisor or its affiliates on our behalf. Our sub-advisor or its affiliates were reimbursed for actual expenses incurred up to 1.0% of the gross offering proceeds from the sale of shares of our common stock in our initial offering other than shares of our common stock sold pursuant to the DRIP. For the years ended December 31, 2013 and 2012, we incurred $116,000 and $5,733,000, respectively, in offering expenses to our sub-advisor in connection with our initial offering.
Until January 6, 2012, our former advisor or its affiliates were entitled to the same reimbursement. For the years ended December 31, 2012 and 2011, we incurred $76,000 and $3,261,000, respectively, in offering expenses to our former advisor or its affiliates in connection with our initial offering.
Follow-On Offering
Pursuant to our follow-on offering, which commenced February 14, 2013 and terminated on October 30, 2013, our other organizational and offering expenses were paid by our sub-advisor or its affiliates on our behalf. Our sub-advisor or its affiliates were reimbursed for actual expenses incurred up to 1.0% of the gross offering proceeds from the sale of shares of our common stock in our follow-on offering other than shares of our common stock sold pursuant to the DRIP. For the year ended December 31, 2013, we incurred $2,755,000 in offering expenses to our sub-advisor in connection with our follow-on offering.
Acquisition and Development Stage
Acquisition Fee
Effective as of January 7, 2012, our sub-advisor or its affiliates receive an acquisition fee of up to 2.60% of the contract purchase price for each property we acquire or 2.0% of the origination or acquisition price for any real estate-related investment we originate or acquire. The acquisition fee for property acquisitions is paid as follows: (i) in shares of common stock in an amount equal to 0.15% of the contract purchase price, at $9.00 or $9.20 per share, as applicable, the then most recent price paid to acquire a share of our common stock in our offerings, net of selling commissions and dealer manager fees, and (ii) the remainder in cash equal to 2.45% of the contract purchase price. Our sub-advisor or its affiliates are entitled to receive these acquisition fees for properties and real estate-related investments we acquire with funds raised in our offerings including acquisitions completed after the termination of the Advisory Agreement, or funded with net proceeds from the sale of a property or real estate-related investment, subject to certain conditions. For the years ended December 31, 2013 and 2012, we incurred $38,246,000 and $18,811,000, respectively, in acquisition fees to our sub-advisor or its affiliates, which included 238,277 shares and 119,082 shares of common stock, respectively.
Until January 6, 2012, our former advisor or its affiliates were entitled to a similar fee; however, such fee was up to 2.75% of the contract purchase price for each property we acquired or 2.0% of the origination or acquisition price for any real estate-related investment we originated or acquired, entirely payable in cash. For the years ended December 31, 2012 and 2011, we incurred $4,579,000 and $6,739,000, respectively, in acquisition fees to our former advisor or its affiliates.
Acquisition fees in connection with the acquisition of properties are (i) expensed as incurred when they relate to the purchase of a business in accordance with ASC Topic 805 and are included in acquisition related expenses in our accompanying consolidated statements of operations and comprehensive income (loss), or (ii) are capitalized when they relate to the purchase of an asset and included in real estate investments, net, in our accompanying consolidated balance sheets, as applicable. Acquisition fees in connection with the acquisition of real estate-related investments are capitalized as part of the associated investment in our accompanying consolidated balance sheets.
Development Fee
Effective as of January 7, 2012, our sub-advisor or its affiliates receive, in the event our sub-advisor or its affiliates provide development-related services, a development fee in an amount that is usual and customary for comparable services rendered for similar projects in the geographic market where the services are provided; however, we will not pay a development fee to our sub-advisor or its affiliates if our sub-advisor or its affiliates elect to receive an acquisition fee based on the cost of

131
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)



such development. For the years ended December 31, 2013 and 2012, we did not incur any development fees to our sub-advisor or its affiliates.
Until January 6, 2012, our former advisor or its affiliates would have been entitled to the same development fee. We did not incur any development fees to our former advisor or its affiliates.
Reimbursement of Acquisition Expenses
Effective as of January 7, 2012, our sub-advisor or its affiliates are reimbursed for acquisition expenses related to selecting, evaluating and acquiring assets, which is reimbursed regardless of whether an asset is acquired. For the years ended December 31, 2013 and 2012, we did not incur any acquisition expenses to our sub-advisor or its affiliates.
Until January 6, 2012, our former advisor or its affiliates were entitled to similar reimbursements of acquisition expenses. For the years ended December 31, 2012 and 2011, we incurred $0 and $21,000, respectively, in acquisition expenses to our former advisor or its affiliates.
Reimbursements of acquisition expenses are (i) expensed as incurred when they relate to the purchase of a business in accordance with ASC Topic 805 and are included in acquisition related expenses in our accompanying consolidated statements of operations and comprehensive income (loss), or (ii) are capitalized when they relate to the purchase of an asset and included in real estate investments, net, in our accompanying consolidated balance sheets, as applicable.
The reimbursement of acquisition expenses, acquisition fees and real estate commissions and other fees paid to unaffiliated parties will not exceed, in the aggregate, 6.0% of the purchase price or total development costs, unless fees in excess of such limits are approved by a majority of our disinterested directors, including a majority of our independent directors, not otherwise interested in the transaction. As of December 31, 2013, such fees and expenses did not exceed 6.0% of the purchase price of our acquisitions, except with respect to our acquisition of land in the Dixie-Lobo Medical Office Building Portfolio on May 2, 2013 and our acquisitions of the Lakewood Ranch property and Philadelphia SNF Portfolio, both of which we acquired in 2011. Pursuant to our charter, prior to the acquisition of the land in the Dixie-Lobo Medical Office Building Portfolio, the Lakewood Ranch property and Philadelphia SNF Portfolio, our directors, including a majority of our independent directors, not otherwise interested in the transaction, approved the fees and expenses associated with the acquisitions in excess of the 6.0% limit and determined that such fees and expenses were commercially competitive, fair and reasonable to us. For a further discussion, see Note 3, Real Estate Investments, Net.
Operational Stage
Asset Management Fee
Effective as of January 7, 2012, our sub-advisor or its affiliates are paid a monthly fee for services rendered in connection with the management of our assets equal to one-twelfth of 0.85% of average invested assets existing as of January 6, 2012 and one-twelfth of 0.75% of the average invested assets acquired after January 6, 2012, subject to our stockholders receiving distributions in an amount equal to 5.0% per annum, cumulative, non-compounded, of average invested capital. For such purposes, average invested assets means the average of the aggregate book value of our assets invested in real estate properties and real estate-related investments, before deducting depreciation, amortization, bad debt and other similar non-cash reserves, computed by taking the average of such values at the end of each month during the period of calculation; and average invested capital means, for a specified period, the aggregate issue price of shares of our common stock purchased by our stockholders, reduced by distributions of net sales proceeds by us to our stockholders and by any amounts paid by us to repurchase shares of our common stock pursuant to our share repurchase plan. For the years ended December 31, 2013 and 2012, we incurred $13,751,000 and $6,666,000, respectively, in asset management fees to our sub-advisor.
Until January 6, 2012, our former advisor or its affiliates were entitled to a similar monthly asset management fee; however, such asset management fee was equal to one-twelfth of 0.85% of average invested assets. For the years ended December 31, 2012 and 2011, we incurred $61,000 and $2,929,000, respectively, in asset management fees to our former advisor or its affiliates.
Asset management fees are included in general and administrative in our accompanying consolidated statements of operations and comprehensive income (loss).

132
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)



Property Management Fee
Effective as of January 7, 2012, our sub-advisor or its affiliates are paid a monthly property management fee of up to 4.0% of the gross monthly cash receipts from each property managed by our sub-advisor or its affiliates. Our sub-advisor or its affiliates may sub-contract its duties to any third-party, including for fees less than the property management fees payable to our sub-advisor or its affiliates. In addition to the above property management fee, for each property managed directly by entities other than our sub-advisor or its affiliates, we pay our sub-advisor or its affiliates a monthly oversight fee of up to 1.0% of the gross cash receipts from the property; provided however, that in no event will we pay both a property management fee and an oversight fee to our sub-advisor or its affiliates with respect to the same property. For the years ended December 31, 2013 and 2012, we incurred $4,418,000 and $2,142,000, respectively, in property management fees and oversight fees to our sub-advisor or its affiliates.
Until January 6, 2012, our former advisor or its affiliates were entitled to similar property management and oversight fees. For the years ended December 31, 2012 and 2011, we incurred $16,000 and $843,000, respectively, in property management fees and oversight fees to our former advisor or its affiliates.
Property management fees and oversight fees are included in rental expenses in our accompanying consolidated statements of operations and comprehensive income (loss).
On-site Personnel and Engineering Payroll
For the years ended December 31, 2013 and 2012, we did not incur payroll for on-site personnel and engineering to our sub-advisor or its affiliates. For the year ended 2011, we incurred $103,000 in payroll for on-site personnel and engineering to our former advisor or its affiliates, which is included in rental expenses in our accompanying consolidated statements of operations and comprehensive income (loss).
Lease Fees
Effective as of January 7, 2012, we pay our sub-advisor or its affiliates a separate fee for any leasing activities in an amount not to exceed the fee customarily charged in arm's-length transactions by others rendering similar services in the same geographic area for similar properties as determined by a survey of brokers and agents in such area. Such fee is generally expected to range from 3.0% to 8.0% of the gross revenues generated during the initial term of the lease. For the years ended December 31, 2013 and 2012, we incurred $3,231,000 and $1,389,000, respectively, in lease fees to our sub-advisor or its affiliates.
Until January 6, 2012, our former advisor or its affiliates were entitled to similar lease fees. For the years ended December 31, 2012 and 2011, we incurred $0 and $395,000, respectively, in lease fees to our former advisor or its affiliates.
Lease fees are capitalized as lease commissions and included in other assets, net in our accompanying consolidated balance sheets.
Construction Management Fee
Effective as of January 7, 2012, in the event that our sub-advisor or its affiliates assist with planning and coordinating the construction of any capital or tenant improvements, our sub-advisor or its affiliates are paid a construction management fee of up to 5.0% of the cost of such improvements. For the years ended December 31, 2013 and 2012, we incurred $182,000 and $82,000, respectively, in construction management fees to our sub-advisor or its affiliates.
Until January 6, 2012, our former advisor or its affiliates were entitled to similar construction management fees. For the years ended December 31, 2012 and 2011, we incurred $0 and $72,000, respectively, in construction management fees to our former advisor or its affiliates.
Construction management fees are capitalized as part of the associated asset and included in real estate investments, net in our accompanying consolidated balance sheets or expensed and included in our accompanying consolidated statements of operations and comprehensive income (loss), as applicable.
Operating Expenses
Effective as of January 7, 2012, we reimburse our sub-advisor or its affiliates for operating expenses incurred in rendering services to us, subject to certain limitations. However, we cannot reimburse our sub-advisor or its affiliates at the end of any fiscal quarter for total operating expenses that, in the four consecutive fiscal quarters then ended, exceed the greater of:

133
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)



(i) 2.0% of our average invested assets, as defined in the Advisory Agreement, or (ii) 25.0% of our net income, as defined in the Advisory Agreement, unless our independent directors determined that such excess expenses were justified based on unusual and nonrecurring factors.
For the 12 months ended December 31, 2013, our operating expenses did not exceed this limitation. Our operating expenses as a percentage of average invested assets and as a percentage of net income were 1.1% and 21.7%, respectively, for the 12 months ended December 31, 2013. For the year ended December 31, 2013, our sub-advisor or its affiliates did not incur any operating expenses on our behalf.
Until January 6, 2012, our former advisor or its affiliates were entitled to a similar reimbursement of operating expenses. For the years ended December 31, 2012 and 2011, our former advisor or its affiliates incurred operating expenses on our behalf of $0 and $22,000, respectively.
Operating expense reimbursements are included in general and administrative in our accompanying consolidated statements of operations and comprehensive income (loss).
Related Party Services Agreement
We entered into a services agreement, effective September 21, 2009, or the Transfer Agent Services Agreement, with Grubb & Ellis Equity Advisors, Transfer Agent, LLC, formerly known as Grubb & Ellis Investor Solutions, LLC, or our former transfer agent, for transfer agent and investor services. Since our former transfer agent was an affiliate of our former advisor, the terms of the Transfer Agent Services Agreement were approved and determined by a majority of our directors, including a majority of our independent directors, as fair and reasonable to us and at fees which are no greater than that which would be paid to an unaffiliated party for similar services.
On November 7, 2011, we provided notice of termination of the Transfer Agent Services Agreement to our former transfer agent. Under the Transfer Agent Services Agreement, we were required to provide 60 days written notice of termination. Therefore, the Transfer Agent Services Agreement terminated on January 6, 2012. We engaged DST Systems, Inc., an unaffiliated party, to serve as our replacement transfer agent on January 6, 2012.
For the years ended December 31, 2012 and 2011, we incurred expenses of $10,000 and $311,000, respectively, for investor services that our former transfer agent provided to us, which is included in general and administrative in our accompanying consolidated statements of operations and comprehensive income (loss).
For the years ended December 31, 2012 and 2011, GEEA incurred expenses of $2,000 and $112,000, respectively, for subscription agreement processing services that our former transfer agent provided to us. As an other organizational and offering expense, these subscription agreement processing expenses became our liability since cumulative other organizational and offering expenses did not exceed 1.0% of the gross proceeds from the sale of shares of our common stock in our initial offering, other than shares of our common stock sold pursuant to the DRIP.
Compensation for Additional Services
Effective as of January 7, 2012, our sub-advisor and its affiliates are paid for services performed for us other than those required to be rendered by our sub-advisor or its affiliates under the Advisory Agreement. The rate of compensation for these services has to be approved by a majority of our board of directors, including a majority of our independent directors, and cannot exceed an amount that would be paid to unaffiliated parties for similar services. For the years ended December 31, 2013 and 2012, our sub-advisor and its affiliates were not compensated for any additional services.
Until January 6, 2012, our former advisor or its affiliates were also entitled to compensation for additional services under similar conditions. For the years ended December 31, 2012 and 2011, we incurred expenses of $0 and $65,000, respectively, for internal controls compliance services our former advisor or its affiliates provided to us.
Liquidity Stage
Disposition Fees
Effective as of January 7, 2012, for services relating to the sale of one or more properties, our sub-advisor or its affiliates are paid a disposition fee up to the lesser of 2.0% of the contract sales price or 50.0% of a customary competitive real estate commission given the circumstances surrounding the sale, in each case as determined by our board of directors, including a majority of our independent directors, upon the provision of a substantial amount of the services in the sales effort. The amount

134
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)



of disposition fees paid, when added to the real estate commissions paid to unaffiliated parties, will not exceed the lesser of the customary competitive real estate commission or an amount equal to 6.0% of the contract sales price. For the years ended December 31, 2013 and 2012, we did not incur any disposition fees to our sub-advisor or its affiliates.
Until January 6, 2012, our former advisor or its affiliates would have been entitled to similar disposition fees. We did not incur any disposition fees to our former advisor or its affiliates.
Subordinated Participation Interest
Subordinated Distribution of Net Sales Proceeds
Effective as of January 7, 2012, in the event of liquidation, our sub-advisor will be paid a subordinated distribution of net sales proceeds. The distribution will be equal to 15.0% of the net proceeds from the sales of properties, subject to certain reductions relating to properties acquired prior to Griffin-American Advisor's appointment as our advisor, as set forth in the operating partnership agreement, after distributions to our stockholders, in the aggregate, of (i) a full return of capital raised from stockholders (less amounts paid to repurchase shares of our common stock pursuant to our share repurchase plan) plus (ii) an annual 8.0% cumulative, non-compounded return on the gross proceeds from the sale of shares of our common stock, as adjusted for distributions of net sale proceeds. Actual amounts to be received depend on the sale prices of properties upon liquidation. For the years ended December 31, 2013 and 2012, we did not incur any such distributions to our sub-advisor.
Until January 6, 2012, our former advisor would have been entitled to a similar subordinated distribution of net sales proceeds. We did not incur any subordinated distribution of net sales proceeds to our former advisor.
Subordinated Distribution upon Listing
Effective as of January 7, 2012, upon the listing of shares of our common stock on a national securities exchange, our sub-advisor will be paid a distribution equal to 15.0% of the amount by which (i) the market value of our outstanding common stock at listing plus distributions paid prior to listing exceeds (ii) the sum of the total amount of capital raised from stockholders (less amounts paid to repurchase shares of our common stock pursuant to our share repurchase plan) and the amount of cash that, if distributed to stockholders as of the date of listing, would have provided them an annual 8.0% cumulative, non-compounded return on the gross proceeds from the sale of shares of our common stock through the date of listing, subject to certain reductions relating to properties acquired prior to Griffin-American Advisor's appointment as our advisor, as set forth in the operating partnership agreement. Actual amounts to be received depend upon the market value of our outstanding stock at the time of listing among other factors. For the years ended December 31, 2013 and 2012, we did not incur any such distributions to our sub-advisor.
Until January 6, 2012, our former advisor would have been entitled to a similar subordinated distribution upon listing. We did not incur any subordinated distribution upon listing to our former advisor.
Subordinated Distribution Upon Termination
Upon termination or non-renewal of the Advisory Agreement, our sub-advisor will be entitled to a subordinated distribution from our operating partnership equal to 15.0% of the amount, if any, by which (i) the appraised value of our assets on the termination date, less any indebtedness secured by such assets, plus total distributions paid through the termination date, exceeds (ii) the sum of the total amount of capital raised from stockholders (less amounts paid to repurchase shares of our common stock pursuant to our share repurchase plan) and the total amount of cash that, if distributed to them as of the termination date, will provide them an annual 8.0% cumulative, non-compounded return on the gross proceeds from the sale of shares of our common stock through the termination date, subject to certain reductions relating to properties acquired prior to Griffin-American Advisor's appointment as our advisor.
As of December 31, 2013 and 2012, we had not recorded any charges to earnings related to the subordinated distribution upon termination.
Executive Stock Purchase Plans
On April 7, 2011, our Chairman of the Board of Directors and Chief Executive Officer, Jeffrey T. Hanson, and our President and Chief Operating Officer, Danny Prosky, each executed an executive stock purchase plan, or the G&E Plan, whereby each executive had irrevocably agreed to invest 100% and 50.0%, respectively, of their net after-tax cash compensation as employees of our sponsor directly into our company by purchasing shares of our common stock on a regular basis, corresponding to regular payroll periods and the payment of any other net after-tax cash compensation, including

135
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)



bonuses. Their first investment under the G&E Plan began with their regularly scheduled payroll payment on April 29, 2011 and was to terminate on the earlier of (i) December 31, 2011, (ii) the termination of our initial offering, (iii) any suspension of our initial offering by our board of directors or regulatory body, or (iv) the date upon which the number of shares of our common stock owned by Mr. Hanson or Mr. Prosky, when combined with all their other investments in our common stock, exceeds the ownership limits set forth in our charter. The shares were purchased pursuant to our initial offering at a price of $9.00 per share, reflecting the elimination of selling commissions and the dealer manager fee in connection with such transactions.
On November 7, 2011, Messrs. Hanson and Prosky tendered their resignations from our former sponsor. On December 30, 2011, Messrs. Hanson and Prosky, as well as our Executive Vice President, General Counsel, Mathieu B. Streiff, each executed a stock purchase plan effective January 1, 2012, whereby each executive irrevocably agreed to invest 100%, 50.0% and 50.0%, respectively, of all of their net after-tax salary and cash bonus compensation that was earned on or after February 1, 2012 as employees of American Healthcare Investors directly into our company by purchasing shares of our common stock. In January 2012, our Chief Financial Officer, Shannon K S Johnson; our Senior Vice President of Acquisitions, Stefan K.L. Oh; and our Secretary, Cora Lo also entered into stock purchase plans in which they each irrevocably agreed to invest 15.0%, 15.0% and 10.0%, respectively, of their net after-tax base salaries that were earned on or after February 1, 2012 as employees of American Healthcare Investors directly into our company by purchasing shares of our common stock. Such arrangements terminated on December 31, 2012. The shares were purchased pursuant to our initial offering at a price of $9.00 per share prior to November 7, 2012 and $9.20 per share on or after November 7, 2012 reflecting the offering price in effect on the date of each stock purchase, exclusive of selling commissions and the dealer manager fee.
Effective January 1, 2013, Messrs. Hanson, Prosky, Streiff and Oh and Mses. Johnson and Lo each adopted an executive stock purchase plan, or the Executive Stock Purchase Plans, on terms similar to each of the stock purchase plans described above. The Executive Stock Purchase Plans each were to terminate on the earlier of (i) December 31, 2013, (ii) the termination of our offerings, (iii) any suspension of our offerings by our board of directors or a regulatory body, or (iv) the date upon which the number of shares of our common stock owned by such person, when combined with all their other investments in our common stock, exceeds the ownership limits set forth in our charter. In connection with the termination of our follow-on offering on October 30, 2013, the Executive Stock Purchase Plans also terminated.
For the years ended December 31, 2013, 2012 and 2011, our executive officers invested the following amounts and we issued the following shares of our common stock pursuant to the applicable stock purchase plan:
 
 
 
 
Years Ended December 31,
 
 
 
 
2013
 
2012
 
2011
Officer's Name
 
Title
 
Amount
 
Shares
 
Amount
 
Share
 
Amount
 
Share
Jeffrey T. Hanson
 
Chairman of the Board of Directors and Chief Executive Officer
 
$
184,000

 
20,010

 
$
201,000

 
22,356

 
$
121,000

 
13,436

Danny Prosky
 
President and Chief Operating Officer
 
105,000

 
11,396

 
115,000

 
12,793

 
93,000

 
10,313

Mathieu B. Streiff
 
Executive Vice President, General Counsel
 
100,000

 
10,886

 
109,000

 
12,099

 
—

 
—

Shannon K S Johnson
 
Chief Financial Officer
 
16,000

 
1,735

 
17,000

 
1,889

 
—

 
—

Stefan K.L. Oh
 
Senior Vice President of Acquisitions
 
14,000

 
1,547

 
18,000

 
1,986

 
—

 
—

Cora Lo
 
Secretary
 
9,000

 
998

 
10,000

 
1,142

 
—

 
—

 
 
 
 
$
428,000

 
46,572

 
$
470,000

 
52,265

 
$
214,000

 
23,749








136
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)



Accounts Payable Due to Affiliates
The following amounts were outstanding to our affiliates as of December 31, 2013 and 2012:
 
 
December 31,
Fee
 
2013
 
2012
Asset and property management fees
 
$
2,201,000

 
$
1,109,000

Construction management fees
 
94,000

 
40,000

Lease commissions
 
83,000

 
364,000

Offering costs
 
28,000

 
277,000

Acquisition fees
 
—

 
16,000

Operating expenses
 
1,000

 
1,000

 
 
$
2,407,000

 
$
1,807,000

13. Equity
Preferred Stock
Our charter authorizes us to issue 200,000,000 shares of our preferred stock, par value $0.01 per share. As of December 31, 2013 and 2012, no shares of preferred stock were issued and outstanding.
Common Stock
Our charter authorizes us to issue 1,000,000,000 shares of our common stock. Until November 6, 2012, we offered to the public up to $3,000,000,000 of shares of our common stock for $10.00 per share in our primary offering and $285,000,000 of shares of our common stock pursuant to our DRIP for $9.50. On November 7, 2012, we began selling shares of our common stock in our initial offering at $10.22 per share in our primary offering and issuing shares pursuant to the DRIP for $9.71 per share. On February 14, 2013, we terminated our initial offering.
On February 14, 2013, we commenced our follow-on offering of up to $1,650,000,000 of shares of our common stock, in which we initially offered to the public up to $1,500,000,000 of shares of our common stock for $10.22 per share in our primary offering and up to $150,000,000 of shares of our common stock for $9.71 per share pursuant to the DRIP. We reserved the right to reallocate the shares of common stock we offered in our follow-on offering between the primary offering and the DRIP. As such, during our follow-on offering, we reallocated an aggregate of $107,200,000 of shares from the DRIP to the primary offering. Accordingly, we offered to the public $1,607,200,000 in our primary offering and $42,800,000 of shares of our common stock pursuant to the DRIP. On October 30, 2013, we terminated our follow-on offering.
On September 9, 2013, we filed a Registration Statement on Form S-3 under the Securities Act to register a maximum of $100,000,000 of additional shares of our common stock pursuant to the Secondary DRIP. The Registration Statement on Form S-3 was automatically effective with the SEC upon its filing; however, we did not commence offering shares pursuant to the Secondary DRIP until October 30, 2013 following the termination of our follow-on offering.
On February 4, 2009, our former advisor purchased 20,000 shares of common stock for total cash consideration of $200,000 and was admitted as our initial stockholder. We used the proceeds from the sale of shares of our common stock to our former advisor to make an initial capital contribution to our operating partnership. We subsequently repurchased the 20,000 shares of our common stock from our former advisor in February 2012 in connection with our transition to our co-sponsors.
On January 4, 2012, Griffin-American Advisor acquired 22,222 shares of our common stock for $200,000.
Through December 31, 2013, we granted an aggregate of 67,500 shares of our restricted common stock to our independent directors. Through December 31, 2013, we had issued 280,801,806 shares of our common stock in connection with our offerings, 10,504,674 shares of our common stock pursuant to the DRIP and the Secondary DRIP and 88,271 shares of our common stock for property acquisition fees that were issued after the termination of our follow-on offering. We had also repurchased 1,481,233 shares of our common stock under our share repurchase plan through December 31, 2013. As of December 31, 2013 and 2012, we had 290,003,240 and 113,199,988 shares of our common stock issued and outstanding, respectively.


137
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)



Offering Costs
Selling Commissions
Initial Offering
Effective as of January 7, 2012, our dealer manager received selling commissions of up to 7.0% of the gross offering proceeds from the sale of shares of our common stock in our initial offering other than shares of our common stock sold pursuant to the DRIP. Our dealer manager could have re-allowed all or a portion of these fees to participating broker-dealers. For the years ended December 31, 2013 and 2012, we incurred $9,102,000 and $41,633,000, respectively, in selling commissions to our dealer manager. Such commissions were charged to stockholders' equity as such amounts were paid to our dealer manager from the gross proceeds of our initial offering.
Follow-On Offering
Pursuant to our follow-on offering, which commenced February 14, 2013 and terminated on October 30, 2013, our dealer manager received selling commissions of up to 7.0% of the gross offering proceeds from the sale of shares of our common stock other than shares of our common stock sold pursuant to the DRIP. Our dealer manager could have re-allowed all or a portion of these fees to participating broker-dealers. For the year ended December 31, 2013, we incurred $107,191,000 in selling commissions to our dealer manager. Such selling commissions were charged to stockholders’ equity as such amounts were reimbursed to our dealer manager from the gross proceeds of our follow-on offering.

Dealer Manager Fee
Initial Offering
Effective as of January 7, 2012, our dealer manager received a dealer manager fee of up to 3.0% of the gross offering proceeds from the sale of shares of our common stock in our initial offering other than shares of our common stock sold pursuant to the DRIP. Our dealer manager could have re-allowed all or a portion of these fees to participating broker-dealers. For the years ended December 31, 2013 and 2012, we incurred $3,981,000 and $18,356,000, respectively, in dealer manager fees to our dealer manager. Such fees were charged to stockholders' equity as such amounts were paid to our dealer manager from the gross proceeds of our initial offering.
Follow-On Offering

Pursuant to our follow-on offering, which commenced February 14, 2013 and terminated on October 30, 2013, our dealer manager received a dealer manager fee of up to 3.0% of the gross offering proceeds from the sale of shares of our common stock other than shares of our common stock sold pursuant to the DRIP. Our dealer manager could have re-allowed all or a portion of the dealer manager fee to participating broker-dealers. For the year ended December 31, 2013, we incurred $47,825,000 in dealer manager fees to our dealer manager. Such fees were charged to stockholders' equity as such amounts were paid to our dealer manager from the gross proceeds of our follow-on offering.
Accumulated Other Comprehensive Income
The changes in accumulated other comprehensive income net of noncontrolling interests by component consisted of the following for the year December 31, 2013:
 
Gains on Intra-Entity Foreign Currency Transactions That Are of a Long-Term Investment Nature
 
Foreign Currency Translation Adjustments
 
Total
Balance — December 31, 2012
$
—

 
$
—

 
$
—

Net change in current period
22,037,000

 
739,000

 
22,776,000

Balance — December 31, 2013
$
22,037,000

 
$
739,000

 
$
22,776,000

Noncontrolling Interests
On February 4, 2009, our former advisor made an initial capital contribution of $2,000 to our operating partnership in exchange for 200 limited partnership units. On January 4, 2012, Griffin-American Advisor contributed $2,000 to acquire 200 limited partnership units of our operating partnership. On September 14, 2012, we entered into an agreement whereby we

138
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)



purchased all of the limited partnership interests held by our former advisor in our operating partnership. Between December 31, 2012 and July 16, 2013, 12 investors contributed their interests in 15 buildings in exchange for 281,600 limited partnership units in our operating partnership at an offering price per unit of $9.50. Pursuant to the operating partnership agreement, each limited partnership unit may be exchanged, at any time on or after the first anniversary date of the issuance, on a one-for-one basis for shares of our common stock, or, at our option, cash equal to the value of an equivalent number of shares of our common stock, or any combination of both. Each limited partnership unit is also entitled to distributions in an amount equal to the per share distributions declared on shares of our common stock.
As of December 31, 2013 and 2012, we owned greater than a 99.90% and 99.96%, respectively, general partnership interest in our operating partnership and our limited partners owned less than a 0.10% and 0.04%, respectively, limited partnership interest in our operating partnership. As such, less than 0.10% and 0.04%, respectively, of the earnings of our operating partnership for the years ended December 31, 2013 and 2012 were allocated to noncontrolling interests, subject to certain limitations.
In addition, as of December 31, 2012, we owned a 98.75% interest in the consolidated limited liability company that owns the Pocatello East MOB property. As such, 1.25% of the earnings of the Pocatello East MOB property were allocated to noncontrolling interests for the year ended December 31, 2012.
On December 31, 2013, we purchased the remaining 1.25% noncontrolling interest in the consolidated limited liability company that owns Pocatello East Medical Office Building, or the Pocatello East MOB property, that was purchased on July 27, 2010. The difference in the amount we paid and the noncontrolling interest balance on the acquisition date was reflected as an adjustment to additional paid-in capital in our accompanying consolidated balance sheets with no gain or loss recognized. As such, 1.25% of the earnings of the Pocatello East MOB property were allocated to noncontrolling interests during 2012 and 2013 through the date of purchase of the noncontrolling interest.
Distribution Reinvestment Plan
We adopted the DRIP that allows stockholders to purchase additional shares of our common stock through the reinvestment of distributions at an offering price equal to 95.0% of the primary offering price of our offerings, subject to certain conditions. On September 9, 2013, we filed a Registration Statement on Form S-3 under the Securities Act to register a maximum of $100,000,000 of additional shares of our common stock pursuant to the Secondary DRIP. We commenced offering shares under the Secondary DRIP on October 30, 2013 following the termination of our follow-on offering.
For the years ended December 31, 2013, 2012 and 2011, $67,905,000, $22,622,000 and $8,817,000, respectively, in distributions were reinvested and 6,993,254, 2,374,407 and 928,058 shares of our common stock, respectively, were issued pursuant to the DRIP and the Secondary DRIP. As of December 31, 2013 and 2012, a total of $101,329,000 and $33,424,000, respectively, in distributions were reinvested and 10,504,674 and 3,511,420 shares of our common stock, respectively, were issued pursuant to the DRIP and the Secondary DRIP. Effective as of November 7, 2012, in connection with the change to the offering price per share of our common stock in our initial offering, we amended the DRIP to issue shares pursuant to the DRIP for $9.71 per share.
Share Repurchase Plan
Our board of directors has approved a share repurchase plan. Our share repurchase plan allows for repurchases of shares of our common stock by us when certain criteria are met. Share repurchases will be made at the sole discretion of our board of directors. All repurchases are subject to a one-year holding period, except for repurchases made in connection with a stockholder’s death or “qualifying disability,” as defined in our share repurchase plan. Subject to the availability of the funds for share repurchases, we will limit the number of shares of our common stock repurchased during any calendar year to 5.0% of the weighted average number of shares of our common stock outstanding during the prior calendar year; provided, however, that shares subject to a repurchase requested upon the death of a stockholder will not be subject to this cap. Funds for the repurchase of shares of our common stock will come exclusively from the cumulative proceeds we receive from the sale of shares of our common stock pursuant to the DRIP and the Secondary DRIP.
Until December 7, 2012, under our share repurchase plan, repurchase prices ranged from $9.25, or 92.5% of the price paid per share, following a one year holding period to an amount not less than 100% of the price paid per share following a four year holding period. On November 6, 2012, our board of directors approved an Amended and Restated Share Repurchase Plan, whereby all shares repurchased on or after December 7, 2012 would be repurchased at 92.5% to 100% of each stockholder's repurchase amount depending on the period of time their shares have been held. Pursuant to the Amended and Restated Share Repurchase Plan, at any time we are engaged in an offering of shares of our common stock, the repurchase amount for shares

139
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)



repurchased under our share repurchase plan will always be equal to or lower than the applicable per share offering price. However, if shares of our common stock are to be repurchased in connection with a stockholder's death or qualifying disability, the repurchase price will be no less than 100% of the price paid to acquire the shares of our common stock from us. Furthermore, our share repurchase plan provides that if there are insufficient funds to honor all repurchase requests, pending requests will be honored among all requests for repurchase in any given repurchase period, as follows: first, pro rata as to repurchases sought upon a stockholder's death; next, pro rata as to repurchases sought by stockholders with a qualifying disability; and, finally, pro rata as to other repurchase requests.
For the years ended December 31, 2013, 2012 and 2011, we received share repurchase requests and repurchased 925,094, 407,337 and 127,802 shares of our common stock, respectively, for an aggregate of $8,938,000, $3,953,000 and $1,198,000, respectively, at an average repurchase price of $9.66, $9.70 and $9.38 per share, respectively. All shares were repurchased using proceeds we received from the sale of shares of our common stock pursuant to the DRIP and the Secondary DRIP.
As of December 31, 2013 and 2012, we had received share repurchase requests and had repurchased 1,481,233 shares of our common stock for an aggregate of $14,299,000 at an average price of $9.65 per share and 556,139 shares of our common stock for an aggregate of $5,361,000 at an average price of $9.64, respectively, using proceeds we received from the sale of shares of our common stock pursuant to the DRIP and the Secondary DRIP.
2009 Incentive Plan
We adopted our incentive plan, pursuant to which our board of directors or a committee of our independent directors may make grants of options, restricted shares of common stock, stock purchase rights, stock appreciation rights or other awards to our independent directors, employees and consultants. The maximum number of shares of our common stock that may be issued pursuant to our incentive plan is 2,000,000.
On October 21, 2009, we granted an aggregate of 15,000 shares of our restricted common stock, as defined in our incentive plan, to our independent directors in connection with their initial election to our board of directors, of which 20.0% vested on the grant date and 20.0% will vest on each of the first four anniversaries of the date of grant. On each of June 8, 2010, June 14, 2011, November 7, 2012 and December 5, 2013 in connection with their re-election, we granted an aggregate of 7,500, 7,500, 15,000 and 15,000 shares, respectively, of our restricted common stock, as defined in our incentive plan, to our independent directors, which will vest over the same period described above. In addition, on November 7, 2012, we granted an aggregate of 7,500 shares of restricted common stock, as defined in our incentive plan, to our independent directors in consideration of the directors' determination of market compensation for independent directors of similar publicly registered real estate investment trusts. These shares of restricted common stock vest under the same period described above. The fair value of each share at the date of grant was estimated at $10.00 or $10.22 per share, as applicable, the then most recent price paid to acquire a share of our common stock in our offerings; and with respect to the initial 20.0% of shares of our restricted common stock that vested on the date of grant, expensed as compensation immediately, and with respect to the remaining shares of our restricted common stock, amortized on a straight-line basis over the vesting period. Shares of our restricted common stock may not be sold, transferred, exchanged, assigned, pledged, hypothecated or otherwise encumbered. Such restrictions expire upon vesting. Shares of our restricted common stock have full voting rights and rights to distributions. For the years ended December 31, 2013, 2012 and 2011, we recognized compensation expense of $133,000, $115,000 and $66,000, respectively, related to the restricted common stock grants ultimately expected to vest. ASC Topic 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. For the years ended December 31, 2013, 2012 and 2011, we did not assume any forfeitures. Stock compensation expense is included in general and administrative in our accompanying consolidated statements of operations and comprehensive income (loss).
As of December 31, 2013 and 2012, there was $280,000 and $260,000, respectively, of total unrecognized compensation expense, net of estimated forfeitures, related to nonvested shares of our restricted common stock. This expense is expected to be recognized over a remaining weighted average period of 2.99 years.

As of December 31, 2013 and 2012, the weighted average grant date fair value of the nonvested shares of our restricted common stock was $306,000 and $289,000, respectively. A summary of the status of the nonvested shares of our restricted common stock as of December 31, 2013, 2012, 2011 and 2010, and the changes for the years ended December 31, 2013, 2012 and 2011, is presented below:

140
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)



 
Number of Nonvested
Shares of our
Restricted Common Stock
 
Weighted
Average Grant
Date Fair Value
Balance — December 31, 2010
15,000

 
$
10.00

Granted
7,500

 
$
10.00

Vested
(6,000
)
 
$
10.00

Forfeited
—

 
—

Balance — December 31, 2011
16,500

 
$
10.00

Granted
22,500

 
$
10.22

Vested
(10,500
)
 
$
10.09

Forfeited
—

 
—

Balance — December 31, 2012
28,500

 
$
10.14

Granted
15,000

 
$
10.22

Vested
(13,500
)
 
$
10.12

Forfeited
—

 
—

Balance — December 31, 2013
30,000

 
$
10.19

Expected to vest — December 31, 2013
30,000

 
$
10.19

14. Fair Value Measurements
Assets and Liabilities Reported at Fair Value
The table below presents our assets and liabilities measured at fair value on a recurring basis as of December 31, 2013, aggregated by the level in the fair value hierarchy within which those measurements fall.
 
Quoted Prices in
Active Markets for
Identical Assets
and Liabilities
(Level 1)
 
Significant Other
Observable Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
Total
Liabilities:
 
 
 
 
 
 
 
Interest rate swaps
$
—

 
$
451,000

 
$
—

 
$
451,000

Foreign currency forward contract
—

 
16,489,000

 
—

 
16,489,000

Contingent consideration obligations
—

 
—

 
4,675,000

 
4,675,000

Total liabilities at fair value
$
—

 
$
16,940,000

 
$
4,675,000

 
$
21,615,000


The table below presents our assets and liabilities measured at fair value on a recurring basis as of December 31, 2012, aggregated by the level in the fair value hierarchy within which those measurements fall.
 
Quoted Prices in
Active Markets for
Identical Assets
and Liabilities
(Level 1)
 
Significant Other
Observable Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
Total
Liabilities:
 
 
 
 
 
 
 
Interest rate swaps
$
—

 
$
795,000

 
$
—

 
$
795,000

Contingent consideration obligations
—

 
—

 
60,204,000

 
60,204,000

Total liabilities at fair value
$
—

 
$
795,000

 
$
60,204,000

 
$
60,999,000


There were no transfers into and out of fair value measurement levels during the years ended December 31, 2013, 2012 and 2011.
Derivative Financial Instruments
We use interest rate swaps to manage interest rate risk associated with floating rate debt and foreign currency forward contracts to mitigate the effects of foreign currency fluctuations. The valuation of these instruments is determined using widely

141
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)



accepted valuation techniques including a discounted cash flow analysis on the expected cash flows of each derivative. This analysis reflects the contractual terms of the derivatives, including the period to maturity, and uses observable market-based inputs, including interest rate curves, spot and forward rates, as well as option volatility. The fair values of interest rate swaps and foreign currency forward contracts are determined using the market standard methodology of netting the discounted future fixed cash payments and the discounted expected variable cash receipts. The variable cash receipts are based on an expectation of future interest rates or foreign currency exchange rates (forward curves) derived from observable market interest rate curves and foreign currency exchange rates curves, as applicable.
To comply with the provisions of ASC Topic 820, we incorporate credit valuation adjustments to appropriately reflect both our own nonperformance risk and the respective counterparty’s nonperformance risk in the fair value measurements. In adjusting the fair value of our derivative contracts for the effect of nonperformance risk, we have considered the impact of netting and any applicable credit enhancements, such as collateral postings, thresholds, mutual puts and guarantees.
Although we have determined that the majority of the inputs used to value our interest rate swaps and foreign currency forward contracts fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with these instruments utilize Level 3 inputs, such as estimates of current credit spreads, to evaluate the likelihood of default by us and our counterparty. However, as of December 31, 2013 and 2012, we have assessed the significance of the impact of the credit valuation adjustments on the overall valuation of our derivative positions and have determined that the credit valuation adjustments are not significant to the overall valuation of our interest rate swaps and foreign currency forward contracts. As a result, we have determined that our interest rate swaps and foreign currency forward contracts valuations in their entirety are classified in Level 2 of the fair value hierarchy.
Contingent Consideration
Assets
On December 22, 2011, we purchased Sierra Providence East Medical Plaza I and in connection with such purchase we recognized $115,000 as a contingent consideration asset as of December 31, 2011. We would have received such consideration to the extent a tenant in approximately 2,000 square feet of GLA did not pay their rental payments to us over the remaining term of their lease, which would have expired in April 2014. The range of payment to us was between $0 and up to a maximum of $115,000. In May 2012, a new tenant assumed the existing lease and pursuant to the agreement with the seller, we received $2,000 and the remaining funds held in escrow of $113,000 were released to the seller.
On September 27, 2012, we purchased the last building of the Silver Star MOB Portfolio and in connection with such purchase we subsequently received $8,000 from the seller as satisfaction of the contingent consideration asset, as two tenants occupied their units at dates subsequent to when originally anticipated at the date of acquisition.

Obligations
In connection with our property acquisitions, we have accrued $4,675,000 and $60,204,000 as contingent consideration obligations as of December 31, 2013 and 2012, respectively. Such consideration will be paid upon various conditions being met including our tenants achieving certain rent coverage ratios, completing renovation projects or sellers' leasing of unoccupied space. Of the amount accrued as of December 31, 2013, $3,208,000 relates to our acquisition of Pacific Northwest Senior Care Portfolio on August 24, 2012 and $1,467,000 relates to various other property acquisitions. Of the amount accrued as of December 31, 2012, $52,585,000 relates to our acquisition of Philadelphia SNF Portfolio on June 30, 2011, $5,492,000 relates to our acquisition of Pacific Northwest Senior Care Portfolio and $2,127,000 relates to various other property acquisitions.
For the year ended December 31, 2012, we recorded an increase in the obligation related to Philadelphia SNF Portfolio of $50,739,000 based on the tenant's significant improvement in the specified rent coverage ratio for the six and twelve months ended December 31, 2012. For the year ended December 31, 2013, we recorded an additional increase in the obligation related to Philadelphia SNF Portfolio of $458,000, and we subsequently paid $53,043,000 to settle the obligation. Such payments resulted in an increase in the monthly rent charged to the tenant and additional rental revenue to us.
We could be required to pay up to $6,525,000 in contingent consideration with respect to our acquisition of Pacific Northwest Senior Care Portfolio. The first $4,700,000 of such contingent consideration can be paid immediately following the acquisition date upon notification that improvements up to such dollar amount have been completed by the tenant. The remaining portion of up to $1,825,000 could be paid within three years from the acquisition date provided that (i) the tenant has achieved a certain specified rent coverage ratio computed in the aggregate for the six most recent calendar months and (ii) the tenant has completed additional improvements in an amount up to $1,825,000. The range of payment is between $0 and up to a

142
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)



maximum of $6,525,000; however, such payment will result in an increase in the monthly rent charged to the tenant and additional rental revenue to us. We have assumed that the tenant will use and request the first $4,700,000 for the improvements and that the tenant will achieve the required rent coverage ratios for six consecutive months to qualify for the additional $1,825,000. As of December 31, 2013, we have made payments of $3,317,000 towards this obligation.

Unobservable Inputs and Reconciliation
The fair value of the contingent consideration is determined based on the facts and circumstances existing at each reporting date and the likelihood of the counterparty achieving the necessary conditions based on a probability weighted discounted cash flow analysis based, in part, on significant inputs which are not observable in the market. As a result, we have determined that our contingent consideration valuations are classified in Level 3 of the fair value hierarchy. Our contingent consideration assets are included in other assets, net and our contingent consideration obligations are included in security deposits, prepaid rent and other liabilities in our accompanying consolidated balance sheets and any changes in their fair value subsequent to their acquisition date valuations are charged to earnings. Gains and losses recognized on contingent consideration assets and obligations are included in acquisition related expenses in our accompanying consolidated statements of operations and comprehensive income (loss).
The following table shows quantitative information about unobservable inputs related to Level 3 fair value measurements used as of December 31, 2013 and 2012 for our most significant contingent consideration obligations:
Property
 
Fair Value as of December 31, 2013
 
Fair Value as of December 31, 2012
 
Unobservable Inputs
 
 Range of Inputs/Inputs
Philadelphia SNF Portfolio(1)
 
$
—

 
$
52,142,000

 
Tenant's Earnings, as Defined, for the 12 Months Prior to Payment
 
$19,359,000
 
 
 
 
 
 
Timing of Payment
 
June 30, 2013
 
 
 
 
 
 
Market Multiplier Rate, as Defined
 
14.44%
 
 
 
 
 
 
Percentage of Eligible Payment Requested
 
100%
Philadelphia SNF Portfolio(2)
 
$
—

 
$
443,000

 
Achieve Required Lease Coverage Ratios
 
Yes
 
 
 
 
 
 
Percentage of Eligible Payment Requested
 
100%
Pacific Northwest Senior Care Portfolio(3)
 
$
3,208,000

 
$
5,492,000

 
Achieve Required Lease Coverage Ratios
 
Yes
 
 
 
 
 
 
Total Estimated Cost of Tenant Improvements
 
$6,525,000
 
 
 
 
 
 
Percentage of Eligible Payment Requested
 
100%
___________
Significant increases or decreases in any of the unobservable inputs in isolation in the aggregate would result in a significantly higher or lower fair value measurement to each contingent consideration obligation as of December 31, 2013 and 2012. Lastly, if the counterparty requests something less than 100% of the eligible payment, which they have the right to do so, then the fair value would decrease.

(1)
The most significant input to the valuation was the tenant's earnings, as defined in the agreement. An increase (decrease) in the assumed earnings would have increased (decreased) the fair value. An increase (decrease) in the projected timing of the payment would have decreased (increased) the fair value and an increase (decrease) in the market multiplier rate would have generally decreased (increased) the fair value, although such input at the then current level did not impact the calculation due to other limiting observable inputs.

(2)
If the lease coverage ratio was not met, then the fair value would have decreased to $0.

(3)
If the lease coverage ratio is not met for Pacific Northwest Senior Care Portfolio, then the fair value would decrease to $1,383,000 and $3,667,000 as of December 31, 2013 and 2012, respectively. A decrease in the total cost of the tenant improvements would decrease the fair value of the tenant improvement allowance. An increase in the total cost of the tenant improvements would have no impact on the payment.

143
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)



The following is a reconciliation of the beginning and ending balances of our contingent consideration assets and obligations for the years ended December 31, 2013, 2012 and 2011:
 
Years Ended December 31,
 
2013
 
2012
 
2011
Contingent Consideration Assets:
 
 
 
 
 
Beginning balance
$
—

 
$
115,000

 
$
—

Realized/unrealized losses recognized in earnings
—

 
(105,000
)
 
—

Settlements of assets
—

 
(10,000
)
 
115,000

Ending balance
$
—

 
$
—

 
$
115,000

Amount of total gains (losses) included in earnings attributable to the change in unrealized gains (losses) related to assets still held
$
—

 
$
—

 
$
—

 
 
 
 
 
 
Contingent Consideration Obligations:
 
 
 
 
 
Beginning balance
$
60,204,000

 
$
6,058,000

 
$
—

Additions to contingent consideration obligations
682,000

 
8,591,000

 
6,058,000

Realized/unrealized losses recognized in earnings
134,000

 
50,145,000

 
—

Settlements of obligations
(56,345,000
)
 
(4,590,000
)
 
—

Ending balance
$
4,675,000

 
$
60,204,000

 
$
6,058,000

Amount of total (gains) losses included in earnings attributable to the change in unrealized (gains) losses related to obligations still held
$
(78,000
)
 
$
50,801,000

 
$
—

Financial Instruments Disclosed at Fair Value
ASC Topic 825, Financial Instruments, requires disclosure of the fair value of financial instruments, whether or not recognized on the face of the balance sheet. Fair value is defined under ASC Topic 820.
Our accompanying consolidated balance sheets include the following financial instruments: real estate notes receivable, net, cash and cash equivalents, accounts and other receivables, net, restricted cash, real estate and escrow deposits, accounts payable and accrued liabilities, accounts payable due to affiliates, mortgage loans payable, net and borrowings under our unsecured line of credit.
We consider the carrying values of real estate notes receivable, net, cash and cash equivalents, accounts and other receivables, net, restricted cash, real estate and escrow deposits, accounts payable and accrued liabilities to approximate the fair value for these financial instruments because of the short period of time since origination or the short period of time between origination of the instruments and their expected realization. The fair value of accounts payable due to affiliates is not determinable due to the related party nature of the accounts payable.
The fair value of the mortgage loans payable and our unsecured line of credit is estimated using a discounted cash flow analysis using borrowing rates available to us for debt instruments with similar terms and maturities. As of December 31, 2013 and 2012, the fair value of the mortgage loans payable was $324,930,000 and $308,472,000, respectively, compared to the carrying value of $329,476,000 and $291,052,000, respectively. The fair value of our unsecured line of credit as of December 31, 2013 and 2012 was $68,243,000 and $199,780,000, respectively, compared to the carrying value of $68,000,000 and $200,000,000, respectively. We have determined that the mortgage loans payable and our unsecured line of credit valuations are classified as Level 2 within the fair value hierarchy.
15. Income Taxes and Distributions
As a REIT, we generally will not be subject to federal income tax on taxable income that we distribute to our stockholders. We have elected to treat certain of our consolidated subsidiaries as TRSs pursuant to the Code. TRSs may participate in services that would otherwise be considered impermissible for REITs and are subject to federal and state income tax at regular corporate tax rates.

144
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)



We did not incur income taxes for the years ended December 31, 2012 and 2011. Components of income (loss) before taxes for the year ended December 31, 2013 was as follows:
 
2013
Domestic
$
9,574,000

Foreign
(1,514,000
)
Income before income taxes
$
8,060,000

The components of income tax expense (benefit) for the year ended December 31, 2013 was as follows:
 
2013
Federal deferred
$
43,000

State deferred
5,000

Foreign current
152,000

Foreign deferred
(1,205,000
)
Total income tax (benefit)
$
(1,005,000
)
Current Income Tax
Federal and state income taxes are generally a function of the level of income recognized by our TRSs. Foreign income taxes are generally a function of our income on our real estate investments located in the United Kingdom.
Deferred Taxes
Deferred income tax is generally a function of the period’s temporary differences (principally basis differences between tax and financial reporting for real estate assets and equity investments) and generation of tax net operating losses that may be realized in future periods depending on sufficient taxable income. For foreign income tax purposes, the UK Senior Housing Portfolio acquisition has been treated as a tax-free transaction resulting in a carry-over basis in assets and liabilities. In accordance with GAAP, we record all of the acquired assets and liabilities at the estimated fair values and recognize the deferred income tax liabilities that represent the tax effect of the difference between the tax basis carried over and the fair value of the assets at the date of this acquisition. If taxable income is generated in these subsidiaries, we recognize a deferred income tax benefit in earnings as a result of the reversal of the deferred income tax liability previously recorded at the acquisition date and we record current income tax expense representing the entire current income tax liability.
Any increases or decreases to the deferred income tax liability are reflected in income tax benefit in our consolidated statements of operations and comprehensive income (loss). We did not have any deferred taxes as of December 31, 2012. The components of deferred tax liabilities as of December 31, 2013 were as follows:
 
2013
Foreign – built-in-gains, real estate properties
$
47,635,000

Other – temporary differences
2,730,000

Total deferred tax liabilities
$
50,365,000


145
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)



Tax Treatment of Distributions
For federal income tax purposes, distributions to stockholders are characterized as ordinary income, capital gain distributions, or nontaxable distributions. Nontaxable distributions will reduce U.S. stockholders’ basis (but not below zero) in their shares. The income tax treatment for distributions reportable for the years ended December 31, 2013, 2012 and 2011, was as follows:
 
Years Ended December 31,
 
2013
 
2012
 
2011
Ordinary income
$
70,200,000

 
56
%
 
$
25,001,000

 
55
%
 
$
9,276,000

 
51
%
Capital gain
—

 
—

 
—

 
—

 
—

 
—

Return of capital
55,329,000

 
44

 
20,575,000

 
45

 
8,912,000

 
49

 
$
125,529,000

 
100
%
 
$
45,576,000

 
100
%
 
$
18,188,000

 
100
%
 
Amounts listed above do not include distributions paid on nonvested shares of our restricted common stock which have been separately reported.
16. Future Minimum Rent
Rental Income
We have operating leases with tenants that expire at various dates through 2033 and in some cases subject to scheduled fixed increases or adjustments based on a consumer price index. Generally, the leases grant tenants renewal options. Leases also provide for additional rents based on certain operating expenses. Future minimum base rent contractually due under operating leases, excluding tenant reimbursements of certain costs, as of December 31, 2013 for each of the next five years ending December 31 and thereafter is as follows:
Year
 
Amount
2014
 
$
215,352,000

2015
 
211,942,000

2016
 
205,771,000

2017
 
198,849,000

2018
 
191,104,000

Thereafter
 
1,606,590,000

 
 
$
2,629,608,000

Rental Expense
We have ground and other lease obligations that generally require fixed annual rental payments and may also include escalation clauses and renewal options. These leases expire at various dates through 2106, excluding extension options. Future minimum lease obligations under non-cancelable ground and other lease obligations as of December 31, 2013 for each of the next five years ending December 31 and thereafter is as follows:
Year
 
Amount
2014
 
$
997,000

2015
 
1,006,000

2016
 
1,019,000

2017
 
1,027,000

2018
 
1,060,000

Thereafter
 
52,331,000

 
 
$
57,440,000



146
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)



17. Business Combinations
2013
For the year ended December 31, 2013, we completed 19 property acquisitions comprising 82 buildings, which have been accounted for as business combinations. The aggregate purchase price was $812,575,000, plus closing costs and acquisition fees of $24,665,000, which are included in acquisition related expenses in our accompanying consolidated statements of operations and comprehensive income (loss). See Note 3, Real Estate Investments, Net, for a listing of the properties acquired, acquisition dates and the amount of financing initially incurred or assumed in connection with such acquisitions.
 
Results of operations for the property acquisitions are reflected in our accompanying consolidated statements of operations and comprehensive income (loss) for the year ended December 31, 2013 for the period subsequent to the acquisition date of each property through December 31, 2013. For the period from the acquisition date through December 31, 2013, we recognized the following amounts of revenue and net income for the property acquisitions:
Acquisition
 
Revenue
 
Net Income
2013 Acquisitions
 
$
24,504,000

 
$
3,434,000


The following summarizes the fair value of our 2013 property acquisitions at the time of acquisition:
 
2013 Acquisitions
 
Building and improvements
$
648,650,000

  
Land
56,548,000

 
Furniture, fixtures and equipment
3,740,000

  
In-place leases
53,240,000

  
Tenant relationships
51,171,000

  
Above market leases
6,923,000

 
Leasehold interest
972,000

  
Total assets acquired
821,244,000

  
Mortgage loans payable, net
(62,712,000
)
 
Below market leases
(4,672,000
)
 
Above market leasehold interests
(2,724,000
)
 
Other liabilities
(682,000
)
(1)
Total liabilities assumed
(70,790,000
)
 
Net assets acquired
$
750,454,000

  
                     
(1)
Included in other liabilities is $395,000 and $287,000 accrued for as contingent consideration in connection with the purchase of Lacombe MOB II and a building in the Central Indiana MOB Portfolio, respectively. See Note 14, Fair Value Measurements — Assets and Liabilities Reported at Fair Value — Contingent Consideration, for a further discussion.

Assuming the property acquisitions in 2013 discussed above had occurred on January 1, 2012, for the years ended December 31, 2013 and 2012, pro forma revenue, net income (loss), net income (loss) attributable to controlling interest and net income (loss) per common share attributable to controlling interest — basic and diluted would have been as follows:

147
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)



 
(Unaudited)
 
Years Ended December 31,
 
2013
 
2012
Revenue
$
306,371,000

 
$
227,491,000

Net income (loss)
$
49,569,000

 
$
(70,000,000
)
Net income (loss) attributable to controlling interest
$
49,514,000

 
$
(69,896,000
)
Net income (loss) per common share attributable to controlling interest — basic and diluted
$
0.18

 
$
(0.45
)

The pro forma adjustments assume that the debt proceeds and the offering proceeds, at a price of $10.00 per share, net of offering costs were raised as of January 1, 2012. In addition, as acquisition related expenses related to the acquisitions are not expected to have a continuing impact, they have been excluded from the pro forma results. The pro forma results are not necessarily indicative of the operating results that would have been obtained had the property acquisitions occurred at the beginning of the periods presented, nor are they necessarily indicative of future operating results.
2012
For the year ended December 31, 2012, we completed 23 property acquisitions comprising 82 buildings, which have been accounted for as business combinations. The aggregate purchase price was $810,971,000, plus closing costs and acquisition fees of $25,112,000, of which $24,887,000 was included in acquisition related expenses in our accompanying consolidated statements of operations and comprehensive income (loss) and $225,000 was capitalized as part of the measurement of the fair value of the tangible and identified intangible assets and liabilities of the properties and included in our accompanying consolidated balance sheets. See Note 3, Real Estate Investments, Net for a listing of the properties acquired, acquisition dates and the amount of financing initially incurred or assumed in connection with such acquisitions.
Results of operations for the property acquisitions are reflected in our accompanying consolidated statements of operations and comprehensive income (loss) for the year ended December 31, 2012 for the period subsequent to the acquisition date of each property through December 31, 2012. We present separately Southeastern SNF Portfolio, which is the one individually significant property acquisition during the year ended December 31, 2012, and aggregate the rest of the property acquisitions during the year ended December 31, 2012. For the period from the acquisition date through December 31, 2012, we recognized the following amounts of revenue and net income for the property acquisitions:
Acquisition
 
Revenue
 
Net Income
Southeastern SNF Portfolio
 
$
18,746,000

 
$
7,028,000

Other 2012 Acquisitions
 
$
27,280,000

 
$
5,304,000

 

148
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)



The following summarizes the fair value of our 2012 property acquisitions at the time of acquisition:
 
Southeastern SNF
Portfolio
 
Other 2012 Acquisitions
 
Building and improvements
$
123,175,000

 
$
489,049,000

  
Land
15,009,000

 
57,003,000

  
Furniture, fixtures and equipment
1,578,000

 
—

  
In-place leases
20,918,000

 
48,517,000

  
Tenant relationships
15,272,000

 
53,760,000

  
Leasehold interest
—

 
3,803,000

  
Master lease
—

 
42,000

  
Above market leases
—

 
10,065,000

  
Defeasible interest
—

 
623,000

 
Total assets acquired
175,952,000

 
662,862,000

  
Mortgage loans payable, net
(92,611,000
)
 
(77,671,000
)
 
Below market leases
—

 
(2,624,000
)
 
Above market leasehold interests
—

 
(2,167,000
)
 
Other liabilities
(9,452,000
)
 
(12,571,000
)
(1)
Total liabilities assumed
(102,063,000
)
 
(95,033,000
)
 
Net assets acquired
$
73,889,000

 
$
567,829,000

  
                 
(1)
Included in other liabilities is $6,525,000, $960,000 and $1,106,000 accrued for as contingent consideration obligations in connection with the acquisition of Pacific Northwest Senior Care Portfolio, Silver Star MOB Portfolio and Central Indiana MOB Portfolio, respectively. See Note 14, Fair Value Measurements — Assets and Liabilities Reported at Fair Value — Contingent Consideration, for a further discussion.
Assuming the property acquisitions in 2012 discussed above had occurred on January 1, 2011, for the years ended December 31, 2012 and 2011, pro forma revenue, net (loss) income, net (loss) income attributable to controlling interest and net (loss) income per common share attributable to controlling interest — basic and diluted would have been as follows:
 
(Unaudited)
 
Years Ended December 31,
 
2012
 
2011
Revenue
$
149,775,000

 
$
135,050,000

Net (loss) income
$
(23,605,000
)
 
$
16,191,000

Net (loss) income attributable to controlling interest
$
(23,608,000
)
 
$
16,189,000

Net (loss) income per common share attributable to controlling interest — basic and diluted
$
(0.16
)
 
$
0.15

 
The pro forma adjustments assume that the debt proceeds and the offering proceeds, at a price of $10.00 per share, net of offering costs were raised as of January 1, 2011. In addition, as acquisition related expenses related to the acquisitions are not expected to have a continuing impact, they have been excluded from the pro forma results. The pro forma results are not necessarily indicative of the operating results that would have been obtained had the acquisitions occurred at the beginning of the periods presented, nor are they necessarily indicative of future operating results.
18. Segment Reporting

As of December 31, 2013, we evaluated our business and made resource allocations based on five reportable business segments—medical office buildings, hospitals, skilled nursing facilities, senior housing and senior housing–RIDEA. Our medical office buildings are typically leased to multiple tenants under separate leases in each building, thus requiring active management and responsibility for many of the associated operating expenses (although many of these are, or can effectively be, passed through to the tenants). Our hospital investments are primarily single tenant properties which lease the facilities to

149
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)



unaffiliated tenants under “triple-net” and generally “master” leases that transfer the obligation for all facility operating costs (including maintenance, repairs, taxes, insurance and capital expenditures) to the tenant. Our skilled nursing facilities and senior housing facilities are acquired and similarly structured as our hospital investments. Our senior housing–RIDEA properties include senior housing facilities that are owned and operated utilizing a RIDEA structure.
We evaluate performance based upon net operating income of the combined properties in each segment. We define net operating income, a non-GAAP financial measure, as total revenues, less rental expenses, which excludes depreciation and amortization, general and administrative expenses, subordinated distribution purchase, acquisition related expenses, interest expense, foreign currency and derivative loss, interest income and income tax benefit. We believe that net income (loss), as defined by GAAP, is the most appropriate earnings measurement. However, we believe that segment net operating income serves as a useful supplement to net income (loss) because it allows investors and our management to measure unlevered property-level operating results and to compare our operating results to the operating results of other real estate companies and between periods on a consistent basis. Segment net operating income should not be considered as an alternative to net income (loss) determined in accordance with GAAP as an indicator of our financial performance, and, accordingly, we believe that in order to facilitate a clear understanding of our consolidated historical operating results, segment operating income should be examined in conjunction with net income (loss) as presented in our accompanying consolidated financial statements.
Interest expense, depreciation and amortization and other expenses not attributable to individual properties are not allocated to individual segments for purposes of assessing segment performance.
Non-segment assets primarily consist of corporate assets including cash and cash equivalents, real estate and escrow deposits, deferred financing costs, other receivables and other assets not attributable to individual properties.
 

150
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)



Summary information for the reportable segments during the years ended December 31, 2013, 2012 and 2011 was as follows:
 
Medical Office Buildings
 
Skilled Nursing Facilities
 
Hospitals
 
Senior Housing
 
Senior Housing–RIDEA
 
Year Ended
December 31, 2013
Revenues:
 
 
 
 
 
 
 
 
 
 
 
Real estate revenue
$
106,660,000

 
$
49,381,000

 
$
23,563,000

 
$
22,492,000

 
$
—

 
$
202,096,000

Resident fees and services
—

 
—

 
—

 
—

 
2,307,000

 
2,307,000

Total revenues
106,660,000

 
49,381,000

 
23,563,000

 
22,492,000

 
2,307,000

 
204,403,000

Expenses:
 
 
 
 
 
 
 
 
 
 
 
Rental expenses
34,572,000

 
3,392,000

 
3,124,000

 
800,000

 
1,499,000

 
43,387,000

Segment net operating income
$
72,088,000

 
$
45,989,000

 
$
20,439,000

 
$
21,692,000

 
$
808,000

 
$
161,016,000

Expenses:
 
 
 
 
 
 
 
 
 
 
 
General and administrative
 
 
 
 
 
 
 
 
 
 
22,519,000

Acquisition related expenses
 
 
 
 
 
 
 
 
 
 
25,501,000

Depreciation and amortization
 
 
 
 
 
 
 
 
 
 
76,188,000

Income from operations
 
 
 
 
 
 
 
 
 
 
36,808,000

Other income (expense):
 
 
 
 
 
 
 
 
 
 
 
Interest expense (including amortization of deferred financing costs and debt discount/premium):
 
 
 
 
 
 
 
 
 
 
 
Interest expense
 
 
 
 
 
 
 
 
 
 
(18,109,000
)
Gain in fair value of derivative financial instruments
 
 
 
 
 
 
 
 
 
 
344,000

Foreign currency and derivative loss
 
 
 
 
 
 
 
 
 
 
(11,312,000
)
Interest income
 
 
 
 
 
 
 
 
 
 
329,000

Income before income taxes
 
 
 
 
 
 
 
 
 
 
8,060,000

Income tax benefit
 
 
 
 
 
 
 
 
 
 
1,005,000

Net income
 
 
 
 
 
 
 
 
 
 
$
9,065,000

 

151
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)



 
Medical Office Buildings
 
Skilled Nursing Facilities
 
Hospitals
 
Senior Housing
 
Senior Housing–RIDEA
 
Year Ended
December 31, 2012
Revenues:
 
 
 
 
 
 
 
 
 
 
 
Real estate revenue
$
49,981,000

 
$
37,432,000

 
$
12,280,000

 
$
1,035,000

 
$
—

 
$
100,728,000

Expenses:
 
 
 
 
 
 
 
 
 
 
 
Rental expenses
16,666,000

 
2,853,000

 
1,516,000

 
96,000

 
—

 
21,131,000

Segment net operating income
$
33,315,000

 
$
34,579,000

 
$
10,764,000

 
$
939,000

 
$
—

 
$
79,597,000

Expenses:
 
 
 
 
 
 
 
 
 
 
 
General and administrative
 
 
 
 
 
 
 
 
 
 
11,067,000

Subordinated distribution purchase
 
 
 
 
 
 
 
 
 
 
4,232,000

Acquisition related expenses
 
 
 
 
 
 
 
 
 
 
75,608,000

Depreciation and amortization
 
 
 
 
 
 
 
 
 
 
38,407,000

Loss from operations
 
 
 
 
 
 
 
 
 
 
(49,717,000
)
Other income (expense):
 
 
 
 
 
 
 
 
 
 
 
Interest expense (including amortization of deferred financing costs and debt discount/premium):
 
 
 
 
 
 
 
 
 
 
 
Interest expense
 
 
 
 
 
 
 
 
 
 
(13,566,000
)
Gain in fair value of derivative financial instruments
 
 
 
 
 
 
 
 
 
 
24,000

Interest income
 
 
 
 
 
 
 
 
 
 
15,000

Net loss
 
 
 
 
 
 
 
 
 
 
$
(63,244,000
)


152
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)



 
Medical Office Buildings
 
Skilled Nursing Facilities
 
Hospitals
 
Senior Housing
 
Senior Housing–RIDEA
 
Year Ended
December 31, 2011
Revenues:
 
 
 
 
 
 
 
 
 
 
 
Real estate revenue
$
21,479,000

 
$
11,327,000

 
$
7,651,000

 
$
—

 
$
—

 
$
40,457,000

Expenses:
 
 
 
 
 
 
 
 
 
 
 
Rental expenses
6,575,000

 
1,030,000

 
725,000

 
—

 
—

 
8,330,000

Segment net operating income
$
14,904,000

 
$
10,297,000

 
$
6,926,000

 
$
—

 
$
—

 
$
32,127,000

Expenses:
 
 
 
 
 
 
 
 
 
 
 
General and administrative
 
 
 
 
 
 
 
 
 
 
5,992,000

Acquisition related expenses
 
 
 
 
 
 
 
 
 
 
10,389,000

Depreciation and amortization
 
 
 
 
 
 
 
 
 
 
14,826,000

Income from operations
 
 
 
 
 
 
 
 
 
 
920,000

Other income (expense):
 
 
 
 
 
 
 
 
 
 
 
Interest expense (including amortization of deferred financing costs and debt discount/premium):
 
 
 
 
 
 
 
 
 
 
 
Interest expense
 
 
 
 
 
 
 
 
 
 
(6,345,000
)
Loss in fair value of derivative financial instruments
 
 
 
 
 
 
 
 
 
 
(366,000
)
Interest income
 
 
 
 
 
 
 
 
 
 
17,000

Net loss
 
 
 
 
 
 
 
 
 
 
$
(5,774,000
)

153
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)



Assets by reportable segments as of December 31, 2013 and 2012, are as follows:
 
December 31,
 
2013
 
2012
Medical office buildings
$
1,296,336,000

 
$
677,444,000

Senior housing
699,420,000

 
116,871,000

Skilled nursing facilities
405,774,000

 
374,773,000

Senior housing–RIDEA
313,279,000

 
—

Hospitals
194,847,000

 
190,289,000

All other
19,070,000

 
95,252,000

Total assets
$
2,928,726,000

 
$
1,454,629,000

Our portfolio of properties and other investments are located in the United States and the United Kingdom. Revenues and assets are attributed to the country in which the property is physically located. The following is a summary of geographic information for our operations for the periods presented:
 
Years Ended December 31,
 
2013
 
2012
 
2011
Revenues:
 
 
 
 
 
United States
$
191,424,000

 
$
100,728,000

 
$
40,457,000

United Kingdom
12,979,000

 
—

 
—

Total revenues
$
204,403,000

 
$
100,728,000

 
$
40,457,000


 
December 31,
 
2013
 
2012
Real estate investments, net:
 
 
 
United States
$
1,965,110,000

 
$
1,112,295,000

United Kingdom
558,589,000

 
—

Total real estate investments, net
$
2,523,699,000

 
$
1,112,295,000

19. Concentration of Credit Risk
Financial instruments that potentially subject us to a concentration of credit risk are primarily real estate notes receivable, cash and cash equivalents, accounts and other receivable, restricted cash and escrow deposits. We are exposed to credit risk with respect to the real estate notes receivable but we believe collection of the outstanding amount is probable and that the risk is further mitigated as the real estate notes receivable are secured by property and there is a guarantee of completion agreement executed between the parent company of the borrower and us. Cash is generally invested in investment-grade, short-term instruments with a maturity of three months or less when purchased. We have cash in financial institutions that is insured by the Federal Deposit Insurance Corporation, or FDIC. As of December 31, 2013 and 2012, we had cash and cash equivalents, restricted cash accounts and escrow deposits in excess of FDIC insured limits. We believe this risk is not significant. Concentration of credit risk with respect to accounts receivable from tenants is limited. We perform credit evaluations of prospective tenants, and security deposits are obtained upon lease execution.
Based on leases in effect as of December 31, 2013, no one state in the United States accounted for 10.0% or more of our annualized base rent. However, we own UK Senior Housing Portfolio located in the United Kingdom, which accounted for 14.8% of our annualized base rent as of December 31, 2013. Accordingly, there is a geographic concentration of risk subject to fluctuations in the United Kingdom's economy.
Based on leases in effect as of December 31, 2013, our five reportable business segments, medical office buildings, skilled nursing facilities, senior housing, senior housing–RIDEA and hospitals, accounted for 45.1%, 18.7%, 18.0%, 10.3% and 7.9% , respectively, of our annualized base rent. As of December 31, 2013, rental payments by one of our tenants at our properties accounted for 10.0% or more of our annualized base rent, as follows:
 

154
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)



Tenant
 
2013 Annualized
Base Rent(1)
 
Percentage of
Annualized
Base Rent
 
Property
 
Reportable Segment
 
GLA
(Sq Ft)
 
Lease Expiration
Date(2)
Myriad Healthcare Limited(3)
 
£
21,610,000

 
14.8
%
 
UK Senior Housing Portfolio
 
Senior Housing
 
962,000

 
09/10/48
__________
(1)
Annualized base rent is based on contractual base rent from leases in effect as of December 31, 2013 and was approximately $35,780,000 based on the currency exchange rate as of December 31, 2013. The loss of this tenant or its inability to pay rent could have a material adverse effect on our business and results of operations.
(2)
UK Senior Housing Portfolio is leased to one tenant under a 35-year absolute net lease with lease termination options on October 1, 2028 and October 1, 2038.
(3)
As of December 31, 2013, we had advanced £10,022,000, or approximately $16,593,000 based on the currency exchange rate as of December 31, 2013, under real estate notes receivable, to affiliates of Myriad Healthcare Limited. See Note 4, Real Estate Notes Receivable, Net, for a further discussion.
In addition, using annualized net operating income as a proxy for annualized based rent, Midwest CCRC Portfolio accounted for 10.3% of our annualized base rent as of December 31, 2013. Midwest CCRC Portfolio is managed by Senior Lifestyle Corporation utilizing a RIDEA structure. As a manager, Senior Lifestyle Corporation does not lease our properties, and, therefore, we are not directly exposed to its credit risk in the same manner or to the same extent as our triple-net tenants. However, the loss of this manager or its inability to efficiently and effectively manage our properties or to provide timely and accurate accounting information with respect thereto could have a material adverse effect on our business and results of operations.
20. Per Share Data
We report earnings (loss) per share pursuant to ASC Topic 260, Earnings per Share. Basic earnings (loss) per share for all periods presented are computed by dividing net income (loss) allocated to controlling interest by the weighted average number of shares of our common stock outstanding during the period. Net income (loss) allocated to controlling interest is calculated as net income (loss) attributable to controlling interest less distributions allocated to participating securities of$151,000, $11,000 and $11,000, respectively, for the years ended December 31, 2013, 2012 and 2011. Diluted earnings (loss) per share are computed based on the weighted average number of shares of our common stock and all potentially dilutive securities, if any. Nonvested shares of our restricted common stock and exchangeable limited partnership units of our operating partnership are participating securities and give rise to potentially dilutive shares of our common stock. As of December 31, 2013, 2012 and 2011, there were 30,000, 28,500 and 16,500 nonvested shares, respectively, of our restricted common stock outstanding, but such shares were excluded from the computation of diluted earnings per share because such shares were anti-dilutive during these periods. As of December 31, 2013, 2012 and 2011, there were 281,800, 42,900 and 200 units, respectively, of exchangeable limited partnership units of our operating partnership outstanding, but such units were also excluded from the computation of diluted earning per share because such units were anti-dilutive during these periods.

155
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)



21. Selected Quarterly Financial Data (Unaudited)
Set forth below is the unaudited selected quarterly financial data. We believe that all necessary adjustments, consisting only of normal recurring adjustments, have been included in the amounts stated below to present fairly, and in accordance with GAAP, the unaudited selected quarterly financial data when read in conjunction with our consolidated financial statements.
 
Quarters Ended
 
December 31, 2013
 
September 30, 2013
 
June 30, 2013
 
March 31, 2013
Revenues
$
66,773,000

 
$
52,018,000

 
$
45,394,000

 
$
40,218,000

Expenses
(62,946,000
)
 
(39,236,000
)
 
(34,680,000
)
 
(30,733,000
)
Income from operations
3,827,000

 
12,782,000

 
10,714,000

 
9,485,000

Other expense
(10,912,000
)
 
(9,190,000
)
 
(4,661,000
)
 
(3,985,000
)
Income tax benefit
1,005,000

 
—

 
—

 
—

Net (loss) income
(6,080,000
)
 
3,592,000

 
6,053,000

 
5,500,000

Less: Net loss (income) attributable to noncontrolling interests
2,000

 
(3,000
)
 
(9,000
)
 
(4,000
)
Net (loss) income attributable to controlling interests
$
(6,078,000
)
 
$
3,589,000

 
$
6,044,000

 
$
5,496,000

Net (loss) income per common share attributable to controlling interest — basic and diluted
$
(0.02
)
 
$
0.02

 
$
0.04

 
$
0.04

Weighted average number of common shares outstanding — basic and diluted
288,930,497

 
228,053,938

 
155,827,697

 
124,240,955

 
 
 
 
 
 
 
 
 
Quarters Ended
 
December 31, 2012
 
September 30, 2012
 
June 30, 2012
 
March 31, 2012
Revenues
$
33,058,000

 
$
27,134,000

 
$
21,807,000

 
$
18,729,000

Expenses(1)
(66,413,000
)
 
(45,026,000
)
 
(19,844,000
)
 
(19,162,000
)
(Loss) income from operations
(33,355,000
)
 
(17,892,000
)
 
1,963,000

 
(433,000
)
Other expense
(3,739,000
)
 
(3,544,000
)
 
(3,178,000
)
 
(3,066,000
)
Net loss
(37,094,000
)
 
(21,436,000
)
 
(1,215,000
)
 
(3,499,000
)
Less: Net income attributable to noncontrolling interests
(1,000
)
 
(2,000
)
 
—

 
—

Net loss attributable to controlling interest
$
(37,095,000
)
 
$
(21,438,000
)
 
$
(1,215,000
)
 
$
(3,499,000
)
Net loss per common share attributable to controlling interest — basic and diluted
$
(0.36
)
 
$
(0.27
)
 
$
(0.02
)
 
$
(0.07
)
Weighted average number of common shares outstanding — basic and diluted
103,025,656

 
78,492,871

 
62,579,602

 
52,044,669

___________
(1)
Expenses during the three months ended September 30, 2012 include $4,232,000 related to the purchase of the subordinated distribution. See Note 2, Summary of Significant Accounting Policies — Subordinated Distribution Purchase for a further discussion.
22. Subsequent Events
Share Repurchases
In January 2014 and February 2014, we repurchased 223,413 shares of our common stock, for an aggregate amount of $2,130,000, under our share repurchase plan.
Property Acquisitions
Subsequent to December 31, 2013, we completed the acquisitions of six buildings from unaffiliated parties. The aggregate purchase price of these properties was $85,150,000 and we paid $2,214,000 in acquisition fees to our advisor entities

156
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)



or their affiliates in connection with these acquisitions. We have not yet measured the fair value of the tangible and identified intangible assets and liabilities of the acquisitions. The following is a summary of our property acquisitions subsequent to December 31, 2013:
Acquisition(1)
 
Location
 
Type
 
Date
Acquired
 
Purchase
Price
 
Line of
Credit(2)
 
Acquisition Fee(3)
Dux MOB Portfolio(4)
 
Chillicothe, OH
 
Medical Office
 
01/09/14
 
$
25,150,000

 
$
23,500,000

 
$
654,000

North Carolina ALF Portfolio(5)
 
Durham, NC
 
Senior Housing
 
02/06/14
 
21,000,000

 
21,600,000

 
546,000

Pennsylvania SNF Portfolio(6)
 
Royersford, PA
 
Skilled Nursing
 
03/06/14
 
39,000,000

 
40,530,000

 
1,014,000

Total
 
 
 
 
 
 
 
$
85,150,000

 
$
85,630,000

 
$
2,214,000

______________
(1)
We own 100% of our properties acquired subsequent to December 31, 2013.
(2)
Represents borrowings under our unsecured line of credit at the time of acquisition. We periodically advance funds and pay down our unsecured line of credit as needed.
(3)
Our advisor entities and their affiliates were paid, as compensation for services rendered in connection with the investigation, selection and acquisition of our properties, an acquisition fee of 2.60% of the contract purchase price, which was paid as follows: (i) in shares of our common stock in an amount equal to 0.15% of the contract purchase price, at $9.20 per share, the then most recent price paid to acquire a share of our common stock in our follow-on offering, net of selling commissions and dealer manager fees, and (ii) the remainder in cash equal to 2.45% of the contract purchase price.
(4)
On January 9, 2014, we added one additional building to our existing Dux MOB Portfolio. The other 14 buildings were purchased in December 2013.
(5)
On February 6, 2014, we added one additional building to our existing North Carolina ALF Portfolio. The other five buildings were purchased in December 2012.
(6)
On March 6, 2014, we added four additional buildings to our existing Pennsylvania SNF Portfolio. The other two buildings were purchased in April 2013.

157
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC

SCHEDULE III — REAL ESTATE AND
ACCUMULATED DEPRECIATION
December 31, 2013


 
 
 
 
 
Initial Cost to Company
 
 
 
Gross Amount of Which Carried at Close of Period(h)
 
 
 
 
Description(a)
 
Encumbrances
 
Land
 
Buildings and
Improvements
 
Cost  Capitalized
Subsequent to
Acquisition(b)
 
Land
 
Buildings and
Improvements
 
Total
(g)
 
Accumulated
Depreciation
(i)(j)
 
Date of
Construction
 
Date  Acquired
Lacombe Medical Office Building (Medical Office)
Lacombe, LA
 
$
—

 
$
409,000

 
$
5,438,000

 
(84,000
)
 
$
409,000

 
$
5,354,000

 
$
5,763,000

 
$
(686,000
)
 
2004
 
03/05/10
Center for Neurosurgery and Spine (Medical Office)
Sartell, MN
 
2,483,000

 
319,000

 
4,689,000

 
17,000

 
319,000

 
4,706,000

 
5,025,000

 
(843,000
)
 
2006
 
03/31/10
Parkway Medical Center (Medical Office)
Beachwood, OH
 
5,450,000

(c)
1,320,000

 
7,192,000

 
745,000

 
1,320,000

 
7,937,000

 
9,257,000

 
(1,403,000
)
 
1972/1987
 
04/12/10
Highlands Ranch Medical Pavilion (Medical Office)
Highlands Ranch, CO
 
—

 
1,234,000

 
5,444,000

 
105,000

 
1,234,000

 
5,549,000

 
6,783,000

 
(918,000
)
 
1999
 
04/30/10
Muskogee Long-Term Acute Care Hospital (Hospital)
Muskogee, OK
 
6,761,000

 
379,000

 
8,314,000

 
300,000

 
379,000

 
8,614,000

 
8,993,000

 
(1,129,000
)
 
2006
 
05/27/10
St. Vincent Medical Office Building (Medical Office)
Cleveland, OH
 
5,050,000

(c)
1,568,000

 
6,746,000

 
266,000

 
1,568,000

 
7,012,000

 
8,580,000

 
(1,188,000
)
 
1984
 
06/25/10
Livingston Medical Arts Pavilion (Medical Office)
Livingston, TX
 
—

 
—

 
4,976,000

 
(90,000
)
 
—

 
4,886,000

 
4,886,000

 
(566,000
)
 
2007
 
06/28/10
Pocatello East Medical Office Building (Medical Office)
Pocatello, ID
 
7,389,000

 
—

 
14,319,000

 
2,847,000

 
—

 
17,166,000

 
17,166,000

 
(1,915,000
)
 
2008
 
07/27/10

158
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC

SCHEDULE III — REAL ESTATE AND
ACCUMULATED DEPRECIATION — (Continued)
December 31, 2013

 
 
 
 
 
Initial Cost to Company
 
 
 
Gross Amount of Which Carried at Close of Period(h)
 
 
 
 
Description(a)
 
Encumbrances
 
Land
 
Buildings and
Improvements
 
Cost  Capitalized
Subsequent to
Acquisition(b)
 
Land
 
Buildings and
Improvements
 
Total
(g)
 
Accumulated
Depreciation
(i)(j)
 
Date of
Construction
 
Date  Acquired
Monument Long-Term Acute Care Hospital Portfolio (Hospital)
 
 
$
23,399,000

 
$
—

 
$
—

 
$
—

 
$
—

 
$
—

 
$
—

 
$
—

 
 
 
 
 
Cape Girardeau, MO
 
(d)

 
799,000

 
6,268,000

 
1,000

 
799,000

 
6,269,000

 
7,068,000

 
(742,000
)
 
2006
 
08/12/10
 
Joplin, MO
 
(d)

 
995,000

 
6,908,000

 
1,000

 
995,000

 
6,909,000

 
7,904,000

 
(864,000
)
 
2007
 
08/31/10
 
Athens, GA
 
(d)

 
1,978,000

 
8,889,000

 
—

 
1,978,000

 
8,889,000

 
10,867,000

 
(985,000
)
 
2008
 
10/29/10
 
Columbia, MO
 
(d)

 
1,433,000

 
9,607,000

 
—

 
1,433,000

 
9,607,000

 
11,040,000

 
(953,000
)
 
2009
 
01/31/11
Virginia Skilled Nursing Facility Portfolio (Skilled Nursing)
Charlottesville, VA
 
—

 
829,000

 
9,175,000

 
—

 
829,000

 
9,175,000

 
10,004,000

 
(1,012,000
)
 
2004
 
09/16/10
 
Bastian, VA
 
—

 
217,000

 
2,546,000

 
506,000

 
217,000

 
3,052,000

 
3,269,000

 
(435,000
)
 
1989
 
09/16/10
 
Lebanon, VA
 
—

 
359,000

 
3,917,000

 
83,000

 
359,000

 
4,000,000

 
4,359,000

 
(467,000
)
 
1990
 
09/16/10
 
Fincastle, VA
 
—

 
302,000

 
3,147,000

 
45,000

 
302,000

 
3,192,000

 
3,494,000

 
(446,000
)
 
1990
 
09/16/10
 
Low Moor, VA
 
—

 
655,000

 
6,817,000

 
87,000

 
655,000

 
6,904,000

 
7,559,000

 
(716,000
)
 
1989/2008
 
09/16/10
 
Midlothian, VA
 
—

 
1,840,000

 
9,991,000

 
—

 
1,840,000

 
9,991,000

 
11,831,000

 
(1,063,000
)
 
1991
 
09/16/10
 
Hot Springs, VA
 
—

 
203,000

 
2,116,000

 
183,000

 
203,000

 
2,299,000

 
2,502,000

 
(344,000
)
 
1990
 
09/16/10
Sylva Medical Office Building (Medical Office)
Sylva, NC
 
—

 
—

 
9,116,000

 
913,000

 
—

 
10,029,000

 
10,029,000

 
(955,000
)
 
2010
 
11/15/10
Surgical Hospital of Humble (Hospital)
Humble, TX
 
6,550,000

(c)
719,000

 
10,413,000

 
—

 
719,000

 
10,413,000

 
11,132,000

 
(991,000
)
 
2000/2010
 
12/10/10
Lawton Medical Office Building Portfolio (Medical Office)
Lawton, OK
 
6,798,000

  
—

 
8,440,000

 
597,000

 
—

 
9,037,000

 
9,037,000

 
(900,000
)
 
1985/2008
 
12/22/10

159
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC

SCHEDULE III — REAL ESTATE AND
ACCUMULATED DEPRECIATION — (Continued)
December 31, 2013

 
 
 
 
 
Initial Cost to Company
 
 
 
Gross Amount of Which Carried at Close of Period(h)
 
 
 
 
Description(a)
 
Encumbrances
 
Land
 
Buildings and
Improvements
 
Cost  Capitalized
Subsequent to
Acquisition(b)
 
Land
 
Buildings and
Improvements
 
Total
(g)
 
Accumulated
Depreciation
(i)(j)
 
Date of
Construction
 
Date  Acquired
Ennis Medical Office Building (Medical Office)
Ennis, TX
 
$
—

 
$
467,000

 
$
5,486,000

 
$
(13,000
)
 
$
467,000

 
$
5,473,000

 
$
5,940,000

 
$
(624,000
)
 
2007
 
12/22/10
St. Anthony North Medical Office Building (Medical Office)
Westminster, CO
 
5,975,000

(c)
—

 
9,543,000

 
103,000

 
—

 
9,646,000

 
9,646,000

 
(1,016,000
)
 
2008
 
03/29/11
Loma Linda Pediatric Specialty Hospital (Hospital)
Loma Linda, CA
 
—

 
1,370,000

 
9,862,000

 
—

 
1,370,000

 
9,862,000

 
11,232,000

 
(797,000
)
 
1971
 
03/31/11
Yuma Skilled Nursing Facility (Skilled Nursing)
Yuma, AZ
 
—

 
768,000

 
10,060,000

 
—

 
768,000

 
10,060,000

 
10,828,000

 
(853,000
)
 
1964/2010
 
04/13/11
Hardy Oak Medical Office Building (Medical Office)
San Antonio, TX
 
—

 
814,000

 
6,184,000

 
121,000

 
814,000

 
6,305,000

 
7,119,000

 
(611,000
)
 
2003
 
04/14/11
Lakewood Ranch Medical Office Building (Medical Office)
Bradenton, FL
 
—

 
—

 
10,324,000

 
360,000

 
—

 
10,684,000

 
10,684,000

 
(909,000
)
 
2003
 
04/15/11
Dixie-Lobo Medical Office Building Portfolio (Medical Office)
Hope, AR
 
—

 
390,000

 
1,243,000

 
(58,000
)
 
390,000

 
1,185,000

 
1,575,000

 
(114,000
)
 
2003
 
05/12/11
 
Lake Charles, LA
 
—

 
—

 
2,046,000

 
—

 
—

 
2,046,000

 
2,046,000

 
(218,000
)
 
2001
 
05/12/11
 
Carlsbad, NM
 
—

 
—

 
3,670,000

 
—

 
—

 
3,670,000

 
3,670,000

 
(357,000
)
 
2002
 
05/12/11
 
Hobbs, NM
 
—

 
—

 
1,913,000

 
—

 
—

 
1,913,000

 
1,913,000

 
(317,000
)
 
2003
 
05/12/11

160
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC

SCHEDULE III — REAL ESTATE AND
ACCUMULATED DEPRECIATION — (Continued)
December 31, 2013

 
 
 
 
 
Initial Cost to Company
 
 
 
Gross Amount of Which Carried at Close of Period(h)
 
 
 
 
Description(a)
 
Encumbrances
 
Land
 
Buildings and
Improvements
 
Cost  Capitalized
Subsequent to
Acquisition(b)
 
Land
 
Buildings and
Improvements
 
Total
(g)
 
Accumulated
Depreciation
(i)(j)
 
Date of
Construction
 
Date  Acquired
 
Alice, TX
 
$
—

 
$
—

 
$
3,535,000

 
$
—

 
$
—

 
$
3,535,000

 
$
3,535,000

 
$
(401,000
)
 
2001
 
05/12/11
 
Lufkin, TX
 
—

 
—

 
2,294,000

 
—

 
—

 
2,294,000

 
2,294,000

 
(239,000
)
 
2001
 
05/12/11
 
Victoria, TX
 
—

 
—

 
4,313,000

 
—

 
—

 
4,313,000

 
4,313,000

 
(476,000
)
 
1986/2003
 
05/12/11
 
Wharton, TX
 
—

 
—

 
3,178,000

 
—

 
—

 
3,178,000

 
3,178,000

 
(305,000
)
 
2001
 
05/12/11
Milestone Medical Office Building Portfolio (Medical Office)
Jersey City, NJ
 
16,000,000

 
—

 
21,551,000

 
233,000

 
—

 
21,784,000

 
21,784,000

 
(1,793,000
)
 
2010
 
05/26/11
 
Benton, AR
 
—

 
—

 
966,000

 
(553,000
)
 
—

 
413,000

 
413,000

 
(102,000
)
 
1992/1999
 
05/26/11
 
Benton, AR
 
—

 
—

 
6,400,000

 
894,000

 
—

 
7,294,000

 
7,294,000

 
(781,000
)
 
1986
 
05/26/11
 
Bryant, AR
 
—

 
495,000

 
3,827,000

 
8,000

 
495,000

 
3,835,000

 
4,330,000

 
(376,000
)
 
1993/2006
 
05/26/11
Philadelphia Skilled Nursing Facility Portfolio (Skilled Nursing)
Philadelphia, PA
 
—

 
1,184,000

 
27,655,000

 
—

 
1,184,000

 
27,655,000

 
28,839,000

 
(2,560,000
)
 
1975
 
06/30/11
 
Philadelphia, PA
 
—

 
1,249,000

 
12,593,000

 
—

 
1,249,000

 
12,593,000

 
13,842,000

 
(1,122,000
)
 
1900
 
06/30/11
 
Philadelphia, PA
 
—

 
719,000

 
9,121,000

 
—

 
719,000

 
9,121,000

 
9,840,000

 
(821,000
)
 
1980
 
06/30/11
 
Philadelphia, PA
 
—

 
887,000

 
10,962,000

 
—

 
887,000

 
10,962,000

 
11,849,000

 
(1,014,000
)
 
1975
 
06/30/11
 
Philadelphia, PA
 
—

 
707,000

 
9,152,000

 
—

 
707,000

 
9,152,000

 
9,859,000

 
(939,000
)
 
1978
 
06/30/11
Maxfield Sarasota Medical Office Building (Medical Office)
Sarasota, FL
 
4,699,000

 
923,000

 
5,702,000

 
69,000

 
923,000

 
5,771,000

 
6,694,000

 
(679,000
)
 
2000
 
07/11/11
Lafayette Physical Rehabilitation Hospital (Hospital)
Lafayette, LA
 
—

 
1,184,000

 
9,322,000

 
—

 
1,184,000

 
9,322,000

 
10,506,000

 
(658,000
)
 
2006
 
09/30/11

161
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC

SCHEDULE III — REAL ESTATE AND
ACCUMULATED DEPRECIATION — (Continued)
December 31, 2013

 
 
 
 
 
Initial Cost to Company
 
 
 
Gross Amount of Which Carried at Close of Period(h)
 
 
 
 
Description(a)
 
Encumbrances
 
Land
 
Buildings and
Improvements
 
Cost  Capitalized
Subsequent to
Acquisition(b)
 
Land
 
Buildings and
Improvements
 
Total
(g)
 
Accumulated
Depreciation
(i)(j)
 
Date of
Construction
 
Date  Acquired
Sierra Providence East Medical Plaza I (Medical Office)
El Paso, TX
 
$
—

 
$
—

 
$
5,696,000

 
$
928,000

 
$
—

 
$
6,624,000

 
$
6,624,000

 
$
(606,000
)
 
2008
 
12/22/11
Southeastern SNF Portfolio (Skilled Nursing)
Mobile, AL
 
4,880,000

 
335,000

 
7,323,000

 
—

 
335,000

 
7,323,000

 
7,658,000

 
(611,000
)
 
1981
 
01/10/12
 
Atlanta, GA
 
11,653,000

 
2,614,000

 
17,233,000

 
—

 
2,614,000

 
17,233,000

 
19,847,000

 
(1,279,000
)
 
1970
 
01/10/12
 
Covington, GA
 
10,969,000

 
1,419,000

 
13,562,000

 
—

 
1,419,000

 
13,562,000

 
14,981,000

 
(1,005,000
)
 
1975/1988
 
01/10/12
 
Gainesville, GA
 
6,848,000

 
1,163,000

 
8,979,000

 
—

 
1,163,000

 
8,979,000

 
10,142,000

 
(772,000
)
 
1994
 
01/10/12
 
Snellville, GA
 
13,014,000

 
2,992,000

 
16,694,000

 
—

 
2,992,000

 
16,694,000

 
19,686,000

 
(1,398,000
)
 
1992
 
01/10/12
 
Conyers, GA
 
7,863,000

 
3,512,000

 
17,485,000

 
—

 
3,512,000

 
17,485,000

 
20,997,000

 
(1,251,000
)
 
1998
 
01/10/12
 
Atlanta, GA
 
4,440,000

 
401,000

 
3,785,000

 
—

 
401,000

 
3,785,000

 
4,186,000

 
(296,000
)
 
1969/1974
 
01/10/12
 
Shreveport, LA
 
10,500,000

 
768,000

 
16,733,000

 
—

 
768,000

 
16,733,000

 
17,501,000

 
(1,219,000
)
 
1972/1980
 
01/10/12
 
Memphis, TN
 
6,594,000

 
1,341,000

 
11,906,000

 
—

 
1,341,000

 
11,906,000

 
13,247,000

 
(892,000
)
 
1996
 
01/10/12
 
Millington, TN
 
4,675,000

 
464,000

 
11,053,000

 
—

 
464,000

 
11,053,000

 
11,517,000

 
(743,000
)
 
1991/1992
 
01/10/12
FLAGS MOB Portfolio (Medical Office)
Okatie, SC
 
7,486,000

 
—

 
7,475,000

 
254,000

 
—

 
7,729,000

 
7,729,000

 
(846,000
)
 
1998
 
01/27/12
 
Boynton, FL
 
4,007,000

 
—

 
5,302,000

 
111,000

 
—

 
5,413,000

 
5,413,000

 
(365,000
)
 
2003
 
01/27/12
 
Austell, GA
 
—

 
1,738,000

 
5,996,000

 
217,000

 
1,738,000

 
6,213,000

 
7,951,000

 
(725,000
)
 
2000
 
01/27/12
 
Tempe, AZ
 
5,190,000

 
—

 
6,531,000

 
40,000

 
—

 
6,571,000

 
6,571,000

 
(462,000
)
 
1997
 
03/23/12
Spokane MOB (Medical Office)
Spokane, WA
 
13,904,000

 
—

 
29,875,000

 
56,000

 
—

 
29,931,000

 
29,931,000

 
(1,653,000
)
 
2004
 
01/31/12
Centre Medical Plaza (Medical Office)
Chula Vista, CA
 
—

 
4,808,000

 
15,777,000

 
344,000

 
4,808,000

 
16,121,000

 
20,929,000

 
(1,042,000
)
 
1976/2000
 
04/26/12

162
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC

SCHEDULE III — REAL ESTATE AND
ACCUMULATED DEPRECIATION — (Continued)
December 31, 2013

 
 
 
 
 
Initial Cost to Company
 
 
 
Gross Amount of Which Carried at Close of Period(h)
 
 
 
 
Description(a)
 
Encumbrances
 
Land
 
Buildings and
Improvements
 
Cost  Capitalized
Subsequent to
Acquisition(b)
 
Land
 
Buildings and
Improvements
 
Total
(g)
 
Accumulated
Depreciation
(i)(j)
 
Date of
Construction
 
Date  Acquired
Gulf Plains MOB Portfolio (Medical Office)
Amarillo, TX
 
$
—

 
$
1,827,000

 
$
12,641,000

 
$
—

 
$
1,827,000

 
$
12,641,000

 
$
14,468,000

 
$
(875,000
)
 
1997/2006
 
04/26/12
 
Houston, TX
 
—

 
—

 
2,703,000

 
—

 
—

 
2,703,000

 
2,703,000

 
(193,000
)
 
1966/2010
 
04/26/12
Midwestern MOB Portfolio (Medical Office)
Champaign, IL
 
3,611,000

 
629,000

 
3,453,000

 
22,000

 
629,000

 
3,475,000

 
4,104,000

 
(228,000
)
 
1995
 
05/22/12
 
Lemont, IL
 
—

 
261,000

 
2,684,000

 
102,000

 
261,000

 
2,786,000

 
3,047,000

 
(295,000
)
 
2001
 
05/22/12
 
Naperville, IL
 
7,064,000

 
693,000

 
7,965,000

 
14,000

 
693,000

 
7,979,000

 
8,672,000

 
(384,000
)
 
2004
 
07/19/12
 
Urbana, IL
 
6,636,000

 
—

 
9,774,000

 
—

 
—

 
9,774,000

 
9,774,000

 
(391,000
)
 
2002
 
08/14/12
Texarkana MOB (Medical Office)
Texarkana, TX
 
—

 
435,000

 
4,980,000

 
12,000

 
435,000

 
4,992,000

 
5,427,000

 
(304,000
)
 
2005
 
06/14/12
Greeley MOB (Medical Office)
Greeley, CO
 
6,600,000

(c)
1,256,000

 
9,456,000

 
—

 
1,256,000

 
9,456,000

 
10,712,000

 
(729,000
)
 
1998/2004
 
06/22/12
Columbia MOB (Medical Office)
Columbia, SC
 
3,450,000

(c)
675,000

 
4,885,000

 
13,000

 
675,000

 
4,898,000

 
5,573,000

 
(398,000
)
 
1988
 
06/26/12
Ola Nalu MOB Portfolio (Medical Office)
Warsaw, IL
 
—

 
—

 
5,107,000

 
7,000

 
—

 
5,114,000

 
5,114,000

 
(239,000
)
 
2006
 
06/29/12
 
Huntsville, AL
 
4,667,000

(c)
—

 
6,757,000

 
65,000

 
—

 
6,822,000

 
6,822,000

 
(386,000
)
 
2005
 
06/29/12
 
Trinity, FL
 
—

 
470,000

 
4,490,000

 
(15,000
)
 
470,000

 
4,475,000

 
4,945,000

 
(218,000
)
 
2006
 
07/12/12
 
Rockwall, TX
 
11,043,000

(c)
1,936,000

 
16,449,000

 
398,000

 
1,936,000

 
16,847,000

 
18,783,000

 
(942,000
)
 
2006
 
06/29/12
 
San Angelo, TX
 
—

 
—

 
3,890,000

 
78,000

 
—

 
3,968,000

 
3,968,000

 
(203,000
)
 
2004
 
06/29/12
 
San Angelo, TX
 
—

 
—

 
3,713,000

 
(77,000
)
 
—

 
3,636,000

 
3,636,000

 
(191,000
)
 
2005
 
06/29/12
 
Schertz, TX
 
—

 
457,000

 
2,583,000

 
11,000

 
457,000

 
2,594,000

 
3,051,000

 
(177,000
)
 
2005
 
06/29/12
 
Hilo, HI
 
—

 
588,000

 
8,185,000

 
—

 
588,000

 
8,185,000

 
8,773,000

 
(375,000
)
 
1996
 
06/29/12
 
Las Vegas, NM
 
—

 
—

 
3,327,000

 
54,000

 
—

 
3,381,000

 
3,381,000

 
(161,000
)
 
2005
 
06/29/12

163
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC

SCHEDULE III — REAL ESTATE AND
ACCUMULATED DEPRECIATION — (Continued)
December 31, 2013

 
 
 
 
 
Initial Cost to Company
 
 
 
Gross Amount of Which Carried at Close of Period(h)
 
 
 
 
Description(a)
 
Encumbrances
 
Land
 
Buildings and
Improvements
 
Cost  Capitalized
Subsequent to
Acquisition(b)
 
Land
 
Buildings and
Improvements
 
Total
(g)
 
Accumulated
Depreciation
(i)(j)
 
Date of
Construction
 
Date  Acquired
Silver Star MOB Portfolio (Medical Office)
Desoto, TX
 
$
—

 
$
917,000

 
$
6,143,000

 
$
3,000

 
$
917,000

 
$
6,146,000

 
$
7,063,000

 
$
(314,000
)
 
2012
 
09/05/12
 
Frisco, TX
 
—

 
894,000

 
12,335,000

 
603,000

 
894,000

 
12,938,000

 
13,832,000

 
(576,000
)
 
2007
 
09/27/12
 
Killeen, TX
 
—

 
265,000

 
1,428,000

 
—

 
265,000

 
1,428,000

 
1,693,000

 
(84,000
)
 
1988/2008
 
07/19/12
 
Rowlett, TX
 
—

 
553,000

 
1,855,000

 
—

 
553,000

 
1,855,000

 
2,408,000

 
(141,000
)
 
2005
 
07/19/12
 
Temple, TX
 
—

 
632,000

 
5,720,000

 
—

 
632,000

 
5,720,000

 
6,352,000

 
(314,000
)
 
1974
 
07/19/12
Shelbyville MOB (Medical Office)
Shelbyville, TN
 
—

 
—

 
5,519,000

 
(9,000
)
 
—

 
5,510,000

 
5,510,000

 
(320,000
)
 
2008
 
07/26/12
Jasper MOB (Medical Office)
Jasper, GA
 
6,163,000

(e)
502,000

 
3,366,000

 
4,000

 
502,000

 
3,370,000

 
3,872,000

 
(168,000
)
 
2003
 
09/27/12
 
Jasper, GA
 
—

(e)
502,000

 
3,376,000

 
3,000

 
502,000

 
3,379,000

 
3,881,000

 
(167,000
)
 
2003
 
09/27/12
 
Jasper, GA
 
—

 
502,000

 
3,552,000

 
3,000

 
502,000

 
3,555,000

 
4,057,000

 
(224,000
)
 
2011
 
08/08/12
Pacific Northwest Senior Care Portfolio (Skilled Nursing and Senior Housing)
Corvallis, OR
 
—

 
625,000

 
4,569,000

 
—

 
625,000

 
4,569,000

 
5,194,000

 
(210,000
)
 
1995
 
08/24/12
 
Bend, OR
 
—

 
643,000

 
4,429,000

 
—

 
643,000

 
4,429,000

 
5,072,000

 
(193,000
)
 
1943
 
08/24/12
 
Prineville, OR
 
—

 
316,000

 
4,415,000

 
—

 
316,000

 
4,415,000

 
4,731,000

 
(181,000
)
 
1994
 
08/24/12
 
Prineville, OR
 
—

 
505,000

 
1,673,000

 
—

 
505,000

 
1,673,000

 
2,178,000

 
(80,000
)
 
1967
 
08/24/12
 
Redmond, OR
 
—

 
181,000

 
4,862,000

 
—

 
181,000

 
4,862,000

 
5,043,000

 
(198,000
)
 
1994
 
08/24/12
 
Redmond, OR
 
—

 
383,000

 
2,147,000

 
—

 
383,000

 
2,147,000

 
2,530,000

 
(97,000
)
 
1948
 
08/24/12
 
Salem, OR
 
—

 
537,000

 
2,694,000

 
—

 
537,000

 
2,694,000

 
3,231,000

 
(132,000
)
 
1988
 
08/24/12
 
Grants Pass, OR
 
—

 
152,000

 
1,396,000

 
—

 
152,000

 
1,396,000

 
1,548,000

 
(59,000
)
 
1963
 
08/24/12
 
Bend, OR
 
—

 
264,000

 
7,546,000

 
—

 
264,000

 
7,546,000

 
7,810,000

 
(302,000
)
 
1995
 
08/24/12
 
Bend, OR
 
—

 
285,000

 
2,024,000

 
—

 
285,000

 
2,024,000

 
2,309,000

 
(104,000
)
 
1968
 
08/24/12
 
North Bend, WA
 
—

 
502,000

 
2,668,000

 
—

 
502,000

 
2,668,000

 
3,170,000

 
(109,000
)
 
1959
 
08/24/12
 
Olympia, WA
 
—

 
301,000

 
2,090,000

 
—

 
301,000

 
2,090,000

 
2,391,000

 
(89,000
)
 
1937/2005
 
08/24/12
 
Tacoma, WA
 
—

 
1,564,000

 
7,114,000

 
—

 
1,564,000

 
7,114,000

 
8,678,000

 
(346,000
)
 
1976
 
08/24/12

164
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC

SCHEDULE III — REAL ESTATE AND
ACCUMULATED DEPRECIATION — (Continued)
December 31, 2013

 
 
 
 
 
Initial Cost to Company
 
 
 
Gross Amount of Which Carried at Close of Period(h)
 
 
 
 
Description(a)
 
Encumbrances
 
Land
 
Buildings and
Improvements
 
Cost  Capitalized
Subsequent to
Acquisition(b)
 
Land
 
Buildings and
Improvements
 
Total
(g)
 
Accumulated
Depreciation
(i)(j)
 
Date of
Construction
 
Date  Acquired
 
Grants Pass, OR
 
$
—

 
$
1,591,000

 
$
5,245,000

 
$
—

 
$
1,591,000

 
$
5,245,000

 
$
6,836,000

 
$
(112,000
)
 
1966
 
05/31/13
East Tennessee MOB Portfolio (Medical Office)
Knoxville, TN
 
—

 
2,208,000

 
21,437,000

 
—

 
2,208,000

 
21,437,000

 
23,645,000

 
(969,000
)
 
2009
 
09/14/12
 
Knoxville, TN
 
—

 
2,962,000

 
17,614,000

 
—

 
2,962,000

 
17,614,000

 
20,576,000

 
(834,000
)
 
2009
 
09/14/12
Los Angeles Hospital Portfolio (Hospital)
Los Angeles, CA
 
—

 
3,058,000

 
15,871,000

 
—

 
3,058,000

 
15,871,000

 
18,929,000

 
(650,000
)
 
1942/1974
 
09/27/12
 
Gardena, CA
 
—

 
5,368,000

 
30,665,000

 
—

 
5,368,000

 
30,665,000

 
36,033,000

 
(1,251,000
)
 
1966
 
09/27/12
 
Norwalk, CA
 
—

 
4,911,000

 
12,890,000

 
—

 
4,911,000

 
12,890,000

 
17,801,000

 
(572,000
)
 
1957/1995
 
09/27/12
Bellaire Hospital (Hospital)
Houston, TX
 
—

 
2,955,000

 
15,433,000

 
85,000

 
2,955,000

 
15,518,000

 
18,473,000

 
(786,000
)
 
1962/1972
 
11/09/12
Massachusetts Senior Care Portfolio (Skilled Nursing and Senior Housing)
Dalton, MA
 
—

 
1,592,000

 
8,061,000

 
—

 
1,592,000

 
8,061,000

 
9,653,000

 
(261,000
)
 
1966
 
12/10/12
 
Hyde Park, MA
 
—

 
915,000

 
2,884,000

 
—

 
915,000

 
2,884,000

 
3,799,000

 
(114,000
)
 
1958
 
12/10/12
 
Dalton, MA
 
—

 
1,414,000

 
6,433,000

 
—

 
1,414,000

 
6,433,000

 
7,847,000

 
(305,000
)
 
1906/2002
 
12/10/12
St. Petersburg Medical Office Building (Medical Office)
St. Petersburg, FL
 
—

 
—

 
8,379,000

 
1,000

 
—

 
8,380,000

 
8,380,000

 
(305,000
)
 
2004
 
12/20/12
Bessemer Medical Office Building (Medical Office)
Bessemer, AL
 
—

 
—

 
20,965,000

 
(4,000
)
 
—

 
20,961,000

 
20,961,000

 
(672,000
)
 
2006
 
12/20/12
Santa Rosa Medical Office Building (Medical Office)
Santa Rosa, CA
 
—

 
1,366,000

 
11,862,000

 
803,000

 
1,366,000

 
12,665,000

 
14,031,000

 
(757,000
)
 
1983
 
12/20/12

165
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC

SCHEDULE III — REAL ESTATE AND
ACCUMULATED DEPRECIATION — (Continued)
December 31, 2013

 
 
 
 
 
Initial Cost to Company
 
 
 
Gross Amount of Which Carried at Close of Period(h)
 
 
 
 
Description(a)
 
Encumbrances
 
Land
 
Buildings and
Improvements
 
Cost  Capitalized
Subsequent to
Acquisition(b)
 
Land
 
Buildings and
Improvements
 
Total
(g)
 
Accumulated
Depreciation
(i)(j)
 
Date of
Construction
 
Date  Acquired
North Carolina ALF Portfolio (Senior Housing)
Fayetteville, NC
 
$
—

 
$
1,251,000

 
$
10,209,000

 
$
1,000

 
$
1,251,000

 
$
10,210,000

 
$
11,461,000

 
$
(325,000
)
 
2009
 
12/21/12
 
Fuquay-Varina, NC
 
—

 
1,845,000

 
15,299,000

 
1,000

 
1,845,000

 
15,300,000

 
17,145,000

 
(461,000
)
 
2010
 
12/21/12
 
Knightdale, NC
 
—

 
2,267,000

 
13,438,000

 
1,000

 
2,267,000

 
13,439,000

 
15,706,000

 
(383,000
)
 
2010
 
12/21/12
 
Lincolnton, NC
 
—

 
1,801,000

 
14,778,000

 
—

 
1,801,000

 
14,778,000

 
16,579,000

 
(411,000
)
 
2008
 
12/21/12
 
Monroe, NC
 
—

 
1,467,000

 
14,732,000

 
—

 
1,467,000

 
14,732,000

 
16,199,000

 
(417,000
)
 
2009
 
12/21/12
Falls of Neuse Raleigh Medical Office Building (Medical Office)
Raleigh, NC
 
—

 
—

 
17,454,000

 
—

 
—

 
17,454,000

 
17,454,000

 
(606,000
)
 
2006
 
12/31/12
Central Indiana MOB Portfolio (Medical Office)
Indianapolis, IN
 
—

 
565,000

 
3,028,000

 
—

 
565,000

 
3,028,000

 
3,593,000

 
(148,000
)
 
1978
 
12/31/12
 
Indianapolis, IN
 
—

 
854,000

 
5,763,000

 
300,000

 
854,000

 
6,063,000

 
6,917,000

 
(310,000
)
 
1991
 
12/31/12
 
Indianapolis, IN
 
—

 
820,000

 
5,656,000

 
8,000

 
820,000

 
5,664,000

 
6,484,000

 
(237,000
)
 
2006
 
12/31/12
 
Carmel, IN
 
5,380,000

 
418,000

 
6,572,000

 
—

 
418,000

 
6,572,000

 
6,990,000

 
(233,000
)
 
1993
 
12/31/12
 
Lafayette, IN
 
—

 
799,000

 
4,975,000

 
13,000

 
799,000

 
4,988,000

 
5,787,000

 
(200,000
)
 
2009
 
12/31/12
 
Noblesville, IN
 
6,248,000

 
786,000

 
6,383,000

 
—

 
786,000

 
6,383,000

 
7,169,000

 
(210,000
)
 
2007
 
03/28/13
 
Avon, IN
 
4,205,000

 
395,000

 
3,330,000

 
—

 
395,000

 
3,330,000

 
3,725,000

 
(104,000
)
 
1993
 
04/26/13
 
Indianapolis, IN
 
2,491,000

 
276,000

 
3,512,000

 
(89,000
)
 
186,000

 
3,513,000

 
3,699,000

 
(81,000
)
 
1994
 
04/26/13
 
Bloomington, IN
 
4,143,000

 
514,000

 
4,344,000

 
—

 
514,000

 
4,344,000

 
4,858,000

 
(170,000
)
 
1995
 
04/26/13
 
Noblesville, IN
 
5,173,000

 
634,000

 
4,155,000

 
—

 
634,000

 
4,155,000

 
4,789,000

 
(160,000
)
 
2002
 
04/26/13
 
Muncie, IN
 
6,184,000

 
727,000

 
6,760,000

 
6,000

 
727,000

 
6,766,000

 
7,493,000

 
(182,000
)
 
2006
 
04/26/13
 
Carmel, IN
 
2,352,000

 
319,000

 
1,804,000

 
3,000

 
319,000

 
1,807,000

 
2,126,000

 
(77,000
)
 
2006
 
04/26/13
 
Indianapolis, IN
 
6,109,000

 
387,000

 
7,280,000

 
—

 
387,000

 
7,280,000

 
7,667,000

 
(147,000
)
 
2003
 
04/26/13

166
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC

SCHEDULE III — REAL ESTATE AND
ACCUMULATED DEPRECIATION — (Continued)
December 31, 2013

 
 
 
 
 
Initial Cost to Company
 
 
 
Gross Amount of Which Carried at Close of Period(h)
 
 
 
 
Description(a)
 
Encumbrances
 
Land
 
Buildings and
Improvements
 
Cost  Capitalized
Subsequent to
Acquisition(b)
 
Land
 
Buildings and
Improvements
 
Total
(g)
 
Accumulated
Depreciation
(i)(j)
 
Date of
Construction
 
Date  Acquired
 
Indianapolis, IN
 
$
—

 
$
437,000

 
$
3,331,000

 
$
5,000

 
$
437,000

 
$
3,336,000

 
$
3,773,000

 
$
(90,000
)
 
2001
 
04/26/13
 
Carmel, IN
 
9,700,000

 
 
 
11,280,000

 
11,000

 
—

 
11,291,000

 
11,291,000

 
(259,000
)
 
2005
 
05/20/13
 
Fishers, IN
 
3,508,000

 
749,000

 
3,501,000

 
192,000

 
749,000

 
3,693,000

 
4,442,000

 
(118,000
)
 
2005
 
05/20/13
 
Indianapolis, IN
 
8,418,000

 
1,655,000

 
11,772,000

 
—

 
1,655,000

 
11,772,000

 
13,427,000

 
(262,000
)
 
2009
 
05/20/13
A & R Medical Office Building (Medical Office)
Ruston, LA
 
—

 
1,002,000

 
16,091,000

 
—

 
1,002,000

 
16,091,000

 
17,093,000

 
(489,000
)
 
1984
 
02/20/13
 
Abilene, TX
 
—

 
980,000

 
8,528,000

 
—

 
980,000

 
8,528,000

 
9,508,000

 
(269,000
)
 
1990
 
02/20/13
Greeley Northern Colorado MOB Portfolio (Medical Office)
Greeley, CO
 
—

 
476,000

 
10,399,000

 
211,000

 
476,000

 
10,610,000

 
11,086,000

 
(313,000
)
 
1954
 
02/28/13
 
Greeley, CO
 
—

 
425,000

 
833,000

 
—

 
425,000

 
833,000

 
1,258,000

 
(63,000
)
 
1974
 
02/28/13
 
Greeley, CO
 
—

 
222,000

 
691,000

 
—

 
222,000

 
691,000

 
913,000

 
(62,000
)
 
1963
 
02/28/13
St. Anthony North Denver MOB II (Medical Office)
Westminister, CO
 
—

 
405,000

 
2,814,000

 
3,000

 
405,000

 
2,817,000

 
3,222,000

 
(115,000
)
 
2008
 
03/22/13
Eagles Landing GA MOB (Medical Office)
Stockbridge, GA
 
—

 
1,227,000

 
8,731,000

 
—

 
1,227,000

 
8,731,000

 
9,958,000

 
(244,000
)
 
2004
 
03/28/13
Eastern Michigan MOB Portfolio (Medical Office)
Novi, MI
 
—

 
1,910,000

 
8,219,000

 
145,000

 
1,910,000

 
8,364,000

 
10,274,000

 
(318,000
)
 
2006
 
03/28/13
 
West Bloomfield, MI
 
—

 
894,000

 
6,377,000

 
55,000

 
894,000

 
6,432,000

 
7,326,000

 
(205,000
)
 
1975
 
03/28/13

167
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC

SCHEDULE III — REAL ESTATE AND
ACCUMULATED DEPRECIATION — (Continued)
December 31, 2013

 
 
 
 
 
Initial Cost to Company
 
 
 
Gross Amount of Which Carried at Close of Period(h)
 
 
 
 
Description(a)
 
Encumbrances
 
Land
 
Buildings and
Improvements
 
Cost  Capitalized
Subsequent to
Acquisition(b)
 
Land
 
Buildings and
Improvements
 
Total
(g)
 
Accumulated
Depreciation
(i)(j)
 
Date of
Construction
 
Date  Acquired
Pennsylvania SNF Portfolio (Skilled Nursing)
Milton, PA
 
$
—

 
$
1,576,000

 
$
6,821,000

 
$
20,000

 
$
1,576,000

 
$
6,841,000

 
$
8,417,000

 
$
(208,000
)
 
1983
 
04/30/13
 
Watsontown, PA
 
—

 
638,000

 
4,610,000

 
48,000

 
638,000

 
4,658,000

 
5,296,000

 
(112,000
)
 
1969
 
04/30/13
Rockwall MOB II (Medical Office)
Rockwall, TX
 
—

 
384,000

 
4,304,000

 
1,000

 
378,000

 
4,311,000

 
4,689,000

 
(84,000
)
 
2008
 
05/23/13
Pittsfield Skilled Nursing Facility (Skilled Nursing)
Pittsfield, MA
 
—

 
3,041,000

 
13,183,000

 
—

 
3,041,000

 
13,183,000

 
16,224,000

 
(291,000
)
 
1995
 
05/29/13
Des Plaines Surgical Center (Medical Office)
Des Plaines, IL
 
—

 
1,223,000

 
6,582,000

 
39,000

 
1,223,000

 
6,621,000

 
7,844,000

 
(155,000
)
 
1989
 
05/31/13
Winn MOB Portfolio (Medical Office)
Decatur, GA
 
—

 
235,000

 
1,931,000

 
—

 
235,000

 
1,931,000

 
2,166,000

 
(56,000
)
 
1976
 
06/03/13
 
Decatur, GA
 
—

 
197,000

 
1,778,000

 
—

 
197,000

 
1,778,000

 
1,975,000

 
(52,000
)
 
1976
 
06/03/13
 
Decatur, GA
 
—

 
329,000

 
1,733,000

 
—

 
329,000

 
1,733,000

 
2,062,000

 
(52,000
)
 
1976
 
06/03/13
 
Decatur, GA
 
—

 
237,000

 
1,784,000

 
—

 
237,000

 
1,784,000

 
2,021,000

 
(43,000
)
 
1976
 
06/03/13
Hinsdale MOB Portfolio (Medical Office)
Hinsdale, IL
 
—

 
1,398,000

 
18,764,000

 
150,000

 
1,398,000

 
18,914,000

 
20,312,000

 
(376,000
)
 
1984
 
07/11/13
 
Hinsdale, IL
 
—

 
858,000

 
4,879,000

 
291,000

 
858,000

 
5,170,000

 
6,028,000

 
(149,000
)
 
1980
 
07/11/13
Johns Creek Medical Office Building (Medical Office)
Johns Creek, GA
 
—

 
1,014,000

 
14,509,000

 
1,168,000

 
1,014,000

 
15,677,000

 
16,691,000

 
(191,000
)
 
2008
 
08/26/13
Winn MOB II (Medical Office)
Decatur, GA
 
—

 
396,000

 
1,677,000

 
—

 
396,000

 
1,677,000

 
2,073,000

 
(37,000
)
 
1971/2002
 
08/27/13

168
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC

SCHEDULE III — REAL ESTATE AND
ACCUMULATED DEPRECIATION — (Continued)
December 31, 2013

 
 
 
 
 
Initial Cost to Company
 
 
 
Gross Amount of Which Carried at Close of Period(h)
 
 
 
 
Description(a)
 
Encumbrances
 
Land
 
Buildings and
Improvements
 
Cost  Capitalized
Subsequent to
Acquisition(b)
 
Land
 
Buildings and
Improvements
 
Total
(g)
 
Accumulated
Depreciation
(i)(j)
 
Date of
Construction
 
Date  Acquired
Greeley Cottonwood MOB (Medical Office)
Greeley, CO
 
$
—

 
$
368,000

 
$
5,872,000

 
$
—

 
$
368,000

 
$
5,872,000

 
$
6,240,000

 
$
(83,000
)
 
1997
 
09/06/13
UK Senior Housing Portfolio (Senior Housing)(f)
Essex. UK
 
—

 
998,000

 
2,317,000

 
—

 
998,000

 
2,317,000

 
3,315,000

 
(30,000
)
 
1999
 
09/11/13
 
Sussex, UK
 
—

 
8,521,000

 
10,254,000

 
—

 
8,521,000

 
10,254,000

 
18,775,000

 
(129,000
)
 
1860
 
09/11/13
 
Jersey, UK
 
—

 
8,456,000

 
7,126,000

 
—

 
8,456,000

 
7,126,000

 
15,582,000

 
(94,000
)
 
1900/2007
 
09/11/13
 
Norwich, UK
 
—

 
105,000

 
365,000

 
—

 
105,000

 
365,000

 
470,000

 
(9,000
)
 
1600/1800
 
09/11/13
 
Middlesex, UK
 
—

 
3,223,000

 
21,181,000

 
—

 
3,223,000

 
21,181,000

 
24,404,000

 
(222,000
)
 
2005
 
09/11/13
 
Liss Hampshire, UK
 
—

 
2,144,000

 
2,513,000

 
—

 
2,144,000

 
2,513,000

 
4,657,000

 
(35,000
)
 
1930/2009
 
09/11/13
 
Chippenham Wiltshire, UK
 
—

 
4,934,000

 
5,553,000

 
—

 
4,934,000

 
5,553,000

 
10,487,000

 
(71,000
)
 
1900/1998
 
09/11/13
 
Taunton Somerset, UK
 
—

 
2,716,000

 
5,510,000

 
—

 
2,716,000

 
5,510,000

 
8,226,000

 
(66,000
)
 
1998
 
09/11/13
 
Kingston upon Thames, UK
 
—

 
27,020,000

 
21,749,000

 
—

 
27,020,000

 
21,749,000

 
48,769,000

 
(273,000
)
 
1870/1980/
2007
 
09/11/13
 
Warwickshire, UK
 
—

 
2,052,000

 
3,307,000

 
—

 
2,052,000

 
3,307,000

 
5,359,000

 
(42,000
)
 
1988
 
09/11/13
 
Wimborne Dorset, UK
 
—

 
7,048,000

 
6,625,000

 
—

 
7,048,000

 
6,625,000

 
13,673,000

 
(91,000
)
 
1980
 
09/11/13
 
Gloucestershire, UK
 
—

 
6,859,000

 
12,940,000

 
—

 
6,859,000

 
12,940,000

 
19,799,000

 
(147,000
)
 
2007
 
09/11/13
 
Swindon Wiltshire, UK
 
—

 
4,056,000

 
4,612,000

 
—

 
4,056,000

 
4,612,000

 
8,668,000

 
(59,000
)
 
1995
 
09/11/13
 
Burton upon Trent, UK
 
—

 
4,365,000

 
5,749,000

 
—

 
4,365,000

 
5,749,000

 
10,114,000

 
(66,000
)
 
1996
 
09/11/13
 
Norfolk, UK
 
—

 
3,686,000

 
4,369,000

 
—

 
3,686,000

 
4,369,000

 
8,055,000

 
(60,000
)
 
1800
 
09/11/13
 
Oxford, UK
 
—

 
9,792,000

 
13,835,000

 
—

 
9,792,000

 
13,835,000

 
23,627,000

 
(176,000
)
 
1890
 
09/11/13
 
Suffolk, UK
 
—

 
3,579,000

 
8,002,000

 
—

 
3,579,000

 
8,002,000

 
11,581,000

 
(93,000
)
 
2008
 
09/11/13
 
Bristol, UK
 
—

 
5,911,000

 
5,479,000

 
—

 
5,911,000

 
5,479,000

 
11,390,000

 
(67,000
)
 
1996
 
09/11/13

169
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC

SCHEDULE III — REAL ESTATE AND
ACCUMULATED DEPRECIATION — (Continued)
December 31, 2013

 
 
 
 
 
Initial Cost to Company
 
 
 
Gross Amount of Which Carried at Close of Period(h)
 
 
 
 
Description(a)
 
Encumbrances
 
Land
 
Buildings and
Improvements
 
Cost  Capitalized
Subsequent to
Acquisition(b)
 
Land
 
Buildings and
Improvements
 
Total
(g)
 
Accumulated
Depreciation
(i)(j)
 
Date of
Construction
 
Date  Acquired
 
Oxfordshire, UK
 
$
—

 
$
3,717,000

 
$
4,920,000

 
$
—

 
$
3,717,000

 
$
4,920,000

 
$
8,637,000

 
$
(66,000
)
 
1862
 
09/11/13
 
Oxfordshire, UK
 
—

 
8,175,000

 
14,831,000

 
—

 
8,175,000

 
14,831,000

 
23,006,000

 
(172,000
)
 
2009
 
09/11/13
 
Berkshire, UK
 
—

 
11,331,000

 
13,618,000

 
—

 
11,331,000

 
13,618,000

 
24,949,000

 
(145,000
)
 
1950
 
09/11/13
 
Berkshire, UK
 
—

 
11,875,000

 
20,566,000

 
—

 
11,875,000

 
20,566,000

 
32,441,000

 
(274,000
)
 
1930
 
09/11/13
 
Merstham Surrey, UK
 
—

 
7,163,000

 
7,438,000

 
—

 
7,163,000

 
7,438,000

 
14,601,000

 
(99,000
)
 
1890/1970/
2009
 
09/11/13
 
Working Surrey, UK
 
—

 
12,254,000

 
12,224,000

 
—

 
12,254,000

 
12,224,000

 
24,478,000

 
(158,000
)
 
1880
 
09/11/13
 
Warlingham Surrey, UK
 
—

 
14,451,000

 
14,988,000

 
—

 
14,451,000

 
14,988,000

 
29,439,000

 
(164,000
)
 
1984
 
09/11/13
 
Dorking Surrey, UK
 
—

 
4,408,000

 
5,337,000

 
—

 
4,408,000

 
5,337,000

 
9,745,000

 
(65,000
)
 
1860
 
09/11/13
 
Camberely Surrey, UK
 
—

 
3,836,000

 
3,912,000

 
—

 
3,836,000

 
3,912,000

 
7,748,000

 
(52,000
)
 
1910
 
09/11/13
 
Cranleigh Surrey, UK
 
—

 
11,720,000

 
9,402,000

 
—

 
11,720,000

 
9,402,000

 
21,122,000

 
(120,000
)
 
1874
 
09/11/13
 
Lightwater Surrey, UK
 
—

 
2,604,000

 
4,439,000

 
—

 
2,604,000

 
4,439,000

 
7,043,000

 
(48,000
)
 
1910
 
09/11/13
 
Lewes Sussex, UK
 
—

 
3,670,000

 
6,244,000

 
—

 
3,670,000

 
6,244,000

 
9,914,000

 
(83,000
)
 
1800
 
09/11/13
 
East Sussex, UK
 
—

 
3,871,000

 
8,956,000

 
—

 
3,871,000

 
8,956,000

 
12,827,000

 
(100,000
)
 
2000
 
09/11/13
 
West Sussex, UK
 
—

 
1,893,000

 
2,449,000

 
—

 
1,893,000

 
2,449,000

 
4,342,000

 
(33,000
)
 
1993
 
09/11/13
 
Buckinghamshire, UK
 
—

 
4,753,000

 
7,358,000

 
—

 
4,753,000

 
7,358,000

 
12,111,000

 
(79,000
)
 
2010
 
09/11/13
 
Buckinghamshire, UK
 
—

 
2,475,000

 
3,804,000

 
—

 
2,475,000

 
3,804,000

 
6,279,000

 
(45,000
)
 
2001
 
09/11/13
 
Kent, UK
 
—

 
2,373,000

 
4,682,000

 
—

 
2,373,000

 
4,682,000

 
7,055,000

 
(52,000
)
 
2008
 
09/11/13
 
Kent, UK
 
—

 
4,459,000

 
5,578,000

 
—

 
4,459,000

 
5,578,000

 
10,037,000

 
(77,000
)
 
1970
 
09/11/13
 
Kent, UK
 
—

 
2,981,000

 
2,916,000

 
—

 
2,981,000

 
2,916,000

 
5,897,000

 
(35,000
)
 
1995
 
09/11/13
 
Scotland, UK
 
—

 
1,041,000

 
3,707,000

 
—

 
1,041,000

 
3,707,000

 
4,748,000

 
(51,000
)
 
1970
 
09/11/13
 
Scotland, UK
 
—

 
6,599,000

 
10,322,000

 
—

 
6,599,000

 
10,322,000

 
16,921,000

 
(118,000
)
 
2006
 
09/11/13
 
Alloa Scotland, UK
 
—

 
1,724,000

 
3,772,000

 
—

 
1,724,000

 
3,772,000

 
5,496,000

 
(63,000
)
 
1999
 
09/11/13
 
Scotland, UK
 
—

 
1,341,000

 
4,901,000

 
—

 
1,341,000

 
4,901,000

 
6,242,000

 
(61,000
)
 
1998
 
09/11/13
 
Scotland, UK
 
—

 
1,378,000

 
4,508,000

 
—

 
1,378,000

 
4,508,000

 
5,886,000

 
(59,000
)
 
1997
 
09/11/13

170
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC

SCHEDULE III — REAL ESTATE AND
ACCUMULATED DEPRECIATION — (Continued)
December 31, 2013

 
 
 
 
 
Initial Cost to Company
 
 
 
Gross Amount of Which Carried at Close of Period(h)
 
 
 
 
Description(a)
 
Encumbrances
 
Land
 
Buildings and
Improvements
 
Cost  Capitalized
Subsequent to
Acquisition(b)
 
Land
 
Buildings and
Improvements
 
Total
(g)
 
Accumulated
Depreciation
(i)(j)
 
Date of
Construction
 
Date  Acquired
 
Scotland, UK
 
$
—

 
$
1,029,000

 
$
3,637,000

 
$
—

 
$
1,029,000

 
$
3,637,000

 
$
4,666,000

 
$
(42,000
)
 
1999
 
09/11/13
Tiger Eye NY MOB Portfolio (Medical Office)
Wallkill, NY
 
—

 
387,000

 
3,230,000

 
—

 
387,000

 
3,230,000

 
3,617,000

 
(32,000
)
 
1993
 
09/20/13
 
Wallkill, NY
 
—

 
1,050,000

 
58,398,000

 
—

 
1,050,000

 
58,398,000

 
59,448,000

 
(455,000
)
 
2008
 
09/20/13
 
Wallkill, NY
 
—

 
370,000

 
4,481,000

 
—

 
370,000

 
4,481,000

 
4,851,000

 
(39,000
)
 
1991
 
09/20/13
 
Middletown, NY
 
—

 
1,100,000

 
16,267,000

 
—

 
1,100,000

 
16,267,000

 
17,367,000

 
(145,000
)
 
2013
 
09/20/13
 
Rock Hill, NY
 
—

 
2,888,000

 
30,048,000

 
—

 
2,888,000

 
30,048,000

 
32,936,000

 
(274,000
)
 
2004
 
09/20/13
 
Wallkill, NY
 
—

 
1,142,000

 
25,458,000

 
—

 
1,142,000

 
25,458,000

 
26,600,000

 
—

 
2001
 
12/23/13
Salt Lake City LTACH (Hospital)
Murray, UT
 
—

 
1,579,000

 
9,756,000

 
—

 
1,579,000

 
9,756,000

 
11,335,000

 
(82,000
)
 
2013
 
09/25/13
Lacombe MOB II (Medical Office)
Lacombe, LA
 
—

 
 
 
4,486,000

 
—

 
 
 
4,486,000

 
4,486,000

 
(43,000
)
 
2009
 
09/27/13
Tennessee MOB Portfolio (Medical Office)
Memphis, TN
 
—

 
465,000

 
4,436,000

 
—

 
465,000

 
4,436,000

 
4,901,000

 
(46,000
)
 
2004
 
10/02/13
 
Hendersonville, TN
 
—

 
781,000

 
5,769,000

 
—

 
781,000

 
5,769,000

 
6,550,000

 
(56,000
)
 
2007
 
10/02/13
Central Indiana MOB Portfolio II (Medical Office)
Indianapolis, IN
 
—

 
296,000

 
2,115,000

 
—

 
296,000

 
2,115,000

 
2,411,000

 
(8,000
)
 
2007
 
12/12/13
 
Indianapolis, IN
 
—

 
130,000

 
871,000

 
—

 
130,000

 
871,000

 
1,001,000

 
(6,000
)
 
2002
 
12/12/13
 
Indianapolis, IN
 
—

 
130,000

 
833,000

 
—

 
130,000

 
833,000

 
963,000

 
(4,000
)
 
2004
 
12/12/13
 
Greenfield, IN
 
—

 
363,000

 
2,636,000

 
—

 
363,000

 
2,636,000

 
2,999,000

 
(12,000
)
 
2007
 
12/12/13
Kennestone Marietta MOB Portfolio (Medical Office)
Marietta, GA
 
—

 
544,000

 
4,165,000

 
—

 
544,000

 
4,165,000

 
4,709,000

 
(12,000
)
 
2007
 
12/13/13
 
Marietta, GA
 
—

 
802,000

 
6,310,000

 
—

 
802,000

 
6,310,000

 
7,112,000

 
(19,000
)
 
2007
 
12/13/13

171
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC

SCHEDULE III — REAL ESTATE AND
ACCUMULATED DEPRECIATION — (Continued)
December 31, 2013

 
 
 
 
 
Initial Cost to Company
 
 
 
Gross Amount of Which Carried at Close of Period(h)
 
 
 
 
Description(a)
 
Encumbrances
 
Land
 
Buildings and
Improvements
 
Cost  Capitalized
Subsequent to
Acquisition(b)
 
Land
 
Buildings and
Improvements
 
Total
(g)
 
Accumulated
Depreciation
(i)(j)
 
Date of
Construction
 
Date  Acquired
Dux MOB Portfolio (Medical Office)
Indianapolis, IN
 
$
—

 
$
389,000

 
$
4,712,000

 
$
—

 
$
389,000

 
$
4,712,000

 
$
5,101,000

 
$
—

 
1983/1990
 
12/19/13
 
San Antonio, TX
 
—

 
756,000

 
18,827,000

 
—

 
756,000

 
18,827,000

 
19,583,000

 
—

 
2006
 
12/19/13
 
Munster, IN
 
—

 
308,000

 
5,356,000

 
—

 
308,000

 
5,356,000

 
5,664,000

 
—

 
1990
 
12/19/13
 
Indianapolis, IN
 
—

 
—

 
4,289,000

 
—

 
—

 
4,289,000

 
4,289,000

 
—

 
2008
 
12/19/13
 
Munster, IN
 
—

 
780,000

 
3,559,000

 
—

 
780,000

 
3,559,000

 
4,339,000

 
—

 
1999
 
12/19/13
 
Munster, IN
 
—

 
1,072,000

 
15,383,000

 
—

 
1,072,000

 
15,383,000

 
16,455,000

 
—

 
1961
 
12/19/13
 
St. John, IN
 
—

 
630,000

 
2,762,000

 
—

 
630,000

 
2,762,000

 
3,392,000

 
—

 
1994
 
12/19/13
 
Batavia, OH
 
—

 
—

 
8,248,000

 
—

 
—

 
8,248,000

 
8,248,000

 
—

 
2006
 
12/19/13
 
Brownsburg, IN
 
—

 
1,341,000

 
15,145,000

 
—

 
1,341,000

 
15,145,000

 
16,486,000

 
—

 
2008
 
12/19/13
 
Lafayette, IN
 
—

 
827,000

 
11,024,000

 
—

 
827,000

 
11,024,000

 
11,851,000

 
—

 
2009
 
12/19/13
 
Lafayette, IN
 
—

 
757,000

 
12,971,000

 
—

 
757,000

 
12,971,000

 
13,728,000

 
—

 
2009
 
12/19/13
 
Indianapolis, IN
 
—

 
—

 
5,316,000

 
—

 
—

 
5,316,000

 
5,316,000

 
—

 
2008
 
12/19/13
 
Evansville, IN
 
—

 
—

 
33,478,000

 
—

 
—

 
33,478,000

 
33,478,000

 
—

 
2006
 
12/19/13
 
Escanaba, MI
 
—

 
—

 
11,495,000

 
—

 
—

 
11,495,000

 
11,495,000

 
—

 
2012
 
12/19/13
Midwest CCRC Portfolio(Senior Housing–RIDEA)
Lincolnwood, IL
 
—

 
4,798,000

 
65,103,000

 
—

 
4,798,000

 
65,103,000

 
69,901,000

 
—

 
1990/1991
 
12/20/13
 
Colorado Springs, CO
 
—

 
11,326,000

 
62,949,000

 
—

 
11,326,000

 
62,949,000

 
74,275,000

 
—

 
1991
 
12/20/13
 
Cincinnati, OH
 
—

 
3,438,000

 
66,861,000

 
—

 
3,438,000

 
66,861,000

 
70,299,000

 
—

 
1986/1990
 
12/20/13
 
Cincinnati, OH
 
—

 
3,498,000

 
56,925,000

 
—

 
3,498,000

 
56,925,000

 
60,423,000

 
—

 
1830/2000
 
12/20/13
 
Cincinnati, OH
 
—

 
479,000

 
12,664,000

 
—

 
479,000

 
12,664,000

 
13,143,000

 
—

 
1988
 
12/20/13
 
 
 
$
315,722,000

 
$
414,275,000

 
$
2,181,264,000

 
$
14,395,000

 
$
414,179,000

 
$
2,195,755,000

 
$
2,609,934,000

 
$
(86,235,000
)
 
 
 
 
 ________________
(a)
We own 100% of our properties as of December 31, 2013.
(b)
The cost capitalized subsequent to acquisition is shown net of dispositions.
(c)
Each of these eight mortgage loans are cross-collateralized in the aggregate principal amount of $48,785,000 as of December 31, 2013.

172
GRIFFIN-AMERICAN HEALTHCARE REIT II, INC

SCHEDULE III — REAL ESTATE AND
ACCUMULATED DEPRECIATION — (Continued)
December 31, 2013

(d)
As of December 31, 2013, a mortgage loan payable in the amount of $23,399,000 was secured by Monument LTACH Portfolio.
(e)
Jasper MOB consists of three medical office buildings. As of December 31, 2013, a mortgage loan payable in the amount of $6,163,000 was secured by two of the medical office buildings.
(f)
Amounts reflected for UK Senior Housing Portfolio are based upon the currency exchange rate as of December 31, 2013.
(g)
The changes in total real estate for the years ended December 31, 2013, 2012 and 2011 are as follows:
 
Amount
Balance — December 31, 2010
$
165,405,000

Acquisitions
212,453,000

Additions
3,448,000

Dispositions
(71,000
)
Balance — December 31, 2011
$
381,235,000

Acquisitions
762,901,000

Additions
5,203,000

Dispositions
(474,000
)
Balance — December 31, 2012
$
1,148,865,000

Acquisitions
1,430,137,000

Additions
6,526,000

Dispositions
(703,000
)
Foreign currency translation adjustment
25,109,000

Balance — December 31, 2013
$
2,609,934,000

 
(h)
Based on the currency exchange rate as of December 31, 2013, for federal income tax purposes, the aggregate cost of our properties is $2,973,664,000.

(i)
The changes in accumulated depreciation for the years ended December 31, 2013, 2012 and 2011 are as follows:
 
Amount
Balance — December 31, 2010
$
(2,070,000
)
Additions
(9,919,000
)
Dispositions
71,000

Balance — December 31, 2011
$
(11,918,000
)
Additions
(24,958,000
)
Dispositions
306,000

Balance — December 31, 2012
$
(36,570,000
)
Additions
(49,935,000
)
Dispositions
366,000

Foreign currency translation adjustment
(96,000
)
Balance — December 31, 2013
$
(86,235,000
)
 
(j)
The cost of buildings and capital improvements is depreciated on a straight-line basis over the estimated useful lives of the buildings and capital improvements, up to 39 years, and the cost for tenant improvements is depreciated over the shorter of the lease term or useful life, ranging from two months to 22.5 years. Furniture, fixtures and equipment is depreciated over the estimated useful life ranging from five years to 10 years.



173

SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
Griffin-American Healthcare REIT II, Inc.
(Registrant)
 
 
 
 
 
 
By
 
/s/ JEFFREY T. HANSON
 
Chief Executive Officer and Chairman of the Board
 
 
Jeffrey T. Hanson
 
 
 
 
 
Date: March 13, 2014
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
 
By
 
/s/ JEFFREY T. HANSON
 
Chief Executive Officer and Chairman of the Board
 
 
Jeffrey T. Hanson
 
(principal executive officer)
 
 
 
 
 
Date: March 13, 2014
 
 
 
 
 
 
 
By  
 
/s/ SHANNON K S JOHNSON
 
Chief Financial Officer
 
 
Shannon K S Johnson
 
(principal financial officer and principal
accounting officer)
 
 
 
 
 
Date: March 13, 2014
 
 
 
 
 
 
 
By
 
/s/ DANNY PROSKY
 
President, Chief Operating Officer and Director
 
 
Danny Prosky
 
 
 
 
 
 
 
Date: March 13, 2014
 
 
 
 
 
 
 
By
 
/s/ PATRICK R. LEARDO
 
Director
 
 
Patrick R. Leardo
 
 
 
 
 
 
 
Date: March 13, 2014
 
 
 
 
 
 
 
By
 
/s/ GERALD W. ROBINSON
 
Director
 
 
Gerald W. Robinson
 
 
 
 
 
 
 
Date: March 13, 2014
 
 
 
 
 
 
 
By
 
/s/ GARY E. STARK
 
Director
 
 
Gary E. Stark
 
 
 
 
 
 
 
Date: March 13, 2014
 
 

174

EXHIBIT INDEX
Following the Registrant’s transition to the co-sponsorship arrangement with Griffin Capital Corporation and American Healthcare Investors LLC, Grubb & Ellis Healthcare REIT II, Inc. and Grubb & Ellis Healthcare REIT II Holdings, LP changed their names to Griffin-American Healthcare REIT II, Inc. and Griffin American Healthcare REIT II Holdings, LP, respectively. The following Exhibit List refers to the entity names used prior to such name changes in order to accurately reflect the names of the parties on the documents listed.
Pursuant to Item 601(a)(2) of Regulation S-K, this Exhibit Index immediately precedes the exhibits.
The following exhibits are included, or incorporated by reference, in this Annual Report on Form 10-K for the fiscal year ended December 31, 2013 (and are numbered in accordance with Item 601 of Regulation S-K).
 
2.1
Share Purchase Agreement In Relation to the Sale and Purchase of the Entire Issued Share Capital of Caring Homes Health Group Limited (to be renamed GA HC CREIT II CH U.K. Senior Housing Portfolio Limited) by and between Myriad Healthcare Limited (to be renamed Caring Homes Healthcare Group Limited) and GA HC REIT II U.K. SH Acquisition LTD, dated July 6, 2013 (included as Exhibit 2.1 to our Quarterly Report on Form 10-Q filed November 13, 2013 and incorporated herein by reference)
 
 
3.1
Second Articles of Amendment and Restatement of Grubb & Ellis Healthcare REIT II, Inc. dated July 30, 2009 (included as Exhibit 3.1 to Pre-Effective Amendment No. 3 to our Registration Statement on Form S-11 (File No. 333-158111) filed August 5, 2009 and incorporated herein by reference)
 
 
3.2
Articles of Amendment to the Second Articles of Amendment and Restatement of Grubb & Ellis Healthcare REIT II, Inc. dated September 1, 2009 (included as Exhibit 3.1 to our Current Report on Form 8-K filed September 3, 2009 and incorporated herein by reference)
 
 
3.3
Second Articles of Amendment to the Second Articles of Amendment and Restatement of Grubb & Ellis Healthcare REIT II, Inc. dated September 18, 2009 (included as Exhibit 3.1 to our Current Report on Form 8-K filed September 21, 2009 and incorporated herein by reference)
 
 
3.4
Third Articles of Amendment to Second Articles of Amendment and Restatement of Grubb & Ellis Healthcare REIT II, Inc. dated June 15, 2011 (included as Exhibit 3.1 to our Current Report on Form 8-K filed June 16, 2011 and incorporated herein by reference)
 
 
3.5
Fourth Articles of Amendment to Second Articles of Amendment and Restatement of Grubb & Ellis Healthcare REIT II, Inc. dated January 3, 2012 (included as Exhibit 3.5 to Post-Effective Amendment No. 14 to our Registration Statement on Form S-11 (File No. 333-158111) filed January 4, 2012 and incorporated herein by reference)
 
 
3.6
Bylaws of Grubb & Ellis Healthcare REIT II, Inc. (included as Exhibit 3.2 to our Registration Statement on Form S-11 (File No. 333-158111) filed March 19, 2009 and incorporated herein by reference)
 
 
3.7
Amendment to Bylaws of Grubb & Ellis Healthcare REIT II, Inc. dated January 3, 2012 (included as Exhibit 3.7 to Post-Effective Amendment No. 14 to our Registration Statement on Form S-11 (File No. 333-158111) filed January 4, 2012 and incorporated herein by reference)
 
 
4.1
Form of Subscription Agreement of Griffin-American Healthcare REIT II, Inc. (included as Exhibit A to Prospectus dated February 14, 2013 filed pursuant to Rule 424(b)(3) (File No. 333-181928) on February 14, 2013 and incorporated herein by reference)
 
 
4.2
Distribution Reinvestment Plan of Griffin-American Healthcare REIT II, Inc. (included as Exhibit B to Prospectus dated February 14, 2013 filed pursuant to Rule 424(b)(3) (File No. 333-181928) on February 14, 2013 and incorporated herein by reference)
 
 
4.3
Share Repurchase Plan of Griffin-American Healthcare REIT II, Inc. (included as Exhibit C to Prospectus dated February 14, 2013 filed pursuant to Rule 424(b)(3) (File No. 333-181928) on February 14, 2013 and incorporated herein by reference)
 
 
10.1
Agreement of Limited Partnership of Grubb & Ellis Healthcare REIT II Holdings, LP (included as Exhibit 10.2 to our Registration Statement on Form S-11 (File No. 333-158111) filed March 19, 2009 and incorporated herein by reference)
 
 
10.2
Advisory Agreement by and among Grubb & Ellis Healthcare REIT II, Inc., Grubb & Ellis Healthcare REIT II Holdings, LP and Griffin-American Healthcare REIT Advisor, LLC, dated November 7, 2011 (included as Exhibit 10.1 to our Current Report on Form 8-K filed November 9, 2011 and incorporated herein by reference)

175

10.3
Amendment to Agreement of Limited Partnership of Grubb & Ellis Healthcare REIT II Holdings, LP, dated January 4, 2012 (included as Exhibit 10.224 to Post-Effective Amendment No. 14 to our Registration Statement on Form S-11 (File No. 333-158111) filed January 4, 2012 and incorporated herein by reference)
 
 
10.4
Form of Indemnification Agreement between Grubb & Ellis Healthcare REIT II, Inc. and Indemnitee made effective as of August 24, 2009 (included as Exhibit 10.1 to our Current Report on Form 8-K filed September 3, 2009 and incorporated herein by reference)
 
 
10.5
Grubb & Ellis Healthcare REIT II, Inc. 2009 Incentive Plan (included as Exhibit 10.3 to Pre-Effective Amendment No. 1 to our Registration Statement on Form S-11 (File No. 333-158111) filed May 8, 2009 and incorporated herein by reference)
 
 
10.6
Second Amendment to Credit Agreement dated as of May 24, 2013 by and among Griffin-American Healthcare REIT II Holdings, LP, subsidiary guarantors, Bank of America, N.A., KeyBank National Association, RBS Citizens, N.A., Comerica Bank, Barclays Bank PLC, Fifth Third Bank, Wells Fargo Bank, N.A., Credit Agricole Corporate and Investment Bank and Sumitomo Mitsui Banking Corporation (included as Exhibit 10.1 to our Current Report on Form 8-K filed May 24, 2013 and incorporated herein by reference)
 
 
10.7
Revolving Note dated May 24, 2013, by Griffin-American Healthcare REIT II Holdings, LP for the benefit of Lenders (included as Exhibit 10.2 to our Current Report on Form 8-K filed May 24, 2013 and incorporated herein by reference)
 
 
10.8
Agreement in Respect of the Leasing of the Caring Homes Elderly Care Home Portfolio and Other Matters Relating to MHL Holdco Limited and its Subsidiaries by and between Myriad Healthcare Limited (to be renamed Caring Homes Healthcare Group Limited), Caring Homes Health Group Limited (to be renamed GA HC CREIT II CH U.K. Senior Housing Portfolio Limited), et al, and GA HC REIT II U.K. SH Acquisition LTD and Griffin-American Healthcare REIT II, Inc., dated July 6, 2013 (included as Exhibit 10.1 to our Quarterly Report on Form 10-Q filed November 13, 2013 and incorporated herein by reference)
 
 
10.9
Agreed Form Lease by and between Caring Homes Health Group Limited (to be renamed GA HC CREIT II CH U.K. Senior Housing Portfolio Limited) and Myriad Healthcare Limited (to be renamed Caring Homes Healthcare Group Limited) (included as Exhibit 10.2 to our Quarterly Report on Form 10-Q filed November 13, 2013 and incorporated herein by reference)
 
 
10.10
Second Amendment to Agreement of Limited Partnership of Griffin-American Healthcare REIT II Holdings, LP, dated September 11, 2013 (included as Exhibit 10.1 to our Current Report on Form 8-K filed on September 12, 2013 and incorporated herein by reference)
 
 
21.1*
Subsidiaries of Griffin-American Healthcare REIT II, Inc.
 
 
31.1*
Certification of Chief Executive Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
 
 
31.2*
Certification of Chief Financial Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
 
 
32.1**
Certification of Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002
 
 
32.2**
Certification of Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002
 
 
101.INS*
XBRL Instance Document
 
 
101.SCH*
XBRL Taxonomy Extension Schema Document
 
 
101.CAL*
XBRL Taxonomy Extension Calculation Linkbase Document
 
 
101.LAB*
XBRL Taxonomy Extension Label Linkbase Document
 
 
101.PRE*
XBRL Taxonomy Extension Presentation Linkbase Document
 
 
101.DEF*
XBRL Taxonomy Extension Definition Linkbase Document
_________
*
Filed herewith.
**
Furnished herewith. In accordance with Item 601(b)(32) of Regulation S-K, this Exhibit is not deemed “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section. Such certifications will not be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except to the extent that the registrant specifically incorporates it by reference.

176